data_1xhs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xhs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.769 ' H1 ' ' HA ' ' A' ' 60' ' ' ASN . 11.2 tpp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.472 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 29.8 mtm180 -87.98 138.1 31.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.945 0.402 . . . . 0.0 110.659 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.2 151.24 18.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.096 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -91.22 127.51 36.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -92.36 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.542 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 20.3 p90 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.369 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 58' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -100.63 118.91 37.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.581 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -71.68 104.14 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.209 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD13 HG11 ' A' ' 55' ' ' VAL . 95.3 mt -72.79 -43.6 62.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.474 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.25 171.09 18.93 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.96 145.99 33.68 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.832 0.825 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 55' ' ' VAL . 23.3 t80 -154.09 101.69 2.42 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.486 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 m -88.96 133.01 34.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.712 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.22 126.37 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.96 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 4.3 t70 -86.15 165.22 16.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.475 HD21 ' N ' ' A' ' 32' ' ' ASN . 0.8 OUTLIER 69.48 28.04 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.715 0.634 . . . . 0.0 111.226 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -135.41 149.96 49.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.51 ' HB3' HD11 ' A' ' 102' ' ' LEU . 99.1 mt-30 -127.76 152.49 47.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.686 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 103' ' ' ILE . 23.7 tp -111.33 131.83 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.941 0.4 . . . . 0.0 111.283 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.04 151.28 21.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -122.93 107.7 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HA ' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -102.84 18.45 21.49 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.54 -57.79 0.62 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.221 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.67 -82.99 0.51 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.65 0.738 . . . . 0.0 109.697 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.54 158.7 62.68 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.539 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -93.52 170.9 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.935 2.424 . . . . 0.0 112.619 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -139.34 152.5 22.44 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -138.41 141.42 39.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.939 0.87 . . . . 0.0 110.963 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 93' ' ' TYR . 23.9 m -150.28 163.88 22.67 Favored Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 123.184 0.303 . . . . 0.0 110.27 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.58 132.15 30.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.564 2.176 . . . . 0.0 111.497 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.99 -123.78 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.767 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.63 90.26 2.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.153 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.79 166.16 34.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.562 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 4.6 m -109.88 106.03 15.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.091 0.445 . . . . 0.0 110.178 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 29' ' ' SER . 67.4 t -82.59 105.56 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 109.848 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 82.9 t60 -79.29 65.3 4.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.66 -175.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.654 ' HA2' ' HZ2' ' A' ' 108' ' ' TRP . . . -100.02 -173.59 30.3 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.334 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -133.55 140.92 47.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.594 HG11 HD13 ' A' ' 25' ' ' LEU . 49.2 t -106.79 130.59 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.14 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -124.74 150.74 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 112.093 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.04 105.51 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 22' ' ' ALA . 2.4 pp -110.92 162.93 8.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.91 147.06 9.72 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.9 0.48 . . . . 0.0 112.014 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.769 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 5.8 p30 -64.84 -41.9 95.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.527 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.31 -37.02 82.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.215 0.531 . . . . 0.0 110.199 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.6 m -56.88 -30.37 63.81 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.159 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 1' ' ' MET . 13.9 tp -66.48 -49.55 66.25 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.59 65.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.696 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -68.2 -47.26 68.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.124 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.75 -47.09 82.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.907 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -61.82 -48.38 80.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.042 0.449 . . . . 0.0 110.776 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.73 69.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.687 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 69' ' ' LEU . 15.4 mt -84.96 -33.1 22.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -85.66 -52.09 6.02 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 C--N 1.326 -0.446 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.76 -169.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 66.4 m-85 -131.33 172.75 11.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.894 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.33 151.82 26.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.014 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HB3' ' CE3' ' A' ' 89' ' ' TRP . 56.0 mtt180 -92.53 111.94 23.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.368 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -104.2 103.96 13.81 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.11 115.91 20.78 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.4 pt -110.06 134.98 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.664 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 101.4 13.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.758 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 159.94 30.16 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.692 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.29 -14.72 40.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.348 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.81 7.19 41.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.85 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 119.65 154.36 9.47 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.976 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m -66.04 126.65 29.28 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.493 -0.416 . . . . 0.0 110.335 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.1 148.06 44.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.663 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.442 ' CE3' ' HB3' ' A' ' 78' ' ' ARG . 98.8 m95 -83.32 124.09 30.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.461 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.87 127.76 55.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.564 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.8 118.22 31.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.996 0.427 . . . . 0.0 110.868 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -100.43 142.26 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.758 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.614 ' HD2' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -46.85 127.18 9.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.303 174.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.8 tp-100 -125.76 2.87 7.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.154 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -135.77 138.23 27.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -28.35 128.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.879 4.386 . . . . 0.0 115.939 -170.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG13 ' CD1' ' A' ' 93' ' ' TYR . 15.9 m -90.76 16.2 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.125 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.32 110.48 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.068 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.99 32.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.184 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 38' ' ' LEU . 36.4 mt -98.53 168.2 10.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.095 0.447 . . . . 0.0 110.687 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -99.18 141.95 31.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.272 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 34' ' ' GLN . 32.6 tp -117.24 125.83 51.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.664 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.546 HD13 HD21 ' A' ' 35' ' ' LEU . 42.5 mt -101.49 87.85 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -12.83 61.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.768 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.8 t -69.4 -50.43 45.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.617 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 109.2 -12.83 33.91 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.542 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.27 151.36 24.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 110.486 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.654 ' HZ2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.5 -31.71 63.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.454 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.439 -0.977 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.833 -172.068 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.822 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 38.4 tpp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -113.68 128.2 56.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.064 0.459 . . . . 0.0 111.181 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.7 mt -128.41 139.66 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.721 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 57.2 t80 -96.9 109.64 22.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.2 106.96 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' OH ' ' HB2' ' A' ' 91' ' ' TYR . 1.2 p90 . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.453 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.69 114.36 28.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.408 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 tp -67.0 102.59 1.0 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.54 HD13 HG12 ' A' ' 55' ' ' VAL . 81.3 mt -64.46 -32.75 74.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.814 0.816 . . . . 0.0 109.135 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.87 135.78 3.16 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.808 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.37 126.34 29.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.1 0.953 . . . . 0.0 109.772 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.7 118.79 12.65 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.6 m -86.08 125.81 33.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.855 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 50' ' ' THR . 13.5 pt -99.94 130.01 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.712 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 39.0 t0 -92.33 159.14 15.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.984 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 49.5 m-80 73.84 29.97 1.39 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.735 0.647 . . . . 0.0 111.582 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 46' ' ' PRO . 97.7 m-85 -133.04 162.07 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.962 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.583 ' HG3' ' HA3' ' A' ' 47' ' ' GLY . 41.1 mt-30 -123.97 152.26 42.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.9 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.6 tp -118.9 126.01 50.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 111.111 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CE1' HD13 ' A' ' 102' ' ' LEU . 68.4 m-85 -92.14 135.19 34.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.874 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 23.4 t -121.79 96.87 5.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.035 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.531 HD23 ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -101.8 18.03 21.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.613 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.17 -55.8 2.75 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.942 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -58.49 -51.88 68.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 110.483 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.445 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 18.1 p90 -160.11 138.4 7.49 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.846 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 41' ' ' TYR . 5.8 Cg_exo -75.27 159.7 40.09 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.912 2.408 . . . . 0.0 112.448 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 6' ' ' TYR . . . -145.27 125.21 2.29 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.71 144.18 35.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.201 0.5 . . . . 0.0 111.48 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 92' ' ' VAL . 31.7 m -144.88 163.25 34.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.674 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 24.5 Cg_endo -63.84 139.04 66.45 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.138 1.892 . . . . 0.0 112.069 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.583 ' HA3' ' HG3' ' A' ' 34' ' ' GLN . . . -176.34 -120.3 0.61 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.949 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.489 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -145.97 88.76 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.084 0.469 . . . . 0.0 109.985 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 104' ' ' GLU . . . 178.56 163.8 30.47 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.625 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.529 HG21 ' HB3' ' A' ' 29' ' ' SER . 1.9 m -109.3 100.15 9.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.073 0.463 . . . . 0.0 111.076 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.5 t -83.3 121.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.549 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.469 ' O ' ' HZ2' ' A' ' 108' ' ' TRP . 0.2 OUTLIER -77.94 56.27 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 -173.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -74.63 155.04 47.94 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.768 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -100.89 120.27 39.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 HD13 ' A' ' 25' ' ' LEU . 11.2 t -93.99 123.89 46.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.41 146.07 47.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -105.94 104.46 14.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.775 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.76 167.36 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.845 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.83 135.45 24.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.007 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.822 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 87.4 m-20 -54.71 -41.06 69.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.152 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.47 70.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.8 m -56.27 -32.2 64.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.952 0.406 . . . . 0.0 110.471 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 13.8 tp -67.78 -49.77 60.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.586 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . . . -58.57 -32.39 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.868 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.54 -40.59 56.65 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 66' ' ' LEU . 8.4 tt -64.83 -47.7 77.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 1.8 p30 -67.45 -43.16 81.78 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.194 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.57 68.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.498 0.666 . . . . 0.0 110.779 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.84 -43.05 13.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.796 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 70' ' ' ARG . 21.3 ttt180 -86.68 7.03 28.32 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -169.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 C-N-CA 124.787 1.235 . . . . 0.0 112.338 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.614 0.245 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' H ' ' CG2' ' A' ' 71' ' ' THR . 10.7 m-85 -122.5 163.13 20.45 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.444 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.85 141.69 35.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HG2' ' CE2' ' A' ' 91' ' ' TYR . 29.5 mtp180 -93.07 124.27 36.92 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -116.96 107.89 15.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.76 110.13 16.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.9 pt -106.06 144.74 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.023 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.06 104.35 16.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.909 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -98.52 162.69 20.97 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.756 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.99 -21.42 58.33 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.678 2.252 . . . . 0.0 112.613 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 25' ' ' LEU . 51.8 m-85 -96.7 -3.91 41.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.532 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.14 157.74 9.14 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.669 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 127.47 31.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.546 -0.385 . . . . 0.0 110.602 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.01 150.52 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.842 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -79.25 121.99 25.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.204 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.8 ttt -108.9 116.45 32.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.367 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.431 ' HB2' ' OH ' ' A' ' 6' ' ' TYR . 96.7 m-85 -94.78 107.97 19.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.279 0.562 . . . . 0.0 110.655 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 45' ' ' VAL . 4.7 t -76.91 119.63 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.824 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.22 119.43 10.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.37 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -170.9 2.24 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.823 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 72.62 167.91 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.662 0.601 . . . . 0.0 110.775 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.15 119.18 5.9 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.745 2.296 . . . . 0.0 112.854 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 99' ' ' GLY . 35.4 m -104.88 1.99 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.778 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -64.93 16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . -128.58 15.18 6.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.6 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.531 ' HG ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -144.59 176.26 9.54 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.682 -0.305 . . . . 0.0 110.907 177.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 54.7 mtpt -76.99 143.96 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.351 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.412 HD13 ' CE1' ' A' ' 36' ' ' TYR . 56.6 tp -110.16 109.75 20.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.84 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.73 91.92 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.69 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -65.87 -26.15 67.51 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -73.56 -15.03 61.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.746 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 68.92 34.3 76.74 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.183 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -117.8 178.3 4.46 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.469 ' HZ2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -119.59 -34.44 3.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.336 0.589 . . . . 0.0 109.653 176.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.16 -175.207 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.876 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 4.0 tmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.444 ' HD2' ' HA3' ' A' ' 86' ' ' GLY . 25.8 mtm180 -123.65 133.74 53.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.541 0.686 . . . . 0.0 112.165 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.411 ' HB ' ' HE2' ' A' ' 1' ' ' MET . 14.3 tt -136.93 148.16 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.486 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 81.4 t80 -92.69 112.01 23.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.74 126.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.174 0.512 . . . . 0.0 111.002 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 11.0 p90 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.503 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.057 0.456 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -137.03 143.67 42.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.158 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 tp -79.61 130.12 35.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.635 HD12 HG11 ' A' ' 55' ' ' VAL . 95.6 mt -93.12 -43.01 9.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.856 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.42 176.59 27.77 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.4 147.54 28.72 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.149 0.976 . . . . 0.0 110.779 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -151.82 86.37 1.32 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.586 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.3 m -82.66 124.5 30.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -112.71 126.35 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.881 0.848 . . . . 0.0 111.524 -172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 7.6 p-10 -85.85 156.67 20.45 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.5 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 51.4 m-80 71.01 33.38 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.118 0.886 . . . . 0.0 110.931 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.25 165.31 26.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.952 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -136.24 144.64 44.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.52 HD22 HD13 ' A' ' 103' ' ' ILE . 18.7 tp -105.44 131.24 53.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.471 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -98.87 128.62 45.11 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 p -110.08 126.45 54.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.826 0.346 . . . . 0.0 110.321 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB3' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -140.98 16.75 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.01 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.81 -63.8 3.74 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.48 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -59.7 -45.36 92.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.582 ' HD1' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -167.65 110.88 0.6 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.71 176.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.41 142.75 98.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.65 2.234 . . . . 0.0 112.807 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' HA2' ' HE2' ' A' ' 6' ' ' TYR . . . -120.32 178.57 16.48 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 151.28 29.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.546 0.673 . . . . 0.0 111.318 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 1.048 HG12 HG12 ' A' ' 92' ' ' VAL . 29.1 m -153.56 165.7 17.23 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.9 148.85 52.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.374 2.049 . . . . 0.0 111.343 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.07 -125.92 1.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.187 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -135.41 91.92 2.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.6 -178.24 48.55 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 23.2 m -122.26 119.89 32.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.916 0.858 . . . . 0.0 110.114 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.69 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 92.9 t -107.01 109.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.44 . . . . 0.0 110.461 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.478 ' O ' ' HH2' ' A' ' 108' ' ' TRP . 7.5 t60 -69.16 119.96 14.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.71 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -128.43 142.85 13.91 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.847 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -98.54 107.66 20.17 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.635 HG11 HD12 ' A' ' 25' ' ' LEU . 57.1 t -80.2 116.98 25.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.79 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.77 150.77 39.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.715 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 1.8 tmt_? -108.49 107.63 18.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 pt -114.74 169.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.602 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 25.6 t70 -53.5 137.88 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.045 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.876 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 9.0 m120 -63.38 -43.91 96.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.616 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.29 77.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.269 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.602 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 67.7 m -56.82 -29.54 62.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.083 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.788 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 37.2 tp -66.6 -47.88 71.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.56 -32.4 65.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -74.3 -55.05 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.748 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.42 -37.28 85.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.097 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.51 -56.56 19.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.255 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.45 -32.46 62.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.79 -58.11 3.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.973 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -85.4 -3.19 58.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 76' ' ' TYR . 75.3 p . . . . . 0 C--N 1.321 -0.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' O ' HG21 ' A' ' 71' ' ' THR . 8.3 m-85 -116.22 162.94 16.73 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.12 46.17 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.789 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptt85 -88.89 127.77 35.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 111.636 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -104.14 121.73 43.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.254 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -87.1 112.75 22.22 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.22 133.28 58.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.396 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -86.94 101.2 13.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.562 -176.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 p -93.67 160.47 32.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.74 -3.13 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.798 2.332 . . . . 0.0 112.648 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.06 4.02 13.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.276 0.56 . . . . 0.0 110.067 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.444 ' HA3' ' HD2' ' A' ' 2' ' ' ARG . . . 126.95 149.54 7.27 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.125 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 8.0 m -65.81 122.25 16.88 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.594 -0.356 . . . . 0.0 110.203 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.15 146.32 43.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.82 120.52 25.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -105.58 113.11 26.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.66 116.03 22.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 1.048 HG12 HG12 ' A' ' 45' ' ' VAL . 8.6 t -108.43 143.09 19.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.946 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CE1' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -46.34 119.12 2.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.475 168.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -104.33 -26.62 12.4 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.637 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.503 ' H ' ' CD ' ' A' ' 96' ' ' PRO . 4.1 ptp180 -162.13 -37.46 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.503 ' CD ' ' H ' ' A' ' 95' ' ' ARG . 98.6 Cg_endo -97.78 103.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.555 1.503 . . . . 0.0 114.749 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.58 HG21 ' CE1' ' A' ' 93' ' ' TYR . 5.6 m -145.89 90.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.275 0.56 . . . . 0.0 110.352 169.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.48 24.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . 112.38 -68.86 0.23 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 38' ' ' LEU . 66.0 mt 61.89 -170.0 0.17 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.13 0.49 . . . . 0.0 111.213 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -109.0 113.25 25.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -87.69 125.31 34.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.19 0.519 . . . . 0.0 110.492 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.52 HD13 HD22 ' A' ' 35' ' ' LEU . 20.6 mt -107.9 92.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -14.51 62.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 110.652 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.2 m -72.73 -22.62 60.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.642 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 62.02 38.52 96.22 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.814 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -142.02 149.73 40.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.478 ' HH2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -89.07 -26.18 21.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 -171.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.9 mt . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.643 -167.581 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.973 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 52.5 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 87' ' ' SER . 10.2 mtt85 -111.82 129.89 55.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 tt -130.53 146.76 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.826 0.346 . . . . 0.0 110.544 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 75.2 t80 -103.31 124.32 48.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.27 130.51 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.0 p90 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.563 -172.294 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -111.82 117.48 32.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.126 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.22 106.29 3.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 HG13 ' A' ' 55' ' ' VAL . 83.3 mt -71.6 -38.31 70.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.352 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.0 157.61 7.25 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.293 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 3.7 p-10 -78.1 143.15 37.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.749 0.785 . . . . 0.0 110.537 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -151.42 116.01 5.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.368 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.3 m -87.59 137.66 32.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.218 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.2 pt -119.99 148.35 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 25.6 t0 -102.28 152.01 21.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 50.9 m-80 77.03 36.33 0.32 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.146 0.978 . . . . 0.0 111.654 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -138.39 136.83 36.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.529 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -111.93 154.32 25.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 42' ' ' PRO . 45.4 tp -118.84 138.2 52.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 0.0 111.749 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.27 147.93 29.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.843 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 20.2 m -116.75 111.82 20.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -112.05 17.42 19.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.764 -177.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.21 -78.15 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.481 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -62.16 -32.73 73.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.844 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.433 ' CE1' HD12 ' A' ' 38' ' ' LEU . 6.6 p90 -165.99 167.15 9.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.552 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.0 Cg_endo -88.9 -178.74 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.989 2.459 . . . . 0.0 112.396 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.23 129.62 2.07 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -110.84 160.1 17.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.708 0.754 . . . . 0.0 111.563 -173.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.908 HG11 HG12 ' A' ' 92' ' ' VAL . 32.3 m -147.82 161.15 36.11 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.805 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 136.24 36.54 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.303 2.002 . . . . 0.0 111.102 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.8 -126.26 1.02 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.237 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.64 82.48 2.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.924 0.393 . . . . 0.0 110.634 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.08 172.68 43.42 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 46.0 m -126.89 106.75 9.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.305 0.552 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 93.7 t -84.06 114.07 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.5 59.16 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.066 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -82.84 165.98 44.42 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.458 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 28.6 mp0 -107.62 124.07 49.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.278 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.485 HG13 HD12 ' A' ' 25' ' ' LEU . 34.0 t -88.17 128.2 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.644 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -123.38 150.99 43.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.873 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -113.69 118.41 34.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.724 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 1' ' ' MET . 2.0 pp -132.45 164.84 33.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.899 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.571 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 13.3 t70 -51.76 143.57 12.74 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.973 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 3.7 m-20 -57.97 -44.96 87.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.43 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.954 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 19.1 m -56.43 -38.13 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 0.0 110.965 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 1' ' ' MET . 10.2 tp -66.54 -52.33 46.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.69 65.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.851 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 -48.97 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.341 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -39.53 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.033 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.78 -50.37 72.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.42 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.74 -19.69 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.91 -49.25 8.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.457 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -75.08 -54.06 7.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.983 -173.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 76' ' ' TYR . 6.6 t . . . . . 0 C--N 1.32 -0.704 0 CA-C-O 122.17 0.986 . . . . 0.0 110.443 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.027 0.441 . . . . 0.0 110.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.528 ' HD2' ' HB ' ' A' ' 71' ' ' THR . 91.4 m-85 -131.24 166.18 21.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.5 127.61 55.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.043 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -86.04 106.96 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -104.93 105.9 16.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -79.79 112.15 16.79 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.57 152.81 10.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.56 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.471 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -99.15 109.61 22.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.235 0.54 . . . . 0.0 111.773 -176.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -96.53 165.62 15.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.89 -2.26 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.45 2.1 . . . . 0.0 112.466 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -120.83 15.63 11.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.017 0.437 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.25 157.42 10.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.218 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 9.2 p -66.37 130.4 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.4 151.33 44.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.335 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -85.65 123.19 30.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 111.41 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.41 ' HE1' ' HB2' ' A' ' 44' ' ' ALA . 21.4 ttt -107.79 124.06 49.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.562 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -91.33 116.21 28.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.908 HG12 HG11 ' A' ' 45' ' ' VAL . 7.2 t -94.63 126.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.499 ' HD1' ' CE1' ' A' ' 76' ' ' TYR . 40.2 t80 -75.29 127.14 32.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.108 0.956 . . . . 0.0 110.808 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' NE2' HG13 ' A' ' 92' ' ' VAL . 28.2 mm-40 -89.44 -161.99 0.83 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.172 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.569 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 38.2 mmt180 70.91 169.38 0.12 Allowed Pre-proline 0 N--CA 1.467 0.391 0 O-C-N 123.358 0.411 . . . . 0.0 110.743 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 18.8 Cg_endo -62.32 134.05 46.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.278 1.985 . . . . 0.0 111.658 171.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.36 10.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.62 126.67 28.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.284 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.76 57.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 38' ' ' LEU . 41.6 mt -86.23 159.84 19.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.811 0.306 . . . . 0.0 110.305 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 48.1 mtmt -88.78 119.09 28.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.17 121.52 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 107' ' ' ASP . 29.4 mt -101.62 94.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.13 -21.03 66.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.03 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 p -73.26 -44.12 59.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 106.53 10.03 29.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.318 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 103' ' ' ILE . 2.7 p30 -111.64 178.8 4.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 -41.21 4.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.766 0.793 . . . . 0.0 109.487 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.489 -172.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.937 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 45.0 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 143.74 33.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.838 0.352 . . . . 0.0 110.565 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.2 146.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.242 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 73.7 t80 -92.86 113.55 25.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.831 0.348 . . . . 0.0 110.287 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.8 147.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.046 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.133 0.492 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.447 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 57.8 tt0 -114.86 129.0 56.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.705 172.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.8 tp -78.95 104.14 9.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.015 0.436 . . . . 0.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.581 HD12 HG11 ' A' ' 55' ' ' VAL . 94.1 mt -70.05 -45.23 67.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.32 168.08 12.32 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.545 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.66 151.86 46.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.163 0.506 . . . . 0.0 109.824 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -156.71 87.05 1.0 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.872 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 15.5 m -77.53 129.25 35.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.08 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.04 134.13 59.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -82.8 156.42 23.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.993 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 67.54 33.97 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.025 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.41 172.09 12.6 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.516 ' HB3' HD11 ' A' ' 102' ' ' LEU . 19.6 mt-30 -139.96 157.0 46.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 43' ' ' GLY . 35.4 tp -123.4 128.75 50.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.836 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.446 ' CE1' HG21 ' A' ' 97' ' ' VAL . 88.2 m-85 -91.06 140.9 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.15 0.5 . . . . 0.0 112.127 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 68.5 m -113.86 109.94 19.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.31 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HB3' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -121.27 6.29 10.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.363 174.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.56 4.52 Favored Glycine 0 C--O 1.229 -0.186 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.989 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 41' ' ' TYR . 15.5 t60 -61.95 -47.27 85.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.784 0.326 . . . . 0.0 111.036 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.454 ' CE2' ' HD2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -167.42 155.53 8.64 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.644 175.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.01 148.15 19.3 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.938 2.426 . . . . 0.0 113.643 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.545 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -120.64 160.33 15.12 Favored Glycine 0 C--O 1.227 -0.337 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.33 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.991 0.896 . . . . 0.0 111.6 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.811 HG11 ' HD2' ' A' ' 93' ' ' TYR . 33.7 m -154.46 167.09 14.56 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.81 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.13 157.04 54.89 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.393 2.062 . . . . 0.0 111.84 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.09 -119.41 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -145.53 92.14 2.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.856 0.36 . . . . 0.0 110.085 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 165.1 33.14 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.354 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 m -101.75 101.85 12.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.875 0.369 . . . . 0.0 110.275 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 70.1 t -82.81 106.72 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.792 -174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -69.52 107.53 3.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.939 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.633 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -123.09 147.2 16.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.1 mp0 -103.9 107.25 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.581 HG11 HD12 ' A' ' 25' ' ' LEU . 26.0 t -81.35 117.07 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.062 0.458 . . . . 0.0 110.223 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -115.29 147.71 40.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.455 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 52.8 ttt180 -108.95 131.93 54.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.986 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.757 HD13 HD22 ' A' ' 63' ' ' LEU . 1.7 pp -140.73 164.14 21.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.667 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.67 142.15 15.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.539 0.209 . . . . 0.0 111.18 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.937 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 95.7 m-20 -54.51 -48.64 71.66 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 0.0 110.979 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.19 75.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.085 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -56.27 -37.0 69.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.835 173.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.757 HD22 HD13 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -66.82 -42.13 86.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -23.67 66.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.843 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.85 -48.5 45.6 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.15 -34.73 78.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.46 -54.87 41.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.499 0.666 . . . . 0.0 110.92 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.76 68.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.39 -56.27 3.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 71' ' ' THR . 39.8 ttt180 -85.19 7.14 22.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 O-C-N 124.602 1.189 . . . . 0.0 111.066 -173.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 4.6 tp10 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 38.5 m-85 -142.6 170.38 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.579 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.96 152.09 36.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -88.93 125.22 34.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -105.18 121.63 44.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.6 tp -91.82 114.69 27.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' SER . 7.3 pt -114.02 148.98 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -90.43 108.54 19.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.719 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 1.4 p -100.02 163.42 18.39 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 83' ' ' THR . 17.7 Cg_endo -61.54 -16.04 45.33 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.481 2.12 . . . . 0.0 112.064 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -97.91 -2.66 40.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.9 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.51 160.21 10.85 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 66.4 m -63.95 121.29 13.74 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.138 0.494 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.64 148.68 30.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.674 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.46 124.28 31.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.183 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.467 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 85.2 mtp -106.7 170.28 8.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.039 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -127.69 117.72 22.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.871 0.367 . . . . 0.0 110.415 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.568 HG11 HG13 ' A' ' 45' ' ' VAL . 4.0 t -101.59 136.82 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.696 0.76 . . . . 0.0 111.189 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.811 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -51.68 120.64 5.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.739 175.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.96 1.35 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.752 -176.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 68.8 mtp180 -132.16 146.61 62.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.25 121.78 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.561 3.507 . . . . 0.0 114.598 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG11 HD13 ' A' ' 100' ' ' LEU . 12.8 m -104.52 14.48 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.862 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.56 96.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.013 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.84 5.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.327 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.49 HD13 HG11 ' A' ' 97' ' ' VAL . 87.2 mt -89.87 165.7 13.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.335 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 30.1 mmmt -90.29 132.25 35.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 34' ' ' GLN . 64.6 tp -105.93 107.78 18.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.374 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 107' ' ' ASP . 51.5 mt -82.12 89.02 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.98 -9.55 39.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.178 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 m -70.79 -27.16 63.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.024 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 85.66 -13.37 56.29 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.171 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 103' ' ' ILE . 5.4 t70 -100.42 141.35 33.38 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.384 -0.48 . . . . 0.0 110.223 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -70.02 -30.96 68.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.551 . . . . 0.0 110.228 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.449 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.955 -179.382 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.517 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 25.1 ttm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -117.61 144.73 44.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 111.188 -175.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.482 ' HB ' HD21 ' A' ' 63' ' ' LEU . 10.6 tt -139.82 150.66 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.908 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -97.22 115.74 28.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.31 158.82 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 p90 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.035 0.445 . . . . 0.0 111.447 -179.627 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.8 tt0 -107.31 119.5 39.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.718 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 tp -81.66 98.39 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.488 . . . . 0.0 109.859 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.675 HD13 HG13 ' A' ' 55' ' ' VAL . 88.8 mt -64.9 -41.78 95.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.711 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.37 153.36 6.08 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.614 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-20 -69.57 143.42 53.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB3' HG21 ' A' ' 55' ' ' VAL . 17.2 t80 -154.48 114.03 3.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.0 m -100.56 132.6 45.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.106 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' THR . 16.3 pt -114.03 141.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.423 . . . . 0.0 111.164 -175.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.26 160.07 14.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.036 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 73.8 28.94 1.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.594 0.758 . . . . 0.0 111.506 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.67 142.28 46.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.467 ' HB3' HD13 ' A' ' 102' ' ' LEU . 49.9 mt-30 -116.05 148.42 40.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . 12.4 tp -103.44 139.33 38.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.488 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.45 134.91 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.5 p -116.49 128.49 55.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.991 0.424 . . . . 0.0 110.131 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.462 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -133.73 17.36 3.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.317 172.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.72 -59.2 4.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.955 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -89.08 -0.77 57.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -156.62 134.09 6.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 121.78 0.38 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.939 2.426 . . . . 0.0 111.378 166.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.69 16.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.645 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 92' ' ' VAL . . . -145.47 146.53 31.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.658 0.729 . . . . 0.0 110.585 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 92' ' ' VAL . 27.3 m -149.44 164.0 22.76 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 123.404 0.44 . . . . 0.0 110.489 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.18 136.47 56.13 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.401 2.067 . . . . 0.0 111.805 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.05 -122.54 0.77 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.826 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -143.05 92.18 2.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.708 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.91 167.71 37.49 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.856 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.1 m -115.03 111.47 21.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.8 t -84.91 118.68 32.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.004 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -78.96 97.9 6.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.68 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.71 172.16 20.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 27.4 mp0 -120.12 133.65 55.46 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.757 0.423 . . . . 0.0 109.886 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.675 HG13 HD13 ' A' ' 25' ' ' LEU . 31.6 t -91.27 120.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -118.14 157.88 26.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.319 0.581 . . . . 0.0 112.008 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.3 tmt_? -127.2 124.12 38.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.631 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.41 -173.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.767 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 62' ' ' THR . 3.7 m-20 -52.11 153.11 2.86 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.683 0.277 . . . . 0.0 110.617 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.0 p-10 -65.42 -38.87 91.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.18 85.13 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.993 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 89.1 m -56.97 -30.26 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.074 0.464 . . . . 0.0 111.373 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.5 tm? -65.48 -48.55 72.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.05 66.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.13 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -49.1 31.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.027 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.62 -36.64 84.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.4 -54.59 45.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.77 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.15 -28.63 69.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.636 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 69' ' ' LEU . 17.4 mt -79.17 -47.72 15.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.637 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -81.62 -49.64 10.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.324 -0.513 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.357 -172.767 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' VAL . 12.0 m-85 -119.37 159.75 23.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.285 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.31 124.9 47.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.765 0.317 . . . . 0.0 110.652 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -79.15 123.53 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.892 0.854 . . . . 0.0 110.766 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.7 145.93 29.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.513 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.06 113.3 25.74 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.205 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.9 pt -110.24 140.98 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.352 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -91.37 102.97 15.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -99.83 158.04 32.82 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.71 -18.38 55.21 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 49.8 m-85 -99.05 -3.16 35.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.834 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.36 161.06 9.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.288 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 p -67.08 107.19 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 110.464 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.71 145.97 29.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.887 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -83.62 125.43 31.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 ttt -114.75 116.64 28.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.41 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.59 108.13 19.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 112.026 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.893 HG12 HG11 ' A' ' 45' ' ' VAL . 4.3 t -81.15 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.815 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.552 ' HD1' HG11 ' A' ' 97' ' ' VAL . 7.2 t80 -63.59 119.84 10.61 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 95' ' ' ARG . 3.3 tp-100 -108.03 -166.51 1.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.467 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 31.7 mtp85 66.92 -177.43 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 54.2 Cg_exo -54.73 100.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.714 1.609 . . . . 0.0 112.468 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.552 HG11 ' HD1' ' A' ' 93' ' ' TYR . 26.9 m -93.53 -10.8 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.677 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.79 103.99 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.529 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.6 -12.05 4.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.077 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 38' ' ' LEU . 73.2 mt -78.24 162.23 26.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -93.2 109.05 20.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 34' ' ' GLN . 61.6 tp -73.75 139.02 44.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.461 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' A' ' 35' ' ' LEU . 62.7 mt -124.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.269 174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.02 -15.58 63.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.46 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -70.99 -20.8 62.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.12 73.91 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.531 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.421 ' O ' HG22 ' A' ' 103' ' ' ILE . 12.2 t70 -134.05 137.19 44.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -71.85 -29.2 64.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.805 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -170.323 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.939 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 43.8 tpp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -134.12 125.77 28.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.093 0.473 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.56 145.96 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -86.49 111.82 20.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 0.0 110.004 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 83.9 t -91.6 136.1 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.315 -0.893 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.634 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' CB ' HG21 ' A' ' 58' ' ' ILE . . . . . . . . 0 C--O 1.234 0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -124.09 121.15 34.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.677 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.32 106.25 1.32 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD11 HG12 ' A' ' 55' ' ' VAL . 84.4 mt -66.68 -38.32 86.55 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.03 159.83 10.11 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.918 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.27 145.26 54.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -139.15 115.04 10.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 52' ' ' HIS . 5.8 p -100.96 131.01 47.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.592 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 pt -117.38 130.39 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.361 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.48 151.71 21.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.871 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.72 33.97 2.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.932 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.95 154.15 51.81 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 102' ' ' LEU . 38.2 mt-30 -128.13 156.8 42.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 103' ' ' ILE . 15.3 tp -114.2 130.25 56.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.585 0.231 . . . . 0.0 110.758 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE1' HD12 ' A' ' 102' ' ' LEU . 86.0 m-85 -99.96 132.34 45.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.609 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.1 m -99.37 102.24 13.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HB3' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -118.75 12.55 13.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.708 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.06 -51.15 4.06 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.035 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.4 -42.3 91.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' CE1' HD13 ' A' ' 38' ' ' LEU . 8.2 p90 -175.05 153.85 1.64 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 6' ' ' TYR . 16.6 Cg_exo -70.24 112.02 3.06 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.237 1.958 . . . . 0.0 111.678 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -90.48 159.51 27.23 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.276 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 34' ' ' GLN . . . -141.83 139.57 32.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.749 0.775 . . . . 0.0 111.433 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 92' ' ' VAL . 26.9 m -145.57 163.22 32.83 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.386 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.16 146.43 76.3 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.547 2.164 . . . . 0.0 111.488 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.0 -111.36 0.39 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.79 92.12 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.08 47.5 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m -124.87 103.86 8.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 117.801 0.801 . . . . 0.0 110.529 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 77.3 t -84.16 104.08 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 1.8 p80 -95.35 94.89 8.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.449 0.642 . . . . 0.0 110.699 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.15 10.4 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.179 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 28.3 mt-10 -127.0 124.66 39.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 25' ' ' LEU . 72.0 t -93.16 118.97 40.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.087 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.14 148.05 40.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.132 0.491 . . . . 0.0 112.054 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -106.87 114.79 29.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.889 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.458 HG21 ' CB ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -127.25 174.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -52.88 144.4 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.956 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.939 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.3 m-20 -60.02 -36.02 76.35 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.424 0.631 . . . . 0.0 109.451 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.54 71.99 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.93 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 m -56.42 -40.44 74.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.67 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 39.1 tp -67.99 -46.69 70.6 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.84 68.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.5 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.15 -43.11 44.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.322 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.64 -42.72 98.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.26 -50.66 73.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.892 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.07 -28.69 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.467 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.0 mt -86.57 -55.36 3.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.603 ' HD3' ' HD2' ' A' ' 76' ' ' TYR . 41.5 ttm180 -85.45 -44.65 12.56 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -168.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.452 HG22 ' HH ' ' A' ' 91' ' ' TYR . 70.3 p . . . . . 0 C--N 1.324 -0.516 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.653 -169.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HG2' ' NH2' ' A' ' 95' ' ' ARG . 25.6 mt-10 . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.603 ' HD2' ' HD3' ' A' ' 70' ' ' ARG . 12.7 m-85 -131.9 170.21 15.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.879 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.4 149.93 21.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HD2' ' CE3' ' A' ' 89' ' ' TRP . 20.7 tpp85 -102.33 134.87 44.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.121 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 10.1 tt0 -135.09 152.5 51.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -119.44 117.55 28.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.849 0.357 . . . . 0.0 110.383 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 pt -109.07 148.73 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.323 0.582 . . . . 0.0 111.292 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -96.75 126.96 42.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.305 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.2 p -122.11 159.92 49.73 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.409 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.4 -10.46 26.17 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.395 2.064 . . . . 0.0 111.582 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 10.8 m-85 -106.97 12.79 28.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.028 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.75 -103.09 0.59 Allowed Glycine 0 C--O 1.217 -0.927 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.144 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.0 t -172.86 133.17 0.55 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.47 144.39 51.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.942 0.401 . . . . 0.0 111.755 -170.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . 0.525 ' CE3' ' HD2' ' A' ' 78' ' ' ARG . 96.3 m95 -82.01 127.25 32.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.303 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.459 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 25.8 ttt -109.13 155.1 21.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.053 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.452 ' HH ' HG22 ' A' ' 71' ' ' THR . 15.0 m-85 -123.83 130.63 52.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.372 . . . . 0.0 110.859 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 45' ' ' VAL . 3.3 t -108.4 134.07 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 121.66 0.743 . . . . 0.0 110.836 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.628 ' CE2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -50.71 134.45 24.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.471 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.557 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 1.9 tp-100 -135.22 33.65 3.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.797 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 27.4 mmt85 -131.31 -177.03 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.345 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 95' ' ' ARG . 6.3 Cg_exo -75.72 135.2 17.5 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.749 1.632 . . . . 0.0 112.674 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.996 HG12 HD13 ' A' ' 100' ' ' LEU . 2.3 m -101.49 11.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -62.73 -6.09 3.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 29.21 1.79 Allowed Glycine 0 C--N 1.308 -1.028 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.312 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.996 HD13 HG12 ' A' ' 97' ' ' VAL . 43.2 mt -113.83 165.08 12.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.851 -0.205 . . . . 0.0 110.548 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -102.81 124.77 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 34' ' ' GLN . 66.5 tp -84.16 143.59 29.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.881 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.529 HD13 HD23 ' A' ' 35' ' ' LEU . 44.8 mt -107.97 94.51 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.22 24.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.064 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 103' ' ' ILE . 59.7 m -161.27 15.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.295 -0.253 . . . . 0.0 111.522 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 52.65 22.82 12.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.476 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 5.9 p-10 -98.99 178.89 4.8 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.943 0.871 . . . . 0.0 108.745 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.583 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 67.2 t-105 -121.69 -38.68 2.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.583 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 46.0 mt . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.403 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 1.008 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 47.1 tpp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.69 51.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.238 -0.289 . . . . 0.0 110.435 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.564 ' HB ' HD21 ' A' ' 63' ' ' LEU . 13.0 tt -140.37 147.81 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.255 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.671 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 84.0 t80 -96.83 111.33 23.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.4 t -96.18 123.32 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.542 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.472 ' CE1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.514 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -96.07 122.1 38.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.619 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.3 tp -73.53 106.4 5.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.08 -44.17 18.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.9 157.53 8.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.3 p30 -77.63 158.27 29.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.499 0.666 . . . . 0.0 110.458 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.07 90.17 1.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -79.87 129.38 34.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -122.91 141.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 111.296 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.9 165.65 13.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 83.5 m-20 69.55 28.7 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.824 0.703 . . . . 0.0 112.081 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.49 157.79 45.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.274 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.577 ' HB3' HD11 ' A' ' 102' ' ' LEU . 34.9 mt-30 -126.31 152.76 45.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.497 HD11 ' O ' ' A' ' 43' ' ' GLY . 38.1 tp -119.02 125.94 50.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 110.565 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.537 ' CE1' HG12 ' A' ' 97' ' ' VAL . 96.4 m-85 -96.72 137.41 35.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.783 0.325 . . . . 0.0 110.721 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.5 p -109.63 101.86 10.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.337 0.589 . . . . 0.0 109.541 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -107.37 2.6 24.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.118 -178.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.74 153.23 18.57 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.9 m80 70.72 -54.58 0.65 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.363 0.601 . . . . 0.0 111.043 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -158.18 129.29 3.74 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.311 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' ' CE1' ' A' ' 6' ' ' TYR . 13.1 Cg_exo -72.77 177.88 7.06 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.563 2.175 . . . . 0.0 112.734 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.497 ' O ' HD11 ' A' ' 35' ' ' LEU . . . -150.93 161.01 28.89 Favored Glycine 0 C--O 1.224 -0.507 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -131.81 158.13 42.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.139 0.969 . . . . 0.0 111.7 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.834 HG11 HG13 ' A' ' 92' ' ' VAL . 35.1 m -150.98 163.38 23.87 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.715 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.71 161.97 39.38 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.585 2.19 . . . . 0.0 111.931 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.54 -127.84 1.9 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 4.2 t-20 -146.28 89.03 1.83 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 109.71 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.45 168.94 41.67 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -103.55 112.13 24.9 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.09 0.445 . . . . 0.0 111.148 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 69.2 t -98.26 114.58 36.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.561 ' HB2' ' CZ3' ' A' ' 108' ' ' TRP . 99.5 m-70 -78.93 105.28 10.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.474 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.671 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -117.55 168.32 12.92 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.553 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 40.7 mt-10 -131.16 128.54 40.26 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 85' ' ' TYR . 60.9 t -92.01 117.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.158 0.504 . . . . 0.0 110.271 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.63 154.9 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.615 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -108.92 130.43 55.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.476 HD12 HD22 ' A' ' 63' ' ' LEU . 1.6 pp -143.22 172.06 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.024 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 56.7 m-20 -51.09 141.87 13.38 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.242 0.339 . . . . 0.0 110.61 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 1.008 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.5 m-20 -55.51 -39.62 70.73 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.709 0.766 . . . . 0.0 109.264 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -36.99 85.57 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.631 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 59' ' ' ASP . 34.2 m -55.61 -38.33 69.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 111.119 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.564 HD21 ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -66.85 -50.73 61.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.247 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -29.49 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.793 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.54 -50.82 56.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.307 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.48 -39.38 90.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 -45.43 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.841 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.68 69.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 111.283 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.67 -53.91 4.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.364 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -85.64 -41.6 15.06 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -173.298 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 93' ' ' TYR . 29.1 m-85 -135.01 160.34 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.624 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.488 ' HB3' ' OE1' ' A' ' 94' ' ' GLN . . . -88.6 136.82 32.8 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.42 102.34 11.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.18 100.65 10.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.411 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 87' ' ' SER . 48.4 tp -76.87 106.58 8.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.986 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.8 pt -101.47 139.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.682 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.444 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 tp-100 -86.36 106.2 17.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.835 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -103.33 162.0 21.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.62 -21.08 71.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.431 2.087 . . . . 0.0 112.019 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HB2' HG11 ' A' ' 55' ' ' VAL . 20.7 m-85 -90.66 -4.44 56.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.344 0.593 . . . . 0.0 109.994 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.51 166.76 12.39 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.552 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 80' ' ' LEU . 7.8 p -66.86 121.38 15.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.08 146.5 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.786 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.88 121.4 28.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 21.4 ttt -105.74 152.12 23.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.474 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.31 120.81 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.539 0.209 . . . . 0.0 110.851 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.834 HG13 HG11 ' A' ' 45' ' ' VAL . 4.1 t -107.94 124.46 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.395 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . 23.8 t80 -62.43 118.78 7.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.607 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.488 ' OE1' ' HB3' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -88.21 -33.86 17.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.768 -170.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 95' ' ' ARG . 41.7 mtm180 -83.03 161.73 56.89 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.4 133.43 56.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.883 2.389 . . . . 0.0 112.547 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.537 HG12 ' CE1' ' A' ' 36' ' ' TYR . 12.4 m -77.67 69.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 122.171 0.986 . . . . 0.0 110.092 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -42.84 -70.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.257 -1.792 . . . . 0.0 112.796 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.99 60.83 0.61 Allowed Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.031 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 38' ' ' LEU . 19.2 mt -111.64 155.79 22.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.652 0.263 . . . . 0.0 110.359 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -98.42 116.19 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 34' ' ' GLN . 52.2 tp -90.47 127.1 36.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.372 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 105' ' ' SER . 5.9 mt -94.99 98.66 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.78 24.56 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.532 0.733 . . . . 0.0 112.786 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 103' ' ' ILE . 42.3 m -160.92 17.45 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.288 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 35.65 50.99 1.07 Allowed Glycine 0 C--N 1.348 1.236 0 O-C-N 124.184 0.928 . . . . 0.0 114.985 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' HD12 ' A' ' 103' ' ' ILE . 6.5 t70 -135.37 132.91 38.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.44 . . . . 0.0 110.824 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.561 ' CZ3' ' HB2' ' A' ' 52' ' ' HIS . 5.5 p90 -96.9 -8.07 31.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.708 0.766 . . . . 0.0 110.018 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 2.0 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.143 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.644 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 31.6 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -120.36 146.9 45.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 117.866 0.303 . . . . 0.0 111.168 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 63' ' ' LEU . 11.9 tt -142.45 140.11 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.599 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 56.0 t80 -88.0 113.65 23.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 87.9 t -91.6 133.93 31.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.54 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HH ' ' HA ' ' A' ' 90' ' ' MET . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.405 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -139.5 116.7 11.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.237 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 tp -67.06 104.1 1.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.549 HD12 HG13 ' A' ' 55' ' ' VAL . 91.0 mt -72.65 -43.37 63.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.307 0.575 . . . . 0.0 109.633 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.37 158.35 8.89 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.09 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.19 143.05 43.37 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -141.26 111.86 7.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.509 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 49.8 m -93.35 127.16 38.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.388 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.95 131.35 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 11.1 m-20 -85.77 153.64 22.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.706 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 13.6 m120 73.17 32.04 1.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.97 0.794 . . . . 0.0 111.616 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -138.25 136.3 36.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.713 0.292 . . . . 0.0 110.875 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -106.55 160.67 15.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.524 HD23 HD13 ' A' ' 103' ' ' ILE . 25.4 tp -115.79 133.66 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.339 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 102' ' ' LEU . 73.9 m-85 -108.57 156.61 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.778 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.3 t -147.11 125.61 12.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.877 0.37 . . . . 0.0 110.282 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.797 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 1.3 pt? -105.54 16.19 25.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.61 -25.34 25.25 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.995 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -111.67 -72.14 0.73 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.577 ' HB2' HD22 ' A' ' 38' ' ' LEU . 3.3 m-85 -82.54 128.32 67.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.266 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -93.98 103.13 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.779 2.319 . . . . 0.0 110.714 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -100.94 157.41 19.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.181 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.47 145.74 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.224 0.512 . . . . 0.0 110.845 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.802 HG12 HG12 ' A' ' 92' ' ' VAL . 24.9 m -146.28 162.26 35.54 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 20.1 Cg_endo -61.25 151.66 77.51 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.622 2.215 . . . . 0.0 112.834 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.3 -130.83 2.24 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -136.49 89.17 2.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.419 0.628 . . . . 0.0 109.816 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.87 -179.33 33.63 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -133.76 104.86 6.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 117.769 0.784 . . . . 0.0 111.02 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.2 t -84.22 109.48 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -81.36 58.45 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.88 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.599 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -72.62 169.27 52.31 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.817 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.8 pt-20 -121.04 114.84 22.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.27 -0.465 . . . . 0.0 109.936 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG13 HD12 ' A' ' 25' ' ' LEU . 28.0 t -86.8 129.91 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.754 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.46 156.98 38.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 111.461 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 13.5 ttp180 -113.03 124.69 53.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.514 172.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.784 HD12 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.19 178.87 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 58' ' ' ILE . 31.8 t70 -52.6 149.55 5.87 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.627 0.251 . . . . 0.0 110.956 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.644 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 94.0 m-20 -66.22 -48.19 71.37 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.884 -0.51 . . . . 0.0 110.779 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.61 78.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.779 -171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -40.35 80.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.034 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -66.29 -53.47 36.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.117 -177.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.72 -28.23 68.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.854 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.88 -50.89 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.561 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.4 -39.91 89.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.946 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.07 -58.31 8.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.948 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -8.96 55.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.688 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.37 -48.75 8.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.11 0.481 . . . . 0.0 110.77 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -86.52 -40.74 14.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.675 -171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.408 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 5.7 t . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 122.133 0.968 . . . . 0.0 111.994 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 71' ' ' THR . 9.2 mp0 . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 93' ' ' TYR . 23.7 m-85 -140.73 148.43 40.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.69 133.25 33.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.794 0.33 . . . . 0.0 111.491 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 78' ' ' ARG . 72.5 mtt180 -77.32 109.1 10.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 9.3 tt0 -110.44 98.79 7.92 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -79.55 113.31 17.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.8 pt -109.04 131.11 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.461 0.648 . . . . 0.0 110.984 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.605 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -95.31 162.98 22.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.972 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.75 -16.81 46.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.538 2.158 . . . . 0.0 112.042 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -97.94 2.0 48.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.902 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.05 158.48 10.94 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -65.75 125.8 26.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.207 0.504 . . . . 0.0 110.495 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.59 150.53 41.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.628 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -82.52 124.42 30.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.027 0.442 . . . . 0.0 111.384 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.444 ' HA ' ' HH ' ' A' ' 6' ' ' TYR . 27.0 ttt -110.85 131.63 54.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.373 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -107.8 109.51 21.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.09 0.472 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.802 HG12 HG12 ' A' ' 45' ' ' VAL . 2.5 t -80.34 126.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.417 ' HA ' ' HD1' ' A' ' 76' ' ' TYR . 5.9 t80 -59.27 102.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -87.2 -14.72 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.122 -170.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -84.99 164.26 42.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.1 115.59 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.605 2.203 . . . . 0.0 112.541 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.53 ' HA ' HD12 ' A' ' 100' ' ' LEU . 29.2 m -86.37 -4.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.507 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.11 -12.3 18.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.388 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' C ' HD13 ' A' ' 100' ' ' LEU . . . -106.21 16.86 41.62 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.173 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.797 ' HG ' ' HB3' ' A' ' 38' ' ' LEU . 7.1 mp -120.82 170.84 9.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.33 134.22 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 36' ' ' TYR . 50.1 tp -102.3 117.17 34.18 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.01 0.433 . . . . 0.0 111.178 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 107' ' ' ASP . 59.9 mt -97.44 95.26 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.45 -22.12 41.36 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.484 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.2 m -70.73 -46.78 62.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 98.41 -0.43 58.38 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -171.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 103' ' ' ILE . 6.2 m-20 -99.28 165.59 11.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.532 . . . . 0.0 109.993 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.87 -49.21 4.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.437 -1.103 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.464 179.785 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.748 ' H1 ' ' HA ' ' A' ' 60' ' ' ASN . 21.2 ttm . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.534 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 98.2 mtt180 -92.05 124.24 36.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.68 HD11 HD22 ' A' ' 63' ' ' LEU . 33.3 mt -121.2 147.18 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HE1' ' O ' ' A' ' 28' ' ' PHE . 92.3 t80 -91.07 111.1 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.76 102.14 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.0 110.487 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.192 177.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.2 tt0 -108.7 98.53 8.02 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.6 116.26 4.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -172.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.488 HD12 HG13 ' A' ' 55' ' ' VAL . 91.4 mt -85.6 -42.34 14.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . 157.6 146.46 4.51 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.273 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 p30 -74.53 151.55 39.47 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.487 0.66 . . . . 0.0 110.443 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' O ' ' HE1' ' A' ' 4' ' ' PHE . 10.3 t80 -157.1 103.77 2.04 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.237 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.52 ' HB2' HG22 ' A' ' 50' ' ' THR . 23.0 p -90.94 122.95 34.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.654 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.427 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 13.3 pt -103.44 125.8 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.308 0.575 . . . . 0.0 111.398 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 27.0 t0 -84.67 161.31 20.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.101 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 42.1 m-80 74.06 26.47 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 111.377 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.49 147.66 43.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 110.653 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.581 HE21 ' HA ' ' A' ' 104' ' ' GLU . 41.8 mt-30 -122.85 156.0 35.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.297 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.8 tp -117.9 135.64 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.036 -170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -101.64 145.26 29.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.198 0.523 . . . . 0.0 111.49 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -108.56 106.16 16.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.518 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.453 HD11 ' CE1' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -117.2 18.8 14.42 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.039 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 -70.01 2.77 Favored Glycine 0 C--N 1.329 0.152 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.536 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -50.9 -48.09 60.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.372 0.606 . . . . 0.0 110.964 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CE1' HD11 ' A' ' 38' ' ' LEU . 5.7 p90 -159.87 165.65 17.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.059 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.6 159.88 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.474 2.116 . . . . 0.0 112.263 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.05 6.04 Favored Glycine 0 C--O 1.223 -0.57 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -123.79 165.59 17.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.81 0.805 . . . . 0.0 111.065 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.611 HG11 HG13 ' A' ' 92' ' ' VAL . 35.2 m -150.88 160.35 32.4 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.48 0.487 . . . . 0.0 110.209 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 28.8 Cg_endo -66.64 128.97 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.037 1.824 . . . . 0.0 111.465 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.86 -120.32 0.51 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.96 91.97 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.607 0.717 . . . . 0.0 110.703 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 164.89 32.79 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.743 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 19.3 m -112.32 105.77 14.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.385 0.592 . . . . 0.0 110.446 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' SER . 65.0 t -82.38 117.75 28.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.523 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.06 100.6 3.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.015 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.54 165.79 23.64 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 47.6 mt-10 -125.06 136.35 53.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 25' ' ' LEU . 41.7 t -86.67 119.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 22' ' ' ALA . 46.6 m-85 -122.04 159.38 27.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.916 0.865 . . . . 0.0 112.669 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.2 tmt_? -112.99 114.15 26.49 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.522 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 ' H2 ' ' A' ' 1' ' ' MET . 2.2 pp -119.55 177.11 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.058 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.74 131.14 38.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.818 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.748 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 3.3 m-20 -66.65 -41.43 88.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.807 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.84 99.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.595 0.236 . . . . 0.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 m -54.92 -40.37 69.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.254 0.55 . . . . 0.0 110.503 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.68 HD22 HD11 ' A' ' 3' ' ' ILE . 3.0 tm? -67.57 -53.49 27.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.344 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.17 -30.25 69.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.046 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.13 -46.97 30.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.83 -47.11 86.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.787 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.652 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 23.0 t70 -63.56 -42.82 98.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.508 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.53 -30.42 70.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.102 0.477 . . . . 0.0 111.297 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 mt -86.14 -50.53 6.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.673 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 3.1 ttt85 -85.98 -41.87 14.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.853 0.358 . . . . 0.0 111.469 -168.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.816 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.402 -177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.673 ' HE2' ' HG2' ' A' ' 70' ' ' ARG . 4.3 m-85 -135.89 150.72 49.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.936 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB2' ' NE2' ' A' ' 94' ' ' GLN . . . -86.45 118.13 25.68 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.081 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.652 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 82.1 mtm180 -74.43 102.61 4.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.215 0.531 . . . . 0.0 109.887 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -103.77 99.17 8.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.3 tp -76.79 112.34 13.27 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.874 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.402 ' C ' HE21 ' A' ' 82' ' ' GLN . 35.5 pt -107.09 138.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.292 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.567 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -90.47 113.86 25.9 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 85' ' ' TYR . 33.6 p -102.71 166.71 11.47 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.159 -172.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.69 1.21 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.643 2.229 . . . . 0.0 111.836 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.482 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 32.9 m-85 -119.83 17.13 12.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.4 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.534 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 115.74 -87.46 0.44 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.932 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -169.5 141.64 2.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.47 147.7 30.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.646 0.26 . . . . 0.0 111.238 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.14 120.08 25.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.59 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.528 ' SD ' HG21 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -105.16 118.65 37.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.448 176.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.66 109.67 21.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.487 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.611 HG13 HG11 ' A' ' 45' ' ' VAL . 2.3 t -93.21 138.86 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HD2' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -47.64 136.27 10.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.303 177.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 77' ' ' ALA . 2.0 tp-100 -138.44 18.99 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.901 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.721 ' HB2' ' HD3' ' A' ' 96' ' ' PRO . 2.2 mmp_? -120.85 -80.51 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 95' ' ' ARG . 34.7 Cg_endo -99.05 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 -162.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.548 ' HA ' HD13 ' A' ' 100' ' ' LEU . 25.1 m 54.2 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.486 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.46 113.82 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.885 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.02 44.41 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -169.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 97' ' ' VAL . 66.1 mt -119.55 165.63 14.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.56 132.15 54.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 34' ' ' GLN . 50.2 tp -102.49 126.89 49.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.084 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 105' ' ' SER . 40.7 mt -90.09 100.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.581 ' HA ' HE21 ' A' ' 34' ' ' GLN . 27.8 mt-10 -67.37 24.01 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.618 -1.174 . . . . 0.0 114.084 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 103' ' ' ILE . 60.7 m -163.89 -17.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.067 -0.396 . . . . 0.0 111.926 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.74 21.51 33.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.159 -1.019 . . . . 0.0 114.443 167.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.91 129.89 41.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.736 0.768 . . . . 0.0 109.288 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -69.45 -29.83 67.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.445 -167.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.769 ' H1 ' ' HA ' ' A' ' 60' ' ' ASN . 11.2 tpp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.472 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 29.8 mtm180 -87.98 138.1 31.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.945 0.402 . . . . 0.0 110.659 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.2 151.24 18.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.096 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -91.22 127.51 36.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -92.36 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.542 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 20.3 p90 -110.7 20.12 17.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.369 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.27 66.35 0.29 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.471 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.682 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . 72.7 p 61.68 152.01 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.4 1.08 . . . . 0.0 111.874 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.703 HD23 ' HE1' ' A' ' 108' ' ' TRP . 2.4 mm? -68.22 -20.77 64.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.47 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -68.44 -19.48 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 44.54 -157.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.173 0.921 . . . . 0.0 111.93 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.616 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -147.68 139.18 23.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.778 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 2.5 mp0 -75.93 -16.37 60.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.441 ' H ' ' HG3' ' A' ' 12' ' ' LYS . . . 67.81 -97.39 0.42 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.421 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -122.29 -37.54 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 0.0 110.293 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 p -178.55 -51.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -47.01 -39.8 13.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.869 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.597 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 69.7 m95 -79.34 4.15 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.778 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 21.2 ptm -128.59 -4.3 5.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.867 0.365 . . . . 0.0 110.327 172.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 m -96.88 -66.47 0.9 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -90.34 -0.1 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.108 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HA ' HG21 ' A' ' 58' ' ' ILE . . . -69.83 110.25 4.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -100.63 118.91 37.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.581 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -71.68 104.14 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.209 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD13 HG11 ' A' ' 55' ' ' VAL . 95.3 mt -72.79 -43.6 62.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.474 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.25 171.09 18.93 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.96 145.99 33.68 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.832 0.825 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.513 ' HB3' HG23 ' A' ' 55' ' ' VAL . 23.3 t80 -154.09 101.69 2.42 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.486 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 m -88.96 133.01 34.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.712 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.22 126.37 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.96 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 4.3 t70 -86.15 165.22 16.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.475 HD21 ' N ' ' A' ' 32' ' ' ASN . 0.8 OUTLIER 69.48 28.04 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.715 0.634 . . . . 0.0 111.226 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -135.41 149.96 49.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.51 ' HB3' HD11 ' A' ' 102' ' ' LEU . 99.1 mt-30 -127.76 152.49 47.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.686 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD21 HD13 ' A' ' 103' ' ' ILE . 23.7 tp -111.33 131.83 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.941 0.4 . . . . 0.0 111.283 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.04 151.28 21.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -122.93 107.7 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.555 ' HA ' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -102.84 18.45 21.49 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.54 -57.79 0.62 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.221 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.67 -82.99 0.51 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.65 0.738 . . . . 0.0 109.697 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.54 158.7 62.68 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.539 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -93.52 170.9 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.935 2.424 . . . . 0.0 112.619 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -139.34 152.5 22.44 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -138.41 141.42 39.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.939 0.87 . . . . 0.0 110.963 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 93' ' ' TYR . 23.9 m -150.28 163.88 22.67 Favored Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 123.184 0.303 . . . . 0.0 110.27 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.58 132.15 30.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.564 2.176 . . . . 0.0 111.497 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.99 -123.78 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.767 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.63 90.26 2.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.153 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.79 166.16 34.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.562 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 4.6 m -109.88 106.03 15.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.091 0.445 . . . . 0.0 110.178 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 29' ' ' SER . 67.4 t -82.59 105.56 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 109.848 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 82.9 t60 -79.29 65.3 4.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.66 -175.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.654 ' HA2' ' HZ2' ' A' ' 108' ' ' TRP . . . -100.02 -173.59 30.3 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.334 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' HB2' HD11 ' A' ' 9' ' ' LEU . 19.5 tt0 -133.55 140.92 47.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.594 HG11 HD13 ' A' ' 25' ' ' LEU . 49.2 t -106.79 130.59 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.14 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -124.74 150.74 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 112.093 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.04 105.51 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 22' ' ' ALA . 2.4 pp -110.92 162.93 8.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.91 147.06 9.72 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.9 0.48 . . . . 0.0 112.014 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.769 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 5.8 p30 -64.84 -41.9 95.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.527 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.31 -37.02 82.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.215 0.531 . . . . 0.0 110.199 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.432 HG21 ' CH2' ' A' ' 18' ' ' TRP . 57.6 m -56.88 -30.37 63.81 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.159 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 1' ' ' MET . 13.9 tp -66.48 -49.55 66.25 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.59 65.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.696 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -68.2 -47.26 68.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.124 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 8.2 tt -63.75 -47.09 82.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.907 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -61.82 -48.38 80.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.042 0.449 . . . . 0.0 110.776 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 72' ' ' ARG . . . -63.14 -27.73 69.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.687 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 HD22 ' HA ' ' A' ' 69' ' ' LEU . 15.4 mt -84.96 -33.1 22.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -85.66 -52.09 6.02 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -116.26 25.15 10.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.76 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.7 ttm180 -61.64 101.16 0.17 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.383 0.611 . . . . 0.0 110.26 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.64 -22.69 7.27 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.779 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.83 80.71 1.33 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.217 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -111.41 -46.79 3.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 66.4 m-85 -131.33 172.75 11.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.894 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.33 151.82 26.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.014 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HB3' ' CE3' ' A' ' 89' ' ' TRP . 56.0 mtt180 -92.53 111.94 23.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.368 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -104.2 103.96 13.81 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.11 115.91 20.78 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.4 pt -110.06 134.98 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.664 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 101.4 13.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.758 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 159.94 30.16 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.692 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.29 -14.72 40.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.348 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.81 7.19 41.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.85 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 119.65 154.36 9.47 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.976 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m -66.04 126.65 29.28 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.493 -0.416 . . . . 0.0 110.335 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.1 148.06 44.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.663 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.442 ' CE3' ' HB3' ' A' ' 78' ' ' ARG . 98.8 m95 -83.32 124.09 30.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.461 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.87 127.76 55.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.564 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.8 118.22 31.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.996 0.427 . . . . 0.0 110.868 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.554 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -100.43 142.26 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.758 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.614 ' HD2' HG13 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -46.85 127.18 9.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.303 174.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.542 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.8 tp-100 -125.76 2.87 7.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.154 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -135.77 138.23 27.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -28.35 128.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.879 4.386 . . . . 0.0 115.939 -170.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG13 ' CD1' ' A' ' 93' ' ' TYR . 15.9 m -90.76 16.2 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.125 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.32 110.48 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.068 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.99 32.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.184 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD21 ' HA ' ' A' ' 38' ' ' LEU . 36.4 mt -98.53 168.2 10.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.095 0.447 . . . . 0.0 110.687 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -99.18 141.95 31.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.272 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.51 HD11 ' HB3' ' A' ' 34' ' ' GLN . 32.6 tp -117.24 125.83 51.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.664 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.546 HD13 HD21 ' A' ' 35' ' ' LEU . 42.5 mt -101.49 87.85 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -12.83 61.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.768 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.8 t -69.4 -50.43 45.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.617 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 109.2 -12.83 33.91 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.542 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.27 151.36 24.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 110.486 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.703 ' HE1' HD23 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -73.5 -31.71 63.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.454 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.29 -74.2 0.6 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.833 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.4 t70 66.51 -48.25 0.44 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -80.98 16.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.561 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 2.7 p30 -89.65 -12.56 39.27 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 166.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 16.9 pttp . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 125.01 1.324 . . . . 0.0 112.448 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.822 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 38.4 tpp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -113.68 128.2 56.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.064 0.459 . . . . 0.0 111.181 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.7 mt -128.41 139.66 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.721 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.579 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 57.2 t80 -96.9 109.64 22.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 9' ' ' LEU . 45.0 t -95.2 106.96 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' OH ' ' HB2' ' A' ' 91' ' ' TYR . 1.2 p90 -87.48 76.13 9.05 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.74 159.45 10.15 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -69.61 89.92 0.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.264 0.532 . . . . 0.0 110.868 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' HB2' HG12 ' A' ' 5' ' ' VAL . 2.1 tm? -79.47 -30.27 42.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.394 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -60.74 -23.6 65.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.674 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -93.08 -47.84 6.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.39 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -99.53 92.05 5.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 0.0 111.969 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -80.73 95.77 6.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.89 -43.04 75.99 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.186 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -140.18 156.23 46.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 m -54.49 -32.72 58.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.242 0.339 . . . . 0.0 111.584 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.469 ' HB3' HG21 ' A' ' 62' ' ' THR . 43.1 m80 -58.12 -31.57 67.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -68.49 -46.23 70.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.516 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.9 ttt -76.33 -28.07 56.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.899 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 m -80.27 131.28 35.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 51.54 17.95 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.894 1.278 . . . . 0.0 112.974 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.08 117.17 19.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.14 0.495 . . . . 0.0 110.606 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.69 114.36 28.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.408 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 tp -67.0 102.59 1.0 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.54 HD13 HG12 ' A' ' 55' ' ' VAL . 81.3 mt -64.46 -32.75 74.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.814 0.816 . . . . 0.0 109.135 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.87 135.78 3.16 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.808 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.37 126.34 29.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.1 0.953 . . . . 0.0 109.772 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.7 118.79 12.65 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.6 m -86.08 125.81 33.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.855 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 50' ' ' THR . 13.5 pt -99.94 130.01 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.712 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 39.0 t0 -92.33 159.14 15.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.984 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 49.5 m-80 73.84 29.97 1.39 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.735 0.647 . . . . 0.0 111.582 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.561 ' CD1' ' HA ' ' A' ' 46' ' ' PRO . 97.7 m-85 -133.04 162.07 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.962 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.583 ' HG3' ' HA3' ' A' ' 47' ' ' GLY . 41.1 mt-30 -123.97 152.26 42.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.9 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.6 tp -118.9 126.01 50.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 111.111 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.412 ' CE1' HD13 ' A' ' 102' ' ' LEU . 68.4 m-85 -92.14 135.19 34.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.874 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.461 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 23.4 t -121.79 96.87 5.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.035 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.531 HD23 ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -101.8 18.03 21.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.613 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.17 -55.8 2.75 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.942 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -58.49 -51.88 68.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 110.483 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.445 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 18.1 p90 -160.11 138.4 7.49 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.846 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 41' ' ' TYR . 5.8 Cg_exo -75.27 159.7 40.09 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.912 2.408 . . . . 0.0 112.448 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.411 ' HA2' ' CE2' ' A' ' 6' ' ' TYR . . . -145.27 125.21 2.29 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.71 144.18 35.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.201 0.5 . . . . 0.0 111.48 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 92' ' ' VAL . 31.7 m -144.88 163.25 34.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.674 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 24.5 Cg_endo -63.84 139.04 66.45 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.138 1.892 . . . . 0.0 112.069 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.583 ' HA3' ' HG3' ' A' ' 34' ' ' GLN . . . -176.34 -120.3 0.61 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.949 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.489 ' C ' HD21 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -145.97 88.76 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.084 0.469 . . . . 0.0 109.985 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 104' ' ' GLU . . . 178.56 163.8 30.47 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.625 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.529 HG21 ' HB3' ' A' ' 29' ' ' SER . 1.9 m -109.3 100.15 9.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.073 0.463 . . . . 0.0 111.076 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.5 t -83.3 121.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.549 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.469 ' O ' ' HZ2' ' A' ' 108' ' ' TRP . 0.2 OUTLIER -77.94 56.27 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 -173.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.579 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -74.63 155.04 47.94 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.768 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -100.89 120.27 39.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG12 HD13 ' A' ' 25' ' ' LEU . 11.2 t -93.99 123.89 46.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.41 146.07 47.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -105.94 104.46 14.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.775 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.76 167.36 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.845 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.83 135.45 24.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.007 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.822 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 87.4 m-20 -54.71 -41.06 69.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.152 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.47 70.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.469 HG21 ' HB3' ' A' ' 17' ' ' HIS . 72.8 m -56.27 -32.2 64.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.952 0.406 . . . . 0.0 110.471 174.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 13.8 tp -67.78 -49.77 60.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.586 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . . . -58.57 -32.39 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.868 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.54 -40.59 56.65 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 66' ' ' LEU . 8.4 tt -64.83 -47.7 77.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 1.8 p30 -67.45 -43.16 81.78 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.194 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.57 68.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.498 0.666 . . . . 0.0 110.779 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.84 -43.05 13.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.796 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 70' ' ' ARG . 21.3 ttt180 -86.68 7.03 28.32 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -169.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 70' ' ' ARG . 0.7 OUTLIER 98.14 -19.16 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.787 1.235 . . . . 0.0 112.338 -178.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.494 ' HD2' ' OD1' ' A' ' 67' ' ' ASP . 34.0 ttt85 62.19 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.408 0.442 . . . . 0.0 111.6 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.54 26.29 2.55 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.237 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.02 -71.56 0.94 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.755 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.0 -34.59 69.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 110.644 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' H ' ' CG2' ' A' ' 71' ' ' THR . 10.7 m-85 -122.5 163.13 20.45 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.444 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.85 141.69 35.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HG2' ' CE2' ' A' ' 91' ' ' TYR . 29.5 mtp180 -93.07 124.27 36.92 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -116.96 107.89 15.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.76 110.13 16.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.9 pt -106.06 144.74 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.023 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.06 104.35 16.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.909 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -98.52 162.69 20.97 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.756 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.99 -21.42 58.33 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.678 2.252 . . . . 0.0 112.613 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.454 ' HB3' HD12 ' A' ' 25' ' ' LEU . 51.8 m-85 -96.7 -3.91 41.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.532 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.14 157.74 9.14 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.669 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 127.47 31.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.546 -0.385 . . . . 0.0 110.602 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.01 150.52 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.842 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -79.25 121.99 25.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.204 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.8 ttt -108.9 116.45 32.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.367 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.431 ' HB2' ' OH ' ' A' ' 6' ' ' TYR . 96.7 m-85 -94.78 107.97 19.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.279 0.562 . . . . 0.0 110.655 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.843 HG11 HG11 ' A' ' 45' ' ' VAL . 4.7 t -76.91 119.63 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.824 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.22 119.43 10.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.37 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -170.9 2.24 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.823 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 72.62 167.91 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.662 0.601 . . . . 0.0 110.775 175.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -54.15 119.18 5.9 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.745 2.296 . . . . 0.0 112.854 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 99' ' ' GLY . 35.4 m -104.88 1.99 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.778 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -64.93 16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . -128.58 15.18 6.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.6 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.531 ' HG ' HD23 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -144.59 176.26 9.54 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.682 -0.305 . . . . 0.0 110.907 177.304 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 54.7 mtpt -76.99 143.96 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.351 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.412 HD13 ' CE1' ' A' ' 36' ' ' TYR . 56.6 tp -110.16 109.75 20.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.84 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.73 91.92 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.69 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -65.87 -26.15 67.51 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -73.56 -15.03 61.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.746 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.666 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 68.92 34.3 76.74 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.183 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.428 ' CG ' ' HA ' ' A' ' 110' ' ' ASP . 2.8 p30 -117.8 178.3 4.46 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.469 ' HZ2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -119.59 -34.44 3.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.336 0.589 . . . . 0.0 109.653 176.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 111' ' ' ARG . 10.5 mp -97.18 -15.85 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.16 -175.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.428 ' HA ' ' CG ' ' A' ' 107' ' ' ASP . 2.8 p30 57.02 2.57 0.11 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.581 1.552 . . . . 0.0 113.204 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -129.1 81.98 2.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.807 0.813 . . . . 0.0 110.37 175.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.54 1.54 56.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.228 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 121.818 0.818 . . . . 0.0 110.928 -176.287 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.876 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 4.0 tmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.444 ' HD2' ' HA3' ' A' ' 86' ' ' GLY . 25.8 mtm180 -123.65 133.74 53.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.541 0.686 . . . . 0.0 112.165 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.411 ' HB ' ' HE2' ' A' ' 1' ' ' MET . 14.3 tt -136.93 148.16 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.486 -176.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 81.4 t80 -92.69 112.01 23.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.74 126.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.174 0.512 . . . . 0.0 111.002 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 11.0 p90 -135.58 -43.68 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.503 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.76 80.46 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.726 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 p 50.46 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.905 0.882 . . . . 0.0 112.119 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.77 -33.44 64.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.754 -177.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -63.06 -60.06 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 52.3 t-80 59.25 -84.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.868 0.73 . . . . 0.0 111.39 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 11' ' ' HIS . 76.4 tttt 174.42 115.68 0.02 OUTLIER 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.811 ' HB2' ' HB2' ' A' ' 19' ' ' MET . 0.0 OUTLIER -126.73 -156.05 0.72 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.023 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.63 -37.82 3.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.396 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.92 -35.3 0.71 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 0.0 110.905 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 18' ' ' TRP . 5.9 m -75.55 169.36 18.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -70.19 9.44 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.039 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.414 ' H ' ' C ' ' A' ' 16' ' ' SER . 50.9 t-105 -76.7 -26.81 55.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 -177.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.811 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 18.0 tpt -100.49 -39.54 7.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.663 . . . . 0.0 110.219 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 m -81.06 134.25 35.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.96 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.535 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 32.4 m-20 75.91 3.13 3.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.698 0.799 . . . . 0.0 111.279 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.6 135.01 43.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.408 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -137.03 143.67 42.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.158 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 tp -79.61 130.12 35.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.635 HD12 HG11 ' A' ' 55' ' ' VAL . 95.6 mt -93.12 -43.01 9.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.856 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.42 176.59 27.77 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.4 147.54 28.72 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.149 0.976 . . . . 0.0 110.779 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -151.82 86.37 1.32 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.586 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.3 m -82.66 124.5 30.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -112.71 126.35 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.881 0.848 . . . . 0.0 111.524 -172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 7.6 p-10 -85.85 156.67 20.45 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.5 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 51.4 m-80 71.01 33.38 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.118 0.886 . . . . 0.0 110.931 -177.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.25 165.31 26.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.952 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -136.24 144.64 44.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.52 HD22 HD13 ' A' ' 103' ' ' ILE . 18.7 tp -105.44 131.24 53.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.471 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -98.87 128.62 45.11 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 p -110.08 126.45 54.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.826 0.346 . . . . 0.0 110.321 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' HB3' HD21 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -140.98 16.75 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.01 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.81 -63.8 3.74 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.48 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -59.7 -45.36 92.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.582 ' HD1' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -167.65 110.88 0.6 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.71 176.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.41 142.75 98.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.65 2.234 . . . . 0.0 112.807 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' HA2' ' HE2' ' A' ' 6' ' ' TYR . . . -120.32 178.57 16.48 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 151.28 29.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.546 0.673 . . . . 0.0 111.318 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 1.048 HG12 HG12 ' A' ' 92' ' ' VAL . 29.1 m -153.56 165.7 17.23 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.9 148.85 52.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.374 2.049 . . . . 0.0 111.343 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.07 -125.92 1.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.187 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -135.41 91.92 2.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.6 -178.24 48.55 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.43 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 23.2 m -122.26 119.89 32.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.916 0.858 . . . . 0.0 110.114 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.69 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 92.9 t -107.01 109.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.44 . . . . 0.0 110.461 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.478 ' O ' ' HH2' ' A' ' 108' ' ' TRP . 7.5 t60 -69.16 119.96 14.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.71 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -128.43 142.85 13.91 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.847 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -98.54 107.66 20.17 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.635 HG11 HD12 ' A' ' 25' ' ' LEU . 57.1 t -80.2 116.98 25.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.79 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.77 150.77 39.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.715 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.422 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 1.8 tmt_? -108.49 107.63 18.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 pt -114.74 169.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.602 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 25.6 t70 -53.5 137.88 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.045 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.876 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 9.0 m120 -63.38 -43.91 96.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.616 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.29 77.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.269 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.602 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 67.7 m -56.82 -29.54 62.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.083 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.788 ' HB2' ' HE1' ' A' ' 1' ' ' MET . 37.2 tp -66.6 -47.88 71.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.56 -32.4 65.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -74.3 -55.05 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.748 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.42 -37.28 85.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.097 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.51 -56.56 19.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.255 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 72' ' ' ARG . . . -55.45 -32.46 62.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.79 -58.11 3.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.973 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.437 ' O ' ' HA3' ' A' ' 74' ' ' GLY . 39.5 ttm180 -85.4 -3.19 58.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 76' ' ' TYR . 75.3 p -106.61 -67.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.649 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 2.3 tmt_? -53.88 -36.55 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.359 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.99 22.71 7.54 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.349 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 70' ' ' ARG . . . -132.22 -29.31 0.56 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.874 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 74.15 18.46 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.568 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' O ' HG21 ' A' ' 71' ' ' THR . 8.3 m-85 -116.22 162.94 16.73 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.12 46.17 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.789 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptt85 -88.89 127.77 35.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 111.636 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -104.14 121.73 43.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.254 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -87.1 112.75 22.22 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.22 133.28 58.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.396 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -86.94 101.2 13.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.562 -176.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 p -93.67 160.47 32.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.74 -3.13 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.798 2.332 . . . . 0.0 112.648 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.06 4.02 13.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.276 0.56 . . . . 0.0 110.067 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.444 ' HA3' ' HD2' ' A' ' 2' ' ' ARG . . . 126.95 149.54 7.27 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.125 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 8.0 m -65.81 122.25 16.88 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.594 -0.356 . . . . 0.0 110.203 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.15 146.32 43.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.82 120.52 25.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -105.58 113.11 26.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.66 116.03 22.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 1.048 HG12 HG12 ' A' ' 45' ' ' VAL . 8.6 t -108.43 143.09 19.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.946 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CE1' HG21 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -46.34 119.12 2.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.475 168.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -104.33 -26.62 12.4 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.637 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.503 ' H ' ' CD ' ' A' ' 96' ' ' PRO . 4.1 ptp180 -162.13 -37.46 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.503 ' CD ' ' H ' ' A' ' 95' ' ' ARG . 98.6 Cg_endo -97.78 103.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.555 1.503 . . . . 0.0 114.749 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG21 ' CE1' ' A' ' 93' ' ' TYR . 5.6 m -145.89 90.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.275 0.56 . . . . 0.0 110.352 169.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.48 24.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . 112.38 -68.86 0.23 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.524 HD21 ' HB3' ' A' ' 38' ' ' LEU . 66.0 mt 61.89 -170.0 0.17 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.13 0.49 . . . . 0.0 111.213 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -109.0 113.25 25.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -87.69 125.31 34.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.19 0.519 . . . . 0.0 110.492 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.52 HD13 HD22 ' A' ' 35' ' ' LEU . 20.6 mt -107.9 92.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -14.51 62.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 110.652 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.2 m -72.73 -22.62 60.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.642 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 62.02 38.52 96.22 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.814 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -142.02 149.73 40.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.478 ' HH2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -89.07 -26.18 21.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 -171.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.83 -28.06 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.643 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.06 76.51 8.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.466 0.65 . . . . 0.0 110.247 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -118.58 -56.62 2.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.903 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -148.05 104.5 3.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.616 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.985 173.178 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.973 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 52.5 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 87' ' ' SER . 10.2 mtt85 -111.82 129.89 55.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 tt -130.53 146.76 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.826 0.346 . . . . 0.0 110.544 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 75.2 t80 -103.31 124.32 48.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.27 130.51 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.23 43.08 2.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.563 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 42' ' ' PRO . . . 152.84 113.74 0.55 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.713 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 10' ' ' ARG . 63.3 p 51.36 103.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.794 0.838 . . . . 0.0 112.79 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -66.54 17.09 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.678 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.511 ' H ' ' C ' ' A' ' 8' ' ' SER . 19.2 mtp180 -58.55 -31.25 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 46.5 106.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.848 1.259 . . . . 0.0 113.726 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.01 121.54 18.38 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.869 -0.519 . . . . 0.0 109.88 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.87 107.34 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.783 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.27 77.47 1.69 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 72.65 173.02 0.3 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -68.94 -16.04 63.64 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.693 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -54.1 -22.61 11.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.918 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.417 ' HA ' HG21 ' A' ' 62' ' ' THR . 52.0 t-105 -88.03 -65.47 1.01 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.093 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.65 -19.73 61.38 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 20' ' ' THR . 23.6 m -85.93 46.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.678 0.751 . . . . 0.0 111.148 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.439 ' HB3' ' O ' ' A' ' 20' ' ' THR . 9.7 p30 163.57 -19.4 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.741 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.0 105.47 0.09 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.793 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -111.82 117.48 32.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.126 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.22 106.29 3.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 HG13 ' A' ' 55' ' ' VAL . 83.3 mt -71.6 -38.31 70.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.352 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.0 157.61 7.25 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.293 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 3.7 p-10 -78.1 143.15 37.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.749 0.785 . . . . 0.0 110.537 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -151.42 116.01 5.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.368 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.3 m -87.59 137.66 32.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.218 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.2 pt -119.99 148.35 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 25.6 t0 -102.28 152.01 21.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 50.9 m-80 77.03 36.33 0.32 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.146 0.978 . . . . 0.0 111.654 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -138.39 136.83 36.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.529 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -111.93 154.32 25.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 42' ' ' PRO . 45.4 tp -118.84 138.2 52.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 0.0 111.749 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.27 147.93 29.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.843 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 20.2 m -116.75 111.82 20.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.511 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -112.05 17.42 19.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.764 -177.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.21 -78.15 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.481 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -62.16 -32.73 73.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.844 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.433 ' CE1' HD12 ' A' ' 38' ' ' LEU . 6.6 p90 -165.99 167.15 9.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.552 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.0 Cg_endo -88.9 -178.74 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.989 2.459 . . . . 0.0 112.396 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.23 129.62 2.07 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -110.84 160.1 17.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.708 0.754 . . . . 0.0 111.563 -173.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.908 HG11 HG12 ' A' ' 92' ' ' VAL . 32.3 m -147.82 161.15 36.11 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.805 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 136.24 36.54 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.303 2.002 . . . . 0.0 111.102 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.8 -126.26 1.02 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.237 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.64 82.48 2.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.924 0.393 . . . . 0.0 110.634 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.08 172.68 43.42 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 46.0 m -126.89 106.75 9.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.305 0.552 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 93.7 t -84.06 114.07 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.5 59.16 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.066 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -82.84 165.98 44.42 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.458 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 28.6 mp0 -107.62 124.07 49.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.278 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.485 HG13 HD12 ' A' ' 25' ' ' LEU . 34.0 t -88.17 128.2 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.644 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -123.38 150.99 43.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.873 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -113.69 118.41 34.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.724 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 1' ' ' MET . 2.0 pp -132.45 164.84 33.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.899 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.571 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 13.3 t70 -51.76 143.57 12.74 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.973 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 3.7 m-20 -57.97 -44.96 87.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.43 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.954 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 19.1 m -56.43 -38.13 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 0.0 110.965 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 1' ' ' MET . 10.2 tp -66.54 -52.33 46.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.69 65.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.851 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 -48.97 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.341 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -39.53 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.033 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.78 -50.37 72.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.42 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 72' ' ' ARG . . . -63.74 -19.69 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.91 -49.25 8.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.457 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -75.08 -54.06 7.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.983 -173.539 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 76' ' ' TYR . 6.6 t -119.5 41.95 2.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.17 0.986 . . . . 0.0 110.443 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 53.7 ttt180 -47.74 -42.84 26.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.787 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.09 13.41 19.43 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.56 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.37 83.79 1.56 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.705 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -127.01 -23.67 3.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.027 0.441 . . . . 0.0 110.327 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.528 ' HD2' ' HB ' ' A' ' 71' ' ' THR . 91.4 m-85 -131.24 166.18 21.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.5 127.61 55.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.043 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -86.04 106.96 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -104.93 105.9 16.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -79.79 112.15 16.79 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.57 152.81 10.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.56 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.471 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -99.15 109.61 22.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.235 0.54 . . . . 0.0 111.773 -176.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -96.53 165.62 15.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.89 -2.26 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.45 2.1 . . . . 0.0 112.466 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -120.83 15.63 11.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.017 0.437 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.25 157.42 10.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.218 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.408 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 9.2 p -66.37 130.4 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.4 151.33 44.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.335 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -85.65 123.19 30.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 111.41 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.41 ' HE1' ' HB2' ' A' ' 44' ' ' ALA . 21.4 ttt -107.79 124.06 49.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.562 175.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -91.33 116.21 28.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.908 HG12 HG11 ' A' ' 45' ' ' VAL . 7.2 t -94.63 126.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.499 ' HD1' ' CE1' ' A' ' 76' ' ' TYR . 40.2 t80 -75.29 127.14 32.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.108 0.956 . . . . 0.0 110.808 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' NE2' HG13 ' A' ' 92' ' ' VAL . 28.2 mm-40 -89.44 -161.99 0.83 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.172 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.569 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 38.2 mmt180 70.91 169.38 0.12 Allowed Pre-proline 0 N--CA 1.467 0.391 0 O-C-N 123.358 0.411 . . . . 0.0 110.743 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.569 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 18.8 Cg_endo -62.32 134.05 46.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.278 1.985 . . . . 0.0 111.658 171.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.36 10.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.62 126.67 28.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.284 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.76 57.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 38' ' ' LEU . 41.6 mt -86.23 159.84 19.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.811 0.306 . . . . 0.0 110.305 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 48.1 mtmt -88.78 119.09 28.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 57.4 tp -97.17 121.52 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 107' ' ' ASP . 29.4 mt -101.62 94.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.13 -21.03 66.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.03 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 p -73.26 -44.12 59.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 106.53 10.03 29.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.318 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' CG ' ' HA ' ' A' ' 110' ' ' ASP . 2.7 p30 -111.64 178.8 4.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.43 ' CE3' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -110.58 -41.21 4.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.766 0.793 . . . . 0.0 109.487 173.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -124.88 19.8 8.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.489 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.457 ' HA ' ' CG ' ' A' ' 107' ' ' ASP . 32.2 t70 55.96 -107.54 0.39 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.52 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -127.08 4.44 6.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.866 0.841 . . . . 0.0 108.785 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.48 65.98 1.42 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.0 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.588 ' HB2' ' HZ1' ' A' ' 113' ' ' LYS . 9.4 mtmp? . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.844 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.937 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 45.0 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 143.74 33.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.838 0.352 . . . . 0.0 110.565 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.2 146.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.242 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.633 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 73.7 t80 -92.86 113.55 25.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.831 0.348 . . . . 0.0 110.287 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.8 147.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.58 67.4 1.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -175.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.21 -163.46 48.95 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.483 ' C ' ' H ' ' A' ' 10' ' ' ARG . 73.0 p 50.55 22.76 1.13 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.898 0.479 . . . . 0.0 112.204 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -70.79 6.06 1.66 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.598 0.713 . . . . 0.0 110.252 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 8' ' ' SER . 15.8 mmm180 -63.8 -42.63 97.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.999 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -87.25 74.34 9.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.569 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 7.3 ttpm? -86.32 69.64 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.701 0.763 . . . . 0.0 109.722 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -173.27 -166.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.653 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.57 -61.09 0.25 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -136.2 -69.82 0.48 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -164.41 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.962 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.579 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 53.0 m-70 -58.61 -18.95 34.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.024 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.409 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 68.6 t-105 -78.09 -65.47 0.97 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.777 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 ptm -64.81 -30.79 71.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -82.09 -28.99 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.076 0.465 . . . . 0.0 111.604 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 10.6 m120 -114.81 16.89 17.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.322 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 18' ' ' TRP . . . -91.63 121.22 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.133 0.492 . . . . 0.0 112.075 -176.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.447 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 57.8 tt0 -114.86 129.0 56.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.705 172.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.8 tp -78.95 104.14 9.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.015 0.436 . . . . 0.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.581 HD12 HG11 ' A' ' 55' ' ' VAL . 94.1 mt -70.05 -45.23 67.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.32 168.08 12.32 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.545 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.66 151.86 46.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.163 0.506 . . . . 0.0 109.824 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -156.71 87.05 1.0 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.872 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 15.5 m -77.53 129.25 35.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.08 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.04 134.13 59.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -82.8 156.42 23.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.993 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 67.54 33.97 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.025 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.41 172.09 12.6 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.516 ' HB3' HD11 ' A' ' 102' ' ' LEU . 19.6 mt-30 -139.96 157.0 46.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 43' ' ' GLY . 35.4 tp -123.4 128.75 50.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.836 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.446 ' CE1' HG21 ' A' ' 97' ' ' VAL . 88.2 m-85 -91.06 140.9 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.15 0.5 . . . . 0.0 112.127 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 68.5 m -113.86 109.94 19.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.31 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HB3' HD21 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -121.27 6.29 10.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.363 174.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.56 4.52 Favored Glycine 0 C--O 1.229 -0.186 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.989 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 41' ' ' TYR . 15.5 t60 -61.95 -47.27 85.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.784 0.326 . . . . 0.0 111.036 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.454 ' CE2' ' HD2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -167.42 155.53 8.64 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.644 175.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.01 148.15 19.3 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.938 2.426 . . . . 0.0 113.643 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.545 ' O ' HD13 ' A' ' 35' ' ' LEU . . . -120.64 160.33 15.12 Favored Glycine 0 C--O 1.227 -0.337 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.33 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.991 0.896 . . . . 0.0 111.6 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.811 HG11 ' HD2' ' A' ' 93' ' ' TYR . 33.7 m -154.46 167.09 14.56 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.81 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.13 157.04 54.89 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.393 2.062 . . . . 0.0 111.84 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.09 -119.41 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -145.53 92.14 2.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.856 0.36 . . . . 0.0 110.085 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 165.1 33.14 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.354 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 m -101.75 101.85 12.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.875 0.369 . . . . 0.0 110.275 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 70.1 t -82.81 106.72 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.792 -174.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -69.52 107.53 3.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.939 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.633 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -123.09 147.2 16.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.1 mp0 -103.9 107.25 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.581 HG11 HD12 ' A' ' 25' ' ' LEU . 26.0 t -81.35 117.07 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.062 0.458 . . . . 0.0 110.223 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -115.29 147.71 40.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.455 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 52.8 ttt180 -108.95 131.93 54.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.986 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.757 HD13 HD22 ' A' ' 63' ' ' LEU . 1.7 pp -140.73 164.14 21.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.667 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.67 142.15 15.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.539 0.209 . . . . 0.0 111.18 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.937 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 95.7 m-20 -54.51 -48.64 71.66 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 0.0 110.979 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.19 75.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.085 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.579 ' OG1' ' HB3' ' A' ' 17' ' ' HIS . 75.5 m -56.27 -37.0 69.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.835 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.757 HD22 HD13 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -66.82 -42.13 86.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -23.67 66.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.843 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.85 -48.5 45.6 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.15 -34.73 78.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.46 -54.87 41.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.499 0.666 . . . . 0.0 110.92 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.76 68.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.39 -56.27 3.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 71' ' ' THR . 39.8 ttt180 -85.19 7.14 22.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.43 ' CB ' ' O ' ' A' ' 70' ' ' ARG . 0.5 OUTLIER 98.4 124.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.602 1.189 . . . . 0.0 111.066 -173.516 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -89.26 -24.96 21.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.707 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.37 47.16 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.223 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.99 -55.75 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 4.6 tp10 -79.46 -37.82 36.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 38.5 m-85 -142.6 170.38 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.579 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.96 152.09 36.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -88.93 125.22 34.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -105.18 121.63 44.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.6 tp -91.82 114.69 27.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 87' ' ' SER . 7.3 pt -114.02 148.98 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -90.43 108.54 19.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.719 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 1.4 p -100.02 163.42 18.39 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 83' ' ' THR . 17.7 Cg_endo -61.54 -16.04 45.33 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.481 2.12 . . . . 0.0 112.064 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -97.91 -2.66 40.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.9 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.51 160.21 10.85 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 66.4 m -63.95 121.29 13.74 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.138 0.494 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.64 148.68 30.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.674 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.46 124.28 31.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.183 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.467 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 85.2 mtp -106.7 170.28 8.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.039 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -127.69 117.72 22.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.871 0.367 . . . . 0.0 110.415 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.568 HG11 HG13 ' A' ' 45' ' ' VAL . 4.0 t -101.59 136.82 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.696 0.76 . . . . 0.0 111.189 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.811 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -51.68 120.64 5.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.739 175.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.96 1.35 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.752 -176.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.432 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 68.8 mtp180 -132.16 146.61 62.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.25 121.78 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.561 3.507 . . . . 0.0 114.598 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG11 HD13 ' A' ' 100' ' ' LEU . 12.8 m -104.52 14.48 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.862 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.56 96.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.013 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.84 5.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.327 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.49 HD13 HG11 ' A' ' 97' ' ' VAL . 87.2 mt -89.87 165.7 13.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.335 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 30.1 mmmt -90.29 132.25 35.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 34' ' ' GLN . 64.6 tp -105.93 107.78 18.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.374 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 107' ' ' ASP . 51.5 mt -82.12 89.02 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.98 -9.55 39.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.178 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 m -70.79 -27.16 63.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.024 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 85.66 -13.37 56.29 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.171 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' O ' HG22 ' A' ' 103' ' ' ILE . 5.4 t70 -100.42 141.35 33.38 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.384 -0.48 . . . . 0.0 110.223 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -70.02 -30.96 68.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.551 . . . . 0.0 110.228 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.61 ' HB3' ' HA ' ' A' ' 112' ' ' ASP . 3.0 mm? -81.39 -36.05 30.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.955 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.68 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.104 0.878 . . . . 0.0 112.262 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.37 -33.71 76.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.61 ' HA ' ' HB3' ' A' ' 109' ' ' LEU . 17.1 t0 57.57 96.69 0.02 OUTLIER 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.569 171.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.0 pttt . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 122.16 0.981 . . . . 0.0 110.301 174.14 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.517 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 25.1 ttm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.471 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -117.61 144.73 44.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 111.188 -175.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.482 ' HB ' HD21 ' A' ' 63' ' ' LEU . 10.6 tt -139.82 150.66 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.908 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -97.22 115.74 28.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG12 ' HA ' ' A' ' 9' ' ' LEU . 16.5 t -102.31 158.82 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -152.17 118.33 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.035 0.445 . . . . 0.0 111.447 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.32 -85.17 1.33 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.321 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -75.42 80.15 2.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.077 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HA ' HG12 ' A' ' 5' ' ' VAL . 2.7 pt? -76.98 -21.18 55.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -80.55 -55.91 4.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.43 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.5 p80 41.11 75.92 0.08 Allowed 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.843 0.714 . . . . 0.0 110.816 -171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt 67.48 -95.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.933 -169.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER 66.0 143.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.858 0.724 . . . . 0.0 111.305 -177.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.56 -15.21 4.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.14 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -148.38 -28.13 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.552 0.215 . . . . 0.0 111.219 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -64.31 163.41 13.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.7 -18.22 40.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.152 0.501 . . . . 0.0 110.711 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.521 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 52.3 t-105 -58.66 -27.6 64.93 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.059 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.2 ttp -81.64 -33.04 31.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.895 0.379 . . . . 0.0 111.467 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 m -91.61 -54.12 4.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -99.16 10.64 41.04 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 18' ' ' TRP . . . -66.73 116.78 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 111.684 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.8 tt0 -107.31 119.5 39.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.718 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 tp -81.66 98.39 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.488 . . . . 0.0 109.859 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.675 HD13 HG13 ' A' ' 55' ' ' VAL . 88.8 mt -64.9 -41.78 95.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.711 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.37 153.36 6.08 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.614 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-20 -69.57 143.42 53.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.503 ' HB3' HG21 ' A' ' 55' ' ' VAL . 17.2 t80 -154.48 114.03 3.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.0 m -100.56 132.6 45.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.106 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 50' ' ' THR . 16.3 pt -114.03 141.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.423 . . . . 0.0 111.164 -175.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.26 160.07 14.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.036 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 73.8 28.94 1.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.594 0.758 . . . . 0.0 111.506 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.67 142.28 46.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.467 ' HB3' HD13 ' A' ' 102' ' ' LEU . 49.9 mt-30 -116.05 148.42 40.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.533 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . 12.4 tp -103.44 139.33 38.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.488 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.45 134.91 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.5 p -116.49 128.49 55.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.991 0.424 . . . . 0.0 110.131 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.462 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -133.73 17.36 3.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.317 172.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.72 -59.2 4.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.955 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -89.08 -0.77 57.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -156.62 134.09 6.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 121.78 0.38 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.939 2.426 . . . . 0.0 111.378 166.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.69 16.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.645 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.432 ' O ' HG21 ' A' ' 92' ' ' VAL . . . -145.47 146.53 31.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.658 0.729 . . . . 0.0 110.585 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.893 HG11 HG12 ' A' ' 92' ' ' VAL . 27.3 m -149.44 164.0 22.76 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 123.404 0.44 . . . . 0.0 110.489 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.18 136.47 56.13 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.401 2.067 . . . . 0.0 111.805 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.05 -122.54 0.77 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.826 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.421 HD21 ' HA ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -143.05 92.18 2.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.708 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.91 167.71 37.49 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.856 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.1 m -115.03 111.47 21.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.8 t -84.91 118.68 32.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.004 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -78.96 97.9 6.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.68 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -130.71 172.16 20.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.459 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 27.4 mp0 -120.12 133.65 55.46 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.757 0.423 . . . . 0.0 109.886 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.675 HG13 HD13 ' A' ' 25' ' ' LEU . 31.6 t -91.27 120.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.546 ' HH ' HD12 ' A' ' 9' ' ' LEU . 16.1 m-85 -118.14 157.88 26.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.319 0.581 . . . . 0.0 112.008 -176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.3 tmt_? -127.2 124.12 38.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.631 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.41 -173.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.767 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 62' ' ' THR . 3.7 m-20 -52.11 153.11 2.86 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.683 0.277 . . . . 0.0 110.617 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.0 p-10 -65.42 -38.87 91.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.18 85.13 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.993 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.403 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 89.1 m -56.97 -30.26 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.074 0.464 . . . . 0.0 111.373 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.5 tm? -65.48 -48.55 72.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.05 66.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.13 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -49.1 31.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.027 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.62 -36.64 84.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.4 -54.59 45.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.77 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.15 -28.63 69.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.636 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 69' ' ' LEU . 17.4 mt -79.17 -47.72 15.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.637 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -81.62 -49.64 10.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t -107.19 -31.08 8.39 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.357 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 52.1 -90.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.53 0.732 . . . . 0.0 112.421 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.79 25.23 20.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.48 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.37 42.99 13.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.19 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -68.44 -31.11 70.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' VAL . 12.0 m-85 -119.37 159.75 23.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.285 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.31 124.9 47.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.765 0.317 . . . . 0.0 110.652 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -79.15 123.53 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.892 0.854 . . . . 0.0 110.766 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.7 145.93 29.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.513 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.06 113.3 25.74 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.205 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.9 pt -110.24 140.98 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.352 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -91.37 102.97 15.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -99.83 158.04 32.82 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.71 -18.38 55.21 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 49.8 m-85 -99.05 -3.16 35.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.834 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.36 161.06 9.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.288 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 p -67.08 107.19 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 110.464 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.71 145.97 29.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.887 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -83.62 125.43 31.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 ttt -114.75 116.64 28.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.41 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.59 108.13 19.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 112.026 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.893 HG12 HG11 ' A' ' 45' ' ' VAL . 4.3 t -81.15 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.815 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.552 ' HD1' HG11 ' A' ' 97' ' ' VAL . 7.2 t80 -63.59 119.84 10.61 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.425 ' HG3' ' H ' ' A' ' 95' ' ' ARG . 3.3 tp-100 -108.03 -166.51 1.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.467 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 31.7 mtp85 66.92 -177.43 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 54.2 Cg_exo -54.73 100.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.714 1.609 . . . . 0.0 112.468 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.552 HG11 ' HD1' ' A' ' 93' ' ' TYR . 26.9 m -93.53 -10.8 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.677 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.79 103.99 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.529 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.6 -12.05 4.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.077 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 38' ' ' LEU . 73.2 mt -78.24 162.23 26.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -93.2 109.05 20.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.467 HD13 ' HB3' ' A' ' 34' ' ' GLN . 61.6 tp -73.75 139.02 44.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.461 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.699 HG23 ' HD3' ' A' ' 111' ' ' ARG . 62.7 mt -124.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.269 174.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.02 -15.58 63.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.46 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -70.99 -20.8 62.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.12 73.91 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.531 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 12.2 t70 -134.05 137.19 44.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -71.85 -29.2 64.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.805 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -116.84 11.48 14.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.454 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 30.1 t70 -82.2 -59.28 2.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.169 0.509 . . . . 0.0 111.146 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.699 ' HD3' HG23 ' A' ' 103' ' ' ILE . 39.4 mtp85 -92.31 11.9 24.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.601 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.27 -48.99 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.391 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.559 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 9.6 mtmp? . . . . . 0 N--CA 1.47 0.55 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.48 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.939 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 43.8 tpp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -134.12 125.77 28.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.093 0.473 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.56 145.96 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -86.49 111.82 20.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 0.0 110.004 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 83.9 t -91.6 136.1 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.494 ' CD1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -100.22 33.45 2.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.634 -174.211 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.7 -160.08 50.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.562 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.421 ' HB3' ' CE2' ' A' ' 108' ' ' TRP . 91.6 p 62.81 -48.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.166 1.387 . . . . 0.0 113.813 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.924 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.4 mp -60.62 -15.6 29.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -53.18 -17.45 1.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -54.13 -50.59 66.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.808 0.337 . . . . 0.0 110.491 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -139.8 123.2 17.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.924 HE22 ' HB3' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -140.29 -55.03 0.53 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.188 0.518 . . . . 0.0 110.663 -173.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 19' ' ' MET . . . -82.51 64.47 4.27 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.846 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -136.05 2.83 2.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 0.0 110.244 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 p -164.13 -172.95 2.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -67.81 -13.62 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.038 0.212 . . . . 0.0 110.919 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.4 -43.85 96.28 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.967 0.413 . . . . 0.0 110.069 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.557 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.4 -100.84 0.37 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.408 ' H ' ' HB3' ' A' ' 19' ' ' MET . 61.5 m 43.71 -78.29 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.841 0.857 . . . . 0.0 112.952 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' MET . 62.8 m-20 -91.71 -8.6 46.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.653 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' CB ' HG21 ' A' ' 58' ' ' ILE . . . -55.71 139.06 46.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.691 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -124.09 121.15 34.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.677 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.32 106.25 1.32 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD11 HG12 ' A' ' 55' ' ' VAL . 84.4 mt -66.68 -38.32 86.55 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.03 159.83 10.11 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.918 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.27 145.26 54.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -139.15 115.04 10.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.553 ' HB3' ' HB3' ' A' ' 52' ' ' HIS . 5.8 p -100.96 131.01 47.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.592 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 pt -117.38 130.39 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.361 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.48 151.71 21.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.871 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.72 33.97 2.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.932 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.95 154.15 51.81 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.543 ' HB3' HD11 ' A' ' 102' ' ' LEU . 38.2 mt-30 -128.13 156.8 42.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.529 HD23 HD13 ' A' ' 103' ' ' ILE . 15.3 tp -114.2 130.25 56.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.585 0.231 . . . . 0.0 110.758 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CE1' HD12 ' A' ' 102' ' ' LEU . 86.0 m-85 -99.96 132.34 45.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.609 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.1 m -99.37 102.24 13.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HB3' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -118.75 12.55 13.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.708 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.06 -51.15 4.06 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.035 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.4 -42.3 91.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' CE1' HD13 ' A' ' 38' ' ' LEU . 8.2 p90 -175.05 153.85 1.64 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 6' ' ' TYR . 16.6 Cg_exo -70.24 112.02 3.06 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.237 1.958 . . . . 0.0 111.678 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -90.48 159.51 27.23 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.276 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 34' ' ' GLN . . . -141.83 139.57 32.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.749 0.775 . . . . 0.0 111.433 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 92' ' ' VAL . 26.9 m -145.57 163.22 32.83 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.386 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.16 146.43 76.3 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.547 2.164 . . . . 0.0 111.488 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.0 -111.36 0.39 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.79 92.12 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.08 47.5 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m -124.87 103.86 8.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 117.801 0.801 . . . . 0.0 110.529 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.555 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 77.3 t -84.16 104.08 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 1.8 p80 -95.35 94.89 8.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.449 0.642 . . . . 0.0 110.699 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.15 10.4 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.179 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 28.3 mt-10 -127.0 124.66 39.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.519 HG12 HD11 ' A' ' 25' ' ' LEU . 72.0 t -93.16 118.97 40.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.087 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.14 148.05 40.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.132 0.491 . . . . 0.0 112.054 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -106.87 114.79 29.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.889 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.458 HG21 ' CB ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -127.25 174.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -52.88 144.4 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.956 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.939 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.3 m-20 -60.02 -36.02 76.35 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.424 0.631 . . . . 0.0 109.451 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.54 71.99 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.93 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 m -56.42 -40.44 74.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.67 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 39.1 tp -67.99 -46.69 70.6 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.84 68.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.5 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.15 -43.11 44.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.322 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.64 -42.72 98.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.26 -50.66 73.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.892 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.07 -28.69 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.467 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.0 mt -86.57 -55.36 3.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.603 ' HD3' ' HD2' ' A' ' 76' ' ' TYR . 41.5 ttm180 -85.45 -44.65 12.56 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -168.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.452 HG22 ' HH ' ' A' ' 91' ' ' TYR . 70.3 p -97.11 -8.82 29.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.653 -169.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -58.12 -33.36 69.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.378 0.609 . . . . 0.0 109.685 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.56 -52.05 3.86 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.281 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.72 53.92 0.3 Allowed Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' HG2' ' NH2' ' A' ' 95' ' ' ARG . 25.6 mt-10 -89.5 -54.57 4.02 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.603 ' HD2' ' HD3' ' A' ' 70' ' ' ARG . 12.7 m-85 -131.9 170.21 15.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.879 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.4 149.93 21.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HD2' ' CE3' ' A' ' 89' ' ' TRP . 20.7 tpp85 -102.33 134.87 44.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.121 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 10.1 tt0 -135.09 152.5 51.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -119.44 117.55 28.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.849 0.357 . . . . 0.0 110.383 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 pt -109.07 148.73 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.323 0.582 . . . . 0.0 111.292 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -96.75 126.96 42.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.305 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.2 p -122.11 159.92 49.73 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.409 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.4 -10.46 26.17 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.395 2.064 . . . . 0.0 111.582 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.509 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 10.8 m-85 -106.97 12.79 28.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.028 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.75 -103.09 0.59 Allowed Glycine 0 C--O 1.217 -0.927 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.144 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.0 t -172.86 133.17 0.55 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.47 144.39 51.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.942 0.401 . . . . 0.0 111.755 -170.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . 0.525 ' CE3' ' HD2' ' A' ' 78' ' ' ARG . 96.3 m95 -82.01 127.25 32.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.303 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.459 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 25.8 ttt -109.13 155.1 21.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.053 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.452 ' HH ' HG22 ' A' ' 71' ' ' THR . 15.0 m-85 -123.83 130.63 52.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.372 . . . . 0.0 110.859 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.574 HG11 HG11 ' A' ' 45' ' ' VAL . 3.3 t -108.4 134.07 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 121.66 0.743 . . . . 0.0 110.836 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.628 ' CE2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -50.71 134.45 24.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.471 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.557 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 1.9 tp-100 -135.22 33.65 3.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.797 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.529 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 27.4 mmt85 -131.31 -177.03 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.345 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.529 ' CD ' ' HB3' ' A' ' 95' ' ' ARG . 6.3 Cg_exo -75.72 135.2 17.5 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.749 1.632 . . . . 0.0 112.674 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.996 HG12 HD13 ' A' ' 100' ' ' LEU . 2.3 m -101.49 11.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -62.73 -6.09 3.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 29.21 1.79 Allowed Glycine 0 C--N 1.308 -1.028 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.312 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.996 HD13 HG12 ' A' ' 97' ' ' VAL . 43.2 mt -113.83 165.08 12.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.851 -0.205 . . . . 0.0 110.548 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -102.81 124.77 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 34' ' ' GLN . 66.5 tp -84.16 143.59 29.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.881 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.529 HD13 HD23 ' A' ' 35' ' ' LEU . 44.8 mt -107.97 94.51 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.22 24.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.064 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 103' ' ' ILE . 59.7 m -161.27 15.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.295 -0.253 . . . . 0.0 111.522 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 52.65 22.82 12.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.476 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 5.9 p-10 -98.99 178.89 4.8 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.943 0.871 . . . . 0.0 108.745 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.583 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 67.2 t-105 -121.69 -38.68 2.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.583 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 46.0 mt -143.29 67.64 1.3 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.403 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -137.91 91.02 2.54 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.658 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.88 -55.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.717 173.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -126.66 -124.61 0.24 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.894 0.378 . . . . 0.0 110.467 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt . . . . . 0 N--CA 1.466 0.345 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.253 -179.731 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.008 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 47.1 tpp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.69 51.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.238 -0.289 . . . . 0.0 110.435 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.564 ' HB ' HD21 ' A' ' 63' ' ' LEU . 13.0 tt -140.37 147.81 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.255 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.671 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 84.0 t80 -96.83 111.33 23.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.4 t -96.18 123.32 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.542 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.472 ' CE1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -80.93 71.16 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.514 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.0 -89.97 0.68 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.699 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.6 p -50.92 113.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.57 -23.09 19.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.627 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -46.56 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.94 0.775 . . . . 0.0 112.154 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 24.0 m170 59.17 -99.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.174 0.59 . . . . 0.0 111.753 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -143.9 111.93 6.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.049 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -140.41 109.75 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 109.705 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.98 -20.68 0.1 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.645 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -159.26 -26.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 18' ' ' TRP . 12.6 m -68.7 160.93 29.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.186 0.517 . . . . 0.0 111.406 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.57 9.29 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.617 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.451 ' H ' ' C ' ' A' ' 16' ' ' SER . 21.7 t-105 -52.41 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.671 0.607 . . . . 0.0 111.872 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.32 93.13 3.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.4 m -148.21 -43.8 0.16 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.078 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -130.59 25.66 5.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.081 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 104.92 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.812 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -96.07 122.1 38.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.619 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.3 tp -73.53 106.4 5.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.08 -44.17 18.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.9 157.53 8.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.586 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.3 p30 -77.63 158.27 29.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.499 0.666 . . . . 0.0 110.458 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.07 90.17 1.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -79.87 129.38 34.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -122.91 141.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 111.296 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.9 165.65 13.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 83.5 m-20 69.55 28.7 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.824 0.703 . . . . 0.0 112.081 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.49 157.79 45.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.274 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.577 ' HB3' HD11 ' A' ' 102' ' ' LEU . 34.9 mt-30 -126.31 152.76 45.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.497 HD11 ' O ' ' A' ' 43' ' ' GLY . 38.1 tp -119.02 125.94 50.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 110.565 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.537 ' CE1' HG12 ' A' ' 97' ' ' VAL . 96.4 m-85 -96.72 137.41 35.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.783 0.325 . . . . 0.0 110.721 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.5 p -109.63 101.86 10.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.337 0.589 . . . . 0.0 109.541 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.562 ' HB3' HD21 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -107.37 2.6 24.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.118 -178.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.74 153.23 18.57 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.9 m80 70.72 -54.58 0.65 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.363 0.601 . . . . 0.0 111.043 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -158.18 129.29 3.74 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.311 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.472 ' HD2' ' CE1' ' A' ' 6' ' ' TYR . 13.1 Cg_exo -72.77 177.88 7.06 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.563 2.175 . . . . 0.0 112.734 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.497 ' O ' HD11 ' A' ' 35' ' ' LEU . . . -150.93 161.01 28.89 Favored Glycine 0 C--O 1.224 -0.507 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.56 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -131.81 158.13 42.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.139 0.969 . . . . 0.0 111.7 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.834 HG11 HG13 ' A' ' 92' ' ' VAL . 35.1 m -150.98 163.38 23.87 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.715 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.71 161.97 39.38 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.585 2.19 . . . . 0.0 111.931 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.54 -127.84 1.9 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.585 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 4.2 t-20 -146.28 89.03 1.83 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 109.71 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.45 168.94 41.67 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -103.55 112.13 24.9 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.09 0.445 . . . . 0.0 111.148 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 69.2 t -98.26 114.58 36.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.561 ' HB2' ' CZ3' ' A' ' 108' ' ' TRP . 99.5 m-70 -78.93 105.28 10.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.474 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.671 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -117.55 168.32 12.92 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.553 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 40.7 mt-10 -131.16 128.54 40.26 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG11 ' HB2' ' A' ' 85' ' ' TYR . 60.9 t -92.01 117.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.158 0.504 . . . . 0.0 110.271 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.63 154.9 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.615 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -108.92 130.43 55.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.476 HD12 HD22 ' A' ' 63' ' ' LEU . 1.6 pp -143.22 172.06 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.024 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.488 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 56.7 m-20 -51.09 141.87 13.38 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.242 0.339 . . . . 0.0 110.61 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 1.008 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.5 m-20 -55.51 -39.62 70.73 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.709 0.766 . . . . 0.0 109.264 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -36.99 85.57 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.631 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 59' ' ' ASP . 34.2 m -55.61 -38.33 69.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 111.119 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.564 HD21 ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -66.85 -50.73 61.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.247 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -29.49 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.793 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.54 -50.82 56.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.307 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.48 -39.38 90.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 -45.43 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.841 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.68 69.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 111.283 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.67 -53.91 4.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.364 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -85.64 -41.6 15.06 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -106.74 -67.56 0.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -173.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 60.57 -68.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.577 0.751 . . . . 0.0 111.05 -169.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.77 -95.73 1.13 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.652 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.77 42.98 0.73 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.477 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -61.13 -39.43 90.0 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 93' ' ' TYR . 29.1 m-85 -135.01 160.34 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.624 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.488 ' HB3' ' OE1' ' A' ' 94' ' ' GLN . . . -88.6 136.82 32.8 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.42 102.34 11.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.18 100.65 10.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.411 -174.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD12 ' HB2' ' A' ' 87' ' ' SER . 48.4 tp -76.87 106.58 8.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.986 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.8 pt -101.47 139.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.682 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.444 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 tp-100 -86.36 106.2 17.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.835 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -103.33 162.0 21.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.62 -21.08 71.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.431 2.087 . . . . 0.0 112.019 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HB2' HG11 ' A' ' 55' ' ' VAL . 20.7 m-85 -90.66 -4.44 56.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.344 0.593 . . . . 0.0 109.994 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.51 166.76 12.39 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.552 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.508 ' HB2' HD12 ' A' ' 80' ' ' LEU . 7.8 p -66.86 121.38 15.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.08 146.5 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.786 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.88 121.4 28.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 21.4 ttt -105.74 152.12 23.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.474 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.31 120.81 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.539 0.209 . . . . 0.0 110.851 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.834 HG13 HG11 ' A' ' 45' ' ' VAL . 4.1 t -107.94 124.46 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.395 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . 23.8 t80 -62.43 118.78 7.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.607 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.488 ' OE1' ' HB3' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -88.21 -33.86 17.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.768 -170.19 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 95' ' ' ARG . 41.7 mtm180 -83.03 161.73 56.89 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.4 133.43 56.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.883 2.389 . . . . 0.0 112.547 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.537 HG12 ' CE1' ' A' ' 36' ' ' TYR . 12.4 m -77.67 69.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 122.171 0.986 . . . . 0.0 110.092 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -42.84 -70.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.257 -1.792 . . . . 0.0 112.796 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.99 60.83 0.61 Allowed Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.031 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.562 HD21 ' HB3' ' A' ' 38' ' ' LEU . 19.2 mt -111.64 155.79 22.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.652 0.263 . . . . 0.0 110.359 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -98.42 116.19 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' A' ' 34' ' ' GLN . 52.2 tp -90.47 127.1 36.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.372 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.536 ' C ' ' H ' ' A' ' 105' ' ' SER . 5.9 mt -94.99 98.66 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.78 24.56 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.532 0.733 . . . . 0.0 112.786 176.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.536 ' H ' ' C ' ' A' ' 103' ' ' ILE . 42.3 m -160.92 17.45 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.288 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 35.65 50.99 1.07 Allowed Glycine 0 C--N 1.348 1.236 0 O-C-N 124.184 0.928 . . . . 0.0 114.985 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.407 ' O ' HD12 ' A' ' 103' ' ' ILE . 6.5 t70 -135.37 132.91 38.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.44 . . . . 0.0 110.824 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.561 ' CZ3' ' HB2' ' A' ' 52' ' ' HIS . 5.5 p90 -96.9 -8.07 31.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.708 0.766 . . . . 0.0 110.018 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 2.0 mt -107.35 17.74 22.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.143 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.34 68.64 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.236 1.017 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.7 ptt85 -147.96 -107.92 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 t0 56.88 30.62 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 157.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.7 tttt . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 122.433 1.111 . . . . 0.0 109.388 179.282 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.644 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 31.6 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -120.36 146.9 45.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 117.866 0.303 . . . . 0.0 111.168 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.585 ' HB ' HD22 ' A' ' 63' ' ' LEU . 11.9 tt -142.45 140.11 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.599 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 56.0 t80 -88.0 113.65 23.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 87.9 t -91.6 133.93 31.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.54 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.444 ' HH ' ' HA ' ' A' ' 90' ' ' MET . 0.6 OUTLIER -98.1 -81.66 0.43 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.405 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' H ' ' HB2' ' A' ' 6' ' ' TYR . . . -62.16 128.99 42.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.784 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.6 m -45.63 110.33 0.24 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 112.405 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.504 HD22 HG21 ' A' ' 20' ' ' THR . 26.8 tp -96.75 11.47 35.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.585 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.46 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 37.0 mtt180 -66.64 6.96 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.431 -1.258 . . . . 0.0 112.046 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -73.79 -14.02 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.625 ' HG2' ' HA ' ' A' ' 21' ' ' ASN . 17.9 tttp 72.98 8.27 5.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.234 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.406 ' HA ' ' CB ' ' A' ' 20' ' ' THR . 11.2 tm0? -175.33 115.8 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.92 -38.65 1.38 Allowed Glycine 0 C--O 1.228 -0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.385 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -101.94 -52.4 3.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 18' ' ' TRP . 21.0 t -167.13 173.94 8.68 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -70.43 8.61 0.77 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.818 0.281 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.662 ' CZ2' ' HB ' ' A' ' 62' ' ' THR . 2.7 t90 -31.96 -44.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.804 1.242 . . . . 0.0 112.386 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.641 ' HB2' ' O ' ' A' ' 18' ' ' TRP . 0.0 OUTLIER 158.92 81.49 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 175.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.504 HG21 HD22 ' A' ' 9' ' ' LEU . 10.9 m -125.54 -7.17 6.89 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.723 0.773 . . . . 0.0 110.533 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.625 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 5.8 m120 -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.841 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 43.06 -162.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 125.257 1.598 . . . . 0.0 114.39 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -139.5 116.7 11.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.237 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 tp -67.06 104.1 1.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.549 HD12 HG13 ' A' ' 55' ' ' VAL . 91.0 mt -72.65 -43.37 63.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.307 0.575 . . . . 0.0 109.633 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.37 158.35 8.89 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.09 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.19 143.05 43.37 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -141.26 111.86 7.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.509 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 49.8 m -93.35 127.16 38.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.388 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.95 131.35 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 11.1 m-20 -85.77 153.64 22.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.706 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 13.6 m120 73.17 32.04 1.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.97 0.794 . . . . 0.0 111.616 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -138.25 136.3 36.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.713 0.292 . . . . 0.0 110.875 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -106.55 160.67 15.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.524 HD23 HD13 ' A' ' 103' ' ' ILE . 25.4 tp -115.79 133.66 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.339 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' CE1' HD12 ' A' ' 102' ' ' LEU . 73.9 m-85 -108.57 156.61 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.778 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.3 t -147.11 125.61 12.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.877 0.37 . . . . 0.0 110.282 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.797 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 1.3 pt? -105.54 16.19 25.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.61 -25.34 25.25 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.995 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -111.67 -72.14 0.73 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.577 ' HB2' HD22 ' A' ' 38' ' ' LEU . 3.3 m-85 -82.54 128.32 67.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.266 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -93.98 103.13 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.779 2.319 . . . . 0.0 110.714 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.45 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -100.94 157.41 19.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.181 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -140.47 145.74 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.224 0.512 . . . . 0.0 110.845 -176.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.802 HG12 HG12 ' A' ' 92' ' ' VAL . 24.9 m -146.28 162.26 35.54 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 20.1 Cg_endo -61.25 151.66 77.51 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.622 2.215 . . . . 0.0 112.834 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.3 -130.83 2.24 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -136.49 89.17 2.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.419 0.628 . . . . 0.0 109.816 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.87 -179.33 33.63 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -133.76 104.86 6.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 117.769 0.784 . . . . 0.0 111.02 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.2 t -84.22 109.48 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -81.36 58.45 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.88 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.599 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -72.62 169.27 52.31 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.817 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.493 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.8 pt-20 -121.04 114.84 22.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.27 -0.465 . . . . 0.0 109.936 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG13 HD12 ' A' ' 25' ' ' LEU . 28.0 t -86.8 129.91 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.754 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.46 ' OH ' ' HG2' ' A' ' 10' ' ' ARG . 75.2 m-85 -125.46 156.98 38.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 111.461 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 13.5 ttp180 -113.03 124.69 53.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.514 172.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.784 HD12 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.19 178.87 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.699 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.495 ' O ' HG12 ' A' ' 58' ' ' ILE . 31.8 t70 -52.6 149.55 5.87 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.627 0.251 . . . . 0.0 110.956 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.644 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 94.0 m-20 -66.22 -48.19 71.37 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.884 -0.51 . . . . 0.0 110.779 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.61 78.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.779 -171.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.662 ' HB ' ' CZ2' ' A' ' 18' ' ' TRP . 1.0 OUTLIER -57.97 -40.35 80.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.034 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.784 HD23 HD12 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -66.29 -53.47 36.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.117 -177.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.72 -28.23 68.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.854 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.88 -50.89 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.561 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.4 -39.91 89.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.946 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.07 -58.31 8.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.948 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -8.96 55.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.688 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.37 -48.75 8.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.11 0.481 . . . . 0.0 110.77 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -86.52 -40.74 14.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.675 -171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.408 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 5.7 t -144.17 91.18 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.133 0.968 . . . . 0.0 111.994 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -91.3 -32.1 15.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.429 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.78 -49.8 1.24 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.887 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.58 38.71 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.181 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.408 ' OE1' ' HA ' ' A' ' 71' ' ' THR . 9.2 mp0 -68.27 -40.58 81.81 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 93' ' ' TYR . 23.7 m-85 -140.73 148.43 40.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.69 133.25 33.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.794 0.33 . . . . 0.0 111.491 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 78' ' ' ARG . 72.5 mtt180 -77.32 109.1 10.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 9.3 tt0 -110.44 98.79 7.92 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -79.55 113.31 17.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.8 pt -109.04 131.11 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.461 0.648 . . . . 0.0 110.984 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.605 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -95.31 162.98 22.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.972 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.75 -16.81 46.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.538 2.158 . . . . 0.0 112.042 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -97.94 2.0 48.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.902 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.05 158.48 10.94 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -65.75 125.8 26.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.207 0.504 . . . . 0.0 110.495 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.59 150.53 41.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.628 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -82.52 124.42 30.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.027 0.442 . . . . 0.0 111.384 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.444 ' HA ' ' HH ' ' A' ' 6' ' ' TYR . 27.0 ttt -110.85 131.63 54.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.373 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -107.8 109.51 21.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.09 0.472 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.802 HG12 HG12 ' A' ' 45' ' ' VAL . 2.5 t -80.34 126.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.417 ' HA ' ' HD1' ' A' ' 76' ' ' TYR . 5.9 t80 -59.27 102.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.435 HE21 ' HA ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -87.2 -14.72 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.122 -170.178 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 34.8 mtm180 -84.99 164.26 42.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -48.1 115.59 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.605 2.203 . . . . 0.0 112.541 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.53 ' HA ' HD12 ' A' ' 100' ' ' LEU . 29.2 m -86.37 -4.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.507 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.11 -12.3 18.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.388 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' C ' HD13 ' A' ' 100' ' ' LEU . . . -106.21 16.86 41.62 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.173 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.797 ' HG ' ' HB3' ' A' ' 38' ' ' LEU . 7.1 mp -120.82 170.84 9.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.33 134.22 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 36' ' ' TYR . 50.1 tp -102.3 117.17 34.18 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.01 0.433 . . . . 0.0 111.178 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 107' ' ' ASP . 59.9 mt -97.44 95.26 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.45 -22.12 41.36 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.484 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.2 m -70.73 -46.78 62.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 98.41 -0.43 58.38 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -171.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 103' ' ' ILE . 6.2 m-20 -99.28 165.59 11.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.532 . . . . 0.0 109.993 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.87 -49.21 4.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.69 79.97 1.73 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.464 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -68.93 -86.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.985 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 72.54 141.37 0.06 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.496 1.141 . . . . 0.0 112.645 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -38.17 -50.75 1.42 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 112.915 -1.948 . . . . 0.0 111.776 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.8 tttp . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 121.656 0.741 . . . . 0.0 110.435 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.748 ' H1 ' ' HA ' ' A' ' 60' ' ' ASN . 21.2 ttm . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.534 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 98.2 mtt180 -92.05 124.24 36.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.68 HD11 HD22 ' A' ' 63' ' ' LEU . 33.3 mt -121.2 147.18 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HE1' ' O ' ' A' ' 28' ' ' PHE . 92.3 t80 -91.07 111.1 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG11 ' HB3' ' A' ' 9' ' ' LEU . 89.1 t -90.76 102.14 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.0 110.487 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -95.02 94.12 7.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.192 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.25 -176.04 17.6 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.724 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.04 120.97 22.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.94 0.4 . . . . 0.0 110.955 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.561 ' HB3' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -93.85 7.37 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.089 175.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -80.57 17.81 1.05 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.176 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -101.37 168.25 9.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 111.344 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -65.04 113.74 4.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.001 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 1.9 mp0 59.13 24.3 12.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.265 -175.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.19 90.16 1.11 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.617 -172.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.651 ' HA ' ' CH2' ' A' ' 18' ' ' TRP . 17.2 m120 73.41 15.92 4.16 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 165.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.561 ' HB2' ' O ' ' A' ' 21' ' ' ASN . 13.0 p -175.64 -54.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.507 0.67 . . . . 0.0 110.803 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.666 ' HA ' ' O ' ' A' ' 20' ' ' THR . 73.2 t60 -69.93 10.6 0.38 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.076 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.651 ' CH2' ' HA ' ' A' ' 15' ' ' ASN . 2.4 m-90 -44.89 -52.46 8.62 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.265 0.555 . . . . 0.0 111.064 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.407 ' HE3' ' OG1' ' A' ' 62' ' ' THR . 9.3 mtm -129.88 -47.83 1.13 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.327 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -81.38 -150.75 0.08 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.501 174.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 16' ' ' SER . 6.7 m-80 -140.38 -76.48 0.32 Allowed 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HB3' ' CD1' ' A' ' 56' ' ' TYR . . . 177.58 120.5 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.878 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.572 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.2 tt0 -108.7 98.53 8.02 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.6 116.26 4.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -172.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.488 HD12 HG13 ' A' ' 55' ' ' VAL . 91.4 mt -85.6 -42.34 14.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . 157.6 146.46 4.51 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.273 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.576 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 p30 -74.53 151.55 39.47 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.487 0.66 . . . . 0.0 110.443 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' O ' ' HE1' ' A' ' 4' ' ' PHE . 10.3 t80 -157.1 103.77 2.04 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.237 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.52 ' HB2' HG22 ' A' ' 50' ' ' THR . 23.0 p -90.94 122.95 34.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.654 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.427 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 13.3 pt -103.44 125.8 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.308 0.575 . . . . 0.0 111.398 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.527 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 27.0 t0 -84.67 161.31 20.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.101 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 42.1 m-80 74.06 26.47 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 111.377 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.49 147.66 43.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 110.653 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.581 HE21 ' HA ' ' A' ' 104' ' ' GLU . 41.8 mt-30 -122.85 156.0 35.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.297 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.8 tp -117.9 135.64 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.036 -170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -101.64 145.26 29.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.198 0.523 . . . . 0.0 111.49 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -108.56 106.16 16.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.518 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.453 HD11 ' CE1' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -117.2 18.8 14.42 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.039 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 -70.01 2.77 Favored Glycine 0 C--N 1.329 0.152 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.536 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -50.9 -48.09 60.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.372 0.606 . . . . 0.0 110.964 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CE1' HD11 ' A' ' 38' ' ' LEU . 5.7 p90 -159.87 165.65 17.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.059 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.6 159.88 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.474 2.116 . . . . 0.0 112.263 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.05 6.04 Favored Glycine 0 C--O 1.223 -0.57 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -123.79 165.59 17.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.81 0.805 . . . . 0.0 111.065 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.611 HG11 HG13 ' A' ' 92' ' ' VAL . 35.2 m -150.88 160.35 32.4 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.48 0.487 . . . . 0.0 110.209 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 28.8 Cg_endo -66.64 128.97 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.037 1.824 . . . . 0.0 111.465 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.86 -120.32 0.51 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.96 91.97 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.607 0.717 . . . . 0.0 110.703 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 164.89 32.79 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.743 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 19.3 m -112.32 105.77 14.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.385 0.592 . . . . 0.0 110.446 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 29' ' ' SER . 65.0 t -82.38 117.75 28.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.523 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.06 100.6 3.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.015 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.54 165.79 23.64 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 47.6 mt-10 -125.06 136.35 53.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.488 HG13 HD12 ' A' ' 25' ' ' LEU . 41.7 t -86.67 119.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 22' ' ' ALA . 46.6 m-85 -122.04 159.38 27.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.916 0.865 . . . . 0.0 112.669 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.2 tmt_? -112.99 114.15 26.49 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.522 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 ' H2 ' ' A' ' 1' ' ' MET . 2.2 pp -119.55 177.11 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.058 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.74 131.14 38.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.818 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.748 ' HA ' ' H1 ' ' A' ' 1' ' ' MET . 3.3 m-20 -66.65 -41.43 88.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.807 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.84 99.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.595 0.236 . . . . 0.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.407 ' OG1' ' HE3' ' A' ' 19' ' ' MET . 29.4 m -54.92 -40.37 69.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.254 0.55 . . . . 0.0 110.503 175.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.68 HD22 HD11 ' A' ' 3' ' ' ILE . 3.0 tm? -67.57 -53.49 27.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.344 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.17 -30.25 69.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.046 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.13 -46.97 30.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -61.83 -47.11 86.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.787 178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.652 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 23.0 t70 -63.56 -42.82 98.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.508 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.53 -30.42 70.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.102 0.477 . . . . 0.0 111.297 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 mt -86.14 -50.53 6.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.673 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 3.1 ttt85 -85.98 -41.87 14.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.853 0.358 . . . . 0.0 111.469 -168.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.63 -83.54 0.36 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.402 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 55.61 -75.75 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.709 0.804 . . . . 0.0 112.801 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.59 -57.54 2.43 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.39 63.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.817 -1.183 . . . . 0.0 114.09 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.77 -28.99 60.97 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 166.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.673 ' HE2' ' HG2' ' A' ' 70' ' ' ARG . 4.3 m-85 -135.89 150.72 49.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.936 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.544 ' HB2' ' NE2' ' A' ' 94' ' ' GLN . . . -86.45 118.13 25.68 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.081 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.652 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 82.1 mtm180 -74.43 102.61 4.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.215 0.531 . . . . 0.0 109.887 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -103.77 99.17 8.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.3 tp -76.79 112.34 13.27 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.874 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.402 ' C ' HE21 ' A' ' 82' ' ' GLN . 35.5 pt -107.09 138.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.292 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.567 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -90.47 113.86 25.9 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 85' ' ' TYR . 33.6 p -102.71 166.71 11.47 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.159 -172.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.69 1.21 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.643 2.229 . . . . 0.0 111.836 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 32.9 m-85 -119.83 17.13 12.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.4 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.534 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 115.74 -87.46 0.44 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.932 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -169.5 141.64 2.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.47 147.7 30.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.646 0.26 . . . . 0.0 111.238 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.14 120.08 25.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.59 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.528 ' SD ' HG21 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -105.16 118.65 37.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.448 176.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.66 109.67 21.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.487 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.611 HG13 HG11 ' A' ' 45' ' ' VAL . 2.3 t -93.21 138.86 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' HD2' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -47.64 136.27 10.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.303 177.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 77' ' ' ALA . 2.0 tp-100 -138.44 18.99 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.901 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.721 ' HB2' ' HD3' ' A' ' 96' ' ' PRO . 2.2 mmp_? -120.85 -80.51 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 95' ' ' ARG . 34.7 Cg_endo -99.05 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 -162.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.548 ' HA ' HD13 ' A' ' 100' ' ' LEU . 25.1 m 54.2 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.486 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.46 113.82 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.885 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.02 44.41 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -169.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.548 HD13 ' HA ' ' A' ' 97' ' ' VAL . 66.1 mt -119.55 165.63 14.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.56 132.15 54.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 34' ' ' GLN . 50.2 tp -102.49 126.89 49.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.084 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 105' ' ' SER . 40.7 mt -90.09 100.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.581 ' HA ' HE21 ' A' ' 34' ' ' GLN . 27.8 mt-10 -67.37 24.01 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.618 -1.174 . . . . 0.0 114.084 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 103' ' ' ILE . 60.7 m -163.89 -17.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.067 -0.396 . . . . 0.0 111.926 -175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.74 21.51 33.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.159 -1.019 . . . . 0.0 114.443 167.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.91 129.89 41.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.736 0.768 . . . . 0.0 109.288 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -69.45 -29.83 67.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.93 -48.01 2.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.445 -167.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 69.33 -51.5 0.6 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.653 0.781 . . . . 0.0 111.586 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -92.92 75.48 4.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.045 0.926 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.21 -131.3 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.857 0.836 . . . . 0.0 110.825 -178.751 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.553 ' HB2' HD22 ' A' ' 63' ' ' LEU . 11.2 tpp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.492 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 29.8 mtm180 -87.98 138.1 31.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.945 0.402 . . . . 0.0 110.659 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.2 151.24 18.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.096 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -91.22 127.51 36.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -92.36 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 20.3 p90 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.369 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -100.63 118.91 37.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.581 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -71.68 104.14 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.209 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 55' ' ' VAL . 95.3 mt -72.79 -43.6 62.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.474 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.25 171.09 18.93 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.96 145.99 33.68 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.832 0.825 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.582 ' HB3' HG23 ' A' ' 55' ' ' VAL . 23.3 t80 -154.09 101.69 2.42 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.486 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 m -88.96 133.01 34.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.712 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.22 126.37 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.96 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 4.3 t70 -86.15 165.22 16.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 3.3 m-20 69.48 28.04 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.715 0.634 . . . . 0.0 111.226 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -135.41 149.96 49.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.522 ' HB3' HD11 ' A' ' 102' ' ' LEU . 99.1 mt-30 -127.76 152.49 47.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.686 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 103' ' ' ILE . 23.7 tp -111.33 131.83 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.941 0.4 . . . . 0.0 111.283 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.04 151.28 21.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -122.93 107.7 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -102.84 18.45 21.49 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.54 -57.79 0.62 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.221 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.67 -82.99 0.51 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.65 0.738 . . . . 0.0 109.697 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.54 158.7 62.68 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.539 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -93.52 170.9 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.935 2.424 . . . . 0.0 112.619 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -139.34 152.5 22.44 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -138.41 141.42 39.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.939 0.87 . . . . 0.0 110.963 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' HD2' ' A' ' 93' ' ' TYR . 23.9 m -150.28 163.88 22.67 Favored Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 123.184 0.303 . . . . 0.0 110.27 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.58 132.15 30.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.564 2.176 . . . . 0.0 111.497 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.99 -123.78 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.767 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.63 90.26 2.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.153 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.79 166.16 34.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.562 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 4.6 m -109.88 106.03 15.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.091 0.445 . . . . 0.0 110.178 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' SER . 67.4 t -82.59 105.56 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 109.848 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.468 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 82.9 t60 -79.29 65.3 4.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.66 -175.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.652 ' HA2' ' HZ2' ' A' ' 108' ' ' TRP . . . -100.02 -173.59 30.3 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.334 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -133.55 140.92 47.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 28' ' ' PHE . 49.2 t -106.79 130.59 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.14 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -124.74 150.74 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 112.093 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.04 105.51 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ALA . 2.4 pp -110.92 162.93 8.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.91 147.06 9.72 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.9 0.48 . . . . 0.0 112.014 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 5.8 p30 -64.84 -41.9 95.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.527 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.31 -37.02 82.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.215 0.531 . . . . 0.0 110.199 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.6 m -56.88 -30.37 63.81 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.159 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' ' 1' ' ' MET . 13.9 tp -66.48 -49.55 66.25 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.59 65.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.696 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -68.2 -47.26 68.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.124 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.75 -47.09 82.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.907 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -61.82 -48.38 80.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.042 0.449 . . . . 0.0 110.776 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.73 69.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.687 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 69' ' ' LEU . 15.4 mt -84.96 -33.1 22.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -85.66 -52.09 6.02 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.564 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 14.4 t . . . . . 0 C--N 1.326 -0.446 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.76 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.564 ' N ' ' HG1' ' A' ' 71' ' ' THR . 17.4 tp10 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 66.4 m-85 -131.33 172.75 11.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.894 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.33 151.82 26.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.014 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' CE3' ' A' ' 89' ' ' TRP . 56.0 mtt180 -92.53 111.94 23.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.368 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -104.2 103.96 13.81 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.11 115.91 20.78 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.4 pt -110.06 134.98 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.664 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 101.4 13.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.758 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 159.94 30.16 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.692 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.29 -14.72 40.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.348 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.81 7.19 41.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.85 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.492 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 119.65 154.36 9.47 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.976 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m -66.04 126.65 29.28 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.493 -0.416 . . . . 0.0 110.335 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.1 148.06 44.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.663 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 78' ' ' ARG . 98.8 m95 -83.32 124.09 30.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.461 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.87 127.76 55.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.564 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.8 118.22 31.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.996 0.427 . . . . 0.0 110.868 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -100.43 142.26 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.758 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.627 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -46.85 127.18 9.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.303 174.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 9.8 tp60 -125.76 2.87 7.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.154 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -135.77 138.23 27.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -28.35 128.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.879 4.386 . . . . 0.0 115.939 -170.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 93' ' ' TYR . 15.9 m -90.76 16.2 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.125 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.32 110.48 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.068 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.99 32.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.184 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 38' ' ' LEU . 36.4 mt -98.53 168.2 10.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.095 0.447 . . . . 0.0 110.687 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -99.18 141.95 31.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.272 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 34' ' ' GLN . 32.6 tp -117.24 125.83 51.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.664 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 35' ' ' LEU . 42.5 mt -101.49 87.85 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -67.18 -12.83 61.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.768 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.8 t -69.4 -50.43 45.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.617 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 109.2 -12.83 33.91 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.542 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.27 151.36 24.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 110.486 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.652 ' HZ2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.5 -31.71 63.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.454 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.439 -0.977 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.833 -172.068 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.835 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 38.4 tpp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -113.68 128.2 56.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.064 0.459 . . . . 0.0 111.181 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.7 mt -128.41 139.66 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.721 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 57.2 t80 -96.9 109.64 22.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.2 106.96 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 91' ' ' TYR . 1.2 p90 . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.453 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -106.69 114.36 28.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.408 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 tp -67.0 102.59 1.0 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 55' ' ' VAL . 81.3 mt -64.46 -32.75 74.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.814 0.816 . . . . 0.0 109.135 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.87 135.78 3.16 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.808 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.37 126.34 29.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.1 0.953 . . . . 0.0 109.772 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.7 118.79 12.65 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.6 m -86.08 125.81 33.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.855 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' THR . 13.5 pt -99.94 130.01 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.712 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 39.0 t0 -92.33 159.14 15.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.984 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 49.5 m-80 73.84 29.97 1.39 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.735 0.647 . . . . 0.0 111.582 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 46' ' ' PRO . 97.7 m-85 -133.04 162.07 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.962 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.581 ' HG3' ' HA3' ' A' ' 47' ' ' GLY . 41.1 mt-30 -123.97 152.26 42.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.9 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.6 tp -118.9 126.01 50.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 111.111 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 102' ' ' LEU . 68.4 m-85 -92.14 135.19 34.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.874 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 23.4 t -121.79 96.87 5.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.035 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -101.8 18.03 21.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.613 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.17 -55.8 2.75 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.942 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -58.49 -51.88 68.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 110.483 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 18.1 p90 -160.11 138.4 7.49 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.846 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 41' ' ' TYR . 5.8 Cg_exo -75.27 159.7 40.09 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.912 2.408 . . . . 0.0 112.448 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 6' ' ' TYR . . . -145.27 125.21 2.29 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.71 144.18 35.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.201 0.5 . . . . 0.0 111.48 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 92' ' ' VAL . 31.7 m -144.88 163.25 34.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.674 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 24.5 Cg_endo -63.84 139.04 66.45 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.138 1.892 . . . . 0.0 112.069 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 34' ' ' GLN . . . -176.34 -120.3 0.61 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.949 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -145.97 88.76 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.084 0.469 . . . . 0.0 109.985 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA3' ' O ' ' A' ' 104' ' ' GLU . . . 178.56 163.8 30.47 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.625 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' HB3' ' A' ' 29' ' ' SER . 1.9 m -109.3 100.15 9.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.073 0.463 . . . . 0.0 111.076 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.5 t -83.3 121.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.549 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.457 ' O ' ' HZ2' ' A' ' 108' ' ' TRP . 0.2 OUTLIER -77.94 56.27 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 -173.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.58 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -74.63 155.04 47.94 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.768 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -100.89 120.27 39.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 HD12 ' A' ' 25' ' ' LEU . 11.2 t -93.99 123.89 46.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.41 146.07 47.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -105.94 104.46 14.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.775 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.76 167.36 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.845 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.83 135.45 24.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.007 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.835 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 87.4 m-20 -54.71 -41.06 69.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.152 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.47 70.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.8 m -56.27 -32.2 64.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.952 0.406 . . . . 0.0 110.471 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 13.8 tp -67.78 -49.77 60.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . . . -58.57 -32.39 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.868 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.54 -40.59 56.65 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 66' ' ' LEU . 8.4 tt -64.83 -47.7 77.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 1.8 p30 -67.45 -43.16 81.78 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.194 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.57 68.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.498 0.666 . . . . 0.0 110.779 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.84 -43.05 13.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.796 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 71' ' ' THR . 21.3 ttt180 -86.68 7.03 28.32 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -169.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.611 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 C-N-CA 124.787 1.235 . . . . 0.0 112.338 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' N ' ' HG1' ' A' ' 71' ' ' THR . 27.8 tt0 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.614 0.245 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' H ' HG21 ' A' ' 71' ' ' THR . 10.7 m-85 -122.5 163.13 20.45 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.444 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.85 141.69 35.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HG2' ' CE2' ' A' ' 91' ' ' TYR . 29.5 mtp180 -93.07 124.27 36.92 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -116.96 107.89 15.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.76 110.13 16.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.9 pt -106.06 144.74 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.023 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.06 104.35 16.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.909 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -98.52 162.69 20.97 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.756 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.99 -21.42 58.33 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.678 2.252 . . . . 0.0 112.613 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' HB3' HD13 ' A' ' 25' ' ' LEU . 51.8 m-85 -96.7 -3.91 41.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.532 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.14 157.74 9.14 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.669 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 127.47 31.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.546 -0.385 . . . . 0.0 110.602 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.01 150.52 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.842 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -79.25 121.99 25.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.204 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.8 ttt -108.9 116.45 32.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.367 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' HB2' ' OH ' ' A' ' 6' ' ' TYR . 96.7 m-85 -94.78 107.97 19.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.279 0.562 . . . . 0.0 110.655 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.873 HG13 HG12 ' A' ' 45' ' ' VAL . 4.7 t -76.91 119.63 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.824 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.22 119.43 10.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.37 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -170.9 2.24 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.823 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 44.2 mtm180 72.62 167.91 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.662 0.601 . . . . 0.0 110.775 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 77.8 Cg_exo -54.15 119.18 5.9 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.745 2.296 . . . . 0.0 112.854 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' GLY . 35.4 m -104.88 1.99 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.778 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -64.93 16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . -128.58 15.18 6.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.6 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -144.59 176.26 9.54 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.682 -0.305 . . . . 0.0 110.907 177.304 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 54.7 mtpt -76.99 143.96 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.351 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 36' ' ' TYR . 56.6 tp -110.16 109.75 20.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.84 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.73 91.92 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.706 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -65.87 -26.15 67.51 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -73.56 -15.03 61.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.746 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 68.92 34.3 76.74 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.183 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -117.8 178.3 4.46 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.457 ' HZ2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -119.59 -34.44 3.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.336 0.589 . . . . 0.0 109.653 176.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.16 -175.207 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.862 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 4.0 tmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.457 ' HD2' ' HA3' ' A' ' 86' ' ' GLY . 25.8 mtm180 -123.65 133.74 53.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.541 0.686 . . . . 0.0 112.165 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.93 148.16 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.486 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.723 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 81.4 t80 -92.69 112.01 23.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.74 126.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.174 0.512 . . . . 0.0 111.002 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 11.0 p90 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.503 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.057 0.456 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -137.03 143.67 42.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.158 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 tp -79.61 130.12 35.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 55' ' ' VAL . 95.6 mt -93.12 -43.01 9.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.856 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.42 176.59 27.77 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.4 147.54 28.72 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.149 0.976 . . . . 0.0 110.779 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -151.82 86.37 1.32 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.586 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.3 m -82.66 124.5 30.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -112.71 126.35 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.881 0.848 . . . . 0.0 111.524 -172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.85 156.67 20.45 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.5 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 71.01 33.38 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.118 0.886 . . . . 0.0 110.931 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.25 165.31 26.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.952 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -136.24 144.64 44.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 103' ' ' ILE . 18.7 tp -105.44 131.24 53.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.471 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -98.87 128.62 45.11 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 p -110.08 126.45 54.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.826 0.346 . . . . 0.0 110.321 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -140.98 16.75 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.01 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.81 -63.8 3.74 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.48 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -59.7 -45.36 92.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.58 ' HD1' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -167.65 110.88 0.6 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.71 176.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.41 142.75 98.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.65 2.234 . . . . 0.0 112.807 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 6' ' ' TYR . . . -120.32 178.57 16.48 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 151.28 29.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.546 0.673 . . . . 0.0 111.318 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 1.069 HG12 HG13 ' A' ' 92' ' ' VAL . 29.1 m -153.56 165.7 17.23 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.9 148.85 52.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.374 2.049 . . . . 0.0 111.343 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.07 -125.92 1.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.187 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -135.41 91.92 2.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.6 -178.24 48.55 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.427 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 23.2 m -122.26 119.89 32.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.916 0.858 . . . . 0.0 110.114 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.713 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 92.9 t -107.01 109.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.44 . . . . 0.0 110.461 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.474 ' O ' ' HH2' ' A' ' 108' ' ' TRP . 7.5 t60 -69.16 119.96 14.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.723 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -128.43 142.85 13.91 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.847 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -98.54 107.66 20.17 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 25' ' ' LEU . 57.1 t -80.2 116.98 25.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.79 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.77 150.77 39.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.715 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 1.8 tmt_? -108.49 107.63 18.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 pt -114.74 169.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.604 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 25.6 t70 -53.5 137.88 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.045 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.862 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 9.0 m120 -63.38 -43.91 96.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.616 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.29 77.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.269 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 67.7 m -56.82 -29.54 62.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.083 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 1' ' ' MET . 37.2 tp -66.6 -47.88 71.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.56 -32.4 65.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -74.3 -55.05 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.748 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.42 -37.28 85.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.097 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.51 -56.56 19.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.255 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.45 -32.46 62.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.79 -58.11 3.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.973 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -85.4 -3.19 58.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' TYR . 75.3 p . . . . . 0 C--N 1.321 -0.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' O ' HG22 ' A' ' 71' ' ' THR . 8.3 m-85 -116.22 162.94 16.73 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.12 46.17 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.789 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptt85 -88.89 127.77 35.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 111.636 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.14 121.73 43.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.254 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -87.1 112.75 22.22 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.22 133.28 58.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.396 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -86.94 101.2 13.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.562 -176.559 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 p -93.67 160.47 32.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.74 -3.13 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.798 2.332 . . . . 0.0 112.648 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.06 4.02 13.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.276 0.56 . . . . 0.0 110.067 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 2' ' ' ARG . . . 126.95 149.54 7.27 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.125 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 8.0 m -65.81 122.25 16.88 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.594 -0.356 . . . . 0.0 110.203 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.15 146.32 43.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.82 120.52 25.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -105.58 113.11 26.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.66 116.03 22.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 1.069 HG13 HG12 ' A' ' 45' ' ' VAL . 8.6 t -108.43 143.09 19.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.946 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -46.34 119.12 2.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.475 168.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -104.33 -26.62 12.4 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.637 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.597 ' H ' ' CD ' ' A' ' 96' ' ' PRO . 4.1 ptp180 -162.13 -37.46 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 95' ' ' ARG . 98.6 Cg_endo -97.78 103.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.555 1.503 . . . . 0.0 114.749 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 93' ' ' TYR . 5.6 m -145.89 90.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.275 0.56 . . . . 0.0 110.352 169.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.48 24.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . 112.38 -68.86 0.23 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 38' ' ' LEU . 66.0 mt 61.89 -170.0 0.17 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.13 0.49 . . . . 0.0 111.213 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -109.0 113.25 25.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -87.69 125.31 34.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.19 0.519 . . . . 0.0 110.492 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 35' ' ' LEU . 20.6 mt -107.9 92.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -14.51 62.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 110.652 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.2 m -72.73 -22.62 60.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.642 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 62.02 38.52 96.22 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.814 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -142.02 149.73 40.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.474 ' HH2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -89.07 -26.18 21.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 -171.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.9 mt . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.643 -167.581 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.989 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 52.5 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 87' ' ' SER . 10.2 mtt85 -111.82 129.89 55.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 tt -130.53 146.76 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.826 0.346 . . . . 0.0 110.544 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 75.2 t80 -103.31 124.32 48.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.27 130.51 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.0 p90 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.563 -172.294 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -111.82 117.48 32.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.126 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.22 106.29 3.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 HG12 ' A' ' 55' ' ' VAL . 83.3 mt -71.6 -38.31 70.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.352 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.0 157.61 7.25 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.293 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 3.7 p-10 -78.1 143.15 37.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.749 0.785 . . . . 0.0 110.537 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -151.42 116.01 5.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.368 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.3 m -87.59 137.66 32.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.218 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.2 pt -119.99 148.35 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 25.6 t0 -102.28 152.01 21.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 50.9 m-80 77.03 36.33 0.32 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.146 0.978 . . . . 0.0 111.654 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -138.39 136.83 36.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.529 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.431 HE21 HD11 ' A' ' 102' ' ' LEU . 24.7 mt-30 -111.93 154.32 25.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 42' ' ' PRO . 45.4 tp -118.84 138.2 52.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 0.0 111.749 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.27 147.93 29.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.843 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 20.2 m -116.75 111.82 20.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -112.05 17.42 19.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.764 -177.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.21 -78.15 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.481 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -62.16 -32.73 73.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.844 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 38' ' ' LEU . 6.6 p90 -165.99 167.15 9.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.59 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.0 Cg_endo -88.9 -178.74 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.989 2.459 . . . . 0.0 112.396 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.23 129.62 2.07 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -110.84 160.1 17.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.708 0.754 . . . . 0.0 111.563 -173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 92' ' ' VAL . 32.3 m -147.82 161.15 36.11 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.805 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 136.24 36.54 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.303 2.002 . . . . 0.0 111.102 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.8 -126.26 1.02 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.237 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.64 82.48 2.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.924 0.393 . . . . 0.0 110.634 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.08 172.68 43.42 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 46.0 m -126.89 106.75 9.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.305 0.552 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 93.7 t -84.06 114.07 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.5 59.16 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.066 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.464 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -82.84 165.98 44.42 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.458 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 28.6 mp0 -107.62 124.07 49.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.278 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.502 HG12 HD12 ' A' ' 25' ' ' LEU . 34.0 t -88.17 128.2 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.644 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -123.38 150.99 43.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.873 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -113.69 118.41 34.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.724 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 1' ' ' MET . 2.0 pp -132.45 164.84 33.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.899 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.574 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 13.3 t70 -51.76 143.57 12.74 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.989 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 3.7 m-20 -57.97 -44.96 87.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.43 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.954 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 19.1 m -56.43 -38.13 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 0.0 110.965 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD22 ' HG2' ' A' ' 1' ' ' MET . 10.2 tp -66.54 -52.33 46.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.69 65.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.851 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 -48.97 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.341 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -39.53 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.033 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.78 -50.37 72.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.42 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.74 -19.69 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.91 -49.25 8.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.457 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.543 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -75.08 -54.06 7.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.983 -173.539 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.628 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 6.6 t . . . . . 0 C--N 1.32 -0.704 0 CA-C-O 122.17 0.986 . . . . 0.0 110.443 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.628 ' N ' ' HG1' ' A' ' 71' ' ' THR . 28.8 tp10 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.027 0.441 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HD2' ' HB ' ' A' ' 71' ' ' THR . 91.4 m-85 -131.24 166.18 21.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.5 127.61 55.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.043 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -86.04 106.96 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -104.93 105.9 16.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -79.79 112.15 16.79 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.57 152.81 10.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.56 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -99.15 109.61 22.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.235 0.54 . . . . 0.0 111.773 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -96.53 165.62 15.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.89 -2.26 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.45 2.1 . . . . 0.0 112.466 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -120.83 15.63 11.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.017 0.437 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.25 157.42 10.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.218 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.409 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 9.2 p -66.37 130.4 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.4 151.33 44.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.335 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -85.65 123.19 30.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 111.41 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 21.4 ttt -107.79 124.06 49.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.562 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -91.33 116.21 28.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 45' ' ' VAL . 7.2 t -94.63 126.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.5 ' HD1' ' CE1' ' A' ' 76' ' ' TYR . 40.2 t80 -75.29 127.14 32.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.108 0.956 . . . . 0.0 110.808 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 76' ' ' TYR . 28.2 mm-40 -89.44 -161.99 0.83 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.172 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 38.2 mmt180 70.91 169.38 0.12 Allowed Pre-proline 0 N--CA 1.467 0.391 0 O-C-N 123.358 0.411 . . . . 0.0 110.743 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 18.8 Cg_endo -62.32 134.05 46.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.278 1.985 . . . . 0.0 111.658 171.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.36 10.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.62 126.67 28.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.284 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.76 57.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 38' ' ' LEU . 41.6 mt -86.23 159.84 19.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.811 0.306 . . . . 0.0 110.305 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 48.1 mtmt -88.78 119.09 28.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD11 HE21 ' A' ' 34' ' ' GLN . 57.4 tp -97.17 121.52 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 107' ' ' ASP . 29.4 mt -101.62 94.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.13 -21.03 66.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.03 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 p -73.26 -44.12 59.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 106.53 10.03 29.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.318 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 103' ' ' ILE . 2.7 p30 -111.64 178.8 4.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 -41.21 4.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.766 0.793 . . . . 0.0 109.487 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.489 -172.855 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.952 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 45.0 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 143.74 33.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.838 0.352 . . . . 0.0 110.565 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.2 146.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.242 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 73.7 t80 -92.86 113.55 25.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.831 0.348 . . . . 0.0 110.287 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.8 147.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.046 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.133 0.492 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 57.8 tt0 -114.86 129.0 56.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.705 172.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.8 tp -78.95 104.14 9.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.015 0.436 . . . . 0.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD12 HG12 ' A' ' 55' ' ' VAL . 94.1 mt -70.05 -45.23 67.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.32 168.08 12.32 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.545 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.66 151.86 46.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.163 0.506 . . . . 0.0 109.824 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -156.71 87.05 1.0 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.872 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 15.5 m -77.53 129.25 35.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.08 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.04 134.13 59.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -82.8 156.42 23.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.993 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 67.54 33.97 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.025 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.41 172.09 12.6 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.632 ' HB3' HD11 ' A' ' 102' ' ' LEU . 93.8 mt-30 -139.96 157.0 46.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 43' ' ' GLY . 35.4 tp -123.4 128.75 50.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.836 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 97' ' ' VAL . 88.2 m-85 -91.06 140.9 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.15 0.5 . . . . 0.0 112.127 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 68.5 m -113.86 109.94 19.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.31 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -121.27 6.29 10.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.363 174.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.56 4.52 Favored Glycine 0 C--O 1.229 -0.186 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.989 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -61.95 -47.27 85.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.784 0.326 . . . . 0.0 111.036 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.42 155.53 8.64 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.644 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.01 148.15 19.3 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.938 2.426 . . . . 0.0 113.643 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -120.64 160.33 15.12 Favored Glycine 0 C--O 1.227 -0.337 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.33 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.991 0.896 . . . . 0.0 111.6 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.818 HG11 ' HD2' ' A' ' 93' ' ' TYR . 33.7 m -154.46 167.09 14.56 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.81 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.13 157.04 54.89 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.393 2.062 . . . . 0.0 111.84 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.09 -119.41 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -145.53 92.14 2.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.856 0.36 . . . . 0.0 110.085 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 165.1 33.14 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.354 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 m -101.75 101.85 12.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.875 0.369 . . . . 0.0 110.275 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' SER . 70.1 t -82.81 106.72 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.792 -174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -69.52 107.53 3.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.939 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -123.09 147.2 16.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.1 mp0 -103.9 107.25 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG12 HD12 ' A' ' 25' ' ' LEU . 26.0 t -81.35 117.07 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.062 0.458 . . . . 0.0 110.223 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -115.29 147.71 40.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.455 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 52.8 ttt180 -108.95 131.93 54.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.986 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.743 HD11 HD23 ' A' ' 63' ' ' LEU . 1.7 pp -140.73 164.14 21.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.667 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.67 142.15 15.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.539 0.209 . . . . 0.0 111.18 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.952 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 95.7 m-20 -54.51 -48.64 71.66 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 0.0 110.979 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.19 75.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.085 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -56.27 -37.0 69.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.835 173.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -66.82 -42.13 86.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -23.67 66.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.843 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.85 -48.5 45.6 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.15 -34.73 78.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.46 -54.87 41.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.499 0.666 . . . . 0.0 110.92 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.76 68.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.39 -56.27 3.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . 39.8 ttt180 -85.19 7.14 22.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.684 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 O-C-N 124.602 1.189 . . . . 0.0 111.066 -173.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.684 ' N ' ' HG1' ' A' ' 71' ' ' THR . 4.6 tp10 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.684 ' H ' HG21 ' A' ' 71' ' ' THR . 38.5 m-85 -142.6 170.38 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.579 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.96 152.09 36.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -88.93 125.22 34.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -105.18 121.63 44.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.6 tp -91.82 114.69 27.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 7.3 pt -114.02 148.98 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -90.43 108.54 19.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.719 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 1.4 p -100.02 163.42 18.39 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 83' ' ' THR . 17.7 Cg_endo -61.54 -16.04 45.33 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.481 2.12 . . . . 0.0 112.064 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -97.91 -2.66 40.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.9 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.51 160.21 10.85 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 66.4 m -63.95 121.29 13.74 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.138 0.494 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.64 148.68 30.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.674 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.46 124.28 31.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.183 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 85.2 mtp -106.7 170.28 8.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.039 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -127.69 117.72 22.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.871 0.367 . . . . 0.0 110.415 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 45' ' ' VAL . 4.0 t -101.59 136.82 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.696 0.76 . . . . 0.0 111.189 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.818 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -51.68 120.64 5.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.739 175.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.9 tp60 -117.96 1.35 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.752 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.454 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 68.8 mtp180 -132.16 146.61 62.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.25 121.78 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.561 3.507 . . . . 0.0 114.598 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 100' ' ' LEU . 12.8 m -104.52 14.48 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.862 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.56 96.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.013 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.84 5.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.327 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 97' ' ' VAL . 87.2 mt -89.87 165.7 13.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.335 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 30.1 mmmt -90.29 132.25 35.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 34' ' ' GLN . 64.6 tp -105.93 107.78 18.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.374 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 107' ' ' ASP . 51.5 mt -82.12 89.02 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.98 -9.55 39.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.178 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 m -70.79 -27.16 63.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.024 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 85.66 -13.37 56.29 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.171 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 103' ' ' ILE . 5.4 t70 -100.42 141.35 33.38 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.384 -0.48 . . . . 0.0 110.223 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -70.02 -30.96 68.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.551 . . . . 0.0 110.228 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.449 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.955 -179.382 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 25.1 ttm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -117.61 144.73 44.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 111.188 -175.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 63' ' ' LEU . 10.6 tt -139.82 150.66 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.908 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -97.22 115.74 28.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.31 158.82 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 1.6 p90 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.035 0.445 . . . . 0.0 111.447 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.8 tt0 -107.31 119.5 39.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.718 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 tp -81.66 98.39 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.488 . . . . 0.0 109.859 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.679 HD12 HG12 ' A' ' 55' ' ' VAL . 88.8 mt -64.9 -41.78 95.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.711 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.37 153.36 6.08 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.614 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-20 -69.57 143.42 53.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 55' ' ' VAL . 17.2 t80 -154.48 114.03 3.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.0 m -100.56 132.6 45.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.106 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 50' ' ' THR . 16.3 pt -114.03 141.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.423 . . . . 0.0 111.164 -175.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.26 160.07 14.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.036 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 73.8 28.94 1.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.594 0.758 . . . . 0.0 111.506 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.67 142.28 46.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB3' HD11 ' A' ' 102' ' ' LEU . 49.9 mt-30 -116.05 148.42 40.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . 12.4 tp -103.44 139.33 38.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.488 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.45 134.91 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.5 p -116.49 128.49 55.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.991 0.424 . . . . 0.0 110.131 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -133.73 17.36 3.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.317 172.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.72 -59.2 4.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.955 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -89.08 -0.77 57.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -156.62 134.09 6.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 121.78 0.38 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.939 2.426 . . . . 0.0 111.378 166.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.69 16.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.645 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -145.47 146.53 31.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.658 0.729 . . . . 0.0 110.585 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.89 HG12 HG13 ' A' ' 92' ' ' VAL . 27.3 m -149.44 164.0 22.76 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 123.404 0.44 . . . . 0.0 110.489 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.18 136.47 56.13 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.401 2.067 . . . . 0.0 111.805 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.05 -122.54 0.77 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.826 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -143.05 92.18 2.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.708 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.91 167.71 37.49 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.856 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.1 m -115.03 111.47 21.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.8 t -84.91 118.68 32.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.004 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -78.96 97.9 6.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.68 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 6' ' ' TYR . . . -130.71 172.16 20.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.459 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 27.4 mp0 -120.12 133.65 55.46 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.757 0.423 . . . . 0.0 109.886 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 25' ' ' LEU . 31.6 t -91.27 120.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -118.14 157.88 26.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.319 0.581 . . . . 0.0 112.008 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.3 tmt_? -127.2 124.12 38.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.631 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.41 -173.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.767 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 62' ' ' THR . 3.7 m-20 -52.11 153.11 2.86 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.683 0.277 . . . . 0.0 110.617 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.0 p-10 -65.42 -38.87 91.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.18 85.13 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.993 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 89.1 m -56.97 -30.26 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.074 0.464 . . . . 0.0 111.373 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.5 tm? -65.48 -48.55 72.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.05 66.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.13 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -49.1 31.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.027 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.62 -36.64 84.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.4 -54.59 45.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.77 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.15 -28.63 69.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.636 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 69' ' ' LEU . 17.4 mt -79.17 -47.72 15.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.637 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -81.62 -49.64 10.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.324 -0.513 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.357 -172.767 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 95' ' ' ARG . 34.2 tt0 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' VAL . 12.0 m-85 -119.37 159.75 23.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.285 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.31 124.9 47.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.765 0.317 . . . . 0.0 110.652 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -79.15 123.53 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.892 0.854 . . . . 0.0 110.766 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -104.7 145.93 29.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.513 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.06 113.3 25.74 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.205 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.9 pt -110.24 140.98 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.352 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.521 HE22 ' HB3' ' A' ' 87' ' ' SER . 9.7 mm100 -91.37 102.97 15.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -99.83 158.04 32.82 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.71 -18.38 55.21 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 49.8 m-85 -99.05 -3.16 35.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.834 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.36 161.06 9.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.288 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.521 ' HB3' HE22 ' A' ' 82' ' ' GLN . 62.3 p -67.08 107.19 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 110.464 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.71 145.97 29.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.887 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -83.62 125.43 31.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 ttt -114.75 116.64 28.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.41 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.59 108.13 19.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 112.026 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.89 HG13 HG12 ' A' ' 45' ' ' VAL . 4.3 t -81.15 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.815 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.561 ' HD1' HG12 ' A' ' 97' ' ' VAL . 7.2 t80 -63.59 119.84 10.61 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.422 ' H ' ' HD1' ' A' ' 76' ' ' TYR . 13.0 tp60 -108.03 -166.51 1.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 31.7 mtp85 66.92 -177.43 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 54.2 Cg_exo -54.73 100.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.714 1.609 . . . . 0.0 112.468 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.561 HG12 ' HD1' ' A' ' 93' ' ' TYR . 26.9 m -93.53 -10.8 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.677 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.79 103.99 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.529 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.6 -12.05 4.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.077 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 38' ' ' LEU . 73.2 mt -78.24 162.23 26.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -93.2 109.05 20.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 34' ' ' GLN . 61.6 tp -73.75 139.02 44.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.461 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 35' ' ' LEU . 62.7 mt -124.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.269 174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.02 -15.58 63.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.46 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -70.99 -20.8 62.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.12 73.91 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.531 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 103' ' ' ILE . 12.2 t70 -134.05 137.19 44.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -71.85 -29.2 64.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.805 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -170.323 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.964 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 43.8 tpp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -134.12 125.77 28.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.093 0.473 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.56 145.96 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -86.49 111.82 20.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 0.0 110.004 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 83.9 t -91.6 136.1 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' CD1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.315 -0.893 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.634 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' CB ' HG22 ' A' ' 58' ' ' ILE . . . . . . . . 0 C--O 1.234 0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -124.09 121.15 34.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.677 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.32 106.25 1.32 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 85' ' ' TYR . 84.4 mt -66.68 -38.32 86.55 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.03 159.83 10.11 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.918 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.27 145.26 54.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -139.15 115.04 10.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 52' ' ' HIS . 5.8 p -100.96 131.01 47.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.592 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 pt -117.38 130.39 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.361 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.48 151.71 21.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.871 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.72 33.97 2.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.932 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.95 154.15 51.81 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 102' ' ' LEU . 38.2 mt-30 -128.13 156.8 42.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 103' ' ' ILE . 15.3 tp -114.2 130.25 56.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.585 0.231 . . . . 0.0 110.758 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 86.0 m-85 -99.96 132.34 45.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.609 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.1 m -99.37 102.24 13.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -118.75 12.55 13.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.708 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.06 -51.15 4.06 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.035 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.4 -42.3 91.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CE1' HD11 ' A' ' 38' ' ' LEU . 8.2 p90 -175.05 153.85 1.64 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 6' ' ' TYR . 16.6 Cg_exo -70.24 112.02 3.06 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.237 1.958 . . . . 0.0 111.678 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -90.48 159.51 27.23 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.276 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 34' ' ' GLN . . . -141.83 139.57 32.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.749 0.775 . . . . 0.0 111.433 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.555 HG12 HG13 ' A' ' 92' ' ' VAL . 26.9 m -145.57 163.22 32.83 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.386 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.16 146.43 76.3 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.547 2.164 . . . . 0.0 111.488 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.0 -111.36 0.39 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.79 92.12 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.08 47.5 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m -124.87 103.86 8.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 117.801 0.801 . . . . 0.0 110.529 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 77.3 t -84.16 104.08 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 1.8 p80 -95.35 94.89 8.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.449 0.642 . . . . 0.0 110.699 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.15 10.4 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.179 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 28.3 mt-10 -127.0 124.66 39.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG12 HD12 ' A' ' 25' ' ' LEU . 72.0 t -93.16 118.97 40.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.087 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.14 148.05 40.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.132 0.491 . . . . 0.0 112.054 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -106.87 114.79 29.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.889 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.25 174.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -52.88 144.4 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.956 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.964 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.3 m-20 -60.02 -36.02 76.35 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.424 0.631 . . . . 0.0 109.451 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.54 71.99 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.93 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 m -56.42 -40.44 74.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 39.1 tp -67.99 -46.69 70.6 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.84 68.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.5 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.15 -43.11 44.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.322 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.64 -42.72 98.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.26 -50.66 73.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.892 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.07 -28.69 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.467 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.0 mt -86.57 -55.36 3.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HD3' ' HD2' ' A' ' 76' ' ' TYR . 41.5 ttm180 -85.45 -44.65 12.56 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -168.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--N 1.324 -0.516 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.653 -169.763 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG2' ' NH2' ' A' ' 95' ' ' ARG . 25.6 mt-10 . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.616 ' HD2' ' HD3' ' A' ' 70' ' ' ARG . 12.7 m-85 -131.9 170.21 15.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.879 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.4 149.93 21.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 89' ' ' TRP . 20.7 tpp85 -102.33 134.87 44.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.121 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 60.7 tt0 -135.09 152.5 51.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -119.44 117.55 28.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.849 0.357 . . . . 0.0 110.383 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 pt -109.07 148.73 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.323 0.582 . . . . 0.0 111.292 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -96.75 126.96 42.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.305 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.2 p -122.11 159.92 49.73 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.409 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.4 -10.46 26.17 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.395 2.064 . . . . 0.0 111.582 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 10.8 m-85 -106.97 12.79 28.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.028 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.75 -103.09 0.59 Allowed Glycine 0 C--O 1.217 -0.927 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.144 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.0 t -172.86 133.17 0.55 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.47 144.39 51.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.942 0.401 . . . . 0.0 111.755 -170.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 78' ' ' ARG . 96.3 m95 -82.01 127.25 32.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.303 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 25.8 ttt -109.13 155.1 21.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.053 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.83 130.63 52.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.372 . . . . 0.0 110.859 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 45' ' ' VAL . 3.3 t -108.4 134.07 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 121.66 0.743 . . . . 0.0 110.836 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.632 ' CE2' HG13 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -50.71 134.45 24.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.471 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 6.4 tp60 -135.22 33.65 3.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.797 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 27.4 mmt85 -131.31 -177.03 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.345 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 95' ' ' ARG . 6.3 Cg_exo -75.72 135.2 17.5 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.749 1.632 . . . . 0.0 112.674 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 100' ' ' LEU . 2.3 m -101.49 11.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -62.73 -6.09 3.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 29.21 1.79 Allowed Glycine 0 C--N 1.308 -1.028 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.312 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.011 HD12 HG12 ' A' ' 97' ' ' VAL . 43.2 mt -113.83 165.08 12.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.851 -0.205 . . . . 0.0 110.548 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -102.81 124.77 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 34' ' ' GLN . 66.5 tp -84.16 143.59 29.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.881 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.552 HD12 HD23 ' A' ' 35' ' ' LEU . 44.8 mt -107.97 94.51 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.22 24.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.064 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 103' ' ' ILE . 59.7 m -161.27 15.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.295 -0.253 . . . . 0.0 111.522 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 52.65 22.82 12.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 5.9 p-10 -98.99 178.89 4.8 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.943 0.871 . . . . 0.0 108.745 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 67.2 t-105 -121.69 -38.68 2.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.582 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 46.0 mt . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.403 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 1.038 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 47.1 tpp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.69 51.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.238 -0.289 . . . . 0.0 110.435 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 63' ' ' LEU . 13.0 tt -140.37 147.81 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.255 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.679 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 84.0 t80 -96.83 111.33 23.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.4 t -96.18 123.32 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.542 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.514 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -96.07 122.1 38.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.619 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.3 tp -73.53 106.4 5.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.08 -44.17 18.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.9 157.53 8.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.3 p30 -77.63 158.27 29.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.499 0.666 . . . . 0.0 110.458 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.07 90.17 1.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -79.87 129.38 34.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -122.91 141.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 111.296 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.9 165.65 13.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 83.5 m-20 69.55 28.7 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.824 0.703 . . . . 0.0 112.081 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.49 157.79 45.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.274 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.687 ' HB3' HD11 ' A' ' 102' ' ' LEU . 34.9 mt-30 -126.31 152.76 45.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 103' ' ' ILE . 38.1 tp -119.02 125.94 50.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 110.565 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE1' HG11 ' A' ' 97' ' ' VAL . 96.4 m-85 -96.72 137.41 35.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.783 0.325 . . . . 0.0 110.721 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.5 p -109.63 101.86 10.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.337 0.589 . . . . 0.0 109.541 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.63 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -107.37 2.6 24.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.118 -178.029 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.74 153.23 18.57 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.9 m80 70.72 -54.58 0.65 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.363 0.601 . . . . 0.0 111.043 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -158.18 129.29 3.74 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.311 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 6' ' ' TYR . 13.1 Cg_exo -72.77 177.88 7.06 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.563 2.175 . . . . 0.0 112.734 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -150.93 161.01 28.89 Favored Glycine 0 C--O 1.224 -0.507 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -131.81 158.13 42.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.139 0.969 . . . . 0.0 111.7 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 92' ' ' VAL . 35.1 m -150.98 163.38 23.87 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.715 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.71 161.97 39.38 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.585 2.19 . . . . 0.0 111.931 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.54 -127.84 1.9 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 4.2 t-20 -146.28 89.03 1.83 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 109.71 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.45 168.94 41.67 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -103.55 112.13 24.9 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.09 0.445 . . . . 0.0 111.148 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.495 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 69.2 t -98.26 114.58 36.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 108' ' ' TRP . 99.5 m-70 -78.93 105.28 10.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.474 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.679 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -117.55 168.32 12.92 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.553 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 40.7 mt-10 -131.16 128.54 40.26 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 85' ' ' TYR . 60.9 t -92.01 117.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.158 0.504 . . . . 0.0 110.271 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.63 154.9 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.615 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -108.92 130.43 55.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 63' ' ' LEU . 1.6 pp -143.22 172.06 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.024 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 56.7 m-20 -51.09 141.87 13.38 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.242 0.339 . . . . 0.0 110.61 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 1.038 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.5 m-20 -55.51 -39.62 70.73 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.709 0.766 . . . . 0.0 109.264 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -36.99 85.57 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.631 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' ASP . 34.2 m -55.61 -38.33 69.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 111.119 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -66.85 -50.73 61.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.247 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -29.49 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.793 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.54 -50.82 56.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.307 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.48 -39.38 90.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 -45.43 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.841 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.68 69.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 111.283 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.67 -53.91 4.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.364 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -85.64 -41.6 15.06 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -173.298 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 93' ' ' TYR . 29.1 m-85 -135.01 160.34 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.624 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB2' ' OE1' ' A' ' 94' ' ' GLN . . . -88.6 136.82 32.8 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.42 102.34 11.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 64.1 tt0 -103.18 100.65 10.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.411 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 87' ' ' SER . 48.4 tp -76.87 106.58 8.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.986 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.8 pt -101.47 139.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.682 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -86.36 106.2 17.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.835 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -103.33 162.0 21.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.62 -21.08 71.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.431 2.087 . . . . 0.0 112.019 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.491 ' HB2' HG11 ' A' ' 55' ' ' VAL . 20.7 m-85 -90.66 -4.44 56.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.344 0.593 . . . . 0.0 109.994 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.51 166.76 12.39 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.552 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 80' ' ' LEU . 7.8 p -66.86 121.38 15.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.08 146.5 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.786 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.88 121.4 28.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 21.4 ttt -105.74 152.12 23.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.474 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.31 120.81 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.539 0.209 . . . . 0.0 110.851 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 45' ' ' VAL . 4.1 t -107.94 124.46 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.395 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . 23.8 t80 -62.43 118.78 7.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.607 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.501 ' OE1' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -88.21 -33.86 17.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.768 -170.19 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 95' ' ' ARG . 41.7 mtm180 -83.03 161.73 56.89 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.4 133.43 56.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.883 2.389 . . . . 0.0 112.547 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 100' ' ' LEU . 12.4 m -77.67 69.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 122.171 0.986 . . . . 0.0 110.092 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -42.84 -70.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.257 -1.792 . . . . 0.0 112.796 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.99 60.83 0.61 Allowed Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.031 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 38' ' ' LEU . 19.2 mt -111.64 155.79 22.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.652 0.263 . . . . 0.0 110.359 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -98.42 116.19 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 34' ' ' GLN . 52.2 tp -90.47 127.1 36.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.372 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.604 HG21 ' H ' ' A' ' 107' ' ' ASP . 5.9 mt -94.99 98.66 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -66.78 24.56 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.532 0.733 . . . . 0.0 112.786 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 103' ' ' ILE . 42.3 m -160.92 17.45 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.288 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 35.65 50.99 1.07 Allowed Glycine 0 C--N 1.348 1.236 0 O-C-N 124.184 0.928 . . . . 0.0 114.985 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.604 ' H ' HG21 ' A' ' 103' ' ' ILE . 6.5 t70 -135.37 132.91 38.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.44 . . . . 0.0 110.824 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 52' ' ' HIS . 5.5 p90 -96.9 -8.07 31.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.708 0.766 . . . . 0.0 110.018 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 2.0 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.143 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.646 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 31.6 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -120.36 146.9 45.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 117.866 0.303 . . . . 0.0 111.168 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.584 ' HB ' HD21 ' A' ' 63' ' ' LEU . 11.9 tt -142.45 140.11 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.605 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 56.0 t80 -88.0 113.65 23.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 87.9 t -91.6 133.93 31.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.54 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.405 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -139.5 116.7 11.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.237 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 tp -67.06 104.1 1.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 HG12 ' A' ' 55' ' ' VAL . 91.0 mt -72.65 -43.37 63.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.307 0.575 . . . . 0.0 109.633 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.37 158.35 8.89 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.09 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.19 143.05 43.37 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -141.26 111.86 7.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.509 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.618 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 49.8 m -93.35 127.16 38.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.388 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.95 131.35 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 11.1 m-20 -85.77 153.64 22.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.706 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 90.6 m-20 73.17 32.04 1.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.97 0.794 . . . . 0.0 111.616 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -138.25 136.3 36.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.713 0.292 . . . . 0.0 110.875 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -106.55 160.67 15.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 103' ' ' ILE . 25.4 tp -115.79 133.66 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.339 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 102' ' ' LEU . 73.9 m-85 -108.57 156.61 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.778 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.3 t -147.11 125.61 12.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.877 0.37 . . . . 0.0 110.282 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.799 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 1.3 pt? -105.54 16.19 25.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.61 -25.34 25.25 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.995 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -111.67 -72.14 0.73 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' HB2' HD21 ' A' ' 38' ' ' LEU . 3.3 m-85 -82.54 128.32 67.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.266 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -93.98 103.13 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.779 2.319 . . . . 0.0 110.714 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -100.94 157.41 19.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.181 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -140.47 145.74 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.224 0.512 . . . . 0.0 110.845 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 92' ' ' VAL . 24.9 m -146.28 162.26 35.54 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 20.1 Cg_endo -61.25 151.66 77.51 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.622 2.215 . . . . 0.0 112.834 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.3 -130.83 2.24 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -136.49 89.17 2.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.419 0.628 . . . . 0.0 109.816 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.87 -179.33 33.63 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -133.76 104.86 6.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 117.769 0.784 . . . . 0.0 111.02 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.2 t -84.22 109.48 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -81.36 58.45 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.88 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.605 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -72.62 169.27 52.31 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.817 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.8 pt-20 -121.04 114.84 22.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.27 -0.465 . . . . 0.0 109.936 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 25' ' ' LEU . 28.0 t -86.8 129.91 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.754 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.46 156.98 38.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 111.461 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 57' ' ' ARG . 13.5 ttp180 -113.03 124.69 53.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.514 172.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.807 HD11 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.19 178.87 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.699 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 58' ' ' ILE . 31.8 t70 -52.6 149.55 5.87 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.627 0.251 . . . . 0.0 110.956 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 94.0 m-20 -66.22 -48.19 71.37 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.884 -0.51 . . . . 0.0 110.779 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.61 78.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.779 -171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -40.35 80.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.034 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.807 HD23 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -66.29 -53.47 36.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.117 -177.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.72 -28.23 68.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.854 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.88 -50.89 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.561 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.4 -39.91 89.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.946 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.07 -58.31 8.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.948 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -8.96 55.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.688 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.37 -48.75 8.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.11 0.481 . . . . 0.0 110.77 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -86.52 -40.74 14.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.675 -171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.494 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 5.7 t . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 122.133 0.968 . . . . 0.0 111.994 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' N ' ' HG1' ' A' ' 71' ' ' THR . 9.2 mp0 . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 93' ' ' TYR . 23.7 m-85 -140.73 148.43 40.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.69 133.25 33.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.794 0.33 . . . . 0.0 111.491 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 78' ' ' ARG . 72.5 mtt180 -77.32 109.1 10.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 53.1 tt0 -110.44 98.79 7.92 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -79.55 113.31 17.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.8 pt -109.04 131.11 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.461 0.648 . . . . 0.0 110.984 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.605 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -95.31 162.98 22.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.972 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.75 -16.81 46.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.538 2.158 . . . . 0.0 112.042 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -97.94 2.0 48.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.902 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.05 158.48 10.94 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -65.75 125.8 26.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.207 0.504 . . . . 0.0 110.495 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.59 150.53 41.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.628 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -82.52 124.42 30.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.027 0.442 . . . . 0.0 111.384 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 27.0 ttt -110.85 131.63 54.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.373 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -107.8 109.51 21.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.09 0.472 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.818 HG13 HG12 ' A' ' 45' ' ' VAL . 2.5 t -80.34 126.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.432 ' HA ' ' HD1' ' A' ' 76' ' ' TYR . 5.9 t80 -59.27 102.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -87.2 -14.72 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.122 -170.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.415 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 34.8 mtm180 -84.99 164.26 42.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 88.0 Cg_exo -48.1 115.59 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.605 2.203 . . . . 0.0 112.541 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.536 ' HA ' HD13 ' A' ' 100' ' ' LEU . 29.2 m -86.37 -4.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.507 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.11 -12.3 18.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.388 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 100' ' ' LEU . . . -106.21 16.86 41.62 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.173 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.799 ' HG ' ' HB3' ' A' ' 38' ' ' LEU . 7.1 mp -120.82 170.84 9.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.33 134.22 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 36' ' ' TYR . 50.1 tp -102.3 117.17 34.18 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.01 0.433 . . . . 0.0 111.178 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 35' ' ' LEU . 59.9 mt -97.44 95.26 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.45 -22.12 41.36 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.484 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.2 m -70.73 -46.78 62.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 98.41 -0.43 58.38 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -171.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -99.28 165.59 11.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.532 . . . . 0.0 109.993 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.87 -49.21 4.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.437 -1.103 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.464 179.785 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.672 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 21.2 ttm . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.545 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 98.2 mtt180 -92.05 124.24 36.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 63' ' ' LEU . 33.3 mt -121.2 147.18 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HE1' ' O ' ' A' ' 28' ' ' PHE . 92.3 t80 -91.07 111.1 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.76 102.14 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.0 110.487 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.192 177.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.2 tt0 -108.7 98.53 8.02 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.6 116.26 4.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -172.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD12 HG12 ' A' ' 55' ' ' VAL . 91.4 mt -85.6 -42.34 14.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . 157.6 146.46 4.51 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.273 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 p30 -74.53 151.55 39.47 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.487 0.66 . . . . 0.0 110.443 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' O ' ' HE1' ' A' ' 4' ' ' PHE . 10.3 t80 -157.1 103.77 2.04 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.237 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HG22 ' A' ' 50' ' ' THR . 23.0 p -90.94 122.95 34.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.654 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 13.3 pt -103.44 125.8 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.308 0.575 . . . . 0.0 111.398 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 27.0 t0 -84.67 161.31 20.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.101 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 42.1 m-80 74.06 26.47 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 111.377 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.49 147.66 43.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 110.653 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 104' ' ' GLU . 41.8 mt-30 -122.85 156.0 35.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.297 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.8 tp -117.9 135.64 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.036 -170.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -101.64 145.26 29.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.198 0.523 . . . . 0.0 111.49 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -108.56 106.16 16.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.518 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -117.2 18.8 14.42 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.039 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 -70.01 2.77 Favored Glycine 0 C--N 1.329 0.152 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.536 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -50.9 -48.09 60.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.372 0.606 . . . . 0.0 110.964 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 5.7 p90 -159.87 165.65 17.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.059 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.6 159.88 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.474 2.116 . . . . 0.0 112.263 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.05 6.04 Favored Glycine 0 C--O 1.223 -0.57 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -123.79 165.59 17.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.81 0.805 . . . . 0.0 111.065 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 92' ' ' VAL . 35.2 m -150.88 160.35 32.4 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.48 0.487 . . . . 0.0 110.209 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 28.8 Cg_endo -66.64 128.97 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.037 1.824 . . . . 0.0 111.465 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.86 -120.32 0.51 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.96 91.97 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.607 0.717 . . . . 0.0 110.703 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 164.89 32.79 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.743 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 19.3 m -112.32 105.77 14.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.385 0.592 . . . . 0.0 110.446 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' SER . 65.0 t -82.38 117.75 28.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.523 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.06 100.6 3.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.015 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.54 165.79 23.64 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 47.6 mt-10 -125.06 136.35 53.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 25' ' ' LEU . 41.7 t -86.67 119.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 46.6 m-85 -122.04 159.38 27.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.916 0.865 . . . . 0.0 112.669 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.2 tmt_? -112.99 114.15 26.49 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.522 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.2 pp -119.55 177.11 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.058 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.74 131.14 38.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.818 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 1' ' ' MET . 3.3 m-20 -66.65 -41.43 88.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.807 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.84 99.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.595 0.236 . . . . 0.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 m -54.92 -40.37 69.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.254 0.55 . . . . 0.0 110.503 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 3' ' ' ILE . 3.0 tm? -67.57 -53.49 27.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.344 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.17 -30.25 69.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.046 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.13 -46.97 30.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 66' ' ' LEU . 7.2 tt -61.83 -47.11 86.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.787 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.666 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 23.0 t70 -63.56 -42.82 98.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.508 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.53 -30.42 70.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.102 0.477 . . . . 0.0 111.297 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 mt -86.14 -50.53 6.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 3.1 ttt85 -85.98 -41.87 14.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.853 0.358 . . . . 0.0 111.469 -168.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.816 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.402 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.677 ' HE2' ' HG2' ' A' ' 70' ' ' ARG . 4.3 m-85 -135.89 150.72 49.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.936 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.45 118.13 25.68 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.081 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.666 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 82.1 mtm180 -74.43 102.61 4.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.215 0.531 . . . . 0.0 109.887 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -103.77 99.17 8.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.3 tp -76.79 112.34 13.27 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.874 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.5 pt -107.09 138.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.292 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -90.47 113.86 25.9 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 85' ' ' TYR . 33.6 p -102.71 166.71 11.47 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.159 -172.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.69 1.21 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.643 2.229 . . . . 0.0 111.836 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 32.9 m-85 -119.83 17.13 12.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.4 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.545 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 115.74 -87.46 0.44 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.932 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -169.5 141.64 2.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.47 147.7 30.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.646 0.26 . . . . 0.0 111.238 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.14 120.08 25.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.59 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.535 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -105.16 118.65 37.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.448 176.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.66 109.67 21.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.487 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -93.21 138.86 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.47 ' HD2' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -47.64 136.27 10.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.303 177.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 6.7 tp60 -138.44 18.99 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.901 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.746 ' HB2' ' HD3' ' A' ' 96' ' ' PRO . 2.2 mmp_? -120.85 -80.51 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 95' ' ' ARG . 34.7 Cg_endo -99.05 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 -162.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 100' ' ' LEU . 25.1 m 54.2 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.486 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.46 113.82 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.885 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.02 44.41 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -169.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 97' ' ' VAL . 66.1 mt -119.55 165.63 14.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.56 132.15 54.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 34' ' ' GLN . 50.2 tp -102.49 126.89 49.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.084 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 106' ' ' GLY . 40.7 mt -90.09 100.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.623 ' HA ' HE21 ' A' ' 34' ' ' GLN . 27.8 mt-10 -67.37 24.01 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.618 -1.174 . . . . 0.0 114.084 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 m -163.89 -17.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.067 -0.396 . . . . 0.0 111.926 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' H ' HG22 ' A' ' 103' ' ' ILE . . . 91.74 21.51 33.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.159 -1.019 . . . . 0.0 114.443 167.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.91 129.89 41.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.736 0.768 . . . . 0.0 109.288 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -69.45 -29.83 67.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.445 -167.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.553 ' HB2' HD22 ' A' ' 63' ' ' LEU . 11.2 tpp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 29.8 mtm180 -87.98 138.1 31.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.945 0.402 . . . . 0.0 110.659 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.2 151.24 18.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.096 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -91.22 127.51 36.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -92.36 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 20.3 p90 -110.7 20.12 17.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.369 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.27 66.35 0.29 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.471 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.693 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . 72.7 p 61.68 152.01 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.4 1.08 . . . . 0.0 111.874 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.703 HD22 ' HE1' ' A' ' 108' ' ' TRP . 2.4 mm? -68.22 -20.77 64.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.47 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -68.44 -19.48 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 44.54 -157.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.173 0.921 . . . . 0.0 111.93 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -147.68 139.18 23.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.795 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 2.5 mp0 -75.93 -16.37 60.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.512 ' H ' ' HG3' ' A' ' 12' ' ' LYS . . . 67.81 -97.39 0.42 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.421 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -122.29 -37.54 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 0.0 110.293 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 p -178.55 -51.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -47.01 -39.8 13.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.869 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.605 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 69.7 m95 -79.34 4.15 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.795 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 21.2 ptm -128.59 -4.3 5.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.867 0.365 . . . . 0.0 110.327 172.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 m -96.88 -66.47 0.9 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -90.34 -0.1 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.108 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . . . -69.83 110.25 4.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -100.63 118.91 37.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.581 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -71.68 104.14 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.209 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 55' ' ' VAL . 95.3 mt -72.79 -43.6 62.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.474 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.25 171.09 18.93 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.96 145.99 33.68 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.832 0.825 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.582 ' HB3' HG23 ' A' ' 55' ' ' VAL . 23.3 t80 -154.09 101.69 2.42 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.486 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 m -88.96 133.01 34.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.712 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.22 126.37 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.96 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 4.3 t70 -86.15 165.22 16.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 3.3 m-20 69.48 28.04 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.715 0.634 . . . . 0.0 111.226 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -135.41 149.96 49.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.522 ' HB3' HD11 ' A' ' 102' ' ' LEU . 99.1 mt-30 -127.76 152.49 47.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.686 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 103' ' ' ILE . 23.7 tp -111.33 131.83 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.941 0.4 . . . . 0.0 111.283 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.04 151.28 21.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -122.93 107.7 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -102.84 18.45 21.49 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.54 -57.79 0.62 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.221 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.67 -82.99 0.51 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.65 0.738 . . . . 0.0 109.697 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.54 158.7 62.68 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.539 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -93.52 170.9 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.935 2.424 . . . . 0.0 112.619 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -139.34 152.5 22.44 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -138.41 141.42 39.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.939 0.87 . . . . 0.0 110.963 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' HD2' ' A' ' 93' ' ' TYR . 23.9 m -150.28 163.88 22.67 Favored Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 123.184 0.303 . . . . 0.0 110.27 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.58 132.15 30.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.564 2.176 . . . . 0.0 111.497 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.99 -123.78 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.767 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.63 90.26 2.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.153 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.79 166.16 34.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.562 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 4.6 m -109.88 106.03 15.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.091 0.445 . . . . 0.0 110.178 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' SER . 67.4 t -82.59 105.56 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 109.848 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.468 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 82.9 t60 -79.29 65.3 4.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.66 -175.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.652 ' HA2' ' HZ2' ' A' ' 108' ' ' TRP . . . -100.02 -173.59 30.3 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.334 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 9' ' ' LEU . 19.5 tt0 -133.55 140.92 47.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 28' ' ' PHE . 49.2 t -106.79 130.59 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.14 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -124.74 150.74 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 112.093 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.04 105.51 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ALA . 2.4 pp -110.92 162.93 8.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.91 147.06 9.72 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.9 0.48 . . . . 0.0 112.014 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 5.8 p30 -64.84 -41.9 95.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.527 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.31 -37.02 82.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.215 0.531 . . . . 0.0 110.199 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' CH2' ' A' ' 18' ' ' TRP . 57.6 m -56.88 -30.37 63.81 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.159 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' ' 1' ' ' MET . 13.9 tp -66.48 -49.55 66.25 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.59 65.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.696 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -68.2 -47.26 68.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.124 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 8.2 tt -63.75 -47.09 82.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.907 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -61.82 -48.38 80.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.042 0.449 . . . . 0.0 110.776 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 72' ' ' ARG . . . -63.14 -27.73 69.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.687 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 69' ' ' LEU . 15.4 mt -84.96 -33.1 22.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -85.66 -52.09 6.02 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -116.26 25.15 10.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.76 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.7 ttm180 -61.64 101.16 0.17 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.383 0.611 . . . . 0.0 110.26 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.64 -22.69 7.27 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.779 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.83 80.71 1.33 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.217 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -111.41 -46.79 3.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 66.4 m-85 -131.33 172.75 11.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.894 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.33 151.82 26.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.014 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' CE3' ' A' ' 89' ' ' TRP . 56.0 mtt180 -92.53 111.94 23.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.368 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -104.2 103.96 13.81 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.11 115.91 20.78 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.4 pt -110.06 134.98 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.664 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 101.4 13.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.758 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 159.94 30.16 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.692 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.29 -14.72 40.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.348 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.81 7.19 41.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.85 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.492 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 119.65 154.36 9.47 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.976 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m -66.04 126.65 29.28 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.493 -0.416 . . . . 0.0 110.335 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.1 148.06 44.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.663 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 78' ' ' ARG . 98.8 m95 -83.32 124.09 30.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.461 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.87 127.76 55.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.564 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.8 118.22 31.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.996 0.427 . . . . 0.0 110.868 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -100.43 142.26 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.758 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.627 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -46.85 127.18 9.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.303 174.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 9.8 tp60 -125.76 2.87 7.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.154 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -135.77 138.23 27.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -28.35 128.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.879 4.386 . . . . 0.0 115.939 -170.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 93' ' ' TYR . 15.9 m -90.76 16.2 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.125 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.32 110.48 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.068 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.99 32.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.184 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 38' ' ' LEU . 36.4 mt -98.53 168.2 10.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.095 0.447 . . . . 0.0 110.687 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -99.18 141.95 31.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.272 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 34' ' ' GLN . 32.6 tp -117.24 125.83 51.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.664 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 35' ' ' LEU . 42.5 mt -101.49 87.85 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -67.18 -12.83 61.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.768 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.8 t -69.4 -50.43 45.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.617 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 109.2 -12.83 33.91 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.542 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.27 151.36 24.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 110.486 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.703 ' HE1' HD22 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -73.5 -31.71 63.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.454 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.29 -74.2 0.6 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.833 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.4 t70 66.51 -48.25 0.44 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -80.98 16.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 2.7 p30 -89.65 -12.56 39.27 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 166.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 16.9 pttp . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 125.01 1.324 . . . . 0.0 112.448 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.835 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 38.4 tpp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -113.68 128.2 56.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.064 0.459 . . . . 0.0 111.181 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.7 mt -128.41 139.66 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.721 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.58 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 57.2 t80 -96.9 109.64 22.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 9' ' ' LEU . 45.0 t -95.2 106.96 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 91' ' ' TYR . 1.2 p90 -87.48 76.13 9.05 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.74 159.45 10.15 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -69.61 89.92 0.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.264 0.532 . . . . 0.0 110.868 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.1 tm? -79.47 -30.27 42.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.394 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -60.74 -23.6 65.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.674 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -93.08 -47.84 6.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.39 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -99.53 92.05 5.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 0.0 111.969 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -80.73 95.77 6.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.89 -43.04 75.99 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.186 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' H ' ' HD1' ' A' ' 18' ' ' TRP . 27.2 t-20 -140.18 156.23 46.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 m -54.49 -32.72 58.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.242 0.339 . . . . 0.0 111.584 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.504 ' HB3' HG23 ' A' ' 62' ' ' THR . 43.1 m80 -58.12 -31.57 67.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.419 ' HD1' ' H ' ' A' ' 15' ' ' ASN . 10.5 m95 -68.49 -46.23 70.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.516 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.9 ttt -76.33 -28.07 56.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.899 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 m -80.27 131.28 35.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 51.54 17.95 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.894 1.278 . . . . 0.0 112.974 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.08 117.17 19.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.14 0.495 . . . . 0.0 110.606 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -106.69 114.36 28.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.408 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 tp -67.0 102.59 1.0 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 55' ' ' VAL . 81.3 mt -64.46 -32.75 74.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.814 0.816 . . . . 0.0 109.135 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.87 135.78 3.16 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.808 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.37 126.34 29.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.1 0.953 . . . . 0.0 109.772 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.7 118.79 12.65 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.6 m -86.08 125.81 33.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.855 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' THR . 13.5 pt -99.94 130.01 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.712 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 39.0 t0 -92.33 159.14 15.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.984 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 49.5 m-80 73.84 29.97 1.39 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.735 0.647 . . . . 0.0 111.582 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 46' ' ' PRO . 97.7 m-85 -133.04 162.07 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.962 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.581 ' HG3' ' HA3' ' A' ' 47' ' ' GLY . 41.1 mt-30 -123.97 152.26 42.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.9 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.6 tp -118.9 126.01 50.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 111.111 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 102' ' ' LEU . 68.4 m-85 -92.14 135.19 34.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.874 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 23.4 t -121.79 96.87 5.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.035 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -101.8 18.03 21.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.613 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.17 -55.8 2.75 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.942 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -58.49 -51.88 68.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 110.483 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 18.1 p90 -160.11 138.4 7.49 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.846 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 41' ' ' TYR . 5.8 Cg_exo -75.27 159.7 40.09 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.912 2.408 . . . . 0.0 112.448 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 6' ' ' TYR . . . -145.27 125.21 2.29 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.71 144.18 35.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.201 0.5 . . . . 0.0 111.48 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 92' ' ' VAL . 31.7 m -144.88 163.25 34.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.674 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 24.5 Cg_endo -63.84 139.04 66.45 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.138 1.892 . . . . 0.0 112.069 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 34' ' ' GLN . . . -176.34 -120.3 0.61 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.949 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.3 t-20 -145.97 88.76 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.084 0.469 . . . . 0.0 109.985 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA3' ' O ' ' A' ' 104' ' ' GLU . . . 178.56 163.8 30.47 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.625 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' HB3' ' A' ' 29' ' ' SER . 1.9 m -109.3 100.15 9.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.073 0.463 . . . . 0.0 111.076 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.5 t -83.3 121.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.549 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.457 ' O ' ' HZ2' ' A' ' 108' ' ' TRP . 0.2 OUTLIER -77.94 56.27 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 -173.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.58 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -74.63 155.04 47.94 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.768 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -100.89 120.27 39.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 HD12 ' A' ' 25' ' ' LEU . 11.2 t -93.99 123.89 46.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.41 146.07 47.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -105.94 104.46 14.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.775 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.76 167.36 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.845 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.83 135.45 24.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.007 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.835 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 87.4 m-20 -54.71 -41.06 69.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.152 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.47 70.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' HIS . 72.8 m -56.27 -32.2 64.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.952 0.406 . . . . 0.0 110.471 174.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 13.8 tp -67.78 -49.77 60.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . . . -58.57 -32.39 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.868 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.54 -40.59 56.65 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 66' ' ' LEU . 8.4 tt -64.83 -47.7 77.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 1.8 p30 -67.45 -43.16 81.78 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.194 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.57 68.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.498 0.666 . . . . 0.0 110.779 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.84 -43.05 13.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.796 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 71' ' ' THR . 21.3 ttt180 -86.68 7.03 28.32 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -169.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.553 HG21 ' H ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER 98.14 -19.16 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.787 1.235 . . . . 0.0 112.338 -178.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HD2' ' OD1' ' A' ' 67' ' ' ASP . 34.0 ttt85 62.19 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.408 0.442 . . . . 0.0 111.6 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.54 26.29 2.55 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.237 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.02 -71.56 0.94 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.755 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.0 -34.59 69.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 110.644 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' H ' HG21 ' A' ' 71' ' ' THR . 10.7 m-85 -122.5 163.13 20.45 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.444 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.85 141.69 35.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HG2' ' CE2' ' A' ' 91' ' ' TYR . 29.5 mtp180 -93.07 124.27 36.92 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -116.96 107.89 15.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.76 110.13 16.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.9 pt -106.06 144.74 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.023 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.06 104.35 16.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.909 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -98.52 162.69 20.97 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.756 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.99 -21.42 58.33 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.678 2.252 . . . . 0.0 112.613 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' HB3' HD13 ' A' ' 25' ' ' LEU . 51.8 m-85 -96.7 -3.91 41.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.532 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.14 157.74 9.14 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.669 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 127.47 31.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.546 -0.385 . . . . 0.0 110.602 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.01 150.52 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.842 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -79.25 121.99 25.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.204 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.8 ttt -108.9 116.45 32.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.367 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' HB2' ' OH ' ' A' ' 6' ' ' TYR . 96.7 m-85 -94.78 107.97 19.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.279 0.562 . . . . 0.0 110.655 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.873 HG13 HG12 ' A' ' 45' ' ' VAL . 4.7 t -76.91 119.63 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.824 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.22 119.43 10.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.37 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -170.9 2.24 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.823 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 44.2 mtm180 72.62 167.91 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.662 0.601 . . . . 0.0 110.775 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 77.8 Cg_exo -54.15 119.18 5.9 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.745 2.296 . . . . 0.0 112.854 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' GLY . 35.4 m -104.88 1.99 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.778 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -64.93 16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . -128.58 15.18 6.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.6 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -144.59 176.26 9.54 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.682 -0.305 . . . . 0.0 110.907 177.304 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 54.7 mtpt -76.99 143.96 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.351 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 36' ' ' TYR . 56.6 tp -110.16 109.75 20.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.84 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.73 91.92 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.706 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -65.87 -26.15 67.51 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -73.56 -15.03 61.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.746 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 68.92 34.3 76.74 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.183 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.438 ' CG ' ' HA ' ' A' ' 110' ' ' ASP . 2.8 p30 -117.8 178.3 4.46 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.457 ' HZ2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -119.59 -34.44 3.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.336 0.589 . . . . 0.0 109.653 176.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 111' ' ' ARG . 10.5 mp -97.18 -15.85 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.16 -175.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 107' ' ' ASP . 2.8 p30 57.02 2.57 0.11 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.581 1.552 . . . . 0.0 113.204 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -129.1 81.98 2.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.807 0.813 . . . . 0.0 110.37 175.407 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.54 1.54 56.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.228 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 121.818 0.818 . . . . 0.0 110.928 -176.287 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.862 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 4.0 tmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.457 ' HD2' ' HA3' ' A' ' 86' ' ' GLY . 25.8 mtm180 -123.65 133.74 53.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.541 0.686 . . . . 0.0 112.165 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.93 148.16 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.486 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.723 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 81.4 t80 -92.69 112.01 23.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.74 126.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.174 0.512 . . . . 0.0 111.002 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 11.0 p90 -135.58 -43.68 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.503 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.76 80.46 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.726 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 p 50.46 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.905 0.882 . . . . 0.0 112.119 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.6 pt? -55.77 -33.44 64.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.754 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -63.06 -60.06 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 52.3 t-80 59.25 -84.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.868 0.73 . . . . 0.0 111.39 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' HIS . 76.4 tttt 174.42 115.68 0.02 OUTLIER 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.829 ' HB2' ' HB2' ' A' ' 19' ' ' MET . 0.0 OUTLIER -126.73 -156.05 0.72 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.023 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.63 -37.82 3.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.396 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.92 -35.3 0.71 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 0.0 110.905 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -75.55 169.36 18.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -70.19 9.44 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.039 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -76.7 -26.81 55.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.829 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 18.0 tpt -100.49 -39.54 7.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.663 . . . . 0.0 110.219 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 m -81.06 134.25 35.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.96 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.552 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 32.4 m-20 75.91 3.13 3.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.698 0.799 . . . . 0.0 111.279 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.6 135.01 43.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.408 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -137.03 143.67 42.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.158 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 tp -79.61 130.12 35.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 55' ' ' VAL . 95.6 mt -93.12 -43.01 9.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.856 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.42 176.59 27.77 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.4 147.54 28.72 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.149 0.976 . . . . 0.0 110.779 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -151.82 86.37 1.32 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.586 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.3 m -82.66 124.5 30.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -112.71 126.35 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.881 0.848 . . . . 0.0 111.524 -172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.85 156.67 20.45 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.5 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 71.01 33.38 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.118 0.886 . . . . 0.0 110.931 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.25 165.31 26.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.952 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -136.24 144.64 44.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 103' ' ' ILE . 18.7 tp -105.44 131.24 53.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.471 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -98.87 128.62 45.11 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 p -110.08 126.45 54.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.826 0.346 . . . . 0.0 110.321 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -140.98 16.75 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.01 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.81 -63.8 3.74 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.48 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -59.7 -45.36 92.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.58 ' HD1' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -167.65 110.88 0.6 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.71 176.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.41 142.75 98.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.65 2.234 . . . . 0.0 112.807 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 6' ' ' TYR . . . -120.32 178.57 16.48 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 151.28 29.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.546 0.673 . . . . 0.0 111.318 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.069 HG12 HG13 ' A' ' 92' ' ' VAL . 29.1 m -153.56 165.7 17.23 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.9 148.85 52.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.374 2.049 . . . . 0.0 111.343 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.07 -125.92 1.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.187 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -135.41 91.92 2.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.6 -178.24 48.55 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.427 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 23.2 m -122.26 119.89 32.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.916 0.858 . . . . 0.0 110.114 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.713 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 92.9 t -107.01 109.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.44 . . . . 0.0 110.461 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.474 ' O ' ' HH2' ' A' ' 108' ' ' TRP . 7.5 t60 -69.16 119.96 14.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.723 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -128.43 142.85 13.91 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.847 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 9' ' ' LEU . 27.4 mm-40 -98.54 107.66 20.17 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 25' ' ' LEU . 57.1 t -80.2 116.98 25.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.79 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.77 150.77 39.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.715 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 1.8 tmt_? -108.49 107.63 18.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 pt -114.74 169.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.604 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 25.6 t70 -53.5 137.88 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.045 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.862 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 9.0 m120 -63.38 -43.91 96.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.616 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.29 77.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.269 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 67.7 m -56.82 -29.54 62.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.083 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 1' ' ' MET . 37.2 tp -66.6 -47.88 71.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.56 -32.4 65.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -74.3 -55.05 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.748 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.42 -37.28 85.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.097 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.51 -56.56 19.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.255 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 72' ' ' ARG . . . -55.45 -32.46 62.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.79 -58.11 3.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.973 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HA3' ' A' ' 74' ' ' GLY . 39.5 ttm180 -85.4 -3.19 58.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' TYR . 75.3 p -106.61 -67.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.649 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 2.3 tmt_? -53.88 -36.55 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.359 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.99 22.71 7.54 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.349 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 70' ' ' ARG . . . -132.22 -29.31 0.56 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.874 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 74.15 18.46 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.568 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' O ' HG22 ' A' ' 71' ' ' THR . 8.3 m-85 -116.22 162.94 16.73 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.52 150.12 46.17 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.789 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptt85 -88.89 127.77 35.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 111.636 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -104.14 121.73 43.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.254 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -87.1 112.75 22.22 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.22 133.28 58.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.396 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -86.94 101.2 13.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.562 -176.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 p -93.67 160.47 32.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.74 -3.13 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.798 2.332 . . . . 0.0 112.648 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.06 4.02 13.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.276 0.56 . . . . 0.0 110.067 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 2' ' ' ARG . . . 126.95 149.54 7.27 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.125 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 8.0 m -65.81 122.25 16.88 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.594 -0.356 . . . . 0.0 110.203 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.15 146.32 43.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.82 120.52 25.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -105.58 113.11 26.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.66 116.03 22.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 1.069 HG13 HG12 ' A' ' 45' ' ' VAL . 8.6 t -108.43 143.09 19.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.946 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -46.34 119.12 2.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.475 168.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -104.33 -26.62 12.4 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.637 -174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.597 ' H ' ' CD ' ' A' ' 96' ' ' PRO . 4.1 ptp180 -162.13 -37.46 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 95' ' ' ARG . 98.6 Cg_endo -97.78 103.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.555 1.503 . . . . 0.0 114.749 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 93' ' ' TYR . 5.6 m -145.89 90.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.275 0.56 . . . . 0.0 110.352 169.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.48 24.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . 112.38 -68.86 0.23 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 38' ' ' LEU . 66.0 mt 61.89 -170.0 0.17 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.13 0.49 . . . . 0.0 111.213 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -109.0 113.25 25.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -87.69 125.31 34.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.19 0.519 . . . . 0.0 110.492 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 35' ' ' LEU . 20.6 mt -107.9 92.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -14.51 62.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 110.652 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.2 m -72.73 -22.62 60.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.642 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 62.02 38.52 96.22 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.814 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -142.02 149.73 40.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.474 ' HH2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -89.07 -26.18 21.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 -171.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.83 -28.06 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.643 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.06 76.51 8.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.466 0.65 . . . . 0.0 110.247 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -118.58 -56.62 2.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.903 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -148.05 104.5 3.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.616 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.985 173.178 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.989 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 52.5 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 87' ' ' SER . 10.2 mtt85 -111.82 129.89 55.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 tt -130.53 146.76 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.826 0.346 . . . . 0.0 110.544 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 75.2 t80 -103.31 124.32 48.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.27 130.51 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.23 43.08 2.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.563 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 42' ' ' PRO . . . 152.84 113.74 0.55 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.713 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 10' ' ' ARG . 63.3 p 51.36 103.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.794 0.838 . . . . 0.0 112.79 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.6 pt? -66.54 17.09 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.678 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' H ' ' C ' ' A' ' 8' ' ' SER . 19.2 mtp180 -58.55 -31.25 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 46.5 106.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.848 1.259 . . . . 0.0 113.726 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.01 121.54 18.38 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.869 -0.519 . . . . 0.0 109.88 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.87 107.34 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.783 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.27 77.47 1.69 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 72.65 173.02 0.3 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -68.94 -16.04 63.64 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.693 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -54.1 -22.61 11.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.918 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' HA ' HG21 ' A' ' 62' ' ' THR . 52.0 t-105 -88.03 -65.47 1.01 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.093 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.65 -19.73 61.38 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 20' ' ' THR . 23.6 m -85.93 46.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.678 0.751 . . . . 0.0 111.148 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 20' ' ' THR . 9.7 p30 163.57 -19.4 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.741 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.0 105.47 0.09 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.793 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -111.82 117.48 32.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.126 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.22 106.29 3.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 HG12 ' A' ' 55' ' ' VAL . 83.3 mt -71.6 -38.31 70.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.352 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.0 157.61 7.25 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.293 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 3.7 p-10 -78.1 143.15 37.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.749 0.785 . . . . 0.0 110.537 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -151.42 116.01 5.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.368 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.3 m -87.59 137.66 32.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.218 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.2 pt -119.99 148.35 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 25.6 t0 -102.28 152.01 21.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 50.9 m-80 77.03 36.33 0.32 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.146 0.978 . . . . 0.0 111.654 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -138.39 136.83 36.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.529 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.431 HE21 HD11 ' A' ' 102' ' ' LEU . 24.7 mt-30 -111.93 154.32 25.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 42' ' ' PRO . 45.4 tp -118.84 138.2 52.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 0.0 111.749 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.27 147.93 29.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.843 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 20.2 m -116.75 111.82 20.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -112.05 17.42 19.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.764 -177.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.21 -78.15 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.481 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -62.16 -32.73 73.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.844 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 38' ' ' LEU . 6.6 p90 -165.99 167.15 9.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.59 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.0 Cg_endo -88.9 -178.74 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.989 2.459 . . . . 0.0 112.396 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.23 129.62 2.07 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -110.84 160.1 17.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.708 0.754 . . . . 0.0 111.563 -173.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 92' ' ' VAL . 32.3 m -147.82 161.15 36.11 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.805 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 136.24 36.54 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.303 2.002 . . . . 0.0 111.102 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.8 -126.26 1.02 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.237 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.64 82.48 2.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.924 0.393 . . . . 0.0 110.634 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.08 172.68 43.42 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 46.0 m -126.89 106.75 9.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.305 0.552 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 93.7 t -84.06 114.07 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.5 59.16 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.066 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -82.84 165.98 44.42 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.458 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 28.6 mp0 -107.62 124.07 49.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.278 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG12 HD12 ' A' ' 25' ' ' LEU . 34.0 t -88.17 128.2 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.644 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -123.38 150.99 43.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.873 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -113.69 118.41 34.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.724 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 1' ' ' MET . 2.0 pp -132.45 164.84 33.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.899 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.574 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 13.3 t70 -51.76 143.57 12.74 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.989 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 3.7 m-20 -57.97 -44.96 87.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.43 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.954 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 19.1 m -56.43 -38.13 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 0.0 110.965 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD22 ' HG2' ' A' ' 1' ' ' MET . 10.2 tp -66.54 -52.33 46.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.69 65.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.851 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 -48.97 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.341 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -39.53 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.033 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.78 -50.37 72.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.42 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 72' ' ' ARG . . . -63.74 -19.69 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.91 -49.25 8.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.457 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.543 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -75.08 -54.06 7.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.983 -173.539 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 76' ' ' TYR . 6.6 t -119.5 41.95 2.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.17 0.986 . . . . 0.0 110.443 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 53.7 ttt180 -47.74 -42.84 26.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.787 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.09 13.41 19.43 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.56 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.37 83.79 1.56 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.705 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -127.01 -23.67 3.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.027 0.441 . . . . 0.0 110.327 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HD2' ' HB ' ' A' ' 71' ' ' THR . 91.4 m-85 -131.24 166.18 21.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.5 127.61 55.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.043 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -86.04 106.96 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -104.93 105.9 16.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -79.79 112.15 16.79 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.57 152.81 10.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.56 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -99.15 109.61 22.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.235 0.54 . . . . 0.0 111.773 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -96.53 165.62 15.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.89 -2.26 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.45 2.1 . . . . 0.0 112.466 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -120.83 15.63 11.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.017 0.437 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.25 157.42 10.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.218 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.409 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 9.2 p -66.37 130.4 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.4 151.33 44.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.335 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -85.65 123.19 30.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 111.41 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 21.4 ttt -107.79 124.06 49.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.562 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -91.33 116.21 28.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 45' ' ' VAL . 7.2 t -94.63 126.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.5 ' HD1' ' CE1' ' A' ' 76' ' ' TYR . 40.2 t80 -75.29 127.14 32.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.108 0.956 . . . . 0.0 110.808 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 76' ' ' TYR . 28.2 mm-40 -89.44 -161.99 0.83 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.172 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 38.2 mmt180 70.91 169.38 0.12 Allowed Pre-proline 0 N--CA 1.467 0.391 0 O-C-N 123.358 0.411 . . . . 0.0 110.743 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 18.8 Cg_endo -62.32 134.05 46.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.278 1.985 . . . . 0.0 111.658 171.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.36 10.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.62 126.67 28.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.284 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.76 57.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 38' ' ' LEU . 41.6 mt -86.23 159.84 19.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.811 0.306 . . . . 0.0 110.305 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 48.1 mtmt -88.78 119.09 28.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD11 HE21 ' A' ' 34' ' ' GLN . 57.4 tp -97.17 121.52 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 107' ' ' ASP . 29.4 mt -101.62 94.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.13 -21.03 66.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.03 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 p -73.26 -44.12 59.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 106.53 10.03 29.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.318 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 103' ' ' ILE . 2.7 p30 -111.64 178.8 4.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.441 ' CE3' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -110.58 -41.21 4.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.766 0.793 . . . . 0.0 109.487 173.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -124.88 19.8 8.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.489 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.439 ' HA ' ' CG ' ' A' ' 107' ' ' ASP . 32.2 t70 55.96 -107.54 0.39 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.52 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -127.08 4.44 6.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.866 0.841 . . . . 0.0 108.785 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.48 65.98 1.42 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.0 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.844 -174.555 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.952 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 45.0 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 143.74 33.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.838 0.352 . . . . 0.0 110.565 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.2 146.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.242 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 73.7 t80 -92.86 113.55 25.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.831 0.348 . . . . 0.0 110.287 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.8 147.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.58 67.4 1.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -175.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.21 -163.46 48.95 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 10' ' ' ARG . 73.0 p 50.55 22.76 1.13 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.898 0.479 . . . . 0.0 112.204 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.7 pt? -70.79 6.06 1.66 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.598 0.713 . . . . 0.0 110.252 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 8' ' ' SER . 15.8 mmm180 -63.8 -42.63 97.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.999 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -87.25 74.34 9.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.32 69.64 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.701 0.763 . . . . 0.0 109.722 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -173.27 -166.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.653 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.57 -61.09 0.25 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -136.2 -69.82 0.48 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -164.41 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.962 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 53.0 m-70 -58.61 -18.95 34.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.024 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.09 -65.47 0.97 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.777 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 ptm -64.81 -30.79 71.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -82.09 -28.99 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.076 0.465 . . . . 0.0 111.604 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 10.6 m120 -114.81 16.89 17.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.322 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 121.22 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.133 0.492 . . . . 0.0 112.075 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 57.8 tt0 -114.86 129.0 56.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.705 172.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.8 tp -78.95 104.14 9.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.015 0.436 . . . . 0.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD12 HG12 ' A' ' 55' ' ' VAL . 94.1 mt -70.05 -45.23 67.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.32 168.08 12.32 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.545 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.66 151.86 46.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.163 0.506 . . . . 0.0 109.824 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -156.71 87.05 1.0 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.872 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 15.5 m -77.53 129.25 35.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.08 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.04 134.13 59.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -82.8 156.42 23.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.993 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 67.54 33.97 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.025 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.41 172.09 12.6 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.632 ' HB3' HD11 ' A' ' 102' ' ' LEU . 93.8 mt-30 -139.96 157.0 46.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 43' ' ' GLY . 35.4 tp -123.4 128.75 50.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.836 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 97' ' ' VAL . 88.2 m-85 -91.06 140.9 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.15 0.5 . . . . 0.0 112.127 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 68.5 m -113.86 109.94 19.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.31 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -121.27 6.29 10.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.363 174.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.56 4.52 Favored Glycine 0 C--O 1.229 -0.186 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.989 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -61.95 -47.27 85.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.784 0.326 . . . . 0.0 111.036 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.42 155.53 8.64 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.644 175.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.01 148.15 19.3 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.938 2.426 . . . . 0.0 113.643 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -120.64 160.33 15.12 Favored Glycine 0 C--O 1.227 -0.337 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.33 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.991 0.896 . . . . 0.0 111.6 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.818 HG11 ' HD2' ' A' ' 93' ' ' TYR . 33.7 m -154.46 167.09 14.56 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.81 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.13 157.04 54.89 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.393 2.062 . . . . 0.0 111.84 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.09 -119.41 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -145.53 92.14 2.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.856 0.36 . . . . 0.0 110.085 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 165.1 33.14 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.354 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 m -101.75 101.85 12.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.875 0.369 . . . . 0.0 110.275 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' SER . 70.1 t -82.81 106.72 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.792 -174.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -69.52 107.53 3.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.939 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -123.09 147.2 16.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.1 mp0 -103.9 107.25 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG12 HD12 ' A' ' 25' ' ' LEU . 26.0 t -81.35 117.07 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.062 0.458 . . . . 0.0 110.223 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -115.29 147.71 40.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.455 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 52.8 ttt180 -108.95 131.93 54.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.986 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.743 HD11 HD23 ' A' ' 63' ' ' LEU . 1.7 pp -140.73 164.14 21.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.667 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.67 142.15 15.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.539 0.209 . . . . 0.0 111.18 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.952 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 95.7 m-20 -54.51 -48.64 71.66 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 0.0 110.979 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.19 75.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.085 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 17' ' ' HIS . 75.5 m -56.27 -37.0 69.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.835 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -66.82 -42.13 86.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -23.67 66.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.843 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.85 -48.5 45.6 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.15 -34.73 78.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.46 -54.87 41.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.499 0.666 . . . . 0.0 110.92 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.76 68.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.39 -56.27 3.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . 39.8 ttt180 -85.19 7.14 22.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.684 HG21 ' H ' ' A' ' 76' ' ' TYR . 0.5 OUTLIER 98.4 124.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.602 1.189 . . . . 0.0 111.066 -173.516 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -89.26 -24.96 21.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.707 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.37 47.16 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.223 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.99 -55.75 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.454 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 4.6 tp10 -79.46 -37.82 36.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.684 ' H ' HG21 ' A' ' 71' ' ' THR . 38.5 m-85 -142.6 170.38 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.579 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.96 152.09 36.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -88.93 125.22 34.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -105.18 121.63 44.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.6 tp -91.82 114.69 27.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 7.3 pt -114.02 148.98 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -90.43 108.54 19.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.719 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 1.4 p -100.02 163.42 18.39 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 83' ' ' THR . 17.7 Cg_endo -61.54 -16.04 45.33 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.481 2.12 . . . . 0.0 112.064 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -97.91 -2.66 40.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.9 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.51 160.21 10.85 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 66.4 m -63.95 121.29 13.74 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.138 0.494 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.64 148.68 30.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.674 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.46 124.28 31.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.183 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 85.2 mtp -106.7 170.28 8.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.039 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -127.69 117.72 22.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.871 0.367 . . . . 0.0 110.415 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 45' ' ' VAL . 4.0 t -101.59 136.82 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.696 0.76 . . . . 0.0 111.189 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.818 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -51.68 120.64 5.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.739 175.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.9 tp60 -117.96 1.35 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.752 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.454 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 68.8 mtp180 -132.16 146.61 62.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.25 121.78 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.561 3.507 . . . . 0.0 114.598 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 100' ' ' LEU . 12.8 m -104.52 14.48 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.862 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.56 96.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.013 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.84 5.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.327 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 97' ' ' VAL . 87.2 mt -89.87 165.7 13.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.335 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 30.1 mmmt -90.29 132.25 35.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 34' ' ' GLN . 64.6 tp -105.93 107.78 18.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.374 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 107' ' ' ASP . 51.5 mt -82.12 89.02 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.98 -9.55 39.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.178 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 m -70.79 -27.16 63.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.024 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 85.66 -13.37 56.29 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.171 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 103' ' ' ILE . 5.4 t70 -100.42 141.35 33.38 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.384 -0.48 . . . . 0.0 110.223 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -70.02 -30.96 68.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.551 . . . . 0.0 110.228 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.619 ' HB3' ' HA ' ' A' ' 112' ' ' ASP . 3.0 mm? -81.39 -36.05 30.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.955 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.68 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.104 0.878 . . . . 0.0 112.262 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -63.37 -33.71 76.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 109' ' ' LEU . 17.1 t0 57.57 96.69 0.02 OUTLIER 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.569 171.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.0 pttt . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 122.16 0.981 . . . . 0.0 110.301 174.14 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 25.1 ttm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -117.61 144.73 44.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 111.188 -175.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 63' ' ' LEU . 10.6 tt -139.82 150.66 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.908 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -97.22 115.74 28.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 9' ' ' LEU . 16.5 t -102.31 158.82 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 1.6 p90 -152.17 118.33 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.035 0.445 . . . . 0.0 111.447 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.32 -85.17 1.33 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.321 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -75.42 80.15 2.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.077 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.648 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.7 pt? -76.98 -21.18 55.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -80.55 -55.91 4.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.43 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.5 p80 41.11 75.92 0.08 Allowed 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.843 0.714 . . . . 0.0 110.816 -171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt 67.48 -95.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.933 -169.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER 66.0 143.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.858 0.724 . . . . 0.0 111.305 -177.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.56 -15.21 4.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.14 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -148.38 -28.13 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.552 0.215 . . . . 0.0 111.219 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -64.31 163.41 13.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.7 -18.22 40.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.152 0.501 . . . . 0.0 110.711 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 52.3 t-105 -58.66 -27.6 64.93 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.059 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.2 ttp -81.64 -33.04 31.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.895 0.379 . . . . 0.0 111.467 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 m -91.61 -54.12 4.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -99.16 10.64 41.04 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' TRP . . . -66.73 116.78 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 111.684 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.8 tt0 -107.31 119.5 39.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.718 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 tp -81.66 98.39 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.488 . . . . 0.0 109.859 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.679 HD12 HG12 ' A' ' 55' ' ' VAL . 88.8 mt -64.9 -41.78 95.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.711 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.37 153.36 6.08 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.614 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-20 -69.57 143.42 53.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 55' ' ' VAL . 17.2 t80 -154.48 114.03 3.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.0 m -100.56 132.6 45.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.106 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 50' ' ' THR . 16.3 pt -114.03 141.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.423 . . . . 0.0 111.164 -175.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.26 160.07 14.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.036 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 73.8 28.94 1.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.594 0.758 . . . . 0.0 111.506 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.67 142.28 46.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB3' HD11 ' A' ' 102' ' ' LEU . 49.9 mt-30 -116.05 148.42 40.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . 12.4 tp -103.44 139.33 38.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.488 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.45 134.91 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.5 p -116.49 128.49 55.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.991 0.424 . . . . 0.0 110.131 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -133.73 17.36 3.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.317 172.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.72 -59.2 4.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.955 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -89.08 -0.77 57.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -156.62 134.09 6.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 121.78 0.38 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.939 2.426 . . . . 0.0 111.378 166.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.69 16.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.645 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -145.47 146.53 31.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.658 0.729 . . . . 0.0 110.585 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.89 HG12 HG13 ' A' ' 92' ' ' VAL . 27.3 m -149.44 164.0 22.76 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 123.404 0.44 . . . . 0.0 110.489 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.18 136.47 56.13 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.401 2.067 . . . . 0.0 111.805 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.05 -122.54 0.77 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.826 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -143.05 92.18 2.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.708 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.91 167.71 37.49 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.856 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.1 m -115.03 111.47 21.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.8 t -84.91 118.68 32.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.004 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -78.96 97.9 6.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.68 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 6' ' ' TYR . . . -130.71 172.16 20.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.459 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 27.4 mp0 -120.12 133.65 55.46 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.757 0.423 . . . . 0.0 109.886 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 25' ' ' LEU . 31.6 t -91.27 120.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -118.14 157.88 26.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.319 0.581 . . . . 0.0 112.008 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.3 tmt_? -127.2 124.12 38.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.631 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.41 -173.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.767 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 62' ' ' THR . 3.7 m-20 -52.11 153.11 2.86 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.683 0.277 . . . . 0.0 110.617 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.0 p-10 -65.42 -38.87 91.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.18 85.13 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.993 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 89.1 m -56.97 -30.26 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.074 0.464 . . . . 0.0 111.373 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.5 tm? -65.48 -48.55 72.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.05 66.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.13 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -49.1 31.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.027 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.62 -36.64 84.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.4 -54.59 45.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.77 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.15 -28.63 69.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.636 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 69' ' ' LEU . 17.4 mt -79.17 -47.72 15.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.637 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -81.62 -49.64 10.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t -107.19 -31.08 8.39 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.357 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 52.1 -90.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.53 0.732 . . . . 0.0 112.421 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.79 25.23 20.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.48 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.37 42.99 13.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.19 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 95' ' ' ARG . 34.2 tt0 -68.44 -31.11 70.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' VAL . 12.0 m-85 -119.37 159.75 23.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.285 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.31 124.9 47.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.765 0.317 . . . . 0.0 110.652 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -79.15 123.53 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.892 0.854 . . . . 0.0 110.766 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -104.7 145.93 29.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.513 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.06 113.3 25.74 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.205 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.9 pt -110.24 140.98 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.352 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.521 HE22 ' HB3' ' A' ' 87' ' ' SER . 9.7 mm100 -91.37 102.97 15.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 -174.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -99.83 158.04 32.82 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.71 -18.38 55.21 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 49.8 m-85 -99.05 -3.16 35.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.834 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.36 161.06 9.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.288 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.521 ' HB3' HE22 ' A' ' 82' ' ' GLN . 62.3 p -67.08 107.19 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 110.464 176.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.71 145.97 29.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.887 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -83.62 125.43 31.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 ttt -114.75 116.64 28.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.41 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.59 108.13 19.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 112.026 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.89 HG13 HG12 ' A' ' 45' ' ' VAL . 4.3 t -81.15 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.815 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.561 ' HD1' HG12 ' A' ' 97' ' ' VAL . 7.2 t80 -63.59 119.84 10.61 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' H ' ' HD1' ' A' ' 76' ' ' TYR . 13.0 tp60 -108.03 -166.51 1.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 31.7 mtp85 66.92 -177.43 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 54.2 Cg_exo -54.73 100.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.714 1.609 . . . . 0.0 112.468 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.561 HG12 ' HD1' ' A' ' 93' ' ' TYR . 26.9 m -93.53 -10.8 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.677 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.79 103.99 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.529 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.6 -12.05 4.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.077 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 38' ' ' LEU . 73.2 mt -78.24 162.23 26.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -93.2 109.05 20.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 34' ' ' GLN . 61.6 tp -73.75 139.02 44.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.461 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.708 HG23 ' HD3' ' A' ' 111' ' ' ARG . 62.7 mt -124.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.269 174.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.02 -15.58 63.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.46 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -70.99 -20.8 62.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.12 73.91 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.531 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 12.2 t70 -134.05 137.19 44.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -71.85 -29.2 64.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.805 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -116.84 11.48 14.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 30.1 t70 -82.2 -59.28 2.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.169 0.509 . . . . 0.0 111.146 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.708 ' HD3' HG23 ' A' ' 103' ' ' ILE . 39.4 mtp85 -92.31 11.9 24.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.601 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.27 -48.99 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.391 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 113' ' ' LYS . 9.6 mtmp? . . . . . 0 N--CA 1.47 0.55 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.48 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.964 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 43.8 tpp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -134.12 125.77 28.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.093 0.473 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.56 145.96 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -86.49 111.82 20.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 0.0 110.004 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 83.9 t -91.6 136.1 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' CD1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -100.22 33.45 2.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.634 -174.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.437 ' H ' HG12 ' A' ' 5' ' ' VAL . . . 67.7 -160.08 50.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.562 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 108' ' ' TRP . 91.6 p 62.81 -48.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.166 1.387 . . . . 0.0 113.813 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mp -60.62 -15.6 29.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -53.18 -17.45 1.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -54.13 -50.59 66.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.808 0.337 . . . . 0.0 110.491 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -139.8 123.2 17.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.562 ' HG3' ' HB2' ' A' ' 19' ' ' MET . 3.7 tp60 -140.29 -55.03 0.53 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.188 0.518 . . . . 0.0 110.663 -173.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 19' ' ' MET . . . -82.51 64.47 4.27 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.846 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -136.05 2.83 2.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 0.0 110.244 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 p -164.13 -172.95 2.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -67.81 -13.62 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.038 0.212 . . . . 0.0 110.919 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.4 -43.85 96.28 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.967 0.413 . . . . 0.0 110.069 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.584 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.4 -100.84 0.37 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 19' ' ' MET . 61.5 m 43.71 -78.29 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.841 0.857 . . . . 0.0 112.952 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' MET . 62.8 m-20 -91.71 -8.6 46.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.653 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' CB ' HG22 ' A' ' 58' ' ' ILE . . . -55.71 139.06 46.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.691 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -124.09 121.15 34.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.677 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.32 106.25 1.32 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 85' ' ' TYR . 84.4 mt -66.68 -38.32 86.55 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.03 159.83 10.11 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.918 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.27 145.26 54.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -139.15 115.04 10.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 52' ' ' HIS . 5.8 p -100.96 131.01 47.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.592 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 pt -117.38 130.39 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.361 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.48 151.71 21.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.871 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.72 33.97 2.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.932 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.95 154.15 51.81 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 102' ' ' LEU . 38.2 mt-30 -128.13 156.8 42.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 103' ' ' ILE . 15.3 tp -114.2 130.25 56.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.585 0.231 . . . . 0.0 110.758 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 86.0 m-85 -99.96 132.34 45.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.609 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.1 m -99.37 102.24 13.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -118.75 12.55 13.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.708 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.06 -51.15 4.06 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.035 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.4 -42.3 91.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CE1' HD11 ' A' ' 38' ' ' LEU . 8.2 p90 -175.05 153.85 1.64 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 6' ' ' TYR . 16.6 Cg_exo -70.24 112.02 3.06 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.237 1.958 . . . . 0.0 111.678 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -90.48 159.51 27.23 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.276 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 34' ' ' GLN . . . -141.83 139.57 32.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.749 0.775 . . . . 0.0 111.433 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.555 HG12 HG13 ' A' ' 92' ' ' VAL . 26.9 m -145.57 163.22 32.83 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.386 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.16 146.43 76.3 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.547 2.164 . . . . 0.0 111.488 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.0 -111.36 0.39 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.79 92.12 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.08 47.5 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m -124.87 103.86 8.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 117.801 0.801 . . . . 0.0 110.529 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 77.3 t -84.16 104.08 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 1.8 p80 -95.35 94.89 8.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.449 0.642 . . . . 0.0 110.699 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.15 10.4 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.179 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 28.3 mt-10 -127.0 124.66 39.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG12 HD12 ' A' ' 25' ' ' LEU . 72.0 t -93.16 118.97 40.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.087 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.14 148.05 40.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.132 0.491 . . . . 0.0 112.054 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -106.87 114.79 29.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.889 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.25 174.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -52.88 144.4 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.956 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.964 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.3 m-20 -60.02 -36.02 76.35 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.424 0.631 . . . . 0.0 109.451 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.54 71.99 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.93 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 m -56.42 -40.44 74.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 39.1 tp -67.99 -46.69 70.6 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.84 68.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.5 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.15 -43.11 44.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.322 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.64 -42.72 98.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.26 -50.66 73.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.892 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.07 -28.69 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.467 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.0 mt -86.57 -55.36 3.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HD3' ' HD2' ' A' ' 76' ' ' TYR . 41.5 ttm180 -85.45 -44.65 12.56 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -168.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -97.11 -8.82 29.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.653 -169.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -58.12 -33.36 69.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.378 0.609 . . . . 0.0 109.685 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.56 -52.05 3.86 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.281 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.72 53.92 0.3 Allowed Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG2' ' NH2' ' A' ' 95' ' ' ARG . 25.6 mt-10 -89.5 -54.57 4.02 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.616 ' HD2' ' HD3' ' A' ' 70' ' ' ARG . 12.7 m-85 -131.9 170.21 15.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.879 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.4 149.93 21.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 89' ' ' TRP . 20.7 tpp85 -102.33 134.87 44.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.121 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 60.7 tt0 -135.09 152.5 51.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -119.44 117.55 28.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.849 0.357 . . . . 0.0 110.383 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 pt -109.07 148.73 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.323 0.582 . . . . 0.0 111.292 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -96.75 126.96 42.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.305 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.2 p -122.11 159.92 49.73 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.409 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.4 -10.46 26.17 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.395 2.064 . . . . 0.0 111.582 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 10.8 m-85 -106.97 12.79 28.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.028 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.75 -103.09 0.59 Allowed Glycine 0 C--O 1.217 -0.927 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.144 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.0 t -172.86 133.17 0.55 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.47 144.39 51.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.942 0.401 . . . . 0.0 111.755 -170.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 78' ' ' ARG . 96.3 m95 -82.01 127.25 32.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.303 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 25.8 ttt -109.13 155.1 21.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.053 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.83 130.63 52.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.372 . . . . 0.0 110.859 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 45' ' ' VAL . 3.3 t -108.4 134.07 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 121.66 0.743 . . . . 0.0 110.836 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.632 ' CE2' HG13 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -50.71 134.45 24.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.471 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 6.4 tp60 -135.22 33.65 3.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.797 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 27.4 mmt85 -131.31 -177.03 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.345 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 95' ' ' ARG . 6.3 Cg_exo -75.72 135.2 17.5 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.749 1.632 . . . . 0.0 112.674 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 100' ' ' LEU . 2.3 m -101.49 11.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -62.73 -6.09 3.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 29.21 1.79 Allowed Glycine 0 C--N 1.308 -1.028 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.312 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.011 HD12 HG12 ' A' ' 97' ' ' VAL . 43.2 mt -113.83 165.08 12.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.851 -0.205 . . . . 0.0 110.548 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -102.81 124.77 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 34' ' ' GLN . 66.5 tp -84.16 143.59 29.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.881 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.552 HD12 HD23 ' A' ' 35' ' ' LEU . 44.8 mt -107.97 94.51 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.22 24.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.064 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 103' ' ' ILE . 59.7 m -161.27 15.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.295 -0.253 . . . . 0.0 111.522 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 52.65 22.82 12.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 5.9 p-10 -98.99 178.89 4.8 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.943 0.871 . . . . 0.0 108.745 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 67.2 t-105 -121.69 -38.68 2.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.582 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 46.0 mt -143.29 67.64 1.3 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.403 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -137.91 91.02 2.54 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.658 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.88 -55.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.717 173.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -126.66 -124.61 0.24 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.894 0.378 . . . . 0.0 110.467 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt . . . . . 0 N--CA 1.466 0.345 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.253 -179.731 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 1.038 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 47.1 tpp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.69 51.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.238 -0.289 . . . . 0.0 110.435 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 63' ' ' LEU . 13.0 tt -140.37 147.81 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.255 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.679 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 84.0 t80 -96.83 111.33 23.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.4 t -96.18 123.32 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.542 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -80.93 71.16 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.514 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.0 -89.97 0.68 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.699 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.6 p -50.92 113.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.57 -23.09 19.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.627 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -46.56 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.94 0.775 . . . . 0.0 112.154 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 24.0 m170 59.17 -99.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.174 0.59 . . . . 0.0 111.753 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -143.9 111.93 6.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.049 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -140.41 109.75 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 109.705 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.98 -20.68 0.1 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.645 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -159.26 -26.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 18' ' ' TRP . 12.6 m -68.7 160.93 29.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.186 0.517 . . . . 0.0 111.406 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.57 9.29 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.617 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' SER . 21.7 t-105 -52.41 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.671 0.607 . . . . 0.0 111.872 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.32 93.13 3.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.4 m -148.21 -43.8 0.16 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.078 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -130.59 25.66 5.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.081 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 104.92 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.812 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -96.07 122.1 38.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.619 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.3 tp -73.53 106.4 5.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.08 -44.17 18.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.9 157.53 8.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.3 p30 -77.63 158.27 29.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.499 0.666 . . . . 0.0 110.458 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.07 90.17 1.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -79.87 129.38 34.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -122.91 141.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 111.296 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.9 165.65 13.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 83.5 m-20 69.55 28.7 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.824 0.703 . . . . 0.0 112.081 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.49 157.79 45.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.274 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.687 ' HB3' HD11 ' A' ' 102' ' ' LEU . 34.9 mt-30 -126.31 152.76 45.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 103' ' ' ILE . 38.1 tp -119.02 125.94 50.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 110.565 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE1' HG11 ' A' ' 97' ' ' VAL . 96.4 m-85 -96.72 137.41 35.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.783 0.325 . . . . 0.0 110.721 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.5 p -109.63 101.86 10.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.337 0.589 . . . . 0.0 109.541 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.63 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -107.37 2.6 24.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.118 -178.029 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.74 153.23 18.57 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.9 m80 70.72 -54.58 0.65 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.363 0.601 . . . . 0.0 111.043 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -158.18 129.29 3.74 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.311 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 6' ' ' TYR . 13.1 Cg_exo -72.77 177.88 7.06 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.563 2.175 . . . . 0.0 112.734 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -150.93 161.01 28.89 Favored Glycine 0 C--O 1.224 -0.507 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -131.81 158.13 42.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.139 0.969 . . . . 0.0 111.7 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 92' ' ' VAL . 35.1 m -150.98 163.38 23.87 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.715 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.71 161.97 39.38 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.585 2.19 . . . . 0.0 111.931 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.54 -127.84 1.9 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 4.2 t-20 -146.28 89.03 1.83 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 109.71 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.45 168.94 41.67 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -103.55 112.13 24.9 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.09 0.445 . . . . 0.0 111.148 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.495 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 69.2 t -98.26 114.58 36.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 108' ' ' TRP . 99.5 m-70 -78.93 105.28 10.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.474 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.679 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -117.55 168.32 12.92 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.553 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 40.7 mt-10 -131.16 128.54 40.26 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 85' ' ' TYR . 60.9 t -92.01 117.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.158 0.504 . . . . 0.0 110.271 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.63 154.9 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.615 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -108.92 130.43 55.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 63' ' ' LEU . 1.6 pp -143.22 172.06 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.024 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 56.7 m-20 -51.09 141.87 13.38 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.242 0.339 . . . . 0.0 110.61 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 1.038 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.5 m-20 -55.51 -39.62 70.73 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.709 0.766 . . . . 0.0 109.264 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -36.99 85.57 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.631 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' ASP . 34.2 m -55.61 -38.33 69.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 111.119 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -66.85 -50.73 61.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.247 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -29.49 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.793 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.54 -50.82 56.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.307 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.48 -39.38 90.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 -45.43 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.841 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.68 69.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 111.283 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.67 -53.91 4.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.364 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -85.64 -41.6 15.06 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -106.74 -67.56 0.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -173.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 60.57 -68.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.577 0.751 . . . . 0.0 111.05 -169.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.77 -95.73 1.13 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.652 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.77 42.98 0.73 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.477 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -61.13 -39.43 90.0 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 93' ' ' TYR . 29.1 m-85 -135.01 160.34 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.624 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB2' ' OE1' ' A' ' 94' ' ' GLN . . . -88.6 136.82 32.8 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.42 102.34 11.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 64.1 tt0 -103.18 100.65 10.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.411 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 87' ' ' SER . 48.4 tp -76.87 106.58 8.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.986 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.8 pt -101.47 139.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.682 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -86.36 106.2 17.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.835 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -103.33 162.0 21.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.62 -21.08 71.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.431 2.087 . . . . 0.0 112.019 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.491 ' HB2' HG11 ' A' ' 55' ' ' VAL . 20.7 m-85 -90.66 -4.44 56.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.344 0.593 . . . . 0.0 109.994 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.51 166.76 12.39 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.552 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 80' ' ' LEU . 7.8 p -66.86 121.38 15.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.08 146.5 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.786 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.88 121.4 28.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 21.4 ttt -105.74 152.12 23.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.474 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.31 120.81 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.539 0.209 . . . . 0.0 110.851 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 45' ' ' VAL . 4.1 t -107.94 124.46 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.395 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . 23.8 t80 -62.43 118.78 7.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.607 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.501 ' OE1' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -88.21 -33.86 17.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.768 -170.19 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 95' ' ' ARG . 41.7 mtm180 -83.03 161.73 56.89 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.4 133.43 56.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.883 2.389 . . . . 0.0 112.547 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 100' ' ' LEU . 12.4 m -77.67 69.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 122.171 0.986 . . . . 0.0 110.092 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -42.84 -70.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.257 -1.792 . . . . 0.0 112.796 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.99 60.83 0.61 Allowed Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.031 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 38' ' ' LEU . 19.2 mt -111.64 155.79 22.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.652 0.263 . . . . 0.0 110.359 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -98.42 116.19 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 34' ' ' GLN . 52.2 tp -90.47 127.1 36.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.372 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.604 HG21 ' H ' ' A' ' 107' ' ' ASP . 5.9 mt -94.99 98.66 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -66.78 24.56 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.532 0.733 . . . . 0.0 112.786 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 103' ' ' ILE . 42.3 m -160.92 17.45 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.288 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 35.65 50.99 1.07 Allowed Glycine 0 C--N 1.348 1.236 0 O-C-N 124.184 0.928 . . . . 0.0 114.985 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.604 ' H ' HG21 ' A' ' 103' ' ' ILE . 6.5 t70 -135.37 132.91 38.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.44 . . . . 0.0 110.824 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 52' ' ' HIS . 5.5 p90 -96.9 -8.07 31.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.708 0.766 . . . . 0.0 110.018 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 2.0 mt -107.35 17.74 22.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.143 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.34 68.64 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.236 1.017 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.7 ptt85 -147.96 -107.92 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 t0 56.88 30.62 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 157.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.7 tttt . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 122.433 1.111 . . . . 0.0 109.388 179.282 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.646 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 31.6 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -120.36 146.9 45.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 117.866 0.303 . . . . 0.0 111.168 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.584 ' HB ' HD21 ' A' ' 63' ' ' LEU . 11.9 tt -142.45 140.11 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 56.0 t80 -88.0 113.65 23.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 87.9 t -91.6 133.93 31.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.54 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -98.1 -81.66 0.43 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.405 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 6' ' ' TYR . . . -62.16 128.99 42.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.784 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.6 m -45.63 110.33 0.24 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 112.405 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 20' ' ' THR . 26.8 tp -96.75 11.47 35.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.585 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 37.0 mtt180 -66.64 6.96 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.431 -1.258 . . . . 0.0 112.046 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -73.79 -14.02 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.677 ' HG2' ' HA ' ' A' ' 21' ' ' ASN . 17.9 tttp 72.98 8.27 5.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.234 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -175.33 115.8 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 174.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.92 -38.65 1.38 Allowed Glycine 0 C--O 1.228 -0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.385 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -101.94 -52.4 3.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' TRP . 21.0 t -167.13 173.94 8.68 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -70.43 8.61 0.77 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.818 0.281 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.674 ' CZ2' ' HB ' ' A' ' 62' ' ' THR . 2.7 t90 -31.96 -44.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.804 1.242 . . . . 0.0 112.386 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 18' ' ' TRP . 0.0 OUTLIER 158.92 81.49 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 175.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.506 HG23 HD21 ' A' ' 9' ' ' LEU . 10.9 m -125.54 -7.17 6.89 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.723 0.773 . . . . 0.0 110.533 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.677 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 21.3 m-20 -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.841 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 43.06 -162.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 125.257 1.598 . . . . 0.0 114.39 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -139.5 116.7 11.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.237 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 tp -67.06 104.1 1.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 HG12 ' A' ' 55' ' ' VAL . 91.0 mt -72.65 -43.37 63.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.307 0.575 . . . . 0.0 109.633 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.37 158.35 8.89 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.09 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.19 143.05 43.37 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -141.26 111.86 7.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.509 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.618 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 49.8 m -93.35 127.16 38.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.388 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.95 131.35 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 11.1 m-20 -85.77 153.64 22.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.706 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 90.6 m-20 73.17 32.04 1.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.97 0.794 . . . . 0.0 111.616 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -138.25 136.3 36.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.713 0.292 . . . . 0.0 110.875 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -106.55 160.67 15.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 103' ' ' ILE . 25.4 tp -115.79 133.66 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.339 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 102' ' ' LEU . 73.9 m-85 -108.57 156.61 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.778 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.3 t -147.11 125.61 12.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.877 0.37 . . . . 0.0 110.282 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.799 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 1.3 pt? -105.54 16.19 25.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.61 -25.34 25.25 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.995 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -111.67 -72.14 0.73 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' HB2' HD21 ' A' ' 38' ' ' LEU . 3.3 m-85 -82.54 128.32 67.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.266 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -93.98 103.13 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.779 2.319 . . . . 0.0 110.714 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -100.94 157.41 19.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.181 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -140.47 145.74 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.224 0.512 . . . . 0.0 110.845 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 92' ' ' VAL . 24.9 m -146.28 162.26 35.54 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 20.1 Cg_endo -61.25 151.66 77.51 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.622 2.215 . . . . 0.0 112.834 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.3 -130.83 2.24 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -136.49 89.17 2.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.419 0.628 . . . . 0.0 109.816 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.87 -179.33 33.63 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -133.76 104.86 6.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 117.769 0.784 . . . . 0.0 111.02 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.2 t -84.22 109.48 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -81.36 58.45 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.88 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.605 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -72.62 169.27 52.31 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.817 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.8 pt-20 -121.04 114.84 22.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.27 -0.465 . . . . 0.0 109.936 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 25' ' ' LEU . 28.0 t -86.8 129.91 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.754 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.482 ' OH ' ' HG2' ' A' ' 10' ' ' ARG . 75.2 m-85 -125.46 156.98 38.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 111.461 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 57' ' ' ARG . 13.5 ttp180 -113.03 124.69 53.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.514 172.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.807 HD11 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.19 178.87 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.699 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 58' ' ' ILE . 31.8 t70 -52.6 149.55 5.87 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.627 0.251 . . . . 0.0 110.956 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 94.0 m-20 -66.22 -48.19 71.37 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.884 -0.51 . . . . 0.0 110.779 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.61 78.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.779 -171.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.674 ' HB ' ' CZ2' ' A' ' 18' ' ' TRP . 1.0 OUTLIER -57.97 -40.35 80.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.034 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.807 HD23 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -66.29 -53.47 36.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.117 -177.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.72 -28.23 68.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.854 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.88 -50.89 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.561 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.4 -39.91 89.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.946 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.07 -58.31 8.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.948 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -8.96 55.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.688 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.37 -48.75 8.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.11 0.481 . . . . 0.0 110.77 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -86.52 -40.74 14.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.675 -171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.417 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 5.7 t -144.17 91.18 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.133 0.968 . . . . 0.0 111.994 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -91.3 -32.1 15.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.429 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.78 -49.8 1.24 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.887 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.58 38.71 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.181 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 71' ' ' THR . 9.2 mp0 -68.27 -40.58 81.81 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 93' ' ' TYR . 23.7 m-85 -140.73 148.43 40.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.69 133.25 33.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.794 0.33 . . . . 0.0 111.491 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 78' ' ' ARG . 72.5 mtt180 -77.32 109.1 10.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 53.1 tt0 -110.44 98.79 7.92 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -79.55 113.31 17.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.8 pt -109.04 131.11 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.461 0.648 . . . . 0.0 110.984 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.605 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -95.31 162.98 22.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.972 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.75 -16.81 46.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.538 2.158 . . . . 0.0 112.042 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -97.94 2.0 48.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.902 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.05 158.48 10.94 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -65.75 125.8 26.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.207 0.504 . . . . 0.0 110.495 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.59 150.53 41.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.628 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -82.52 124.42 30.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.027 0.442 . . . . 0.0 111.384 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 27.0 ttt -110.85 131.63 54.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.373 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -107.8 109.51 21.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.09 0.472 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.818 HG13 HG12 ' A' ' 45' ' ' VAL . 2.5 t -80.34 126.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.432 ' HA ' ' HD1' ' A' ' 76' ' ' TYR . 5.9 t80 -59.27 102.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -87.2 -14.72 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.122 -170.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.415 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 34.8 mtm180 -84.99 164.26 42.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 88.0 Cg_exo -48.1 115.59 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.605 2.203 . . . . 0.0 112.541 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.536 ' HA ' HD13 ' A' ' 100' ' ' LEU . 29.2 m -86.37 -4.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.507 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.11 -12.3 18.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.388 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 100' ' ' LEU . . . -106.21 16.86 41.62 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.173 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.799 ' HG ' ' HB3' ' A' ' 38' ' ' LEU . 7.1 mp -120.82 170.84 9.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.33 134.22 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 36' ' ' TYR . 50.1 tp -102.3 117.17 34.18 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.01 0.433 . . . . 0.0 111.178 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 35' ' ' LEU . 59.9 mt -97.44 95.26 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.45 -22.12 41.36 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.484 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.2 m -70.73 -46.78 62.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 98.41 -0.43 58.38 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -171.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -99.28 165.59 11.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.532 . . . . 0.0 109.993 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.87 -49.21 4.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.69 79.97 1.73 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.464 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -68.93 -86.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.985 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 72.54 141.37 0.06 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.496 1.141 . . . . 0.0 112.645 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -38.17 -50.75 1.42 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 112.915 -1.948 . . . . 0.0 111.776 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.8 tttp . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 121.656 0.741 . . . . 0.0 110.435 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.672 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 21.2 ttm . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.545 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 98.2 mtt180 -92.05 124.24 36.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 63' ' ' LEU . 33.3 mt -121.2 147.18 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HE1' ' O ' ' A' ' 28' ' ' PHE . 92.3 t80 -91.07 111.1 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG11 ' HB3' ' A' ' 9' ' ' LEU . 89.1 t -90.76 102.14 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.0 110.487 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -95.02 94.12 7.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.192 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.25 -176.04 17.6 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.724 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.04 120.97 22.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.94 0.4 . . . . 0.0 110.955 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.643 ' HB3' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -93.85 7.37 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.089 175.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -80.57 17.81 1.05 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.176 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -101.37 168.25 9.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 111.344 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -65.04 113.74 4.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.001 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 1.9 mp0 59.13 24.3 12.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.265 -175.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.19 90.16 1.11 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.617 -172.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.665 ' HA ' ' CH2' ' A' ' 18' ' ' TRP . 17.2 m120 73.41 15.92 4.16 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 165.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.558 ' HB2' ' O ' ' A' ' 21' ' ' ASN . 13.0 p -175.64 -54.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.507 0.67 . . . . 0.0 110.803 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.693 ' HA ' ' O ' ' A' ' 20' ' ' THR . 73.2 t60 -69.93 10.6 0.38 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.076 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.665 ' CH2' ' HA ' ' A' ' 15' ' ' ASN . 2.4 m-90 -44.89 -52.46 8.62 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.265 0.555 . . . . 0.0 111.064 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.3 mtm -129.88 -47.83 1.13 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.327 171.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -81.38 -150.75 0.08 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.501 174.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 16' ' ' SER . 6.7 m-80 -140.38 -76.48 0.32 Allowed 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 56' ' ' TYR . . . 177.58 120.5 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.878 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.2 tt0 -108.7 98.53 8.02 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.6 116.26 4.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -172.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD12 HG12 ' A' ' 55' ' ' VAL . 91.4 mt -85.6 -42.34 14.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . 157.6 146.46 4.51 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.273 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 p30 -74.53 151.55 39.47 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.487 0.66 . . . . 0.0 110.443 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' O ' ' HE1' ' A' ' 4' ' ' PHE . 10.3 t80 -157.1 103.77 2.04 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.237 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HG22 ' A' ' 50' ' ' THR . 23.0 p -90.94 122.95 34.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.654 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 13.3 pt -103.44 125.8 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.308 0.575 . . . . 0.0 111.398 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 27.0 t0 -84.67 161.31 20.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.101 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 42.1 m-80 74.06 26.47 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 111.377 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.49 147.66 43.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 110.653 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 104' ' ' GLU . 41.8 mt-30 -122.85 156.0 35.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.297 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.8 tp -117.9 135.64 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.036 -170.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -101.64 145.26 29.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.198 0.523 . . . . 0.0 111.49 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -108.56 106.16 16.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.518 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -117.2 18.8 14.42 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.039 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 -70.01 2.77 Favored Glycine 0 C--N 1.329 0.152 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.536 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -50.9 -48.09 60.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.372 0.606 . . . . 0.0 110.964 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 5.7 p90 -159.87 165.65 17.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.059 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.6 159.88 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.474 2.116 . . . . 0.0 112.263 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.05 6.04 Favored Glycine 0 C--O 1.223 -0.57 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -123.79 165.59 17.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.81 0.805 . . . . 0.0 111.065 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 92' ' ' VAL . 35.2 m -150.88 160.35 32.4 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.48 0.487 . . . . 0.0 110.209 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 28.8 Cg_endo -66.64 128.97 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.037 1.824 . . . . 0.0 111.465 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.86 -120.32 0.51 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.96 91.97 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.607 0.717 . . . . 0.0 110.703 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 164.89 32.79 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.743 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 19.3 m -112.32 105.77 14.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.385 0.592 . . . . 0.0 110.446 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' SER . 65.0 t -82.38 117.75 28.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.523 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.06 100.6 3.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.015 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.54 165.79 23.64 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 47.6 mt-10 -125.06 136.35 53.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 25' ' ' LEU . 41.7 t -86.67 119.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 46.6 m-85 -122.04 159.38 27.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.916 0.865 . . . . 0.0 112.669 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.2 tmt_? -112.99 114.15 26.49 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.522 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.446 HG22 ' HB ' ' A' ' 20' ' ' THR . 2.2 pp -119.55 177.11 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.058 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.74 131.14 38.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.818 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 1' ' ' MET . 3.3 m-20 -66.65 -41.43 88.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.807 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.84 99.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.595 0.236 . . . . 0.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 m -54.92 -40.37 69.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.254 0.55 . . . . 0.0 110.503 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 3' ' ' ILE . 3.0 tm? -67.57 -53.49 27.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.344 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.17 -30.25 69.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.046 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.13 -46.97 30.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 66' ' ' LEU . 7.2 tt -61.83 -47.11 86.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.787 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.666 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 23.0 t70 -63.56 -42.82 98.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.508 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.53 -30.42 70.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.102 0.477 . . . . 0.0 111.297 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 mt -86.14 -50.53 6.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 3.1 ttt85 -85.98 -41.87 14.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.853 0.358 . . . . 0.0 111.469 -168.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -95.63 -83.54 0.36 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.402 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 55.61 -75.75 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.709 0.804 . . . . 0.0 112.801 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.59 -57.54 2.43 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.39 63.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.817 -1.183 . . . . 0.0 114.09 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.77 -28.99 60.97 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 166.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.677 ' HE2' ' HG2' ' A' ' 70' ' ' ARG . 4.3 m-85 -135.89 150.72 49.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.936 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.45 118.13 25.68 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.081 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.666 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 82.1 mtm180 -74.43 102.61 4.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.215 0.531 . . . . 0.0 109.887 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -103.77 99.17 8.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.3 tp -76.79 112.34 13.27 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.874 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.5 pt -107.09 138.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.292 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -90.47 113.86 25.9 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 85' ' ' TYR . 33.6 p -102.71 166.71 11.47 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.159 -172.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.69 1.21 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.643 2.229 . . . . 0.0 111.836 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 32.9 m-85 -119.83 17.13 12.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.4 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 115.74 -87.46 0.44 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.932 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -169.5 141.64 2.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.47 147.7 30.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.646 0.26 . . . . 0.0 111.238 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.14 120.08 25.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.59 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.535 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -105.16 118.65 37.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.448 176.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.66 109.67 21.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.487 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -93.21 138.86 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.47 ' HD2' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -47.64 136.27 10.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.303 177.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 6.7 tp60 -138.44 18.99 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.901 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.746 ' HB2' ' HD3' ' A' ' 96' ' ' PRO . 2.2 mmp_? -120.85 -80.51 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 95' ' ' ARG . 34.7 Cg_endo -99.05 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 -162.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 100' ' ' LEU . 25.1 m 54.2 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.486 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.46 113.82 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.885 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.02 44.41 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -169.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 97' ' ' VAL . 66.1 mt -119.55 165.63 14.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.56 132.15 54.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 34' ' ' GLN . 50.2 tp -102.49 126.89 49.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.084 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 106' ' ' GLY . 40.7 mt -90.09 100.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.623 ' HA ' HE21 ' A' ' 34' ' ' GLN . 27.8 mt-10 -67.37 24.01 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.618 -1.174 . . . . 0.0 114.084 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 m -163.89 -17.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.067 -0.396 . . . . 0.0 111.926 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' H ' HG22 ' A' ' 103' ' ' ILE . . . 91.74 21.51 33.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.159 -1.019 . . . . 0.0 114.443 167.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.91 129.89 41.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.736 0.768 . . . . 0.0 109.288 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -69.45 -29.83 67.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.93 -48.01 2.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.445 -167.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 69.33 -51.5 0.6 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.653 0.781 . . . . 0.0 111.586 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -92.92 75.48 4.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.045 0.926 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.21 -131.3 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.857 0.836 . . . . 0.0 110.825 -178.751 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.553 ' HB2' HD22 ' A' ' 63' ' ' LEU . 11.2 tpp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.492 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 29.8 mtm180 -87.98 138.1 31.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.945 0.402 . . . . 0.0 110.659 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.2 151.24 18.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.096 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -91.22 127.51 36.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -92.36 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 20.3 p90 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.369 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . . . . . . . . 0 N--CA 1.454 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -100.63 118.91 37.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.581 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -71.68 104.14 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.209 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 55' ' ' VAL . 95.3 mt -72.79 -43.6 62.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.474 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.25 171.09 18.93 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.96 145.99 33.68 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.832 0.825 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.582 ' HB3' HG23 ' A' ' 55' ' ' VAL . 23.3 t80 -154.09 101.69 2.42 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.486 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 m -88.96 133.01 34.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.712 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.22 126.37 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.96 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 4.3 t70 -86.15 165.22 16.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.48 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.8 OUTLIER 69.48 28.04 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.715 0.634 . . . . 0.0 111.226 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -135.41 149.96 49.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.522 ' HB3' HD11 ' A' ' 102' ' ' LEU . 99.1 mt-30 -127.76 152.49 47.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.686 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 103' ' ' ILE . 23.7 tp -111.33 131.83 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.941 0.4 . . . . 0.0 111.283 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.04 151.28 21.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -122.93 107.7 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -102.84 18.45 21.49 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.54 -57.79 0.62 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.221 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.67 -82.99 0.51 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.65 0.738 . . . . 0.0 109.697 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.54 158.7 62.68 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.539 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -93.52 170.9 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.935 2.424 . . . . 0.0 112.619 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -139.34 152.5 22.44 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -138.41 141.42 39.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.939 0.87 . . . . 0.0 110.963 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' HD2' ' A' ' 93' ' ' TYR . 23.9 m -150.28 163.88 22.67 Favored Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 123.184 0.303 . . . . 0.0 110.27 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.58 132.15 30.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.564 2.176 . . . . 0.0 111.497 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.99 -123.78 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.767 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.63 90.26 2.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.153 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.79 166.16 34.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.562 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 4.6 m -109.88 106.03 15.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.091 0.445 . . . . 0.0 110.178 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' SER . 67.4 t -82.59 105.56 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 109.848 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.468 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 82.9 t60 -79.29 65.3 4.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.66 -175.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.652 ' HA2' ' HZ2' ' A' ' 108' ' ' TRP . . . -100.02 -173.59 30.3 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.334 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -133.55 140.92 47.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 28' ' ' PHE . 49.2 t -106.79 130.59 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.14 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -124.74 150.74 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 112.093 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.04 105.51 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ALA . 2.4 pp -110.92 162.93 8.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.91 147.06 9.72 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.9 0.48 . . . . 0.0 112.014 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 5.8 p30 -64.84 -41.9 95.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.527 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.31 -37.02 82.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.215 0.531 . . . . 0.0 110.199 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.6 m -56.88 -30.37 63.81 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.159 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' ' 1' ' ' MET . 13.9 tp -66.48 -49.55 66.25 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.59 65.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.696 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -68.2 -47.26 68.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.124 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.75 -47.09 82.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.907 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -61.82 -48.38 80.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.042 0.449 . . . . 0.0 110.776 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.14 -27.73 69.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.687 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 69' ' ' LEU . 15.4 mt -84.96 -33.1 22.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -85.66 -52.09 6.02 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.564 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 14.4 t . . . . . 0 C--N 1.326 -0.446 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.76 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.564 ' N ' ' HG1' ' A' ' 71' ' ' THR . 17.4 tp10 . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 66.4 m-85 -131.33 172.75 11.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.894 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.33 151.82 26.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.014 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' CE3' ' A' ' 89' ' ' TRP . 56.0 mtt180 -92.53 111.94 23.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.368 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -104.2 103.96 13.81 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.11 115.91 20.78 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.4 pt -110.06 134.98 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.664 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 101.4 13.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.758 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 159.94 30.16 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.692 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.29 -14.72 40.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.348 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.81 7.19 41.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.85 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.492 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 119.65 154.36 9.47 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.976 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m -66.04 126.65 29.28 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.493 -0.416 . . . . 0.0 110.335 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.1 148.06 44.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.663 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 78' ' ' ARG . 98.8 m95 -83.32 124.09 30.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.461 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.87 127.76 55.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.564 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.8 118.22 31.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.996 0.427 . . . . 0.0 110.868 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -100.43 142.26 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.758 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.627 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -46.85 127.18 9.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.303 174.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.8 tp-100 -125.76 2.87 7.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.154 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -135.77 138.23 27.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -28.35 128.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.879 4.386 . . . . 0.0 115.939 -170.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 93' ' ' TYR . 15.9 m -90.76 16.2 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.125 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.32 110.48 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.068 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.99 32.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.184 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 38' ' ' LEU . 36.4 mt -98.53 168.2 10.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.095 0.447 . . . . 0.0 110.687 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -99.18 141.95 31.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.272 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 34' ' ' GLN . 32.6 tp -117.24 125.83 51.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.664 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 35' ' ' LEU . 42.5 mt -101.49 87.85 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -67.18 -12.83 61.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.768 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.8 t -69.4 -50.43 45.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.617 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 109.2 -12.83 33.91 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.542 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.27 151.36 24.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 110.486 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.652 ' HZ2' ' HA2' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -73.5 -31.71 63.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.454 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt . . . . . 0 N--CA 1.439 -0.977 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.833 -172.068 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.835 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 38.4 tpp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -113.68 128.2 56.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.064 0.459 . . . . 0.0 111.181 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.7 mt -128.41 139.66 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.721 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.58 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 57.2 t80 -96.9 109.64 22.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.2 106.96 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 91' ' ' TYR . 1.2 p90 . . . . . 0 C--N 1.316 -0.864 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.453 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.14 0.495 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.69 114.36 28.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.408 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 tp -67.0 102.59 1.0 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 55' ' ' VAL . 81.3 mt -64.46 -32.75 74.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.814 0.816 . . . . 0.0 109.135 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.87 135.78 3.16 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.808 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.37 126.34 29.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.1 0.953 . . . . 0.0 109.772 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.7 118.79 12.65 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.6 m -86.08 125.81 33.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.855 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' THR . 13.5 pt -99.94 130.01 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.712 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 39.0 t0 -92.33 159.14 15.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.984 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 49.5 m-80 73.84 29.97 1.39 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.735 0.647 . . . . 0.0 111.582 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 46' ' ' PRO . 97.7 m-85 -133.04 162.07 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.962 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.581 ' HG3' ' HA3' ' A' ' 47' ' ' GLY . 41.1 mt-30 -123.97 152.26 42.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.9 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.6 tp -118.9 126.01 50.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 111.111 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 102' ' ' LEU . 68.4 m-85 -92.14 135.19 34.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.874 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 23.4 t -121.79 96.87 5.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.035 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -101.8 18.03 21.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.613 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.17 -55.8 2.75 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.942 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -58.49 -51.88 68.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 110.483 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 18.1 p90 -160.11 138.4 7.49 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.846 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 41' ' ' TYR . 5.8 Cg_exo -75.27 159.7 40.09 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.912 2.408 . . . . 0.0 112.448 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 6' ' ' TYR . . . -145.27 125.21 2.29 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.71 144.18 35.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.201 0.5 . . . . 0.0 111.48 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 92' ' ' VAL . 31.7 m -144.88 163.25 34.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.674 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 24.5 Cg_endo -63.84 139.04 66.45 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.138 1.892 . . . . 0.0 112.069 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 34' ' ' GLN . . . -176.34 -120.3 0.61 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.949 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.496 ' C ' HD22 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -145.97 88.76 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.084 0.469 . . . . 0.0 109.985 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA3' ' O ' ' A' ' 104' ' ' GLU . . . 178.56 163.8 30.47 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.625 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' HB3' ' A' ' 29' ' ' SER . 1.9 m -109.3 100.15 9.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.073 0.463 . . . . 0.0 111.076 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.5 t -83.3 121.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.549 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.457 ' O ' ' HZ2' ' A' ' 108' ' ' TRP . 0.2 OUTLIER -77.94 56.27 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 -173.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.58 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -74.63 155.04 47.94 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.768 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -100.89 120.27 39.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 HD12 ' A' ' 25' ' ' LEU . 11.2 t -93.99 123.89 46.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.41 146.07 47.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -105.94 104.46 14.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.775 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.76 167.36 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.845 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.83 135.45 24.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.007 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.835 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 87.4 m-20 -54.71 -41.06 69.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.152 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.47 70.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 72.8 m -56.27 -32.2 64.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.952 0.406 . . . . 0.0 110.471 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 13.8 tp -67.78 -49.77 60.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . . . -58.57 -32.39 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.868 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.54 -40.59 56.65 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 66' ' ' LEU . 8.4 tt -64.83 -47.7 77.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 1.8 p30 -67.45 -43.16 81.78 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.194 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.57 68.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.498 0.666 . . . . 0.0 110.779 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.84 -43.05 13.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.796 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 71' ' ' THR . 21.3 ttt180 -86.68 7.03 28.32 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -169.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.611 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.361 0 C-N-CA 124.787 1.235 . . . . 0.0 112.338 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' N ' ' HG1' ' A' ' 71' ' ' THR . 27.8 tt0 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.614 0.245 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.553 ' H ' HG21 ' A' ' 71' ' ' THR . 10.7 m-85 -122.5 163.13 20.45 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.444 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.85 141.69 35.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HG2' ' CE2' ' A' ' 91' ' ' TYR . 29.5 mtp180 -93.07 124.27 36.92 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -116.96 107.89 15.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.76 110.13 16.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.9 pt -106.06 144.74 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.023 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.06 104.35 16.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.909 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -98.52 162.69 20.97 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.756 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.99 -21.42 58.33 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.678 2.252 . . . . 0.0 112.613 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.483 ' HB3' HD13 ' A' ' 25' ' ' LEU . 51.8 m-85 -96.7 -3.91 41.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.532 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.14 157.74 9.14 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.669 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 127.47 31.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.546 -0.385 . . . . 0.0 110.602 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.01 150.52 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.842 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -79.25 121.99 25.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.204 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.8 ttt -108.9 116.45 32.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.367 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.447 ' HB2' ' OH ' ' A' ' 6' ' ' TYR . 96.7 m-85 -94.78 107.97 19.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.279 0.562 . . . . 0.0 110.655 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.873 HG13 HG12 ' A' ' 45' ' ' VAL . 4.7 t -76.91 119.63 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.824 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.22 119.43 10.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.37 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -170.9 2.24 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.823 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 44.2 mtm180 72.62 167.91 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.662 0.601 . . . . 0.0 110.775 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 77.8 Cg_exo -54.15 119.18 5.9 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.745 2.296 . . . . 0.0 112.854 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' GLY . 35.4 m -104.88 1.99 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.778 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -64.93 16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . -128.58 15.18 6.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.6 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -144.59 176.26 9.54 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.682 -0.305 . . . . 0.0 110.907 177.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 54.7 mtpt -76.99 143.96 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.351 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 36' ' ' TYR . 56.6 tp -110.16 109.75 20.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.84 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.73 91.92 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.706 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -65.87 -26.15 67.51 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -73.56 -15.03 61.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.746 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 68.92 34.3 76.74 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.183 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -117.8 178.3 4.46 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.457 ' HZ2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -119.59 -34.44 3.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.336 0.589 . . . . 0.0 109.653 176.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.16 -175.207 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.862 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 4.0 tmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.457 ' HD2' ' HA3' ' A' ' 86' ' ' GLY . 25.8 mtm180 -123.65 133.74 53.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.541 0.686 . . . . 0.0 112.165 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.93 148.16 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.486 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.723 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 81.4 t80 -92.69 112.01 23.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.74 126.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.174 0.512 . . . . 0.0 111.002 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 11.0 p90 . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.503 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.057 0.456 . . . . 0.0 111.408 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -137.03 143.67 42.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.158 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 tp -79.61 130.12 35.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 55' ' ' VAL . 95.6 mt -93.12 -43.01 9.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.856 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.42 176.59 27.77 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.4 147.54 28.72 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.149 0.976 . . . . 0.0 110.779 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -151.82 86.37 1.32 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.586 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.3 m -82.66 124.5 30.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -112.71 126.35 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.881 0.848 . . . . 0.0 111.524 -172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.85 156.67 20.45 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.5 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 71.01 33.38 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.118 0.886 . . . . 0.0 110.931 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.25 165.31 26.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.952 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -136.24 144.64 44.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 103' ' ' ILE . 18.7 tp -105.44 131.24 53.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.471 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -98.87 128.62 45.11 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 p -110.08 126.45 54.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.826 0.346 . . . . 0.0 110.321 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -140.98 16.75 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.01 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.81 -63.8 3.74 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.48 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -59.7 -45.36 92.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.58 ' HD1' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -167.65 110.88 0.6 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.71 176.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.41 142.75 98.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.65 2.234 . . . . 0.0 112.807 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 6' ' ' TYR . . . -120.32 178.57 16.48 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 151.28 29.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.546 0.673 . . . . 0.0 111.318 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 1.069 HG12 HG13 ' A' ' 92' ' ' VAL . 29.1 m -153.56 165.7 17.23 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.9 148.85 52.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.374 2.049 . . . . 0.0 111.343 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.07 -125.92 1.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.187 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -135.41 91.92 2.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.6 -178.24 48.55 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.427 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 23.2 m -122.26 119.89 32.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.916 0.858 . . . . 0.0 110.114 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.713 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 92.9 t -107.01 109.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.44 . . . . 0.0 110.461 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.474 ' O ' ' HH2' ' A' ' 108' ' ' TRP . 7.5 t60 -69.16 119.96 14.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.723 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -128.43 142.85 13.91 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.847 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -98.54 107.66 20.17 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 25' ' ' LEU . 57.1 t -80.2 116.98 25.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.79 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.77 150.77 39.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.715 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 1.8 tmt_? -108.49 107.63 18.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 pt -114.74 169.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.604 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 25.6 t70 -53.5 137.88 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.045 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.862 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 9.0 m120 -63.38 -43.91 96.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.616 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.29 77.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.269 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 67.7 m -56.82 -29.54 62.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.083 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 1' ' ' MET . 37.2 tp -66.6 -47.88 71.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.56 -32.4 65.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -74.3 -55.05 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.748 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.42 -37.28 85.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.097 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.51 -56.56 19.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.255 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.45 -32.46 62.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.79 -58.11 3.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.973 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -85.4 -3.19 58.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' TYR . 75.3 p . . . . . 0 C--N 1.321 -0.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 CA--C 1.536 0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.43 ' O ' HG22 ' A' ' 71' ' ' THR . 8.3 m-85 -116.22 162.94 16.73 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . . . -124.52 150.12 46.17 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.789 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptt85 -88.89 127.77 35.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 111.636 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -104.14 121.73 43.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.254 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -87.1 112.75 22.22 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.22 133.28 58.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.396 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -86.94 101.2 13.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.562 -176.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 p -93.67 160.47 32.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.74 -3.13 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.798 2.332 . . . . 0.0 112.648 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.06 4.02 13.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.276 0.56 . . . . 0.0 110.067 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 2' ' ' ARG . . . 126.95 149.54 7.27 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.125 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 8.0 m -65.81 122.25 16.88 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.594 -0.356 . . . . 0.0 110.203 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.15 146.32 43.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.82 120.52 25.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -105.58 113.11 26.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.66 116.03 22.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 1.069 HG13 HG12 ' A' ' 45' ' ' VAL . 8.6 t -108.43 143.09 19.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.946 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -46.34 119.12 2.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.475 168.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' A' ' 77' ' ' ALA . 4.2 tp-100 -104.33 -26.62 12.4 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.637 -174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.597 ' H ' ' CD ' ' A' ' 96' ' ' PRO . 4.1 ptp180 -162.13 -37.46 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 95' ' ' ARG . 98.6 Cg_endo -97.78 103.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.555 1.503 . . . . 0.0 114.749 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 93' ' ' TYR . 5.6 m -145.89 90.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.275 0.56 . . . . 0.0 110.352 169.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.48 24.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . 112.38 -68.86 0.23 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 38' ' ' LEU . 66.0 mt 61.89 -170.0 0.17 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.13 0.49 . . . . 0.0 111.213 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -109.0 113.25 25.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -87.69 125.31 34.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.19 0.519 . . . . 0.0 110.492 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 35' ' ' LEU . 20.6 mt -107.9 92.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -14.51 62.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 110.652 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.2 m -72.73 -22.62 60.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.642 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 62.02 38.52 96.22 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.814 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -142.02 149.73 40.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.474 ' HH2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -89.07 -26.18 21.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 -171.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.9 mt . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.643 -167.581 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.989 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 52.5 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 87' ' ' SER . 10.2 mtt85 -111.82 129.89 55.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 tt -130.53 146.76 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.826 0.346 . . . . 0.0 110.544 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 75.2 t80 -103.31 124.32 48.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.27 130.51 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.0 p90 . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.563 -172.294 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.793 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -111.82 117.48 32.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.126 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.22 106.29 3.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 HG12 ' A' ' 55' ' ' VAL . 83.3 mt -71.6 -38.31 70.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.352 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.0 157.61 7.25 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.293 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 3.7 p-10 -78.1 143.15 37.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.749 0.785 . . . . 0.0 110.537 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -151.42 116.01 5.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.368 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.3 m -87.59 137.66 32.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.218 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.2 pt -119.99 148.35 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 25.6 t0 -102.28 152.01 21.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 50.9 m-80 77.03 36.33 0.32 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.146 0.978 . . . . 0.0 111.654 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -138.39 136.83 36.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.529 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.431 HE21 HD11 ' A' ' 102' ' ' LEU . 24.7 mt-30 -111.93 154.32 25.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 42' ' ' PRO . 45.4 tp -118.84 138.2 52.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 0.0 111.749 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.27 147.93 29.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.843 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 20.2 m -116.75 111.82 20.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -112.05 17.42 19.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.764 -177.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.21 -78.15 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.481 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -62.16 -32.73 73.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.844 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 38' ' ' LEU . 6.6 p90 -165.99 167.15 9.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.59 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.0 Cg_endo -88.9 -178.74 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.989 2.459 . . . . 0.0 112.396 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.23 129.62 2.07 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -110.84 160.1 17.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.708 0.754 . . . . 0.0 111.563 -173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 92' ' ' VAL . 32.3 m -147.82 161.15 36.11 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.805 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 136.24 36.54 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.303 2.002 . . . . 0.0 111.102 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.8 -126.26 1.02 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.237 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.64 82.48 2.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.924 0.393 . . . . 0.0 110.634 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.08 172.68 43.42 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 46.0 m -126.89 106.75 9.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.305 0.552 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 93.7 t -84.06 114.07 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.5 59.16 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.066 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.464 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -82.84 165.98 44.42 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.458 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 28.6 mp0 -107.62 124.07 49.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.278 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.502 HG12 HD12 ' A' ' 25' ' ' LEU . 34.0 t -88.17 128.2 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.644 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -123.38 150.99 43.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.873 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -113.69 118.41 34.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.724 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 1' ' ' MET . 2.0 pp -132.45 164.84 33.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.899 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.574 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 13.3 t70 -51.76 143.57 12.74 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.989 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 3.7 m-20 -57.97 -44.96 87.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.43 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.954 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 19.1 m -56.43 -38.13 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 0.0 110.965 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.454 HD22 ' HG2' ' A' ' 1' ' ' MET . 10.2 tp -66.54 -52.33 46.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.69 65.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.851 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 -48.97 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.341 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -39.53 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.033 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.78 -50.37 72.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.42 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.74 -19.69 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.91 -49.25 8.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.457 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.543 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -75.08 -54.06 7.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.983 -173.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.628 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 6.6 t . . . . . 0 C--N 1.32 -0.704 0 CA-C-O 122.17 0.986 . . . . 0.0 110.443 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.628 ' N ' ' HG1' ' A' ' 71' ' ' THR . 28.8 tp10 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.027 0.441 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HD2' ' HB ' ' A' ' 71' ' ' THR . 91.4 m-85 -131.24 166.18 21.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.5 127.61 55.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.043 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -86.04 106.96 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -104.93 105.9 16.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -79.79 112.15 16.79 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.57 152.81 10.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.56 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.491 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -99.15 109.61 22.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.235 0.54 . . . . 0.0 111.773 -176.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -96.53 165.62 15.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.89 -2.26 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.45 2.1 . . . . 0.0 112.466 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -120.83 15.63 11.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.017 0.437 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.25 157.42 10.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.218 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.409 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 9.2 p -66.37 130.4 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.4 151.33 44.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.335 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -85.65 123.19 30.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 111.41 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 21.4 ttt -107.79 124.06 49.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.562 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -91.33 116.21 28.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 45' ' ' VAL . 7.2 t -94.63 126.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.5 ' HD1' ' CE1' ' A' ' 76' ' ' TYR . 40.2 t80 -75.29 127.14 32.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.108 0.956 . . . . 0.0 110.808 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 76' ' ' TYR . 28.2 mm-40 -89.44 -161.99 0.83 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.172 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 38.2 mmt180 70.91 169.38 0.12 Allowed Pre-proline 0 N--CA 1.467 0.391 0 O-C-N 123.358 0.411 . . . . 0.0 110.743 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 18.8 Cg_endo -62.32 134.05 46.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.278 1.985 . . . . 0.0 111.658 171.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.36 10.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.62 126.67 28.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.284 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.76 57.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 38' ' ' LEU . 41.6 mt -86.23 159.84 19.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.811 0.306 . . . . 0.0 110.305 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 48.1 mtmt -88.78 119.09 28.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD11 HE21 ' A' ' 34' ' ' GLN . 57.4 tp -97.17 121.52 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 107' ' ' ASP . 29.4 mt -101.62 94.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.13 -21.03 66.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.03 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 p -73.26 -44.12 59.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 106.53 10.03 29.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.318 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 103' ' ' ILE . 2.7 p30 -111.64 178.8 4.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 -41.21 4.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.766 0.793 . . . . 0.0 109.487 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt . . . . . 0 C--N 1.325 -0.498 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.489 -172.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.952 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 45.0 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 143.74 33.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.838 0.352 . . . . 0.0 110.565 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.2 146.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.242 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 73.7 t80 -92.86 113.55 25.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.831 0.348 . . . . 0.0 110.287 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.8 147.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.046 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -175.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.131 0 CA-C-O 121.133 0.492 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 57.8 tt0 -114.86 129.0 56.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.705 172.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.8 tp -78.95 104.14 9.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.015 0.436 . . . . 0.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.598 HD12 HG12 ' A' ' 55' ' ' VAL . 94.1 mt -70.05 -45.23 67.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.32 168.08 12.32 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.545 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.66 151.86 46.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.163 0.506 . . . . 0.0 109.824 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -156.71 87.05 1.0 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.872 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 15.5 m -77.53 129.25 35.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.08 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.04 134.13 59.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -82.8 156.42 23.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.993 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 67.54 33.97 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.025 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.41 172.09 12.6 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.632 ' HB3' HD11 ' A' ' 102' ' ' LEU . 19.6 mt-30 -139.96 157.0 46.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 43' ' ' GLY . 35.4 tp -123.4 128.75 50.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.836 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 97' ' ' VAL . 88.2 m-85 -91.06 140.9 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.15 0.5 . . . . 0.0 112.127 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 68.5 m -113.86 109.94 19.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.31 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -121.27 6.29 10.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.363 174.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.56 4.52 Favored Glycine 0 C--O 1.229 -0.186 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.989 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 41' ' ' TYR . 15.5 t60 -61.95 -47.27 85.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.784 0.326 . . . . 0.0 111.036 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CE2' ' HD2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -167.42 155.53 8.64 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.644 175.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.01 148.15 19.3 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.938 2.426 . . . . 0.0 113.643 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -120.64 160.33 15.12 Favored Glycine 0 C--O 1.227 -0.337 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.33 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.991 0.896 . . . . 0.0 111.6 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.818 HG11 ' HD2' ' A' ' 93' ' ' TYR . 33.7 m -154.46 167.09 14.56 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.81 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.13 157.04 54.89 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.393 2.062 . . . . 0.0 111.84 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.09 -119.41 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -145.53 92.14 2.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.856 0.36 . . . . 0.0 110.085 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 165.1 33.14 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.354 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 m -101.75 101.85 12.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.875 0.369 . . . . 0.0 110.275 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' SER . 70.1 t -82.81 106.72 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.792 -174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -69.52 107.53 3.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.939 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -123.09 147.2 16.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.1 mp0 -103.9 107.25 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG12 HD12 ' A' ' 25' ' ' LEU . 26.0 t -81.35 117.07 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.062 0.458 . . . . 0.0 110.223 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -115.29 147.71 40.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.455 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 52.8 ttt180 -108.95 131.93 54.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.986 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.743 HD11 HD23 ' A' ' 63' ' ' LEU . 1.7 pp -140.73 164.14 21.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.667 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.67 142.15 15.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.539 0.209 . . . . 0.0 111.18 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.952 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 95.7 m-20 -54.51 -48.64 71.66 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 0.0 110.979 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.19 75.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.085 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -56.27 -37.0 69.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.835 173.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -66.82 -42.13 86.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -23.67 66.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.843 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.85 -48.5 45.6 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.15 -34.73 78.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.46 -54.87 41.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.499 0.666 . . . . 0.0 110.92 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.76 68.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.39 -56.27 3.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . 39.8 ttt180 -85.19 7.14 22.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.684 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 O-C-N 124.602 1.189 . . . . 0.0 111.066 -173.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.684 ' N ' ' HG1' ' A' ' 71' ' ' THR . 4.6 tp10 . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.684 ' H ' HG21 ' A' ' 71' ' ' THR . 38.5 m-85 -142.6 170.38 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.579 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.96 152.09 36.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -88.93 125.22 34.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -105.18 121.63 44.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.6 tp -91.82 114.69 27.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 7.3 pt -114.02 148.98 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -90.43 108.54 19.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.719 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 1.4 p -100.02 163.42 18.39 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 83' ' ' THR . 17.7 Cg_endo -61.54 -16.04 45.33 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.481 2.12 . . . . 0.0 112.064 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -97.91 -2.66 40.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.9 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.51 160.21 10.85 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 66.4 m -63.95 121.29 13.74 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.138 0.494 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.64 148.68 30.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.674 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.46 124.28 31.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.183 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 85.2 mtp -106.7 170.28 8.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.039 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -127.69 117.72 22.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.871 0.367 . . . . 0.0 110.415 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 45' ' ' VAL . 4.0 t -101.59 136.82 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.696 0.76 . . . . 0.0 111.189 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.818 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -51.68 120.64 5.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.739 175.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.96 1.35 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.752 -176.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.454 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 68.8 mtp180 -132.16 146.61 62.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.25 121.78 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.561 3.507 . . . . 0.0 114.598 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 100' ' ' LEU . 12.8 m -104.52 14.48 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.862 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.56 96.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.013 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.84 5.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.327 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 97' ' ' VAL . 87.2 mt -89.87 165.7 13.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.335 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 30.1 mmmt -90.29 132.25 35.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 34' ' ' GLN . 64.6 tp -105.93 107.78 18.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.374 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 107' ' ' ASP . 51.5 mt -82.12 89.02 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.98 -9.55 39.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.178 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 m -70.79 -27.16 63.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.024 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 85.66 -13.37 56.29 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.171 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 103' ' ' ILE . 5.4 t70 -100.42 141.35 33.38 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.384 -0.48 . . . . 0.0 110.223 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -70.02 -30.96 68.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.551 . . . . 0.0 110.228 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.449 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.955 -179.382 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 25.1 ttm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -117.61 144.73 44.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 111.188 -175.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 63' ' ' LEU . 10.6 tt -139.82 150.66 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.908 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -97.22 115.74 28.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.5 t -102.31 158.82 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 1.6 p90 . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.035 0.445 . . . . 0.0 111.447 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 CA-C-O 121.349 0.595 . . . . 0.0 111.684 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.8 tt0 -107.31 119.5 39.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.718 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 tp -81.66 98.39 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.488 . . . . 0.0 109.859 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.679 HD12 HG12 ' A' ' 55' ' ' VAL . 88.8 mt -64.9 -41.78 95.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.711 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.37 153.36 6.08 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.614 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-20 -69.57 143.42 53.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 55' ' ' VAL . 17.2 t80 -154.48 114.03 3.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.0 m -100.56 132.6 45.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.106 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 50' ' ' THR . 16.3 pt -114.03 141.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.423 . . . . 0.0 111.164 -175.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.26 160.07 14.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.036 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 73.8 28.94 1.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.594 0.758 . . . . 0.0 111.506 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.67 142.28 46.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB3' HD11 ' A' ' 102' ' ' LEU . 49.9 mt-30 -116.05 148.42 40.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . 12.4 tp -103.44 139.33 38.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.488 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.45 134.91 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.5 p -116.49 128.49 55.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.991 0.424 . . . . 0.0 110.131 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -133.73 17.36 3.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.317 172.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.72 -59.2 4.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.955 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -89.08 -0.77 57.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -156.62 134.09 6.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 121.78 0.38 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.939 2.426 . . . . 0.0 111.378 166.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.69 16.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.645 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -145.47 146.53 31.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.658 0.729 . . . . 0.0 110.585 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.89 HG12 HG13 ' A' ' 92' ' ' VAL . 27.3 m -149.44 164.0 22.76 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 123.404 0.44 . . . . 0.0 110.489 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.18 136.47 56.13 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.401 2.067 . . . . 0.0 111.805 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.05 -122.54 0.77 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.826 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -143.05 92.18 2.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.708 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.91 167.71 37.49 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.856 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.1 m -115.03 111.47 21.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.8 t -84.91 118.68 32.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.004 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -78.96 97.9 6.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.68 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 6' ' ' TYR . . . -130.71 172.16 20.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.459 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 27.4 mp0 -120.12 133.65 55.46 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.757 0.423 . . . . 0.0 109.886 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 25' ' ' LEU . 31.6 t -91.27 120.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -118.14 157.88 26.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.319 0.581 . . . . 0.0 112.008 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.3 tmt_? -127.2 124.12 38.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.631 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.41 -173.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.767 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 62' ' ' THR . 3.7 m-20 -52.11 153.11 2.86 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.683 0.277 . . . . 0.0 110.617 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.0 p-10 -65.42 -38.87 91.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.18 85.13 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.993 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 89.1 m -56.97 -30.26 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.074 0.464 . . . . 0.0 111.373 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.5 tm? -65.48 -48.55 72.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.05 66.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.13 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -49.1 31.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.027 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.62 -36.64 84.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.4 -54.59 45.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.77 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.15 -28.63 69.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.636 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 69' ' ' LEU . 17.4 mt -79.17 -47.72 15.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.637 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -81.62 -49.64 10.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 C--N 1.324 -0.513 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.357 -172.767 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 95' ' ' ARG . 34.2 tt0 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' VAL . 12.0 m-85 -119.37 159.75 23.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.285 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.31 124.9 47.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.765 0.317 . . . . 0.0 110.652 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -79.15 123.53 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.892 0.854 . . . . 0.0 110.766 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.7 145.93 29.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.513 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.06 113.3 25.74 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.205 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.9 pt -110.24 140.98 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.352 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -91.37 102.97 15.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -99.83 158.04 32.82 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.71 -18.38 55.21 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 49.8 m-85 -99.05 -3.16 35.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.834 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.36 161.06 9.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.288 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 p -67.08 107.19 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 110.464 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.71 145.97 29.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.887 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -83.62 125.43 31.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 ttt -114.75 116.64 28.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.41 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.59 108.13 19.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 112.026 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.89 HG13 HG12 ' A' ' 45' ' ' VAL . 4.3 t -81.15 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.815 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.561 ' HD1' HG12 ' A' ' 97' ' ' VAL . 7.2 t80 -63.59 119.84 10.61 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.422 ' H ' ' HD1' ' A' ' 76' ' ' TYR . 3.3 tp-100 -108.03 -166.51 1.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 31.7 mtp85 66.92 -177.43 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 54.2 Cg_exo -54.73 100.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.714 1.609 . . . . 0.0 112.468 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.561 HG12 ' HD1' ' A' ' 93' ' ' TYR . 26.9 m -93.53 -10.8 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.677 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.79 103.99 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.529 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.6 -12.05 4.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.077 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 38' ' ' LEU . 73.2 mt -78.24 162.23 26.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -93.2 109.05 20.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 34' ' ' GLN . 61.6 tp -73.75 139.02 44.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.461 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' A' ' 35' ' ' LEU . 62.7 mt -124.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.269 174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.02 -15.58 63.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.46 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -70.99 -20.8 62.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.12 73.91 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.531 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.431 ' O ' HG21 ' A' ' 103' ' ' ILE . 12.2 t70 -134.05 137.19 44.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -71.85 -29.2 64.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.805 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -170.323 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.964 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 43.8 tpp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -134.12 125.77 28.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.093 0.473 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.56 145.96 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -86.49 111.82 20.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 0.0 110.004 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 83.9 t -91.6 136.1 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' CD1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.315 -0.893 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.634 -174.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' CB ' HG22 ' A' ' 58' ' ' ILE . . . . . . . . 0 C--O 1.234 0.263 0 CA-C-O 121.566 0.698 . . . . 0.0 112.691 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -124.09 121.15 34.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.677 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.32 106.25 1.32 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 85' ' ' TYR . 84.4 mt -66.68 -38.32 86.55 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.03 159.83 10.11 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.918 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.27 145.26 54.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -139.15 115.04 10.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 52' ' ' HIS . 5.8 p -100.96 131.01 47.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.592 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 pt -117.38 130.39 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.361 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.48 151.71 21.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.871 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.72 33.97 2.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.932 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.95 154.15 51.81 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 102' ' ' LEU . 38.2 mt-30 -128.13 156.8 42.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 103' ' ' ILE . 15.3 tp -114.2 130.25 56.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.585 0.231 . . . . 0.0 110.758 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 86.0 m-85 -99.96 132.34 45.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.609 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.1 m -99.37 102.24 13.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -118.75 12.55 13.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.708 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.06 -51.15 4.06 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.035 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.4 -42.3 91.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CE1' HD11 ' A' ' 38' ' ' LEU . 8.2 p90 -175.05 153.85 1.64 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 6' ' ' TYR . 16.6 Cg_exo -70.24 112.02 3.06 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.237 1.958 . . . . 0.0 111.678 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -90.48 159.51 27.23 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.276 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 34' ' ' GLN . . . -141.83 139.57 32.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.749 0.775 . . . . 0.0 111.433 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.555 HG12 HG13 ' A' ' 92' ' ' VAL . 26.9 m -145.57 163.22 32.83 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.386 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.16 146.43 76.3 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.547 2.164 . . . . 0.0 111.488 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.0 -111.36 0.39 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.79 92.12 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.08 47.5 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m -124.87 103.86 8.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 117.801 0.801 . . . . 0.0 110.529 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 77.3 t -84.16 104.08 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 1.8 p80 -95.35 94.89 8.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.449 0.642 . . . . 0.0 110.699 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.15 10.4 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.179 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 28.3 mt-10 -127.0 124.66 39.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.515 HG12 HD12 ' A' ' 25' ' ' LEU . 72.0 t -93.16 118.97 40.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.087 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.14 148.05 40.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.132 0.491 . . . . 0.0 112.054 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -106.87 114.79 29.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.889 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.25 174.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -52.88 144.4 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.956 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.964 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.3 m-20 -60.02 -36.02 76.35 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.424 0.631 . . . . 0.0 109.451 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.54 71.99 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.93 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 m -56.42 -40.44 74.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 39.1 tp -67.99 -46.69 70.6 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.84 68.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.5 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.15 -43.11 44.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.322 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.64 -42.72 98.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.26 -50.66 73.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.892 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.07 -28.69 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.467 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.0 mt -86.57 -55.36 3.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HD3' ' HD2' ' A' ' 76' ' ' TYR . 41.5 ttm180 -85.45 -44.65 12.56 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -168.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--N 1.324 -0.516 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.653 -169.763 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG2' ' NH2' ' A' ' 95' ' ' ARG . 25.6 mt-10 . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.616 ' HD2' ' HD3' ' A' ' 70' ' ' ARG . 12.7 m-85 -131.9 170.21 15.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.879 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.4 149.93 21.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 89' ' ' TRP . 20.7 tpp85 -102.33 134.87 44.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.121 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 10.1 tt0 -135.09 152.5 51.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -119.44 117.55 28.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.849 0.357 . . . . 0.0 110.383 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 pt -109.07 148.73 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.323 0.582 . . . . 0.0 111.292 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -96.75 126.96 42.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.305 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.2 p -122.11 159.92 49.73 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.409 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.4 -10.46 26.17 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.395 2.064 . . . . 0.0 111.582 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 10.8 m-85 -106.97 12.79 28.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.028 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.75 -103.09 0.59 Allowed Glycine 0 C--O 1.217 -0.927 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.144 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.0 t -172.86 133.17 0.55 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.47 144.39 51.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.942 0.401 . . . . 0.0 111.755 -170.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 78' ' ' ARG . 96.3 m95 -82.01 127.25 32.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.303 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 25.8 ttt -109.13 155.1 21.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.053 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.83 130.63 52.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.372 . . . . 0.0 110.859 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 45' ' ' VAL . 3.3 t -108.4 134.07 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 121.66 0.743 . . . . 0.0 110.836 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.632 ' CE2' HG13 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -50.71 134.45 24.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.471 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 1.9 tp-100 -135.22 33.65 3.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.797 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 27.4 mmt85 -131.31 -177.03 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.345 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 95' ' ' ARG . 6.3 Cg_exo -75.72 135.2 17.5 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.749 1.632 . . . . 0.0 112.674 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 100' ' ' LEU . 2.3 m -101.49 11.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -62.73 -6.09 3.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 29.21 1.79 Allowed Glycine 0 C--N 1.308 -1.028 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.312 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.011 HD12 HG12 ' A' ' 97' ' ' VAL . 43.2 mt -113.83 165.08 12.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.851 -0.205 . . . . 0.0 110.548 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -102.81 124.77 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 34' ' ' GLN . 66.5 tp -84.16 143.59 29.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.881 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.552 HD12 HD23 ' A' ' 35' ' ' LEU . 44.8 mt -107.97 94.51 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.22 24.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.064 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 103' ' ' ILE . 59.7 m -161.27 15.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.295 -0.253 . . . . 0.0 111.522 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 52.65 22.82 12.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 5.9 p-10 -98.99 178.89 4.8 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.943 0.871 . . . . 0.0 108.745 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 67.2 t-105 -121.69 -38.68 2.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.582 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 46.0 mt . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.403 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 1.038 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 47.1 tpp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.69 51.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.238 -0.289 . . . . 0.0 110.435 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 63' ' ' LEU . 13.0 tt -140.37 147.81 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.255 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.679 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 84.0 t80 -96.83 111.33 23.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.4 t -96.18 123.32 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.542 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.756 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.514 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.228 0 CA-C-O 121.0 0.429 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -96.07 122.1 38.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.619 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.3 tp -73.53 106.4 5.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.08 -44.17 18.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.9 157.53 8.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.3 p30 -77.63 158.27 29.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.499 0.666 . . . . 0.0 110.458 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.07 90.17 1.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -79.87 129.38 34.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -122.91 141.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 111.296 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.9 165.65 13.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 83.5 m-20 69.55 28.7 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.824 0.703 . . . . 0.0 112.081 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.49 157.79 45.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.274 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.687 ' HB3' HD11 ' A' ' 102' ' ' LEU . 34.9 mt-30 -126.31 152.76 45.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 103' ' ' ILE . 38.1 tp -119.02 125.94 50.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 110.565 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE1' HG11 ' A' ' 97' ' ' VAL . 96.4 m-85 -96.72 137.41 35.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.783 0.325 . . . . 0.0 110.721 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.5 p -109.63 101.86 10.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.337 0.589 . . . . 0.0 109.541 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.63 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -107.37 2.6 24.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.118 -178.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.74 153.23 18.57 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.9 m80 70.72 -54.58 0.65 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.363 0.601 . . . . 0.0 111.043 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -158.18 129.29 3.74 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.311 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 6' ' ' TYR . 13.1 Cg_exo -72.77 177.88 7.06 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.563 2.175 . . . . 0.0 112.734 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -150.93 161.01 28.89 Favored Glycine 0 C--O 1.224 -0.507 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -131.81 158.13 42.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.139 0.969 . . . . 0.0 111.7 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 92' ' ' VAL . 35.1 m -150.98 163.38 23.87 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.715 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.71 161.97 39.38 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.585 2.19 . . . . 0.0 111.931 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.54 -127.84 1.9 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 4.2 t-20 -146.28 89.03 1.83 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 109.71 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.45 168.94 41.67 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -103.55 112.13 24.9 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.09 0.445 . . . . 0.0 111.148 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.495 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 69.2 t -98.26 114.58 36.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 108' ' ' TRP . 99.5 m-70 -78.93 105.28 10.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.474 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.679 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -117.55 168.32 12.92 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.553 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 40.7 mt-10 -131.16 128.54 40.26 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 85' ' ' TYR . 60.9 t -92.01 117.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.158 0.504 . . . . 0.0 110.271 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.63 154.9 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.615 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -108.92 130.43 55.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 63' ' ' LEU . 1.6 pp -143.22 172.06 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.024 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 56.7 m-20 -51.09 141.87 13.38 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.242 0.339 . . . . 0.0 110.61 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 1.038 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.5 m-20 -55.51 -39.62 70.73 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.709 0.766 . . . . 0.0 109.264 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -36.99 85.57 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.631 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' ASP . 34.2 m -55.61 -38.33 69.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 111.119 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -66.85 -50.73 61.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.247 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -29.49 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.793 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.54 -50.82 56.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.307 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.48 -39.38 90.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 -45.43 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.841 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.68 69.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 111.283 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.67 -53.91 4.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.364 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -85.64 -41.6 15.06 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.327 -0.412 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -173.298 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 . . . . . 0 C--O 1.234 0.254 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 93' ' ' TYR . 29.1 m-85 -135.01 160.34 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.624 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB2' ' OE1' ' A' ' 94' ' ' GLN . . . -88.6 136.82 32.8 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.42 102.34 11.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 9.8 tt0 -103.18 100.65 10.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.411 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 87' ' ' SER . 48.4 tp -76.87 106.58 8.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.986 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.8 pt -101.47 139.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.682 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 tp-100 -86.36 106.2 17.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.835 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -103.33 162.0 21.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.62 -21.08 71.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.431 2.087 . . . . 0.0 112.019 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.491 ' HB2' HG11 ' A' ' 55' ' ' VAL . 20.7 m-85 -90.66 -4.44 56.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.344 0.593 . . . . 0.0 109.994 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.51 166.76 12.39 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.552 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 80' ' ' LEU . 7.8 p -66.86 121.38 15.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.08 146.5 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.786 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.88 121.4 28.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 21.4 ttt -105.74 152.12 23.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.474 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.31 120.81 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.539 0.209 . . . . 0.0 110.851 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 45' ' ' VAL . 4.1 t -107.94 124.46 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.395 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . 23.8 t80 -62.43 118.78 7.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.607 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.501 ' OE1' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -88.21 -33.86 17.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.768 -170.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 95' ' ' ARG . 41.7 mtm180 -83.03 161.73 56.89 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.4 133.43 56.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.883 2.389 . . . . 0.0 112.547 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 100' ' ' LEU . 12.4 m -77.67 69.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 122.171 0.986 . . . . 0.0 110.092 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -42.84 -70.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.257 -1.792 . . . . 0.0 112.796 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.99 60.83 0.61 Allowed Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.031 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 38' ' ' LEU . 19.2 mt -111.64 155.79 22.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.652 0.263 . . . . 0.0 110.359 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -98.42 116.19 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 34' ' ' GLN . 52.2 tp -90.47 127.1 36.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.372 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.604 HG21 ' H ' ' A' ' 107' ' ' ASP . 5.9 mt -94.99 98.66 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -66.78 24.56 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.532 0.733 . . . . 0.0 112.786 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 103' ' ' ILE . 42.3 m -160.92 17.45 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.288 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 35.65 50.99 1.07 Allowed Glycine 0 C--N 1.348 1.236 0 O-C-N 124.184 0.928 . . . . 0.0 114.985 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.604 ' H ' HG21 ' A' ' 103' ' ' ILE . 6.5 t70 -135.37 132.91 38.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.44 . . . . 0.0 110.824 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 52' ' ' HIS . 5.5 p90 -96.9 -8.07 31.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.708 0.766 . . . . 0.0 110.018 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 2.0 mt . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.143 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.646 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 31.6 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -120.36 146.9 45.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 117.866 0.303 . . . . 0.0 111.168 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.584 ' HB ' HD21 ' A' ' 63' ' ' LEU . 11.9 tt -142.45 140.11 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.605 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 56.0 t80 -88.0 113.65 23.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 87.9 t -91.6 133.93 31.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.54 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.405 -178.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -139.5 116.7 11.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.237 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 tp -67.06 104.1 1.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 HG12 ' A' ' 55' ' ' VAL . 91.0 mt -72.65 -43.37 63.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.307 0.575 . . . . 0.0 109.633 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.37 158.35 8.89 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.09 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.19 143.05 43.37 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -141.26 111.86 7.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.509 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.618 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 49.8 m -93.35 127.16 38.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.388 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.95 131.35 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 11.1 m-20 -85.77 153.64 22.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.706 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 13.6 m120 73.17 32.04 1.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.97 0.794 . . . . 0.0 111.616 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -138.25 136.3 36.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.713 0.292 . . . . 0.0 110.875 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -106.55 160.67 15.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 103' ' ' ILE . 25.4 tp -115.79 133.66 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.339 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 102' ' ' LEU . 73.9 m-85 -108.57 156.61 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.778 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.3 t -147.11 125.61 12.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.877 0.37 . . . . 0.0 110.282 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.799 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 1.3 pt? -105.54 16.19 25.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.61 -25.34 25.25 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.995 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -111.67 -72.14 0.73 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' HB2' HD21 ' A' ' 38' ' ' LEU . 3.3 m-85 -82.54 128.32 67.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.266 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -93.98 103.13 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.779 2.319 . . . . 0.0 110.714 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -100.94 157.41 19.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.181 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -140.47 145.74 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.224 0.512 . . . . 0.0 110.845 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 92' ' ' VAL . 24.9 m -146.28 162.26 35.54 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 20.1 Cg_endo -61.25 151.66 77.51 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.622 2.215 . . . . 0.0 112.834 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.3 -130.83 2.24 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -136.49 89.17 2.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.419 0.628 . . . . 0.0 109.816 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.87 -179.33 33.63 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -133.76 104.86 6.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 117.769 0.784 . . . . 0.0 111.02 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.2 t -84.22 109.48 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -81.36 58.45 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.88 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.605 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -72.62 169.27 52.31 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.817 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.8 pt-20 -121.04 114.84 22.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.27 -0.465 . . . . 0.0 109.936 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 25' ' ' LEU . 28.0 t -86.8 129.91 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.754 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -125.46 156.98 38.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 111.461 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 57' ' ' ARG . 13.5 ttp180 -113.03 124.69 53.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.514 172.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.807 HD11 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.19 178.87 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 58' ' ' ILE . 31.8 t70 -52.6 149.55 5.87 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.627 0.251 . . . . 0.0 110.956 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 94.0 m-20 -66.22 -48.19 71.37 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.884 -0.51 . . . . 0.0 110.779 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.61 78.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.779 -171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.97 -40.35 80.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.034 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.807 HD23 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -66.29 -53.47 36.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.117 -177.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.72 -28.23 68.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.854 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.88 -50.89 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.561 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.4 -39.91 89.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.946 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.07 -58.31 8.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.948 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -8.96 55.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.688 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.37 -48.75 8.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.11 0.481 . . . . 0.0 110.77 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -86.52 -40.74 14.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.675 -171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.494 ' HG1' ' N ' ' A' ' 75' ' ' GLU . 5.7 t . . . . . 0 C--N 1.322 -0.591 0 CA-C-O 122.133 0.968 . . . . 0.0 111.994 -173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' N ' ' HG1' ' A' ' 71' ' ' THR . 9.2 mp0 . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 93' ' ' TYR . 23.7 m-85 -140.73 148.43 40.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.69 133.25 33.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.794 0.33 . . . . 0.0 111.491 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 78' ' ' ARG . 72.5 mtt180 -77.32 109.1 10.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 9.3 tt0 -110.44 98.79 7.92 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -79.55 113.31 17.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.8 pt -109.04 131.11 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.461 0.648 . . . . 0.0 110.984 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.605 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -95.31 162.98 22.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.972 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.75 -16.81 46.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.538 2.158 . . . . 0.0 112.042 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -97.94 2.0 48.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.902 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.05 158.48 10.94 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -65.75 125.8 26.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.207 0.504 . . . . 0.0 110.495 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.59 150.53 41.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.628 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -82.52 124.42 30.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.027 0.442 . . . . 0.0 111.384 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 27.0 ttt -110.85 131.63 54.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.373 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -107.8 109.51 21.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.09 0.472 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.818 HG13 HG12 ' A' ' 45' ' ' VAL . 2.5 t -80.34 126.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.432 ' HA ' ' HD1' ' A' ' 76' ' ' TYR . 5.9 t80 -59.27 102.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.461 HE21 ' HA ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -87.2 -14.72 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.122 -170.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.415 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 34.8 mtm180 -84.99 164.26 42.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 88.0 Cg_exo -48.1 115.59 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.605 2.203 . . . . 0.0 112.541 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.536 ' HA ' HD13 ' A' ' 100' ' ' LEU . 29.2 m -86.37 -4.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.507 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.11 -12.3 18.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.388 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 100' ' ' LEU . . . -106.21 16.86 41.62 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.173 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.799 ' HG ' ' HB3' ' A' ' 38' ' ' LEU . 7.1 mp -120.82 170.84 9.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.33 134.22 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 36' ' ' TYR . 50.1 tp -102.3 117.17 34.18 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.01 0.433 . . . . 0.0 111.178 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 35' ' ' LEU . 59.9 mt -97.44 95.26 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.45 -22.12 41.36 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.484 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.2 m -70.73 -46.78 62.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 98.41 -0.43 58.38 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -171.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -99.28 165.59 11.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.532 . . . . 0.0 109.993 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.87 -49.21 4.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.1 mt . . . . . 0 N--CA 1.437 -1.103 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.464 179.785 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.672 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 21.2 ttm . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.545 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 98.2 mtt180 -92.05 124.24 36.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 63' ' ' LEU . 33.3 mt -121.2 147.18 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HE1' ' O ' ' A' ' 28' ' ' PHE . 92.3 t80 -91.07 111.1 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.1 t -90.76 102.14 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.0 110.487 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 p90 . . . . . 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.192 177.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 56' ' ' TYR . . . . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.078 0.466 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.2 tt0 -108.7 98.53 8.02 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.6 116.26 4.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -172.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.48 HD12 HG12 ' A' ' 55' ' ' VAL . 91.4 mt -85.6 -42.34 14.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . 157.6 146.46 4.51 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.273 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 p30 -74.53 151.55 39.47 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.487 0.66 . . . . 0.0 110.443 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' O ' ' HE1' ' A' ' 4' ' ' PHE . 10.3 t80 -157.1 103.77 2.04 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.237 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HG22 ' A' ' 50' ' ' THR . 23.0 p -90.94 122.95 34.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.654 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 13.3 pt -103.44 125.8 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.308 0.575 . . . . 0.0 111.398 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 27.0 t0 -84.67 161.31 20.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.101 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 42.1 m-80 74.06 26.47 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 111.377 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.49 147.66 43.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 110.653 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 104' ' ' GLU . 41.8 mt-30 -122.85 156.0 35.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.297 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.8 tp -117.9 135.64 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.036 -170.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -101.64 145.26 29.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.198 0.523 . . . . 0.0 111.49 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -108.56 106.16 16.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.518 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -117.2 18.8 14.42 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.039 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 -70.01 2.77 Favored Glycine 0 C--N 1.329 0.152 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.536 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -50.9 -48.09 60.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.372 0.606 . . . . 0.0 110.964 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 5.7 p90 -159.87 165.65 17.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.059 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.6 159.88 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.474 2.116 . . . . 0.0 112.263 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.05 6.04 Favored Glycine 0 C--O 1.223 -0.57 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -123.79 165.59 17.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.81 0.805 . . . . 0.0 111.065 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 92' ' ' VAL . 35.2 m -150.88 160.35 32.4 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.48 0.487 . . . . 0.0 110.209 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 28.8 Cg_endo -66.64 128.97 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.037 1.824 . . . . 0.0 111.465 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.86 -120.32 0.51 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.96 91.97 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.607 0.717 . . . . 0.0 110.703 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 164.89 32.79 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.743 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 19.3 m -112.32 105.77 14.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.385 0.592 . . . . 0.0 110.446 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' SER . 65.0 t -82.38 117.75 28.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.523 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.06 100.6 3.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.015 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.54 165.79 23.64 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 47.6 mt-10 -125.06 136.35 53.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 25' ' ' LEU . 41.7 t -86.67 119.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 46.6 m-85 -122.04 159.38 27.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.916 0.865 . . . . 0.0 112.669 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.2 tmt_? -112.99 114.15 26.49 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.522 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.2 pp -119.55 177.11 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.058 173.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.74 131.14 38.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.818 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 1' ' ' MET . 3.3 m-20 -66.65 -41.43 88.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.807 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.84 99.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.595 0.236 . . . . 0.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 m -54.92 -40.37 69.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.254 0.55 . . . . 0.0 110.503 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 3' ' ' ILE . 3.0 tm? -67.57 -53.49 27.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.344 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.17 -30.25 69.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.046 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.13 -46.97 30.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 66' ' ' LEU . 7.2 tt -61.83 -47.11 86.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.787 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.666 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 23.0 t70 -63.56 -42.82 98.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.508 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.53 -30.42 70.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.102 0.477 . . . . 0.0 111.297 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 mt -86.14 -50.53 6.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 3.1 ttt85 -85.98 -41.87 14.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.853 0.358 . . . . 0.0 111.469 -168.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.816 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.402 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 C--O 1.234 0.251 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.677 ' HE2' ' HG2' ' A' ' 70' ' ' ARG . 4.3 m-85 -135.89 150.72 49.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.936 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HB2' ' NE2' ' A' ' 94' ' ' GLN . . . -86.45 118.13 25.68 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.081 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.666 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 82.1 mtm180 -74.43 102.61 4.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.215 0.531 . . . . 0.0 109.887 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -103.77 99.17 8.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.3 tp -76.79 112.34 13.27 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.874 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.421 ' C ' HE21 ' A' ' 82' ' ' GLN . 35.5 pt -107.09 138.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.292 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.64 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -90.47 113.86 25.9 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 85' ' ' TYR . 33.6 p -102.71 166.71 11.47 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.159 -172.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.69 1.21 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.643 2.229 . . . . 0.0 111.836 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 32.9 m-85 -119.83 17.13 12.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.4 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.545 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 115.74 -87.46 0.44 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.932 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -169.5 141.64 2.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.47 147.7 30.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.646 0.26 . . . . 0.0 111.238 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.14 120.08 25.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.59 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.535 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -105.16 118.65 37.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.448 176.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.66 109.67 21.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.487 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -93.21 138.86 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.47 ' HD2' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -47.64 136.27 10.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.303 177.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.0 tp-100 -138.44 18.99 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.901 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.746 ' HB2' ' HD3' ' A' ' 96' ' ' PRO . 2.2 mmp_? -120.85 -80.51 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 95' ' ' ARG . 34.7 Cg_endo -99.05 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 -162.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 100' ' ' LEU . 25.1 m 54.2 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.486 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.46 113.82 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.885 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.02 44.41 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -169.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 97' ' ' VAL . 66.1 mt -119.55 165.63 14.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.56 132.15 54.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 34' ' ' GLN . 50.2 tp -102.49 126.89 49.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.084 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 106' ' ' GLY . 40.7 mt -90.09 100.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.623 ' HA ' HE21 ' A' ' 34' ' ' GLN . 27.8 mt-10 -67.37 24.01 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.618 -1.174 . . . . 0.0 114.084 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 m -163.89 -17.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.067 -0.396 . . . . 0.0 111.926 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' H ' HG22 ' A' ' 103' ' ' ILE . . . 91.74 21.51 33.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.159 -1.019 . . . . 0.0 114.443 167.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.91 129.89 41.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.736 0.768 . . . . 0.0 109.288 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -69.45 -29.83 67.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.445 -167.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.553 ' HB2' HD22 ' A' ' 63' ' ' LEU . 11.2 tpp . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 29.8 mtm180 -87.98 138.1 31.75 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.945 0.402 . . . . 0.0 110.659 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -142.2 151.24 18.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.096 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -91.22 127.51 36.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.521 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -92.36 106.37 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.14 0.495 . . . . 0.0 110.828 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HA ' ' CH2' ' A' ' 108' ' ' TRP . 20.3 p90 -110.7 20.12 17.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.369 177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.27 66.35 0.29 Allowed Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.471 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.693 ' HA ' ' CD1' ' A' ' 108' ' ' TRP . 72.7 p 61.68 152.01 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.4 1.08 . . . . 0.0 111.874 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.703 HD22 ' HE1' ' A' ' 108' ' ' TRP . 2.4 mm? -68.22 -20.77 64.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.47 177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.6 mtp180 -68.44 -19.48 64.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 44.54 -157.92 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.173 0.921 . . . . 0.0 111.93 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.512 ' HG3' ' H ' ' A' ' 14' ' ' GLY . 0.1 OUTLIER -147.68 139.18 23.8 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.795 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 2.5 mp0 -75.93 -16.37 60.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.175 0.512 . . . . 0.0 110.727 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.512 ' H ' ' HG3' ' A' ' 12' ' ' LYS . . . 67.81 -97.39 0.42 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.421 178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -122.29 -37.54 2.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.742 0.306 . . . . 0.0 110.293 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 p -178.55 -51.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.471 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -47.01 -39.8 13.31 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.487 -0.779 . . . . 0.0 112.869 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.605 ' CZ2' ' HB2' ' A' ' 66' ' ' LEU . 69.7 m95 -79.34 4.15 16.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -168.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.795 ' HB3' ' HG3' ' A' ' 13' ' ' GLN . 21.2 ptm -128.59 -4.3 5.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.867 0.365 . . . . 0.0 110.327 172.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.4 m -96.88 -66.47 0.9 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -90.34 -0.1 57.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.108 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 58' ' ' ILE . . . -69.83 110.25 4.87 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.717 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -100.63 118.91 37.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.581 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 45.3 tp -71.68 104.14 3.27 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.209 177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.576 HD12 HG12 ' A' ' 55' ' ' VAL . 95.3 mt -72.79 -43.6 62.57 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.474 177.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.25 171.09 18.93 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -78.96 145.99 33.68 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 121.832 0.825 . . . . 0.0 110.206 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.582 ' HB3' HG23 ' A' ' 55' ' ' VAL . 23.3 t80 -154.09 101.69 2.42 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.486 -177.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.2 m -88.96 133.01 34.46 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.712 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 pt -113.22 126.37 70.62 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-O 121.126 0.488 . . . . 0.0 110.96 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 4.3 t70 -86.15 165.22 16.74 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.559 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.48 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.8 OUTLIER 69.48 28.04 4.76 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.715 0.634 . . . . 0.0 111.226 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -135.41 149.96 49.76 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.522 ' HB3' HD11 ' A' ' 102' ' ' LEU . 99.1 mt-30 -127.76 152.49 47.69 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.686 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.576 HD23 HD12 ' A' ' 103' ' ' ILE . 23.7 tp -111.33 131.83 54.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.941 0.4 . . . . 0.0 111.283 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.04 151.28 21.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -122.93 107.7 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 169.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HA ' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -102.84 18.45 21.49 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.141 0.422 . . . . 0.0 112.141 -173.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.54 -57.79 0.62 Allowed Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.221 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -104.67 -82.99 0.51 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.65 0.738 . . . . 0.0 109.697 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.54 158.7 62.68 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.716 -1.129 . . . . 0.0 110.539 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -93.52 170.9 2.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.935 2.424 . . . . 0.0 112.619 176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -139.34 152.5 22.44 Favored Glycine 0 C--O 1.221 -0.717 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -138.41 141.42 39.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 117.939 0.87 . . . . 0.0 110.963 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' HD2' ' A' ' 93' ' ' TYR . 23.9 m -150.28 163.88 22.67 Favored Pre-proline 0 N--CA 1.464 0.274 0 O-C-N 123.184 0.303 . . . . 0.0 110.27 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.58 132.15 30.08 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.564 2.176 . . . . 0.0 111.497 173.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -170.99 -123.78 0.71 Allowed Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.767 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -139.63 90.26 2.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.843 0.354 . . . . 0.0 110.153 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.79 166.16 34.93 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.921 -0.656 . . . . 0.0 111.562 178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 4.6 m -109.88 106.03 15.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.091 0.445 . . . . 0.0 110.178 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 29' ' ' SER . 67.4 t -82.59 105.56 12.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.041 0.448 . . . . 0.0 109.848 -177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.468 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 82.9 t60 -79.29 65.3 4.43 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.66 -175.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.652 ' HA2' ' HZ2' ' A' ' 108' ' ' TRP . . . -100.02 -173.59 30.3 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.334 -175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.572 ' HB2' HD12 ' A' ' 9' ' ' LEU . 19.5 tt0 -133.55 140.92 47.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 28' ' ' PHE . 49.2 t -106.79 130.59 58.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.959 0.409 . . . . 0.0 111.14 -176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -124.74 150.74 45.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.249 0.547 . . . . 0.0 112.093 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.04 105.51 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.144 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HA ' ' A' ' 22' ' ' ALA . 2.4 pp -110.92 162.93 8.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.91 147.06 9.72 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 122.9 0.48 . . . . 0.0 112.014 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.443 ' O ' ' HB3' ' A' ' 63' ' ' LEU . 5.8 p30 -64.84 -41.9 95.34 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.527 -177.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.31 -37.02 82.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.215 0.531 . . . . 0.0 110.199 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' CH2' ' A' ' 18' ' ' TRP . 57.6 m -56.88 -30.37 63.81 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.159 173.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.553 HD22 ' HB2' ' A' ' 1' ' ' MET . 13.9 tp -66.48 -49.55 66.25 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.28 -29.59 65.94 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.696 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -68.2 -47.26 68.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.124 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.605 ' HB2' ' CZ2' ' A' ' 18' ' ' TRP . 8.2 tt -63.75 -47.09 82.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.907 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -61.82 -48.38 80.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.042 0.449 . . . . 0.0 110.776 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 72' ' ' ARG . . . -63.14 -27.73 69.58 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.687 -178.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 69' ' ' LEU . 15.4 mt -84.96 -33.1 22.72 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -85.66 -52.09 6.02 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -171.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.4 t -116.26 25.15 10.86 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.76 -169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 30.7 ttm180 -61.64 101.16 0.17 Allowed 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.383 0.611 . . . . 0.0 110.26 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 122.64 -22.69 7.27 Favored Glycine 0 N--CA 1.434 -1.447 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.779 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.83 80.71 1.33 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.217 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -111.41 -46.79 3.24 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.784 0.326 . . . . 0.0 110.748 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.568 ' HA ' ' HB2' ' A' ' 94' ' ' GLN . 66.4 m-85 -131.33 172.75 11.8 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.894 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.33 151.82 26.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.014 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HB3' ' CE3' ' A' ' 89' ' ' TRP . 56.0 mtt180 -92.53 111.94 23.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.368 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -104.2 103.96 13.81 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.0 tp -81.11 115.91 20.78 Favored 'General case' 0 C--N 1.315 -0.891 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.4 pt -110.06 134.98 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.664 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.09 101.4 13.43 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.758 -175.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 p -97.14 159.94 30.16 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.692 178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.29 -14.72 40.24 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.348 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -101.81 7.19 41.81 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.85 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.492 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 119.65 154.36 9.47 Favored Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.976 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 m -66.04 126.65 29.28 Favored 'General case' 0 C--N 1.318 -0.774 0 O-C-N 122.493 -0.416 . . . . 0.0 110.335 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.1 148.06 44.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.663 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 78' ' ' ARG . 98.8 m95 -83.32 124.09 30.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.238 0.542 . . . . 0.0 111.461 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 22.5 ttt -111.87 127.76 55.93 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.564 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -93.8 118.22 31.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.996 0.427 . . . . 0.0 110.868 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.549 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -100.43 142.26 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.758 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.627 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -46.85 127.18 9.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 114.07 -1.423 . . . . 0.0 110.303 174.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.568 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.8 tp-100 -125.76 2.87 7.46 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.154 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 -135.77 138.23 27.52 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -28.35 128.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.781 1 C-N-CA 125.879 4.386 . . . . 0.0 115.939 -170.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' A' ' 93' ' ' TYR . 15.9 m -90.76 16.2 1.1 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.125 177.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -60.32 110.48 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.068 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.54 23.99 32.14 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.184 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HA ' ' A' ' 38' ' ' LEU . 36.4 mt -98.53 168.2 10.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.095 0.447 . . . . 0.0 110.687 177.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -99.18 141.95 31.29 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.272 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 34' ' ' GLN . 32.6 tp -117.24 125.83 51.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.664 -175.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.576 HD12 HD23 ' A' ' 35' ' ' LEU . 42.5 mt -101.49 87.85 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -67.18 -12.83 61.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.768 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 39.8 t -69.4 -50.43 45.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.617 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 109.2 -12.83 33.91 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.542 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -106.27 151.36 24.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.193 0.52 . . . . 0.0 110.486 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.703 ' HE1' HD22 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -73.5 -31.71 63.86 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.454 -175.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 10.5 mt -99.29 -74.2 0.6 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.833 -172.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.4 t70 66.51 -48.25 0.44 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 170.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -80.98 16.01 1.63 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -165.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.576 ' O ' ' HG2' ' A' ' 113' ' ' LYS . 2.7 p30 -89.65 -12.56 39.27 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 166.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.576 ' HG2' ' O ' ' A' ' 112' ' ' ASP . 16.9 pttp . . . . . 0 N--CA 1.474 0.756 0 C-N-CA 125.01 1.324 . . . . 0.0 112.448 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.835 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 38.4 tpp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -113.68 128.2 56.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.064 0.459 . . . . 0.0 111.181 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.7 mt -128.41 139.66 51.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.721 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.58 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 57.2 t80 -96.9 109.64 22.32 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 9' ' ' LEU . 45.0 t -95.2 106.96 18.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.555 0.693 . . . . 0.0 110.974 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.447 ' OH ' ' HB2' ' A' ' 91' ' ' TYR . 1.2 p90 -87.48 76.13 9.05 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.453 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 161.74 159.45 10.15 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.4 t -69.61 89.92 0.55 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.264 0.532 . . . . 0.0 110.868 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' HB2' HG11 ' A' ' 5' ' ' VAL . 2.1 tm? -79.47 -30.27 42.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.394 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -60.74 -23.6 65.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.674 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -93.08 -47.84 6.78 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.39 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -99.53 92.05 5.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.947 0.403 . . . . 0.0 111.969 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -80.73 95.77 6.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 172.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.89 -43.04 75.99 Favored Glycine 0 N--CA 1.453 -0.181 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.186 -175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' H ' ' HD1' ' A' ' 18' ' ' TRP . 27.2 t-20 -140.18 156.23 46.61 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.6 m -54.49 -32.72 58.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.242 0.339 . . . . 0.0 111.584 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.504 ' HB3' HG23 ' A' ' 62' ' ' THR . 43.1 m80 -58.12 -31.57 67.3 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.419 ' HD1' ' H ' ' A' ' 15' ' ' ASN . 10.5 m95 -68.49 -46.23 70.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.516 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 26.9 ttt -76.33 -28.07 56.75 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.899 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.0 m -80.27 131.28 35.64 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 -173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.5 p30 51.54 17.95 0.63 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.894 1.278 . . . . 0.0 112.974 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.08 117.17 19.13 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.14 0.495 . . . . 0.0 110.606 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.69 114.36 28.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.408 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 62.3 tp -67.0 102.59 1.0 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HG12 ' A' ' 55' ' ' VAL . 81.3 mt -64.46 -32.75 74.51 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.814 0.816 . . . . 0.0 109.135 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.87 135.78 3.16 Favored Glycine 0 N--CA 1.439 -1.121 0 CA-C-N 114.229 -1.35 . . . . 0.0 110.808 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -70.37 126.34 29.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.1 0.953 . . . . 0.0 109.772 175.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -139.7 118.79 12.65 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.814 -167.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.702 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.6 m -86.08 125.81 33.72 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.855 -175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 50' ' ' THR . 13.5 pt -99.94 130.01 49.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.712 178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 39.0 t0 -92.33 159.14 15.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.984 -176.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 49.5 m-80 73.84 29.97 1.39 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.735 0.647 . . . . 0.0 111.582 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CD1' ' HA ' ' A' ' 46' ' ' PRO . 97.7 m-85 -133.04 162.07 32.69 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.962 174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.581 ' HG3' ' HA3' ' A' ' 47' ' ' GLY . 41.1 mt-30 -123.97 152.26 42.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.9 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 41.6 tp -118.9 126.01 50.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 111.111 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.423 ' CE1' HD13 ' A' ' 102' ' ' LEU . 68.4 m-85 -92.14 135.19 34.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.874 174.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.479 ' HB3' ' HB2' ' A' ' 101' ' ' LYS . 23.4 t -121.79 96.87 5.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.122 0.487 . . . . 0.0 110.035 -178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.518 HD22 ' HG ' ' A' ' 100' ' ' LEU . 0.2 OUTLIER -101.8 18.03 21.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.613 179.095 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.17 -55.8 2.75 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.942 177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -58.49 -51.88 68.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 0.0 110.483 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 18.1 p90 -160.11 138.4 7.49 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.846 -178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 41' ' ' TYR . 5.8 Cg_exo -75.27 159.7 40.09 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.912 2.408 . . . . 0.0 112.448 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 6' ' ' TYR . . . -145.27 125.21 2.29 Favored Glycine 0 C--O 1.224 -0.489 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.71 144.18 35.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.201 0.5 . . . . 0.0 111.48 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.873 HG12 HG13 ' A' ' 92' ' ' VAL . 31.7 m -144.88 163.25 34.26 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.674 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . 24.5 Cg_endo -63.84 139.04 66.45 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.138 1.892 . . . . 0.0 112.069 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.581 ' HA3' ' HG3' ' A' ' 34' ' ' GLN . . . -176.34 -120.3 0.61 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.229 -0.51 . . . . 0.0 111.949 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.496 ' C ' HD22 ' A' ' 48' ' ' ASN . 0.2 OUTLIER -145.97 88.76 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.084 0.469 . . . . 0.0 109.985 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.706 ' HA3' ' O ' ' A' ' 104' ' ' GLU . . . 178.56 163.8 30.47 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.625 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.581 HG22 ' HB3' ' A' ' 29' ' ' SER . 1.9 m -109.3 100.15 9.31 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.073 0.463 . . . . 0.0 111.076 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.702 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.5 t -83.3 121.6 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.549 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.457 ' O ' ' HZ2' ' A' ' 108' ' ' TRP . 0.2 OUTLIER -77.94 56.27 1.55 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.842 -173.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.58 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -74.63 155.04 47.94 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.768 -171.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -100.89 120.27 39.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG12 HD12 ' A' ' 25' ' ' LEU . 11.2 t -93.99 123.89 46.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -122.41 146.07 47.7 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -105.94 104.46 14.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.775 170.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pp -123.76 167.36 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.845 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.83 135.45 24.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.007 177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.835 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 87.4 m-20 -54.71 -41.06 69.84 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.152 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -69.8 -32.47 70.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.457 -175.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' HIS . 72.8 m -56.27 -32.2 64.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.952 0.406 . . . . 0.0 110.471 174.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 13.8 tp -67.78 -49.77 60.61 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.6 ' HA ' ' OD2' ' A' ' 67' ' ' ASP . . . -58.57 -32.39 68.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.868 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -75.54 -40.59 56.65 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.424 HD23 ' C ' ' A' ' 66' ' ' LEU . 8.4 tt -64.83 -47.7 77.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.6 ' OD2' ' HA ' ' A' ' 64' ' ' ALA . 1.8 p30 -67.45 -43.16 81.78 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.194 -175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -32.57 68.27 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.498 0.666 . . . . 0.0 110.779 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.84 -43.05 13.6 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.796 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' O ' HG22 ' A' ' 71' ' ' THR . 21.3 ttt180 -86.68 7.03 28.32 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -169.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.553 HG21 ' H ' ' A' ' 76' ' ' TYR . 0.7 OUTLIER 98.14 -19.16 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.787 1.235 . . . . 0.0 112.338 -178.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HD2' ' OD1' ' A' ' 67' ' ' ASP . 34.0 ttt85 62.19 -83.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.408 0.442 . . . . 0.0 111.6 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -140.54 26.29 2.55 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.237 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.02 -71.56 0.94 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.755 177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.0 -34.59 69.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.614 0.245 . . . . 0.0 110.644 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.553 ' H ' HG21 ' A' ' 71' ' ' THR . 10.7 m-85 -122.5 163.13 20.45 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.444 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -102.85 141.69 35.23 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HG2' ' CE2' ' A' ' 91' ' ' TYR . 29.5 mtp180 -93.07 124.27 36.92 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -116.96 107.89 15.12 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.5 tp -81.76 110.13 16.8 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.9 pt -106.06 144.74 14.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.023 -177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.06 104.35 16.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.909 -176.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 p -98.52 162.69 20.97 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.756 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.99 -21.42 58.33 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.678 2.252 . . . . 0.0 112.613 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.483 ' HB3' HD13 ' A' ' 25' ' ' LEU . 51.8 m-85 -96.7 -3.91 41.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.079 0.466 . . . . 0.0 110.532 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.14 157.74 9.14 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.669 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 127.47 31.82 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 122.546 -0.385 . . . . 0.0 110.602 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.01 150.52 44.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.842 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -79.25 121.99 25.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.204 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.8 ttt -108.9 116.45 32.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.367 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.447 ' HB2' ' OH ' ' A' ' 6' ' ' TYR . 96.7 m-85 -94.78 107.97 19.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.279 0.562 . . . . 0.0 110.655 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.873 HG13 HG12 ' A' ' 45' ' ' VAL . 4.7 t -76.91 119.63 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.824 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -65.22 119.43 10.87 Favored 'General case' 0 CA--C 1.512 -0.511 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.37 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.64 -170.9 2.24 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.355 -0.839 . . . . 0.0 108.823 -177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 44.2 mtm180 72.62 167.91 0.12 Allowed Pre-proline 0 CA--C 1.533 0.313 0 O-C-N 123.662 0.601 . . . . 0.0 110.775 175.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 77.8 Cg_exo -54.15 119.18 5.9 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.745 2.296 . . . . 0.0 112.854 176.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.491 ' C ' ' H ' ' A' ' 99' ' ' GLY . 35.4 m -104.88 1.99 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.778 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -64.93 16.18 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . -128.58 15.18 6.04 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.6 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.518 ' HG ' HD22 ' A' ' 38' ' ' LEU . 0.0 OUTLIER -144.59 176.26 9.54 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.682 -0.305 . . . . 0.0 110.907 177.304 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 37' ' ' SER . 54.7 mtpt -76.99 143.96 39.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.351 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 36' ' ' TYR . 56.6 tp -110.16 109.75 20.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.84 175.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 62.6 mt -99.73 91.92 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.706 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 0.1 OUTLIER -65.87 -26.15 67.51 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.263 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.1 p -73.56 -15.03 61.3 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.746 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 68.92 34.3 76.74 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.283 -0.484 . . . . 0.0 113.183 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.438 ' CG ' ' HA ' ' A' ' 110' ' ' ASP . 2.8 p30 -117.8 178.3 4.46 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.457 ' HZ2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -119.59 -34.44 3.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.336 0.589 . . . . 0.0 109.653 176.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' C ' ' H ' ' A' ' 111' ' ' ARG . 10.5 mp -97.18 -15.85 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.16 -175.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.438 ' HA ' ' CG ' ' A' ' 107' ' ' ASP . 2.8 p30 57.02 2.57 0.11 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.581 1.552 . . . . 0.0 113.204 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' H ' ' C ' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -129.1 81.98 2.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.807 0.813 . . . . 0.0 110.37 175.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -90.54 1.54 56.62 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.228 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 121.818 0.818 . . . . 0.0 110.928 -176.287 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.862 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 4.0 tmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.457 ' HD2' ' HA3' ' A' ' 86' ' ' GLY . 25.8 mtm180 -123.65 133.74 53.87 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.541 0.686 . . . . 0.0 112.165 -177.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.3 tt -136.93 148.16 26.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.486 -176.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.723 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 81.4 t80 -92.69 112.01 23.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.2 t -95.74 126.98 48.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.174 0.512 . . . . 0.0 111.002 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HE2' ' HA2' ' A' ' 43' ' ' GLY . 11.0 p90 -135.58 -43.68 0.68 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.503 -178.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.76 80.46 0.56 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.726 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.1 p 50.46 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.905 0.882 . . . . 0.0 112.119 -178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.6 pt? -55.77 -33.44 64.35 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.754 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -63.06 -60.06 3.95 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 52.3 t-80 59.25 -84.6 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.868 0.73 . . . . 0.0 111.39 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 11' ' ' HIS . 76.4 tttt 174.42 115.68 0.02 OUTLIER 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -178.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.829 ' HB2' ' HB2' ' A' ' 19' ' ' MET . 0.0 OUTLIER -126.73 -156.05 0.72 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.023 179.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.63 -37.82 3.63 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.396 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.92 -35.3 0.71 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.819 0.342 . . . . 0.0 110.905 -176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 m -75.55 169.36 18.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.748 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -70.19 9.44 0.58 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.129 -0.487 . . . . 0.0 112.039 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 50.9 t-105 -76.7 -26.81 55.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.026 0.441 . . . . 0.0 111.031 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.829 ' HB2' ' HB2' ' A' ' 13' ' ' GLN . 18.0 tpt -100.49 -39.54 7.89 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.491 0.663 . . . . 0.0 110.219 178.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 m -81.06 134.25 35.63 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.96 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.552 ' CB ' ' HB2' ' A' ' 59' ' ' ASP . 32.4 m-20 75.91 3.13 3.75 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.698 0.799 . . . . 0.0 111.279 177.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -101.6 135.01 43.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.408 -176.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -137.03 143.67 42.83 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.158 175.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.1 tp -79.61 130.12 35.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.038 178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 55' ' ' VAL . 95.6 mt -93.12 -43.01 9.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.856 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.42 176.59 27.77 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -82.4 147.54 28.72 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 122.149 0.976 . . . . 0.0 110.779 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -151.82 86.37 1.32 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.586 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.3 m -82.66 124.5 30.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.702 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.7 pt -112.71 126.35 70.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.881 0.848 . . . . 0.0 111.524 -172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -85.85 156.67 20.45 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.5 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 71.01 33.38 2.1 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 124.118 0.886 . . . . 0.0 110.931 -177.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -136.25 165.31 26.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.404 -0.817 . . . . 0.0 108.952 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -136.24 144.64 44.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.739 0.304 . . . . 0.0 110.961 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 HD23 HD12 ' A' ' 103' ' ' ILE . 18.7 tp -105.44 131.24 53.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.471 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -98.87 128.62 45.11 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 174.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 p -110.08 126.45 54.03 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.826 0.346 . . . . 0.0 110.321 176.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.7 OUTLIER -140.98 16.75 2.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.01 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.81 -63.8 3.74 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.103 -0.57 . . . . 0.0 113.48 176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -59.7 -45.36 92.36 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.678 0.275 . . . . 0.0 111.249 -173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.58 ' HD1' ' O ' ' A' ' 41' ' ' TYR . 0.1 OUTLIER -167.65 110.88 0.6 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.71 176.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.41 142.75 98.85 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.65 2.234 . . . . 0.0 112.807 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.504 ' HA2' ' HE2' ' A' ' 6' ' ' TYR . . . -120.32 178.57 16.48 Favored Glycine 0 C--O 1.223 -0.544 0 N-CA-C 111.389 -0.685 . . . . 0.0 111.389 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.13 151.28 29.08 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 117.546 0.673 . . . . 0.0 111.318 -175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.069 HG12 HG13 ' A' ' 92' ' ' VAL . 29.1 m -153.56 165.7 17.23 Favored Pre-proline 0 N--CA 1.468 0.453 0 O-C-N 123.383 0.427 . . . . 0.0 110.215 -178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.9 148.85 52.51 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.374 2.049 . . . . 0.0 111.343 171.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.07 -125.92 1.26 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.187 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -135.41 91.92 2.78 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.6 -178.24 48.55 Favored Glycine 0 C--O 1.224 -0.52 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.427 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 23.2 m -122.26 119.89 32.5 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 117.916 0.858 . . . . 0.0 110.114 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.713 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 92.9 t -107.01 109.03 26.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.023 0.44 . . . . 0.0 110.461 -177.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.474 ' O ' ' HH2' ' A' ' 108' ' ' TRP . 7.5 t60 -69.16 119.96 14.25 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.723 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -128.43 142.85 13.91 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.002 -1.094 . . . . 0.0 112.847 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 9' ' ' LEU . 27.4 mm-40 -98.54 107.66 20.17 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 25' ' ' LEU . 57.1 t -80.2 116.98 25.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.79 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -118.77 150.77 39.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.715 -175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.427 ' HD3' ' C ' ' A' ' 57' ' ' ARG . 1.8 tmt_? -108.49 107.63 18.24 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 170.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 pt -114.74 169.95 5.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.604 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 25.6 t70 -53.5 137.88 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.045 177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.862 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 9.0 m120 -63.38 -43.91 96.27 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.616 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.59 -34.29 77.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.269 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.604 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 67.7 m -56.82 -29.54 62.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.083 173.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 1' ' ' MET . 37.2 tp -66.6 -47.88 71.29 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.56 -32.4 65.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.286 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -74.3 -55.05 6.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.748 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.42 -37.28 85.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.097 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.51 -56.56 19.9 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.255 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 72' ' ' ARG . . . -55.45 -32.46 62.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.857 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.79 -58.11 3.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.973 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' O ' ' HA3' ' A' ' 74' ' ' GLY . 39.5 ttm180 -85.4 -3.19 58.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -169.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 76' ' ' TYR . 75.3 p -106.61 -67.59 0.93 Allowed 'General case' 0 C--N 1.321 -0.67 0 O-C-N 121.429 -0.794 . . . . 0.0 110.649 175.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 2.3 tmt_? -53.88 -36.55 62.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.359 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.99 22.71 7.54 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.349 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 70' ' ' ARG . . . -132.22 -29.31 0.56 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.874 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 74.15 18.46 3.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.133 0.492 . . . . 0.0 111.568 176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.43 ' O ' HG22 ' A' ' 71' ' ' THR . 8.3 m-85 -116.22 162.94 16.73 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HB3' ' NE2' ' A' ' 94' ' ' GLN . . . -124.52 150.12 46.17 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.789 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ptt85 -88.89 127.77 35.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 111.636 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -104.14 121.73 43.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.902 -1.045 . . . . 0.0 108.254 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.4 tp -87.1 112.75 22.22 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.844 -176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 31.5 pt -112.22 133.28 58.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.396 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 87' ' ' SER . 0.0 OUTLIER -86.94 101.2 13.19 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.562 -176.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 p -93.67 160.47 32.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.021 -0.672 . . . . 0.0 109.679 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -63.74 -3.13 5.16 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.798 2.332 . . . . 0.0 112.648 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -116.06 4.02 13.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.276 0.56 . . . . 0.0 110.067 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.457 ' HA3' ' HD2' ' A' ' 2' ' ' ARG . . . 126.95 149.54 7.27 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.125 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 82' ' ' GLN . 8.0 m -65.81 122.25 16.88 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 122.594 -0.356 . . . . 0.0 110.203 178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.15 146.32 43.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.645 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -82.82 120.52 25.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.772 178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 24.7 ttt -105.58 113.11 26.49 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.392 176.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 -83.66 116.03 22.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.508 0.67 . . . . 0.0 111.192 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 1.069 HG13 HG12 ' A' ' 45' ' ' VAL . 8.6 t -108.43 143.09 19.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.946 -173.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.58 ' CE1' HG22 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -46.34 119.12 2.21 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.475 168.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.409 ' NE2' ' HB3' ' A' ' 77' ' ' ALA . 4.2 tp-100 -104.33 -26.62 12.4 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.637 -174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.597 ' H ' ' CD ' ' A' ' 96' ' ' PRO . 4.1 ptp180 -162.13 -37.46 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 95' ' ' ARG . 98.6 Cg_endo -97.78 103.66 0.07 OUTLIER 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.555 1.503 . . . . 0.0 114.749 -174.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.58 HG22 ' CE1' ' A' ' 93' ' ' TYR . 5.6 m -145.89 90.13 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.275 0.56 . . . . 0.0 110.352 169.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -64.48 24.15 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 97' ' ' VAL . . . 112.38 -68.86 0.23 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 38' ' ' LEU . 66.0 mt 61.89 -170.0 0.17 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.13 0.49 . . . . 0.0 111.213 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.5 ttmm -109.0 113.25 25.96 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 173.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.0 tt -87.69 125.31 34.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.19 0.519 . . . . 0.0 110.492 -177.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.55 HD12 HD23 ' A' ' 35' ' ' LEU . 20.6 mt -107.9 92.44 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -14.51 62.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.167 0.508 . . . . 0.0 110.652 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.2 m -72.73 -22.62 60.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.642 175.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.713 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 62.02 38.52 96.22 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.814 176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -142.02 149.73 40.38 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.474 ' HH2' ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -89.07 -26.18 21.53 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 -171.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 29.9 mt -118.83 -28.06 5.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.643 -167.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.06 76.51 8.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.466 0.65 . . . . 0.0 110.247 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -118.58 -56.62 2.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.903 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -148.05 104.5 3.56 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.616 -178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 114.636 -1.165 . . . . 0.0 108.985 173.178 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.989 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 52.5 tpp . . . . . 0 N--CA 1.476 0.846 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 87' ' ' SER . 10.2 mtt85 -111.82 129.89 55.99 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.2 tt -130.53 146.76 33.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.826 0.346 . . . . 0.0 110.544 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 75.2 t80 -103.31 124.32 48.45 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.836 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -90.27 130.51 39.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.23 43.08 2.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.563 -172.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 42' ' ' PRO . . . 152.84 113.74 0.55 Allowed Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 119.836 -1.173 . . . . 0.0 112.713 177.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 10' ' ' ARG . 63.3 p 51.36 103.3 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.794 0.838 . . . . 0.0 112.79 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.6 pt? -66.54 17.09 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.678 178.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.465 ' H ' ' C ' ' A' ' 8' ' ' SER . 19.2 mtp180 -58.55 -31.25 67.8 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 175.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 46.5 106.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.848 1.259 . . . . 0.0 113.726 173.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.01 121.54 18.38 Favored 'General case' 0 C--N 1.32 -0.687 0 O-C-N 121.869 -0.519 . . . . 0.0 109.88 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -70.87 107.34 3.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.783 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.27 77.47 1.69 Allowed Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 172.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 72.65 173.02 0.3 Allowed 'General case' 0 C--O 1.236 0.395 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.2 m -68.94 -16.04 63.64 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.693 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 -54.1 -22.61 11.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.918 175.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.422 ' HA ' HG21 ' A' ' 62' ' ' THR . 52.0 t-105 -88.03 -65.47 1.01 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.093 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -72.65 -19.73 61.38 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.484 HG22 ' O ' ' A' ' 20' ' ' THR . 23.6 m -85.93 46.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.678 0.751 . . . . 0.0 111.148 -176.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 20' ' ' THR . 9.7 p30 163.57 -19.4 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.299 -0.864 . . . . 0.0 108.741 -177.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.0 105.47 0.09 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.793 177.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -111.82 117.48 32.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.126 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.4 tp -71.22 106.29 3.75 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 HG12 ' A' ' 55' ' ' VAL . 83.3 mt -71.6 -38.31 70.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.352 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.0 157.61 7.25 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.293 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 3.7 p-10 -78.1 143.15 37.6 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.749 0.785 . . . . 0.0 110.537 176.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -151.42 116.01 5.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.368 -173.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 17.3 m -87.59 137.66 32.14 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.218 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 50' ' ' THR . 5.2 pt -119.99 148.35 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 25.6 t0 -102.28 152.01 21.56 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.148 -173.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 50.9 m-80 77.03 36.33 0.32 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.146 0.978 . . . . 0.0 111.654 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -138.39 136.83 36.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.529 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 HE21 HD11 ' A' ' 102' ' ' LEU . 24.7 mt-30 -111.93 154.32 25.4 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' A' ' 42' ' ' PRO . 45.4 tp -118.84 138.2 52.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 0.0 111.749 -175.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -107.27 147.93 29.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.843 175.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 20.2 m -116.75 111.82 20.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.534 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -112.05 17.42 19.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.759 0.314 . . . . 0.0 111.764 -177.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.21 -78.15 0.45 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.481 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -62.16 -32.73 73.37 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.043 0.449 . . . . 0.0 110.844 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 38' ' ' LEU . 6.6 p90 -165.99 167.15 9.04 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.59 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.0 Cg_endo -88.9 -178.74 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.989 2.459 . . . . 0.0 112.396 176.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -163.23 129.62 2.07 Favored Glycine 0 C--O 1.224 -0.474 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -110.84 160.1 17.06 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 117.708 0.754 . . . . 0.0 111.563 -173.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.918 HG12 HG13 ' A' ' 92' ' ' VAL . 32.3 m -147.82 161.15 36.11 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.805 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.31 136.24 36.54 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.303 2.002 . . . . 0.0 111.102 172.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.8 -126.26 1.02 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.237 -178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.64 82.48 2.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.924 0.393 . . . . 0.0 110.634 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.08 172.68 43.42 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 46.0 m -126.89 106.75 9.53 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 117.305 0.552 . . . . 0.0 110.664 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 106' ' ' GLY . 93.7 t -84.06 114.07 23.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -82.5 59.16 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.066 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -82.84 165.98 44.42 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.458 -171.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 28.6 mp0 -107.62 124.07 49.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.278 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.502 HG12 HD12 ' A' ' 25' ' ' LEU . 34.0 t -88.17 128.2 40.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.949 0.404 . . . . 0.0 110.644 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -123.38 150.99 43.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.873 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -113.69 118.41 34.26 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.724 172.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 1' ' ' MET . 2.0 pp -132.45 164.84 33.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.899 178.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.574 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 13.3 t70 -51.76 143.57 12.74 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.791 0.329 . . . . 0.0 111.279 178.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.989 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 3.7 m-20 -57.97 -44.96 87.39 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.96 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.64 -31.43 70.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.954 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.574 ' OG1' ' HB3' ' A' ' 59' ' ' ASP . 19.1 m -56.43 -38.13 71.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.811 0.339 . . . . 0.0 110.965 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 HD22 ' HG2' ' A' ' 1' ' ' MET . 10.2 tp -66.54 -52.33 46.91 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.69 65.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.851 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -75.53 -48.97 20.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.341 178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.8 tt -61.03 -39.53 90.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.033 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -61.78 -50.37 72.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.42 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 72' ' ' ARG . . . -63.74 -19.69 65.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.57 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.5 mt -85.91 -49.25 8.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.457 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.543 ' HA ' ' HE ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -75.08 -54.06 7.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.983 -173.539 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.534 ' HB ' ' HD2' ' A' ' 76' ' ' TYR . 6.6 t -119.5 41.95 2.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 122.17 0.986 . . . . 0.0 110.443 -172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 53.7 ttt180 -47.74 -42.84 26.35 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.787 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -115.09 13.41 19.43 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.56 -176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.37 83.79 1.56 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.705 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -127.01 -23.67 3.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.027 0.441 . . . . 0.0 110.327 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.534 ' HD2' ' HB ' ' A' ' 71' ' ' THR . 91.4 m-85 -131.24 166.18 21.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.539 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.5 127.61 55.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.043 177.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 51.1 mtt85 -86.04 106.96 17.56 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.105 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -104.93 105.9 16.16 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 tp -79.79 112.15 16.79 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 38.5 pt -108.57 152.81 10.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.56 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.491 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -99.15 109.61 22.28 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.235 0.54 . . . . 0.0 111.773 -176.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 p -96.53 165.62 15.74 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.89 -2.26 8.35 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.45 2.1 . . . . 0.0 112.466 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -120.83 15.63 11.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.017 0.437 . . . . 0.0 110.415 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.25 157.42 10.55 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.218 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.409 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 9.2 p -66.37 130.4 43.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.838 0.352 . . . . 0.0 110.731 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.4 151.33 44.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.335 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -85.65 123.19 30.78 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 111.41 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 21.4 ttt -107.79 124.06 49.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.562 175.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -91.33 116.21 28.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.942 0.401 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.918 HG13 HG12 ' A' ' 45' ' ' VAL . 7.2 t -94.63 126.75 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.867 175.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.5 ' HD1' ' CE1' ' A' ' 76' ' ' TYR . 40.2 t80 -75.29 127.14 32.49 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-O 122.108 0.956 . . . . 0.0 110.808 -178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.454 ' HG2' ' HA ' ' A' ' 76' ' ' TYR . 28.2 mm-40 -89.44 -161.99 0.83 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.172 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 38.2 mmt180 70.91 169.38 0.12 Allowed Pre-proline 0 N--CA 1.467 0.391 0 O-C-N 123.358 0.411 . . . . 0.0 110.743 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.578 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 18.8 Cg_endo -62.32 134.05 46.52 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.278 1.985 . . . . 0.0 111.658 171.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.0 m -101.36 10.59 7.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.55 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.62 126.67 28.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.284 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 101.67 -11.76 57.89 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.891 176.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD22 ' HB3' ' A' ' 38' ' ' LEU . 41.6 mt -86.23 159.84 19.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.811 0.306 . . . . 0.0 110.305 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.407 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 48.1 mtmt -88.78 119.09 28.96 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD11 HE21 ' A' ' 34' ' ' GLN . 57.4 tp -97.17 121.52 39.15 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.057 0.456 . . . . 0.0 110.979 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.458 HG21 ' O ' ' A' ' 107' ' ' ASP . 29.4 mt -101.62 94.28 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -65.13 -21.03 66.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.03 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 25.9 p -73.26 -44.12 59.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.095 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 106.53 10.03 29.91 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.318 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 103' ' ' ILE . 2.7 p30 -111.64 178.8 4.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.441 ' CE3' ' HA2' ' A' ' 7' ' ' GLY . 0.0 OUTLIER -110.58 -41.21 4.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.766 0.793 . . . . 0.0 109.487 173.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 87.8 mt -124.88 19.8 8.45 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.489 -172.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.439 ' HA ' ' CG ' ' A' ' 107' ' ' ASP . 32.2 t70 55.96 -107.54 0.39 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.52 -175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -127.08 4.44 6.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.866 0.841 . . . . 0.0 108.785 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.48 65.98 1.42 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.089 -1.414 . . . . 0.0 109.0 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.844 -174.555 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.952 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 45.0 tpp . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.88 143.74 33.49 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 120.838 0.352 . . . . 0.0 110.565 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -137.2 146.68 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.242 -174.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.639 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 73.7 t80 -92.86 113.55 25.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.831 0.348 . . . . 0.0 110.287 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.3 t -91.8 147.88 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.58 67.4 1.53 Allowed 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -175.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.21 -163.46 48.95 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.574 -1.011 . . . . 0.0 110.574 -172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 10' ' ' ARG . 73.0 p 50.55 22.76 1.13 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.898 0.479 . . . . 0.0 112.204 -178.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 9' ' ' LEU . 2.7 pt? -70.79 6.06 1.66 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.598 0.713 . . . . 0.0 110.252 177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 8' ' ' SER . 15.8 mmm180 -63.8 -42.63 97.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.999 176.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 -87.25 74.34 9.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.464 -178.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.32 69.64 10.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.701 0.763 . . . . 0.0 109.722 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -173.27 -166.74 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.653 -176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.57 -61.09 0.25 Allowed Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -136.2 -69.82 0.48 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 169.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -164.41 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.962 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.592 ' HB3' ' OG1' ' A' ' 62' ' ' THR . 53.0 m-70 -58.61 -18.95 34.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.024 -178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 68.6 t-105 -78.09 -65.47 0.97 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.777 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.7 ptm -64.81 -30.79 71.81 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -172.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 20.5 m -82.09 -28.99 32.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.076 0.465 . . . . 0.0 111.604 -176.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 17' ' ' HIS . 10.6 m120 -114.81 16.89 17.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.322 -170.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -91.63 121.22 33.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.133 0.492 . . . . 0.0 112.075 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.467 ' OE1' ' HD3' ' A' ' 57' ' ' ARG . 57.8 tt0 -114.86 129.0 56.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.705 172.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 52.8 tp -78.95 104.14 9.38 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.015 0.436 . . . . 0.0 110.258 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.598 HD12 HG12 ' A' ' 55' ' ' VAL . 94.1 mt -70.05 -45.23 67.56 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.775 178.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 144.32 168.08 12.32 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.545 175.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.66 151.86 46.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.163 0.506 . . . . 0.0 109.824 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -156.71 87.05 1.0 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.872 175.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 15.5 m -77.53 129.25 35.44 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.08 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 pt -115.04 134.13 59.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.207 0.527 . . . . 0.0 111.288 -175.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -82.8 156.42 23.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.993 -177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 67.54 33.97 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.025 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -131.41 172.09 12.6 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 171.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.632 ' HB3' HD11 ' A' ' 102' ' ' LEU . 19.6 mt-30 -139.96 157.0 46.38 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.623 -177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD12 ' O ' ' A' ' 43' ' ' GLY . 35.4 tp -123.4 128.75 50.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.836 -177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.455 ' CE1' HG21 ' A' ' 97' ' ' VAL . 88.2 m-85 -91.06 140.9 29.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.15 0.5 . . . . 0.0 112.127 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 101' ' ' LYS . 68.5 m -113.86 109.94 19.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.31 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.443 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -121.27 6.29 10.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.363 174.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.18 -54.56 4.52 Favored Glycine 0 C--O 1.229 -0.186 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.989 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 41' ' ' TYR . 15.5 t60 -61.95 -47.27 85.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.784 0.326 . . . . 0.0 111.036 -176.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CE2' ' HD2' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -167.42 155.53 8.64 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.644 175.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -80.01 148.15 19.3 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.938 2.426 . . . . 0.0 113.643 -176.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -120.64 160.33 15.12 Favored Glycine 0 C--O 1.227 -0.337 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 173.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -143.28 142.33 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.991 0.896 . . . . 0.0 111.6 -171.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.818 HG11 ' HD2' ' A' ' 93' ' ' TYR . 33.7 m -154.46 167.09 14.56 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.81 -176.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -72.13 157.04 54.89 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 122.393 2.062 . . . . 0.0 111.84 172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 170.09 -119.41 0.81 Allowed Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -145.53 92.14 2.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.856 0.36 . . . . 0.0 110.085 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 165.1 33.14 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.354 176.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.9 m -101.75 101.85 12.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.875 0.369 . . . . 0.0 110.275 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 29' ' ' SER . 70.1 t -82.81 106.72 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 CA-C-O 121.245 0.545 . . . . 0.0 110.792 -174.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -69.52 107.53 3.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.939 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.639 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -123.09 147.2 16.67 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.742 -178.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 54.1 mp0 -103.9 107.25 18.05 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG12 HD12 ' A' ' 25' ' ' LEU . 26.0 t -81.35 117.07 26.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.062 0.458 . . . . 0.0 110.223 -178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -115.29 147.71 40.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.455 -177.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 52.8 ttt180 -108.95 131.93 54.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.986 174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.743 HD11 HD23 ' A' ' 63' ' ' LEU . 1.7 pp -140.73 164.14 21.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.667 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.67 142.15 15.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.539 0.209 . . . . 0.0 111.18 176.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.952 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 95.7 m-20 -54.51 -48.64 71.66 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.885 0.374 . . . . 0.0 110.979 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.77 -33.19 75.07 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.085 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.592 ' OG1' ' HB3' ' A' ' 17' ' ' HIS . 75.5 m -56.27 -37.0 69.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.835 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.743 HD23 HD11 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -66.82 -42.13 86.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -23.67 66.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.843 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -71.85 -48.5 45.6 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -66.15 -34.73 78.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.891 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -57.46 -54.87 41.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.499 0.666 . . . . 0.0 110.92 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.13 -25.76 68.5 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.268 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.39 -56.27 3.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' HB ' ' A' ' 71' ' ' THR . 39.8 ttt180 -85.19 7.14 22.98 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -167.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.684 HG21 ' H ' ' A' ' 76' ' ' TYR . 0.5 OUTLIER 98.4 124.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.602 1.189 . . . . 0.0 111.066 -173.516 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.3 ttt180 -89.26 -24.96 21.95 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.702 -1.59 . . . . 0.0 110.707 177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.37 47.16 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.352 -0.927 . . . . 0.0 112.223 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.99 -55.75 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.892 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.454 ' OE2' ' HD3' ' A' ' 95' ' ' ARG . 4.6 tp10 -79.46 -37.82 36.0 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.684 ' H ' HG21 ' A' ' 71' ' ' THR . 38.5 m-85 -142.6 170.38 15.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.579 -178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.96 152.09 36.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 169.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.3 mtm105 -88.93 125.22 34.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.935 0.398 . . . . 0.0 111.159 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -105.18 121.63 44.23 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.6 tp -91.82 114.69 27.29 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 87' ' ' SER . 7.3 pt -114.02 148.98 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.683 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.4 tp60 -90.43 108.54 19.84 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.719 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 84' ' ' PRO . 1.4 p -100.02 163.42 18.39 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 83' ' ' THR . 17.7 Cg_endo -61.54 -16.04 45.33 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.481 2.12 . . . . 0.0 112.064 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -97.91 -2.66 40.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.9 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 122.51 160.21 10.85 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' ILE . 66.4 m -63.95 121.29 13.74 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.138 0.494 . . . . 0.0 111.051 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.64 148.68 30.91 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.674 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -85.46 124.28 31.86 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.183 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 4' ' ' PHE . 85.2 mtp -106.7 170.28 8.03 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.039 172.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -127.69 117.72 22.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.871 0.367 . . . . 0.0 110.415 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.587 HG13 HG12 ' A' ' 45' ' ' VAL . 4.0 t -101.59 136.82 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-O 121.696 0.76 . . . . 0.0 111.189 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.818 ' HD2' HG11 ' A' ' 45' ' ' VAL . 0.1 OUTLIER -51.68 120.64 5.42 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.805 -1.543 . . . . 0.0 109.739 175.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.428 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -117.96 1.35 12.04 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.752 -176.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.454 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 68.8 mtp180 -132.16 146.61 62.35 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -39.25 121.78 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 124.561 3.507 . . . . 0.0 114.598 -174.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 100' ' ' LEU . 12.8 m -104.52 14.48 6.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.862 177.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.56 96.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.013 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.84 5.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.327 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 97' ' ' VAL . 87.2 mt -89.87 165.7 13.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.708 0.29 . . . . 0.0 110.335 178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 37' ' ' SER . 30.1 mmmt -90.29 132.25 35.64 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.632 HD11 ' HB3' ' A' ' 34' ' ' GLN . 64.6 tp -105.93 107.78 18.95 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.374 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.417 HG21 ' O ' ' A' ' 107' ' ' ASP . 51.5 mt -82.12 89.02 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.98 -9.55 39.99 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.178 176.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 9.5 m -70.79 -27.16 63.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.024 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.579 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 85.66 -13.37 56.29 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.171 178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 103' ' ' ILE . 5.4 t70 -100.42 141.35 33.38 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.384 -0.48 . . . . 0.0 110.223 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -70.02 -30.96 68.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.258 0.551 . . . . 0.0 110.228 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.619 ' HB3' ' HA ' ' A' ' 112' ' ' ASP . 3.0 mm? -81.39 -36.05 30.03 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.955 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.68 -79.62 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.104 0.878 . . . . 0.0 112.262 175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' HD3' ' H ' ' A' ' 111' ' ' ARG . 0.0 OUTLIER -63.37 -33.71 76.14 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 173.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.619 ' HA ' ' HB3' ' A' ' 109' ' ' LEU . 17.1 t0 57.57 96.69 0.02 OUTLIER 'General case' 0 C--O 1.233 0.209 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.569 171.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 47.0 pttt . . . . . 0 C--N 1.323 -0.574 0 CA-C-O 122.16 0.981 . . . . 0.0 110.301 174.14 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 25.1 ttm . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.464 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -117.61 144.73 44.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.014 0.435 . . . . 0.0 111.188 -175.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.492 ' HB ' HD21 ' A' ' 63' ' ' LEU . 10.6 tt -139.82 150.66 22.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.908 -174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -97.22 115.74 28.15 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.648 HG11 ' HA ' ' A' ' 9' ' ' LEU . 16.5 t -102.31 158.82 4.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . 1.6 p90 -152.17 118.33 5.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.035 0.445 . . . . 0.0 111.447 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.32 -85.17 1.33 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.321 177.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -75.42 80.15 2.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.055 0.455 . . . . 0.0 111.077 177.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.648 ' HA ' HG11 ' A' ' 5' ' ' VAL . 2.7 pt? -76.98 -21.18 55.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.177 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -80.55 -55.91 4.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.43 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.5 p80 41.11 75.92 0.08 Allowed 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.843 0.714 . . . . 0.0 110.816 -171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 41.8 ttmt 67.48 -95.41 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.933 -169.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.426 HE21 ' HB3' ' A' ' 13' ' ' GLN . 0.8 OUTLIER 66.0 143.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 O-C-N 123.858 0.724 . . . . 0.0 111.305 -177.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.56 -15.21 4.15 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.14 -178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.3 p30 -148.38 -28.13 0.31 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.552 0.215 . . . . 0.0 111.219 178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -64.31 163.41 13.03 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -59.7 -18.22 40.71 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.152 0.501 . . . . 0.0 110.711 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.492 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 52.3 t-105 -58.66 -27.6 64.93 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.059 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 57.2 ttp -81.64 -33.04 31.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.895 0.379 . . . . 0.0 111.467 -178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.3 m -91.61 -54.12 4.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -99.16 10.64 41.04 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -168.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 18' ' ' TRP . . . -66.73 116.78 8.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.349 0.595 . . . . 0.0 111.684 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.8 tt0 -107.31 119.5 39.56 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.718 173.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.7 tp -81.66 98.39 8.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.126 0.488 . . . . 0.0 109.859 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.679 HD12 HG12 ' A' ' 55' ' ' VAL . 88.8 mt -64.9 -41.78 95.32 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.711 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.37 153.36 6.08 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.614 175.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 m-20 -69.57 143.42 53.35 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.528 ' HB3' HG23 ' A' ' 55' ' ' VAL . 17.2 t80 -154.48 114.03 3.75 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.367 -175.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 16.0 m -100.56 132.6 45.86 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.106 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 50' ' ' THR . 16.3 pt -114.03 141.46 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.989 0.423 . . . . 0.0 111.164 -175.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.26 160.07 14.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.036 -176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 73.8 28.94 1.53 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.594 0.758 . . . . 0.0 111.506 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -134.67 142.28 46.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.849 0.357 . . . . 0.0 110.486 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' HB3' HD11 ' A' ' 102' ' ' LEU . 49.9 mt-30 -116.05 148.42 40.22 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.611 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 103' ' ' ILE . 12.4 tp -103.44 139.33 38.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.488 -174.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.45 134.91 49.8 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.5 p -116.49 128.49 55.5 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 120.991 0.424 . . . . 0.0 110.131 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.476 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.8 OUTLIER -133.73 17.36 3.91 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.71 0.767 . . . . 0.0 109.317 172.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.72 -59.2 4.94 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 114.766 -1.106 . . . . 0.0 112.955 173.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -89.08 -0.77 57.7 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.608 0.242 . . . . 0.0 111.004 -174.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -156.62 134.09 6.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -94.1 121.78 0.38 Allowed 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.939 2.426 . . . . 0.0 111.378 166.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.35 154.69 16.81 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.645 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.477 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -145.47 146.53 31.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 117.658 0.729 . . . . 0.0 110.585 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.89 HG12 HG13 ' A' ' 92' ' ' VAL . 27.3 m -149.44 164.0 22.76 Favored Pre-proline 0 N--CA 1.465 0.312 0 O-C-N 123.404 0.44 . . . . 0.0 110.489 -178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.18 136.47 56.13 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.401 2.067 . . . . 0.0 111.805 173.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.05 -122.54 0.77 Allowed Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.826 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.425 HD22 ' HA ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -143.05 92.18 2.36 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.324 0.583 . . . . 0.0 110.708 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.91 167.71 37.49 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.856 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.1 m -115.03 111.47 21.16 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.397 0.599 . . . . 0.0 110.395 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 29' ' ' SER . 59.8 t -84.91 118.68 32.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.004 -175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -78.96 97.9 6.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.68 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 6' ' ' TYR . . . -130.71 172.16 20.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.084 -1.055 . . . . 0.0 113.459 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 27.4 mp0 -120.12 133.65 55.46 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.757 0.423 . . . . 0.0 109.886 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG12 HD12 ' A' ' 25' ' ' LEU . 31.6 t -91.27 120.27 39.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -118.14 157.88 26.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.319 0.581 . . . . 0.0 112.008 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.3 tmt_? -127.2 124.12 38.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.631 176.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.41 -173.85 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.767 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.5 ' HB2' ' H ' ' A' ' 62' ' ' THR . 3.7 m-20 -52.11 153.11 2.86 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.683 0.277 . . . . 0.0 110.617 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.0 p-10 -65.42 -38.87 91.19 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 173.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.68 -43.18 85.13 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.993 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.5 ' H ' ' HB2' ' A' ' 59' ' ' ASP . 89.1 m -56.97 -30.26 63.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.074 0.464 . . . . 0.0 111.373 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 1' ' ' MET . 2.5 tm? -65.48 -48.55 72.23 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.01 -21.05 66.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.13 175.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.88 -49.1 31.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.027 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 tt -64.62 -36.64 84.9 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -57.4 -54.59 45.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.77 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.15 -28.63 69.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.636 -176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 69' ' ' LEU . 17.4 mt -79.17 -47.72 15.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.637 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.6 ttt85 -81.62 -49.64 10.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -173.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.1 t -107.19 -31.08 8.39 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.357 -172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.0 tpt180 52.1 -90.77 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.53 0.732 . . . . 0.0 112.421 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.79 25.23 20.24 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.48 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.37 42.99 13.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.19 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HG3' ' HD2' ' A' ' 95' ' ' ARG . 34.2 tt0 -68.44 -31.11 70.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 176.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 92' ' ' VAL . 12.0 m-85 -119.37 159.75 23.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.285 177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.31 124.9 47.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.765 0.317 . . . . 0.0 110.652 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -79.15 123.53 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.892 0.854 . . . . 0.0 110.766 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.7 145.93 29.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.513 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.4 tp -111.06 113.3 25.74 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.205 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 35.9 pt -110.24 140.98 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.352 -177.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -91.37 102.97 15.66 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.655 -174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -99.83 158.04 32.82 Favored Pre-proline 0 C--N 1.32 -0.703 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.71 -18.38 55.21 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.505 2.137 . . . . 0.0 112.078 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 49.8 m-85 -99.05 -3.16 35.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.834 -177.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 135.36 161.06 9.2 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.288 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 p -67.08 107.19 2.2 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.759 0.314 . . . . 0.0 110.464 176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.71 145.97 29.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.887 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -83.62 125.43 31.82 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.909 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 23.7 ttt -114.75 116.64 28.97 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.41 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -90.59 108.13 19.61 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.387 0.613 . . . . 0.0 112.026 -173.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.89 HG13 HG12 ' A' ' 45' ' ' VAL . 4.3 t -81.15 128.44 38.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.815 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.561 ' HD1' HG12 ' A' ' 97' ' ' VAL . 7.2 t80 -63.59 119.84 10.61 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 177.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.422 ' H ' ' HD1' ' A' ' 76' ' ' TYR . 3.3 tp-100 -108.03 -166.51 1.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.517 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 31.7 mtp85 66.92 -177.43 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 54.2 Cg_exo -54.73 100.58 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.714 1.609 . . . . 0.0 112.468 174.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.561 HG12 ' HD1' ' A' ' 93' ' ' TYR . 26.9 m -93.53 -10.8 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.677 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.79 103.99 0.31 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.529 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.6 -12.05 4.0 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.077 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 38' ' ' LEU . 73.2 mt -78.24 162.23 26.71 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -93.2 109.05 20.56 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 34' ' ' GLN . 61.6 tp -73.75 139.02 44.96 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.461 -174.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.708 HG23 ' HD3' ' A' ' 111' ' ' ARG . 62.7 mt -124.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.269 174.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.02 -15.58 63.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.989 0.423 . . . . 0.0 110.46 177.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 10.5 m -70.99 -20.8 62.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 67.31 29.12 73.91 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.531 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 110' ' ' ASP . 12.2 t70 -134.05 137.19 44.5 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 54.2 t-105 -71.85 -29.2 64.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.805 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 33.2 mt -116.84 11.48 14.48 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.904 0.383 . . . . 0.0 111.415 -170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . 30.1 t70 -82.2 -59.28 2.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.169 0.509 . . . . 0.0 111.146 -178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.708 ' HD3' HG23 ' A' ' 103' ' ' ILE . 39.4 mtp85 -92.31 11.9 24.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.601 -175.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -66.27 -48.99 68.66 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.391 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.448 ' NZ ' ' HB2' ' A' ' 113' ' ' LYS . 9.6 mtmp? . . . . . 0 N--CA 1.47 0.55 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.48 173.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.964 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 43.8 tpp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -134.12 125.77 28.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.093 0.473 . . . . 0.0 111.289 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 64.7 mt -127.56 145.96 34.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.129 -176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -86.49 111.82 20.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.901 0.382 . . . . 0.0 110.004 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 54' ' ' GLU . 83.9 t -91.6 136.1 25.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.209 0.528 . . . . 0.0 109.971 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' CD1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -100.22 33.45 2.65 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.634 -174.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.437 ' H ' HG12 ' A' ' 5' ' ' VAL . . . 67.7 -160.08 50.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.562 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.441 ' HB3' ' CE2' ' A' ' 108' ' ' TRP . 91.6 p 62.81 -48.04 0.2 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 125.166 1.387 . . . . 0.0 113.813 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.976 ' HB3' HE22 ' A' ' 13' ' ' GLN . 10.4 mp -60.62 -15.6 29.89 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -173.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -53.18 -17.45 1.67 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -54.13 -50.59 66.58 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.808 0.337 . . . . 0.0 110.491 175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -139.8 123.2 17.11 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.976 HE22 ' HB3' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -140.29 -55.03 0.53 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.188 0.518 . . . . 0.0 110.663 -173.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA2' ' HB3' ' A' ' 19' ' ' MET . . . -82.51 64.47 4.27 Favored Glycine 0 N--CA 1.439 -1.16 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.846 -176.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -136.05 2.83 2.86 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.143 0.497 . . . . 0.0 110.244 176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 34.9 p -164.13 -172.95 2.96 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.992 -174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -67.81 -13.62 62.28 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.038 0.212 . . . . 0.0 110.919 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.4 -43.85 96.28 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 120.967 0.413 . . . . 0.0 110.069 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.584 ' HB3' ' HA2' ' A' ' 14' ' ' GLY . 0.0 OUTLIER -108.4 -100.84 0.37 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.458 ' H ' ' HB3' ' A' ' 19' ' ' MET . 61.5 m 43.71 -78.29 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.841 0.857 . . . . 0.0 112.952 -171.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.425 ' N ' ' O ' ' A' ' 19' ' ' MET . 62.8 m-20 -91.71 -8.6 46.52 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.046 0.45 . . . . 0.0 110.653 -176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' CB ' HG22 ' A' ' 58' ' ' ILE . . . -55.71 139.06 46.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.691 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -124.09 121.15 34.4 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.677 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.7 tp -65.32 106.25 1.32 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 85' ' ' TYR . 84.4 mt -66.68 -38.32 86.55 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.031 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 160.03 159.83 10.11 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.918 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -68.27 145.26 54.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -139.15 115.04 10.12 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.599 ' HB3' ' HB3' ' A' ' 52' ' ' HIS . 5.8 p -100.96 131.01 47.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.592 177.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 pt -117.38 130.39 72.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.361 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.48 151.71 21.85 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.871 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 70.72 33.97 2.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.932 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -134.95 154.15 51.81 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.627 ' HB3' HD11 ' A' ' 102' ' ' LEU . 38.2 mt-30 -128.13 156.8 42.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.552 HD23 HD12 ' A' ' 103' ' ' ILE . 15.3 tp -114.2 130.25 56.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.585 0.231 . . . . 0.0 110.758 -176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.462 ' O ' ' HA ' ' A' ' 42' ' ' PRO . 86.0 m-85 -99.96 132.34 45.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.976 0.417 . . . . 0.0 111.609 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.1 m -99.37 102.24 13.78 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HB3' HD13 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -118.75 12.55 13.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.708 179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.06 -51.15 4.06 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.035 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -59.4 -42.3 91.44 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.436 ' CE1' HD11 ' A' ' 38' ' ' LEU . 8.2 p90 -175.05 153.85 1.64 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 6' ' ' TYR . 16.6 Cg_exo -70.24 112.02 3.06 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.237 1.958 . . . . 0.0 111.678 170.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -90.48 159.51 27.23 Favored Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.276 178.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 34' ' ' GLN . . . -141.83 139.57 32.73 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.749 0.775 . . . . 0.0 111.433 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.555 HG12 HG13 ' A' ' 92' ' ' VAL . 26.9 m -145.57 163.22 32.83 Favored Pre-proline 0 N--CA 1.465 0.294 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.386 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.16 146.43 76.3 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 122.547 2.164 . . . . 0.0 111.488 173.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.0 -111.36 0.39 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.759 -0.536 . . . . 0.0 111.759 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -147.79 92.12 2.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.049 0.452 . . . . 0.0 110.251 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.35 178.08 47.5 Favored Glycine 0 C--O 1.224 -0.478 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m -124.87 103.86 8.29 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 117.801 0.801 . . . . 0.0 110.529 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.588 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 77.3 t -84.16 104.08 12.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.599 ' HB3' ' HB3' ' A' ' 29' ' ' SER . 1.8 p80 -95.35 94.89 8.11 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.449 0.642 . . . . 0.0 110.699 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.66 -154.15 10.4 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.179 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.478 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 28.3 mt-10 -127.0 124.66 39.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.501 0.191 . . . . 0.0 111.416 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.515 HG12 HD12 ' A' ' 25' ' ' LEU . 72.0 t -93.16 118.97 40.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.087 171.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -116.14 148.05 40.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.132 0.491 . . . . 0.0 112.054 -177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -106.87 114.79 29.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.23 -0.895 . . . . 0.0 108.889 169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.52 ' H ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -127.25 174.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -178.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -52.88 144.4 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.956 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.964 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 5.3 m-20 -60.02 -36.02 76.35 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.424 0.631 . . . . 0.0 109.451 175.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.09 -31.54 71.99 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.93 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.2 m -56.42 -40.44 74.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.929 0.395 . . . . 0.0 110.856 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 39.1 tp -67.99 -46.69 70.6 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -31.84 68.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.5 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.15 -43.11 44.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.322 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.6 tt -63.64 -42.72 98.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.462 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.26 -50.66 73.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.892 177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.07 -28.69 64.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.467 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.0 mt -86.57 -55.36 3.91 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.616 ' HD3' ' HD2' ' A' ' 76' ' ' TYR . 41.5 ttm180 -85.45 -44.65 12.56 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -168.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 70.3 p -97.11 -8.82 29.28 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.231 -0.587 . . . . 0.0 111.653 -169.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.6 ttt180 -58.12 -33.36 69.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.378 0.609 . . . . 0.0 109.685 172.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.56 -52.05 3.86 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.281 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.72 53.92 0.3 Allowed Glycine 0 CA--C 1.499 -0.939 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HG2' ' NH2' ' A' ' 95' ' ' ARG . 25.6 mt-10 -89.5 -54.57 4.02 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -171.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.616 ' HD2' ' HD3' ' A' ' 70' ' ' ARG . 12.7 m-85 -131.9 170.21 15.19 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.879 -168.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -91.4 149.93 21.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.934 0.397 . . . . 0.0 111.183 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.531 ' HD2' ' CE3' ' A' ' 89' ' ' TRP . 20.7 tpp85 -102.33 134.87 44.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.121 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.454 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 10.1 tt0 -135.09 152.5 51.72 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.4 tp -119.44 117.55 28.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.849 0.357 . . . . 0.0 110.383 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 pt -109.07 148.73 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.323 0.582 . . . . 0.0 111.292 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -96.75 126.96 42.28 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.305 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.2 p -122.11 159.92 49.73 Favored Pre-proline 0 N--CA 1.449 -0.485 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.409 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.4 -10.46 26.17 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.395 2.064 . . . . 0.0 111.582 174.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.53 ' HB3' ' HB3' ' A' ' 25' ' ' LEU . 10.8 m-85 -106.97 12.79 28.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.028 -177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.75 -103.09 0.59 Allowed Glycine 0 C--O 1.217 -0.927 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.144 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 40.0 t -172.86 133.17 0.55 Allowed 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.47 144.39 51.13 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.942 0.401 . . . . 0.0 111.755 -170.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . 0.531 ' CE3' ' HD2' ' A' ' 78' ' ' ARG . 96.3 m95 -82.01 127.25 32.89 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.303 176.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 25.8 ttt -109.13 155.1 21.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.053 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.83 130.63 52.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.88 0.372 . . . . 0.0 110.859 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.555 HG13 HG12 ' A' ' 45' ' ' VAL . 3.3 t -108.4 134.07 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.73 0 CA-C-O 121.66 0.743 . . . . 0.0 110.836 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.632 ' CE2' HG13 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -50.71 134.45 24.8 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.471 178.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 1.9 tp-100 -135.22 33.65 3.08 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.797 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HB3' ' CD ' ' A' ' 96' ' ' PRO . 27.4 mmt85 -131.31 -177.03 0.61 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.345 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.534 ' CD ' ' HB3' ' A' ' 95' ' ' ARG . 6.3 Cg_exo -75.72 135.2 17.5 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 121.749 1.632 . . . . 0.0 112.674 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.011 HG12 HD12 ' A' ' 100' ' ' LEU . 2.3 m -101.49 11.6 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 120.863 0.363 . . . . 0.0 110.894 174.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -62.73 -6.09 3.31 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -145.27 29.21 1.79 Allowed Glycine 0 C--N 1.308 -1.028 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.312 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.011 HD12 HG12 ' A' ' 97' ' ' VAL . 43.2 mt -113.83 165.08 12.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.851 -0.205 . . . . 0.0 110.548 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -102.81 124.77 48.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 174.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.627 HD11 ' HB3' ' A' ' 34' ' ' GLN . 66.5 tp -84.16 143.59 29.55 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.881 177.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.552 HD12 HD23 ' A' ' 35' ' ' LEU . 44.8 mt -107.97 94.51 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 169.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.22 24.75 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.023 -1.444 . . . . 0.0 113.064 -176.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.426 ' H ' ' C ' ' A' ' 103' ' ' ILE . 59.7 m -161.27 15.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.295 -0.253 . . . . 0.0 111.522 -175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 52.65 22.82 12.36 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 168.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 5.9 p-10 -98.99 178.89 4.8 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 117.943 0.871 . . . . 0.0 108.745 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CD1' ' HG ' ' A' ' 109' ' ' LEU . 67.2 t-105 -121.69 -38.68 2.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 170.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.582 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 46.0 mt -143.29 67.64 1.3 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.403 -174.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -137.91 91.02 2.54 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.287 -0.565 . . . . 0.0 111.658 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.88 -55.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.717 173.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -126.66 -124.61 0.24 Allowed 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.894 0.378 . . . . 0.0 110.467 -176.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt . . . . . 0 N--CA 1.466 0.345 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.253 -179.731 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 1.038 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 47.1 tpp . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.6 140.69 51.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 122.238 -0.289 . . . . 0.0 110.435 -177.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.575 ' HB ' HD21 ' A' ' 63' ' ' LEU . 13.0 tt -140.37 147.81 22.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.255 -179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.679 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 84.0 t80 -96.83 111.33 23.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.11 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 65.4 t -96.18 123.32 48.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.542 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.461 ' CE1' ' HD2' ' A' ' 42' ' ' PRO . 0.2 OUTLIER -80.93 71.16 7.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.514 179.527 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.0 -89.97 0.68 Allowed Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.511 -0.768 . . . . 0.0 113.699 173.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.6 p -50.92 113.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 110.672 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 tp -92.57 -23.09 19.17 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.627 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -46.56 -82.1 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.94 0.775 . . . . 0.0 112.154 -173.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 24.0 m170 59.17 -99.78 0.1 Allowed 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.174 0.59 . . . . 0.0 111.753 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -143.9 111.93 6.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.049 -176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -140.41 109.75 6.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.116 0.484 . . . . 0.0 109.705 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -146.98 -20.68 0.1 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.645 174.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -159.26 -26.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.561 0.208 . . . . 0.0 111.561 -176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 18' ' ' TRP . 12.6 m -68.7 160.93 29.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.186 0.517 . . . . 0.0 111.406 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -71.57 9.29 0.87 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.617 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.424 ' H ' ' C ' ' A' ' 16' ' ' SER . 21.7 t-105 -52.41 -60.93 2.64 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.671 0.607 . . . . 0.0 111.872 -173.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.32 93.13 3.92 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 35.4 m -148.21 -43.8 0.16 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.078 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -130.59 25.66 5.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.081 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.67 104.92 0.72 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.812 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -96.07 122.1 38.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.619 -177.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.3 tp -73.53 106.4 5.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.256 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.7 mt -81.08 -44.17 18.4 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.684 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.9 157.53 8.49 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 175.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.3 p30 -77.63 158.27 29.83 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.499 0.666 . . . . 0.0 110.458 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.07 90.17 1.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.34 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -79.87 129.38 34.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 pt -122.91 141.92 41.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.387 . . . . 0.0 111.296 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -91.9 165.65 13.12 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.489 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 48' ' ' ASN . 83.5 m-20 69.55 28.7 4.51 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.824 0.703 . . . . 0.0 112.081 178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -136.49 157.79 45.96 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.839 0.352 . . . . 0.0 110.274 172.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.687 ' HB3' HD11 ' A' ' 102' ' ' LEU . 34.9 mt-30 -126.31 152.76 45.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.505 HD23 HD12 ' A' ' 103' ' ' ILE . 38.1 tp -119.02 125.94 50.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.681 0.277 . . . . 0.0 110.565 -174.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE1' HG11 ' A' ' 97' ' ' VAL . 96.4 m-85 -96.72 137.41 35.84 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.783 0.325 . . . . 0.0 110.721 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.5 p -109.63 101.86 10.74 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.337 0.589 . . . . 0.0 109.541 174.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.63 ' HB3' HD22 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -107.37 2.6 24.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.118 -178.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 84.74 153.23 18.57 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 -175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.9 m80 70.72 -54.58 0.65 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.363 0.601 . . . . 0.0 111.043 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -158.18 129.29 3.74 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.311 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' A' ' 6' ' ' TYR . 13.1 Cg_exo -72.77 177.88 7.06 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.563 2.175 . . . . 0.0 112.734 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -150.93 161.01 28.89 Favored Glycine 0 C--O 1.224 -0.507 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 176.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -131.81 158.13 42.08 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.139 0.969 . . . . 0.0 111.7 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.882 HG12 HG13 ' A' ' 92' ' ' VAL . 35.1 m -150.98 163.38 23.87 Favored Pre-proline 0 N--CA 1.465 0.305 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.715 177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.71 161.97 39.38 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 122.585 2.19 . . . . 0.0 111.931 173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.54 -127.84 1.9 Allowed Glycine 0 N--CA 1.449 -0.494 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 4.2 t-20 -146.28 89.03 1.83 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.202 0.525 . . . . 0.0 109.71 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.45 168.94 41.67 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.7 m -103.55 112.13 24.9 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 117.09 0.445 . . . . 0.0 111.148 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.495 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 69.2 t -98.26 114.58 36.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 108' ' ' TRP . 99.5 m-70 -78.93 105.28 10.14 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.474 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.679 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -117.55 168.32 12.92 Favored Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.553 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 40.7 mt-10 -131.16 128.54 40.26 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 85' ' ' TYR . 60.9 t -92.01 117.47 35.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.158 0.504 . . . . 0.0 110.271 177.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.63 154.9 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.615 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.8 ttp180 -108.92 130.43 55.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.507 HD11 HD23 ' A' ' 63' ' ' LEU . 1.6 pp -143.22 172.06 8.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.024 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 62' ' ' THR . 56.7 m-20 -51.09 141.87 13.38 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.242 0.339 . . . . 0.0 110.61 176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 1.038 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 4.5 m-20 -55.51 -39.62 70.73 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.709 0.766 . . . . 0.0 109.264 174.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.45 -36.99 85.57 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.631 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 59' ' ' ASP . 34.2 m -55.61 -38.33 69.31 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.232 0.539 . . . . 0.0 111.119 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.575 HD21 ' HB ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -66.85 -50.73 61.59 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.247 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -62.69 -29.49 70.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.793 177.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -67.54 -50.82 56.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.307 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tt -61.48 -39.38 90.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.978 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.85 -45.43 89.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.841 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.28 -28.68 69.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.998 0.428 . . . . 0.0 111.283 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.6 mt -85.67 -53.91 4.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.364 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -85.64 -41.6 15.06 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.3 p -106.74 -67.56 0.94 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -173.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 60.57 -68.86 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.577 0.751 . . . . 0.0 111.05 -169.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.77 -95.73 1.13 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.652 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.77 42.98 0.73 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.455 -0.879 . . . . 0.0 113.477 -174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -61.13 -39.43 90.0 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' CD2' ' HA ' ' A' ' 93' ' ' TYR . 29.1 m-85 -135.01 160.34 38.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.624 173.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB2' ' OE1' ' A' ' 94' ' ' GLN . . . -88.6 136.82 32.8 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 170.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -83.42 102.34 11.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 9.8 tt0 -103.18 100.65 10.57 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.411 -174.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.517 HD11 ' HB2' ' A' ' 87' ' ' SER . 48.4 tp -76.87 106.58 8.63 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.986 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 39.8 pt -101.47 139.1 23.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.682 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.459 ' HA ' ' NE2' ' A' ' 82' ' ' GLN . 6.4 tp-100 -86.36 106.2 17.24 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.835 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -103.33 162.0 21.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.62 -21.08 71.19 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.431 2.087 . . . . 0.0 112.019 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.491 ' HB2' HG11 ' A' ' 55' ' ' VAL . 20.7 m-85 -90.66 -4.44 56.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.344 0.593 . . . . 0.0 109.994 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 125.51 166.76 12.39 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.552 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.517 ' HB2' HD11 ' A' ' 80' ' ' LEU . 7.8 p -66.86 121.38 15.36 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.861 0.362 . . . . 0.0 111.196 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.08 146.5 43.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.786 -177.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -85.88 121.4 28.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.941 0.4 . . . . 0.0 111.22 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 21.4 ttt -105.74 152.12 23.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.734 -0.667 . . . . 0.0 109.474 175.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.31 120.81 37.11 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.539 0.209 . . . . 0.0 110.851 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.882 HG13 HG12 ' A' ' 45' ' ' VAL . 4.1 t -107.94 124.46 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.395 177.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.48 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . 23.8 t80 -62.43 118.78 7.98 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.607 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.501 ' OE1' ' HB2' ' A' ' 77' ' ' ALA . 0.1 OUTLIER -88.21 -33.86 17.98 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.768 -170.19 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 95' ' ' ARG . 41.7 mtm180 -83.03 161.73 56.89 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.955 -173.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.4 133.43 56.23 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.883 2.389 . . . . 0.0 112.547 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.549 HG12 HD12 ' A' ' 100' ' ' LEU . 12.4 m -77.67 69.87 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 122.171 0.986 . . . . 0.0 110.092 178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -42.84 -70.73 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 113.257 -1.792 . . . . 0.0 112.796 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -136.99 60.83 0.61 Allowed Glycine 0 C--N 1.304 -1.242 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.031 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 38' ' ' LEU . 19.2 mt -111.64 155.79 22.84 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.652 0.263 . . . . 0.0 110.359 -178.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -98.42 116.19 30.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 34' ' ' GLN . 52.2 tp -90.47 127.1 36.12 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.372 -174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.604 HG21 ' H ' ' A' ' 107' ' ' ASP . 5.9 mt -94.99 98.66 8.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 172.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER -66.78 24.56 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.532 0.733 . . . . 0.0 112.786 176.061 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 103' ' ' ILE . 42.3 m -160.92 17.45 0.12 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.829 0.452 . . . . 0.0 110.288 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 51' ' ' VAL . . . 35.65 50.99 1.07 Allowed Glycine 0 C--N 1.348 1.236 0 O-C-N 124.184 0.928 . . . . 0.0 114.985 173.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.604 ' H ' HG21 ' A' ' 103' ' ' ILE . 6.5 t70 -135.37 132.91 38.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.025 0.44 . . . . 0.0 110.824 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.582 ' CZ3' ' HB2' ' A' ' 52' ' ' HIS . 5.5 p90 -96.9 -8.07 31.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.708 0.766 . . . . 0.0 110.018 -177.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 108' ' ' TRP . 2.0 mt -107.35 17.74 22.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.143 -174.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -72.34 68.64 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.236 1.017 . . . . 0.0 110.531 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.7 ptt85 -147.96 -107.92 0.08 Allowed 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.9 t0 56.88 30.62 18.24 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 157.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 76.7 tttt . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 122.433 1.111 . . . . 0.0 109.388 179.282 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.646 ' HB2' ' HA ' ' A' ' 60' ' ' ASN . 31.6 ttm . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -120.36 146.9 45.71 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 117.866 0.303 . . . . 0.0 111.168 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.584 ' HB ' HD21 ' A' ' 63' ' ' LEU . 11.9 tt -142.45 140.11 28.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.304 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.605 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 56.0 t80 -88.0 113.65 23.85 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' ' HG3' ' A' ' 54' ' ' GLU . 87.9 t -91.6 133.93 31.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.213 0.53 . . . . 0.0 110.54 -178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.406 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -98.1 -81.66 0.43 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.405 -178.056 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 6' ' ' TYR . . . -62.16 128.99 42.9 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.182 -1.008 . . . . 0.0 110.784 174.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.6 m -45.63 110.33 0.24 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.488 0.661 . . . . 0.0 112.405 -174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 HD21 HG23 ' A' ' 20' ' ' THR . 26.8 tp -96.75 11.47 35.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.585 -177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.482 ' HG2' ' OH ' ' A' ' 56' ' ' TYR . 37.0 mtt180 -66.64 6.96 0.4 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.431 -1.258 . . . . 0.0 112.046 -177.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -73.79 -14.02 61.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 168.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.677 ' HG2' ' HA ' ' A' ' 21' ' ' ASN . 17.9 tttp 72.98 8.27 5.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.234 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -175.33 115.8 0.15 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 174.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.92 -38.65 1.38 Allowed Glycine 0 C--O 1.228 -0.263 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.385 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -101.94 -52.4 3.18 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 18' ' ' TRP . 21.0 t -167.13 173.94 8.68 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 177.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -70.43 8.61 0.77 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 117.818 0.281 . . . . 0.0 111.074 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.674 ' CZ2' ' HB ' ' A' ' 62' ' ' THR . 2.7 t90 -31.96 -44.23 0.08 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.804 1.242 . . . . 0.0 112.386 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.647 ' HB2' ' O ' ' A' ' 18' ' ' TRP . 0.0 OUTLIER 158.92 81.49 0.0 OUTLIER 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 175.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.506 HG23 HD21 ' A' ' 9' ' ' LEU . 10.9 m -125.54 -7.17 6.89 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.723 0.773 . . . . 0.0 110.533 -174.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.677 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 5.8 m120 -65.86 -34.32 77.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.841 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 43.06 -162.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 125.257 1.598 . . . . 0.0 114.39 172.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -139.5 116.7 11.15 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.237 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.6 tp -67.06 104.1 1.33 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.827 0.346 . . . . 0.0 110.369 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 HG12 ' A' ' 55' ' ' VAL . 91.0 mt -72.65 -43.37 63.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.307 0.575 . . . . 0.0 109.633 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 157.37 158.35 8.89 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.09 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -75.19 143.05 43.37 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -141.26 111.86 7.01 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.509 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.618 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 49.8 m -93.35 127.16 38.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.388 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.2 pt -111.95 131.35 63.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.249 0.547 . . . . 0.0 110.877 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 32' ' ' ASN . 11.1 m-20 -85.77 153.64 22.15 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.706 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' PRO . 13.6 m120 73.17 32.04 1.35 Allowed 'General case' 0 C--N 1.328 -0.368 0 O-C-N 123.97 0.794 . . . . 0.0 111.616 178.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -138.25 136.3 36.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.713 0.292 . . . . 0.0 110.875 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -106.55 160.67 15.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.587 HD23 HD12 ' A' ' 103' ' ' ILE . 25.4 tp -115.79 133.66 55.8 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.339 -178.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 102' ' ' LEU . 73.9 m-85 -108.57 156.61 19.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.778 174.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.3 t -147.11 125.61 12.42 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.877 0.37 . . . . 0.0 110.282 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.799 ' HB3' ' HG ' ' A' ' 100' ' ' LEU . 1.3 pt? -105.54 16.19 25.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.61 -25.34 25.25 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.995 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -111.67 -72.14 0.73 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' HB2' HD21 ' A' ' 38' ' ' LEU . 3.3 m-85 -82.54 128.32 67.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.266 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -93.98 103.13 0.14 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 122.779 2.319 . . . . 0.0 110.714 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 35' ' ' LEU . . . -100.94 157.41 19.19 Favored Glycine 0 C--O 1.223 -0.574 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.181 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 92' ' ' VAL . . . -140.47 145.74 37.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 117.224 0.512 . . . . 0.0 110.845 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.818 HG12 HG13 ' A' ' 92' ' ' VAL . 24.9 m -146.28 162.26 35.54 Favored Pre-proline 0 N--CA 1.468 0.451 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 20.1 Cg_endo -61.25 151.66 77.51 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.622 2.215 . . . . 0.0 112.834 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.3 -130.83 2.24 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.449 -1.06 . . . . 0.0 110.449 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -136.49 89.17 2.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.419 0.628 . . . . 0.0 109.816 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -158.87 -179.33 33.63 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 176.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.5 m -133.76 104.86 6.51 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 117.769 0.784 . . . . 0.0 111.02 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 29' ' ' SER . 61.2 t -84.22 109.48 17.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -81.36 58.45 3.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 0.0 109.88 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.605 ' HA3' ' CZ ' ' A' ' 4' ' ' PHE . . . -72.62 169.27 52.31 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.817 -169.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG3' ' HB ' ' A' ' 5' ' ' VAL . 3.8 pt-20 -121.04 114.84 22.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.27 -0.465 . . . . 0.0 109.936 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG12 HD12 ' A' ' 25' ' ' LEU . 28.0 t -86.8 129.91 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.754 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.482 ' OH ' ' HG2' ' A' ' 10' ' ' ARG . 75.2 m-85 -125.46 156.98 38.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.175 0.512 . . . . 0.0 111.461 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 57' ' ' ARG . 13.5 ttp180 -113.03 124.69 53.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.514 172.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.807 HD11 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -127.19 178.87 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.699 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.499 ' O ' HG12 ' A' ' 58' ' ' ILE . 31.8 t70 -52.6 149.55 5.87 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.627 0.251 . . . . 0.0 110.956 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 94.0 m-20 -66.22 -48.19 71.37 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.884 -0.51 . . . . 0.0 110.779 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.58 -34.61 78.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.779 -171.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.674 ' HB ' ' CZ2' ' A' ' 18' ' ' TRP . 1.0 OUTLIER -57.97 -40.35 80.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.101 0.476 . . . . 0.0 111.034 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.807 HD23 HD11 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -66.29 -53.47 36.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.117 -177.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.72 -28.23 68.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.854 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.88 -50.89 15.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.561 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.4 -39.91 89.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.282 -0.417 . . . . 0.0 109.946 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.07 -58.31 8.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.948 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.67 -8.96 55.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.688 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 mt -86.37 -48.75 8.18 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.11 0.481 . . . . 0.0 110.77 172.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -86.52 -40.74 14.96 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.675 -171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.417 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 5.7 t -144.17 91.18 2.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.133 0.968 . . . . 0.0 111.994 -173.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -91.3 -32.1 15.84 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.429 177.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -101.78 -49.8 1.24 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.887 -173.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.58 38.71 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.181 -177.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' OE1' ' HA ' ' A' ' 71' ' ' THR . 9.2 mp0 -68.27 -40.58 81.81 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' HD1' ' HA ' ' A' ' 93' ' ' TYR . 23.7 m-85 -140.73 148.43 40.71 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.69 133.25 33.7 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.794 0.33 . . . . 0.0 111.491 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 78' ' ' ARG . 72.5 mtt180 -77.32 109.1 10.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.982 175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 90' ' ' MET . 9.3 tt0 -110.44 98.79 7.92 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -79.55 113.31 17.6 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 28.8 pt -109.04 131.11 60.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.461 0.648 . . . . 0.0 110.984 -177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.56 99.17 9.36 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.605 -178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 p -95.31 162.98 22.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.972 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.75 -16.81 46.2 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.538 2.158 . . . . 0.0 112.042 176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -97.94 2.0 48.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.902 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 118.05 158.48 10.94 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.1 m -65.75 125.8 26.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 117.207 0.504 . . . . 0.0 110.495 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.59 150.53 41.55 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.628 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -82.52 124.42 30.09 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.027 0.442 . . . . 0.0 111.384 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.402 ' HB3' ' HB3' ' A' ' 79' ' ' GLN . 27.0 ttt -110.85 131.63 54.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.373 172.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -107.8 109.51 21.08 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.09 0.472 . . . . 0.0 110.47 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.818 HG13 HG12 ' A' ' 45' ' ' VAL . 2.5 t -80.34 126.71 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 176.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.432 ' HA ' ' HD1' ' A' ' 76' ' ' TYR . 5.9 t80 -59.27 102.95 0.15 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.461 HE21 ' HA ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -87.2 -14.72 40.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.122 -170.178 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.415 ' HB3' ' HD2' ' A' ' 96' ' ' PRO . 34.8 mtm180 -84.99 164.26 42.46 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 95' ' ' ARG . 88.0 Cg_exo -48.1 115.59 1.58 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.605 2.203 . . . . 0.0 112.541 178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.536 ' HA ' HD13 ' A' ' 100' ' ' LEU . 29.2 m -86.37 -4.08 9.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.507 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -62.11 -12.3 18.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.388 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 100' ' ' LEU . . . -106.21 16.86 41.62 Favored Glycine 0 C--N 1.306 -1.128 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.173 -175.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.799 ' HG ' ' HB3' ' A' ' 38' ' ' LEU . 7.1 mp -120.82 170.84 9.09 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.33 134.22 34.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.431 HD13 ' CE1' ' A' ' 36' ' ' TYR . 50.1 tp -102.3 117.17 34.18 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.01 0.433 . . . . 0.0 111.178 -176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.587 HD12 HD23 ' A' ' 35' ' ' LEU . 59.9 mt -97.44 95.26 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 174.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.45 -22.12 41.36 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.484 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 22.2 m -70.73 -46.78 62.41 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.856 -176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' VAL . . . 98.41 -0.43 58.38 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -171.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' O ' HG21 ' A' ' 103' ' ' ILE . 6.2 m-20 -99.28 165.59 11.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.136 -0.532 . . . . 0.0 109.993 176.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -98.87 -49.21 4.63 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 173.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 26.1 mt -103.69 79.97 1.73 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 113.291 -1.777 . . . . 0.0 109.464 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -68.93 -86.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.985 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 16.0 mmm180 72.54 141.37 0.06 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.496 1.141 . . . . 0.0 112.645 170.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -38.17 -50.75 1.42 Allowed 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 112.915 -1.948 . . . . 0.0 111.776 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 26.8 tttp . . . . . 0 N--CA 1.461 0.087 0 CA-C-O 121.656 0.741 . . . . 0.0 110.435 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.672 ' HB3' ' HG ' ' A' ' 63' ' ' LEU . 21.2 ttm . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.545 ' NH1' ' HA3' ' A' ' 86' ' ' GLY . 98.2 mtt180 -92.05 124.24 36.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.815 0.34 . . . . 0.0 110.839 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.685 HD11 HD23 ' A' ' 63' ' ' LEU . 33.3 mt -121.2 147.18 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.568 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HE1' ' O ' ' A' ' 28' ' ' PHE . 92.3 t80 -91.07 111.1 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 172.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG11 ' HB3' ' A' ' 9' ' ' LEU . 89.1 t -90.76 102.14 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.306 0.574 . . . . 0.0 110.487 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -95.02 94.12 7.79 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.192 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 126.25 -176.04 17.6 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.724 -177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.3 t -76.04 120.97 22.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.94 0.4 . . . . 0.0 110.955 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.643 ' HB3' HG11 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -93.85 7.37 45.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.532 0.682 . . . . 0.0 110.089 175.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.9 mtt180 -80.57 17.81 1.05 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.176 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -101.37 168.25 9.65 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.877 0.37 . . . . 0.0 111.344 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -65.04 113.74 4.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.001 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 1.9 mp0 59.13 24.3 12.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.265 -175.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.19 90.16 1.11 Allowed Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.617 -172.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.665 ' HA ' ' CH2' ' A' ' 18' ' ' TRP . 17.2 m120 73.41 15.92 4.16 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 165.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.558 ' HB2' ' O ' ' A' ' 21' ' ' ASN . 13.0 p -175.64 -54.13 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.507 0.67 . . . . 0.0 110.803 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.693 ' HA ' ' O ' ' A' ' 20' ' ' THR . 73.2 t60 -69.93 10.6 0.38 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.827 -1.079 . . . . 0.0 112.076 -178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.665 ' CH2' ' HA ' ' A' ' 15' ' ' ASN . 2.4 m-90 -44.89 -52.46 8.62 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.265 0.555 . . . . 0.0 111.064 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 9.3 mtm -129.88 -47.83 1.13 Allowed 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.327 171.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.693 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 0.2 OUTLIER -81.38 -150.75 0.08 Allowed 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.501 174.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 16' ' ' SER . 6.7 m-80 -140.38 -76.48 0.32 Allowed 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB1' ' CD1' ' A' ' 56' ' ' TYR . . . 177.58 120.5 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.878 -175.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' A' ' 57' ' ' ARG . 48.2 tt0 -108.7 98.53 8.02 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.0 tp -61.6 116.26 4.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.548 -172.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.48 HD12 HG12 ' A' ' 55' ' ' VAL . 91.4 mt -85.6 -42.34 14.44 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 173.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA3' ' CE1' ' A' ' 85' ' ' TYR . . . 157.6 146.46 4.51 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.273 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.603 ' HA ' ' HA ' ' A' ' 54' ' ' GLU . 4.2 p30 -74.53 151.55 39.47 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-O 121.487 0.66 . . . . 0.0 110.443 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' O ' ' HE1' ' A' ' 4' ' ' PHE . 10.3 t80 -157.1 103.77 2.04 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.237 -174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.526 ' HB2' HG22 ' A' ' 50' ' ' THR . 23.0 p -90.94 122.95 34.06 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.654 177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 13.3 pt -103.44 125.8 57.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.308 0.575 . . . . 0.0 111.398 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 27.0 t0 -84.67 161.31 20.13 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.101 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 31' ' ' ASP . 42.1 m-80 74.06 26.47 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 111.377 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.49 147.66 43.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.85 0.357 . . . . 0.0 110.653 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 104' ' ' GLU . 41.8 mt-30 -122.85 156.0 35.49 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.297 178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 46.8 tp -117.9 135.64 53.98 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.036 -170.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -101.64 145.26 29.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.198 0.523 . . . . 0.0 111.49 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 m -108.56 106.16 16.11 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.518 172.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 41' ' ' TYR . 0.4 OUTLIER -117.2 18.8 14.42 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.039 178.636 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.75 -70.01 2.77 Favored Glycine 0 C--N 1.329 0.152 0 CA-C-N 115.628 -0.714 . . . . 0.0 113.536 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -50.9 -48.09 60.6 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.372 0.606 . . . . 0.0 110.964 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.448 ' O ' ' HG ' ' A' ' 38' ' ' LEU . 5.7 p90 -159.87 165.65 17.48 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.059 -177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.6 159.88 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.474 2.116 . . . . 0.0 112.263 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.96 138.05 6.04 Favored Glycine 0 C--O 1.223 -0.57 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 92' ' ' VAL . . . -123.79 165.59 17.05 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.81 0.805 . . . . 0.0 111.065 -174.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG12 HG13 ' A' ' 92' ' ' VAL . 35.2 m -150.88 160.35 32.4 Favored Pre-proline 0 N--CA 1.466 0.342 0 O-C-N 123.48 0.487 . . . . 0.0 110.209 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 45' ' ' VAL . 28.8 Cg_endo -66.64 128.97 20.06 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.037 1.824 . . . . 0.0 111.465 172.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.86 -120.32 0.51 Allowed Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -142.96 91.97 2.35 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.607 0.717 . . . . 0.0 110.703 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.64 164.89 32.79 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.743 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 31' ' ' ASP . 19.3 m -112.32 105.77 14.14 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 117.385 0.592 . . . . 0.0 110.446 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 29' ' ' SER . 65.0 t -82.38 117.75 28.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.523 -172.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -74.06 100.6 3.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.015 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -132.54 165.79 23.64 Favored Glycine 0 N--CA 1.442 -0.926 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.807 178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 47.6 mt-10 -125.06 136.35 53.59 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.857 -0.424 . . . . 0.0 109.857 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.48 HG12 HD12 ' A' ' 25' ' ' LEU . 41.7 t -86.67 119.8 35.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HB1' ' A' ' 22' ' ' ALA . 46.6 m-85 -122.04 159.38 27.17 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.916 0.865 . . . . 0.0 112.669 -175.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.578 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 1.2 tmt_? -112.99 114.15 26.49 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.522 176.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.446 HG22 ' HB ' ' A' ' 20' ' ' THR . 2.2 pp -119.55 177.11 3.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.058 173.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -53.74 131.14 38.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.931 0.396 . . . . 0.0 111.818 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 1' ' ' MET . 3.3 m-20 -66.65 -41.43 88.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.807 -178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.84 99.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.595 0.236 . . . . 0.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 29.4 m -54.92 -40.37 69.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.254 0.55 . . . . 0.0 110.503 175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 3' ' ' ILE . 3.0 tm? -67.57 -53.49 27.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.344 -178.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.17 -30.25 69.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.046 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -75.13 -46.97 30.9 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.417 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.401 HD23 ' C ' ' A' ' 66' ' ' LEU . 7.2 tt -61.83 -47.11 86.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.787 178.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.666 ' OD1' ' HD3' ' A' ' 78' ' ' ARG . 23.0 t70 -63.56 -42.82 98.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.508 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.53 -30.42 70.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.102 0.477 . . . . 0.0 111.297 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.0 mt -86.14 -50.53 6.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' HG2' ' HE2' ' A' ' 76' ' ' TYR . 3.1 ttt85 -85.98 -41.87 14.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.853 0.358 . . . . 0.0 111.469 -168.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.408 HG23 ' HD2' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -95.63 -83.54 0.36 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.402 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 50.5 ttp180 55.61 -75.75 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.709 0.804 . . . . 0.0 112.801 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.59 -57.54 2.43 Favored Glycine 0 N--CA 1.446 -0.69 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 157.39 63.69 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 119.817 -1.183 . . . . 0.0 114.09 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -74.77 -28.99 60.97 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 166.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.677 ' HE2' ' HG2' ' A' ' 70' ' ' ARG . 4.3 m-85 -135.89 150.72 49.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.334 -1.303 . . . . 0.0 107.936 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' HB2' ' NE2' ' A' ' 94' ' ' GLN . . . -86.45 118.13 25.68 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.081 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.666 ' HD3' ' OD1' ' A' ' 67' ' ' ASP . 82.1 mtm180 -74.43 102.61 4.5 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.215 0.531 . . . . 0.0 109.887 175.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -103.77 99.17 8.94 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.3 tp -76.79 112.34 13.27 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.524 -0.47 . . . . 0.0 109.874 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.421 ' C ' HE21 ' A' ' 82' ' ' GLN . 35.5 pt -107.09 138.79 31.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.292 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.64 HE21 ' CA ' ' A' ' 82' ' ' GLN . 0.0 OUTLIER -90.47 113.86 25.9 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.052 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 85' ' ' TYR . 33.6 p -102.71 166.71 11.47 Favored Pre-proline 0 N--CA 1.442 -0.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.159 -172.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -64.69 1.21 1.89 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.643 2.229 . . . . 0.0 111.836 173.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.486 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 32.9 m-85 -119.83 17.13 12.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.4 178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' HA3' ' NH1' ' A' ' 2' ' ' ARG . . . 115.74 -87.46 0.44 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.932 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 43.7 t -169.5 141.64 2.45 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -147.47 147.7 30.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.646 0.26 . . . . 0.0 111.238 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -83.14 120.08 25.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.59 176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.535 ' SD ' HG23 ' A' ' 92' ' ' VAL . 0.9 OUTLIER -105.16 118.65 37.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.448 176.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -95.66 109.67 21.9 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 111.487 -177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.689 HG13 HG12 ' A' ' 45' ' ' VAL . 2.3 t -93.21 138.86 19.23 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.47 ' HD2' ' CG1' ' A' ' 45' ' ' VAL . 0.0 OUTLIER -47.64 136.27 10.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.303 177.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.487 ' HB2' ' HA ' ' A' ' 76' ' ' TYR . 2.0 tp-100 -138.44 18.99 2.73 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.901 178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.746 ' HB2' ' HD3' ' A' ' 96' ' ' PRO . 2.2 mmp_? -120.85 -80.51 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 95' ' ' ARG . 34.7 Cg_endo -99.05 -86.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.231 0 C-N-CA 122.358 2.039 . . . . 0.0 116.196 -162.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.626 ' HA ' HD12 ' A' ' 100' ' ' LEU . 25.1 m 54.2 77.11 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 126.032 1.733 . . . . 0.0 112.486 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -178.46 113.82 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 113.441 -1.709 . . . . 0.0 107.885 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 90.05 20.02 44.41 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -169.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 97' ' ' VAL . 66.1 mt -119.55 165.63 14.17 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -108.56 132.15 54.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.947 0.403 . . . . 0.0 110.497 177.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.52 HD11 ' HB3' ' A' ' 34' ' ' GLN . 50.2 tp -102.49 126.89 49.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.084 -176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 106' ' ' GLY . 40.7 mt -90.09 100.07 10.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.623 ' HA ' HE21 ' A' ' 34' ' ' GLN . 27.8 mt-10 -67.37 24.01 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.618 -1.174 . . . . 0.0 114.084 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 60.7 m -163.89 -17.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.067 -0.396 . . . . 0.0 111.926 -175.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' H ' HG22 ' A' ' 103' ' ' ILE . . . 91.74 21.51 33.72 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.159 -1.019 . . . . 0.0 114.443 167.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -94.91 129.89 41.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.736 0.768 . . . . 0.0 109.288 172.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -69.45 -29.83 67.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.654 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.93 -48.01 2.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.445 -167.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.6 t70 69.33 -51.5 0.6 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.653 0.781 . . . . 0.0 111.586 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -92.92 75.48 4.81 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.045 0.926 . . . . 0.0 111.185 -177.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.21 -131.3 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 173.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.857 0.836 . . . . 0.0 110.825 -178.751 . . . . . . . . 0 0 . 1 stop_ save_